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Development of Monoaminergic Systems:
Morphogenetic Roles and Early Specification
Although monoaminergic systems (serotonin, noradrenalin and dopamine) seem
diffuse and unspecific, their actions on the refinement of the cerebral structure and
wiring are crucial. Despite an abundant literature about monoamines actions on adult
brain, little is known about monoaminergic development per se and its action on other
developing structures. In my thesis, I wanted to investigate these different aspects by
studying i) the influence of serotonin on the development of the murine somatosensory
thalamocortical system, ii) the developmental expression pattern ofmonoamine oxidase
A (MAOA) and B (MAOB): two major enzymes of degradation of monoamines and,
iii) the influence of essential molecules such as the transcription factor Pax6 or the
chemoattractive/chemorepellent molecule Netrin-1 on monoaminergic development.
Serotonin is often regarded as a powerful morphogen, however proofs of its
action are often missing. In my thesis, I demonstrated that a transient excess of
serotonin created pharmacologically by inhibition of MAOA enzyme altered the
formation in barrels of both thalamocortical axons and granular neurons in the layer IV
of the developing somatosensory cortex. Thalamocortical axon alterations are
characterised by a state of exuberance. A small family of molecules, neurotrophins has
been shown to control early events in the developing thalamus and cortex such as cell
survival, neurite outgrowth, migration, or dendritic and axonal morphologies. I showed
that trkB, an essential neurotrophin receptor was expressed in the cortex during the
critical period of serotonin sensitivity. Analysis of mice lacking trkB showed subtle
alterations in the thalamocortical projections, suggesting that trkB is not essential in the
establishment of the barrel field. By obtaining mice lacking MAOA and trkB, I showed
a synergistic altered phenotype in the thalamocortical projection, suggesting that in
normal conditions serotonin and trkB signalling act synergistically in the refinement of
the somatosensory thalamocortical map.
I also studied the spatio-temporal pattern of MAOA and MAOB and showed
striking features during early development: MAOA is tightly linked to the
serotoninergic and catecholaminergic phenotypes and MAOB is tightly linked to the
glial cell lineage.
Analysis of mice lacking Pax6 showed that Pax6 was not essential to
monoaminergic development but this study revealed that Netrin-1 was potentially
important to the axonal pathfinding of dopaminergic neurons. Analysis of mice lacking
Netrin-1 or its receptor deleted in colorectal cancer (DCC) confirmed that Netrin-1 is
important but not essential for the axonal guidance of subsets of dopaminergic neurons.
More interestingly, this study revealed that the interaction between Netrin-1 and DCC




5, 7-DHT : 5, 7-dihydroxytryptamine
5-HIAA : acide-5-hydroxyindole acetic
5-HT : serotonin




5n : trigeminal motor nucleus
7n : facial nucleus
1 On : dorsal motor vagus nucleus
12n : hypoglossal nucleus
A1-A17 : catecholaminergic groups
A1 : primary auditory area
A6 : locus coeruleus
A6s : locus subcoeruleus
A8 : retrorubral field
A9 : substantia nigra
A10 : ventral tegmental area
A13 : zona incerta
A15d : bed nucleus
A15v : supraoptic nucleus
A : adrenaline/adrenalin
AA : anterior amygdala
AADC : aromatic L-amino acid decarboxylase
AB : anterobasal nuclei
ac : anterior commissure
ACB /Acb : accumbens nucleus
ACC : nucleus accumbens
ACh-E : acetylcholinesterase
ACX : archicortex
AEP : entopeduncular area
AH : anterior hypothalamus
Amb : ambiguus
AMPo : anterior medial preoptic nucleus
a-MPT: alpha-methylparatyrosine
AP : alar plate
AS : anterior snout
B1-B9 : serotoninergic groups
B1 : raphe pallidus
B2 : raphe obscurus
B 3 : raphe paragigantocellularis
B4 : raphe magnus
B5 : raphe pontis
B6-B7 : raphe dorsalis
B8 : raphe centralis superior
B9 : nucleus tegmenti reticularis ponti
BDNF : brain derived neurotrophic factor
BMP : bone morphogenetic protein
BP : basal plate
BrdU : bromodeoxyuridine
BST : bed nucleus of stria terminalis
C1-C3 : putative adrenergic neuronal groups
CA : catecholaminergic
CB : cerebellar primordium
cc : corpus callosum
Ce : central amygdaloid nucleus
CCK : cholecystokinin
CGEL : caudal ganglionic eminence, lateral part
CGEM : caudal ganglionic eminence, medial part
Ch(7): cholinergic group (7)
Chp : choroid plexus
Cing : cingulate cortex
CL : central thalami nucleus
CM : central median thalamic nucleus
CNS : central nervous system
CO : cytochrome oxidase
Coll: collicullus
COMT : catecholamine-O-methyltransferase
cs : superior colliculus
CTX : cortex




DCC : deleted in colorectal cancer
DMH : dorsal medial hypothalamic nucleus
DPMe : deep mesencephalic nucleus
dt /DT : dorsal thalamus




FAD : flavine adenine dinucleotide
FGF : fibroblast growth factor
FP : floor plate
FP : fore paw
fr : fasciculus retroflexus
fx : fornix bundle
GABA : gamma aminobutiric acid
GDNF : glial derived neurotrophic factor
GNRH : growth hormone-realising hormone
Hb : habenula
HCC : hypothalamic cell cord
HDC : histidine decarboxylase
HP : hind paw
HPLC : high-pressure liquid chromatography
HVA : homovanylic acid:
ic : internal capsule
Ic : inferior colliculus
IMAO : monoamine oxidase inhibitor
IMD : intermediate thalamic nucleus
ION : infraorbital nerve lesion
ITA : intermediate telencephalic territory
Is : isthmus
LC/Lc : locus coeruleus
LD : lateral dorsal thalamic nucleus
L-DOPA : L-dihydroxyphenylalanine
LGE : lateral ganglionic eminence
LH : lateral hypothalamus
LH : luteinizing hormone
LL : lower lip
LL : lateral lemnisc
LTP : long term potentiation
Ml : primary motor area
M2 : secondary motor area
MA : mammillary region
MAO : monoamine oxidase
MAOA : monoamine oxidase type A
MAOB : monoamine oxidase type B
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mb : mammillary body
mes : mesencephalon
mfb : medial forebrain bundle
MGE : medial ganglionic eminence
mGlur : metabotropic glutamate receptor
MHPG : 3-methoxy-4-hydroxyphenylglycol
mlf: medial longitudinal fasciculus
mm : mammillary body
MPTP : l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine
mtg : mammilotegmental tract
NA: noradrenaline
NGF : nerve growth factor
MHb : medial habenula
NMDA : N-methyl-D-aspartate
NMN : normetanephrin
MnPO : medial preoptic nucleus
MnR : raphe median nucleus
NPC : posterior commissure nucleus
NPY : neuropeptide Y
NT-(4) : neurotrphin (4)
OB : olfactory bulb
oe : olfactory epithelium
olf: olfactory nerve
OR : optic recess
OT : olfactory tubercle
OXT : oxytocin
pl-p6 : prosomeres; pc posterior commissure
PAVH : paraventricular hypothalamic nucleus
pc/ PC : posterior commissure
PC : paracentral thalamic nucleus
PCPA : parachlorophenylethylamine
PEP : posterior entopeduncular area
PF : prechordal floor plate
(S)PF : (sub)parafascicular thalamic nucleus
pir: piriform cortex
PLCpi : phospholipaseC-pi
PM : premotor area
PMBSF : posteromedial barrel subfield
PNMT: phenylethanolamine-N-methyltransferase
PNS : peripheral nervous system
POA : anterior preoptic area
POP : posterior preoptic area
PP : prechordal plate
PR : parietal rostral field
pt/PECT : pretectum
ptc : pretectal commissure
PV : paraventricular thalamic nucleus
PV : ventral sensory area
rl-r8 : rhombomeres
RCH : retrochiasmatic
Re : reuniens nucleus
REM : rapid eye movement sleep
RD : Raphe dorsal
Rh : rhomboid nucleus
RMg : Raphe magnus nucleus
Rsg : retrosplenial cortex
RP : roofplate
51 : primary somatosensory cortex
52 : secondary somatosensory cortex
sc : superior colliculus
SCF1: suprachiasmatic
SDFI : succinate dehydrogenase
SE : septum
SERT : serotonin transporter
Shh : sonic hedgehog
stm : stria medullaris
SN : substantia nigra
SNc : substantia nigra pars compacta
SNr : substantia nigra pars reticulata
SPV : supraoptico-paraventricular region
StFly : striato-hypothalamic nucleus
Str : striatum
sut/sth: subthalamic nucleus
tc/TC : thalamocortical axons
te : thalamic eminence
tect: midbrain tectum
TH : tyrosine-hydroxylase
TpOH : tryptophan hydroxylase
TrkB : tyrosine kinase receptor type B
Trp : tryptophan
TTX : tetrodotoxin
TU : tuberal hypothalamic region
V1 : primary visual area
V2 : secondary visual area
VB : ventrobosal thalamic nucleus (also VP)
VIP : vasopressin
VMAT : vesicular monoamine transporter
vt/VT : ventral thalamus
VTA : ventral tegmental area
Zi : zona incerta
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1 The serotoninergic system
In the 1940s, scientists were aware of a substance present in the serum that
induced powerful contractions of smooth muscles. In the 1970s, with the work of
Page and his collaborators, a substance proposed to be a possible cause of high blood
pressure (a serum tonic factor; Page, 1968, 1976) was isolated from platelets. At the
same time, in Italy, a molecule present in high concentration in the intestinal mucosa
and that caused contractions of gastrointestinal smooth muscle was characterised
(Espaner, 1963). The molecule isolated from blood platelets was named "serotonin";
that from the intestinal tract was called "enteramine". Both molecules were purified,
crystallised and shown to be the same indolamine, 5-hydroxytryptamine (5-HT). In
the brain, 5-HT is a neurotransmitter implicated in various physiological and
behavioural functions such as sleep, modification of circadian rhythms, nociception,
eating, thermoregulation, arousal and sexual behaviour.
1.1 Localisation
The distribution of serotonin-containing cell bodies and their projections were
originally described using fluorescent histochemical methods, first established by
Falck and his collaborators (Swedish school) in the 1970s. In 1968, Falck and his
collaborators first located the raphe nuclei and their projections (Dahlstrom and
Fuxe, 1964; Fuxe et al, 1968). Later, the fluorescent method was supplanted by more
sensitive immunohistochemical methods using antibodies generated against serotonin
or tryptophan hydroxylase (TpOH). Using these techniques, Steinbusch and his
collaborators provided a precise mapping of serotoninergic neurons and their
projections (Steinbusch et al., 1978; Steinbusch, 1981).
Serotonin-containing cell bodies constitute the raphe nuclei and are classically
distributed in nine groups (B1-B9), where B1 is the most posterior group and B9 the
most anterior (Moore, 1981; Steinbusch and Nieuwhuys, 1983). Most of the
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serotoninergic innervation arises from the most rostral components of the raphe:
from the raphe dorsal (B6-B7) and from the raphe median (B5-B8) (Dahlstrom and
Fuxe, 1964). The projections of these two raphe nuclei do not overlap completely
and a relative specificity in the area of projection of each was reported. The
innervation of the hippocampus arises mainly from B8 (fiber type M; Jacobs et ah,
1974) whereas the innervation of the striatum arises principally from B7 (fiber type
D). The serotoninergic innervation of the cortex arises from both nuclei but the
projections of the neurons of these two groups are well separated (Tohyama et ah,
1980). The posterior nuclei B1-B3 (overall B3 or nucleus of the raphe magnus)
mainly project to the medulla. In addition, diffuse 5-HT containing terminals are
found all over the central nervous system (cortex, hippocampus, striatum,
accumbens, substantia nigra, hypothalamus) (Doucet et al., 1988). Figure 1-1
provides a sagittal view of the different serotoninergic groups in adult rodent.
1.2 Metabolism
5-HT does not cross the blood brain barrier and the brain contains only 1-2%
of the entire amount of 5-HT contained in the body (Bradley, 1989). In the central
nervous system (CNS), 5-HT synthesis is located exclusively in serotoninergic
neurons. In the peripheral nervous system (PNS), neurons of the gastro-intestinal
plexus, the body of the pineal gland and enterochromaffin cells produce 5-HT
whereas platelets only take up 5-HT.
The precursor of 5-HT is the essential amino acid tryptophan. In the blood,
90% of tryptophan is linked to serum-albumin and 10% of tryptophan is free to cross
the brain blood barrier. Tryptophan is accumulated in serotoninergic neurons by a
non-specific aminergic transporter (used by several uncharged amino acids). At this
step, a competition between uncharged amino acids is possible.
In serotoninergic neurons, tryptophan is hydroxylated by tryptophan
hydroxylase (TpOH) into 5-hydroxytryptophan that is then decarboxylated by the
aromatic amino acid decarboxylase (AADC). AADC is not specifically located in
serotoninergic neurons.
9+
In serotoninergic cell bodies, 5-HT is stored into vesicles by a Ca -
dependent mechanism. Vesicles are then transported to dendritic and axonal
terminals. Inside the vesicles, 5-HT is protected from the oxidative action of
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Cerebellum
Figure 1-1 Serotoninergic cell groups within the rodent brainstem. Bl, nucleus raphe
pallidus; B2, nucleus raphe obscurus; B3, nucleus paragigantocellularis; B4, nucleus
raphe magnus; B5 nucleus raphe pontis; B6 and B7, nucleus raphe dorsallis; B8, nucleus
centralis superior; B9, nucleus tegmenti reticularis pontis and adjacent tegmentum.
Serotoninergic cell groups that belong to the caudal group appear in red whereas
serotoninergic cell groups that belong to the rostral group appear in green. (From Kandel,
Schwartz, and Jessel, (1991), third edition).
monoamine oxidase A (MAOA). Then, 5-HT is released into the synaptic cleft upon
stimulation. 5-HT could be taken up into the terminals that released it by the
serotonin transporter (SERT) located on the membrane. SERT is mainly located on
serotoninergic neurons and platelets (Blakely et al., 1991; Hoffman et ah, 1991;
Lesch et ah, 1993). However, during development SERT is also located on non-
aminergic neurons (Hansson et ah, 1998; Lebrand et ah, 1998). This is consistent
with the unexpected role of serotonin in the general development of the brain (i.e.:
the thalamocortical system). Finally, 5-HT is either degraded enzymatically by
MAOA to 5-hydroxyindole acetic acid (5-HIAA), or stored again in synaptic
vesicles. 5-HIAA is the primary metabolite of serotonin and is excreted in urine. The
brain accounts for only 5% of body production of 5-HIAA. Dosages of 5-HIAA
concentration in urine offer a good evaluation of the metabolism of 5-HT when
pathological alterations of the serotoninergic systems are suspected. Figure 1-2
illustrates these metabolic steps.
Several mechanisms contribute to the regulation of serotonin synthesis.
Serotoninergic neurons are sensitive to changes in plasma levels of tryptophan, and
thus dietary changes can regulate serotonin levels in the brain. Increases in
intracellular serotonin levels do not significantly alter serotonin synthesis in vivo.
Short-term requirements for increases in serotonin synthesis appear to be
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accomplished by Ca -dependent phosphorylation of TpOH. In contrast, situations
which require a long-term increase in serotonin availability appear to induce TpOH
synthesis.
1.3 Receptors and transduction pathway
Seven subtypes of serotonin receptors (5HT1-5HT7) have been identified, with
further subdivision of the 5-HT1 subtype. With the exception of 5-HT3 receptor,
which is ionotropic, all 5-HT receptors exhibit the typical seven transmembrane-
spanning segments, and are all coupled to G proteins to exert their effects. They
either modulate the activity of an enzyme linked to the membrane (adenylate cyclase,
phospholipase C, phospholipase A2) or an ionic channel (Hoyer et al., 1994). For
example, 5-HTla, 5-HTlb, 5-HTld and 5-HT4 either activate or inhibit adenylate
cyclase and 5-HTlc and 5-HT2 receptors preferentially stimulate the activation of
phospholipase C to produce increased levels of diacylglycerol and inositol 1,4,5-
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triphosphate. 5-HTla, 5-HTlb, 5-HTlc, 5-HTld have high affinity for 5-HT whereas
5-HT2 and 5-HT4 have 200-500% less affinity for 5-HT than the first group.
Serotonin receptors can also be separated into two groups according to their gene
structures. 5-HTlc and 5-HT2 are derived from genes that contain multiple introns.
In contrast, 5-HT1 is encoded by a gene lacking introns. Interestingly, 5-HTla is
more closely related to the (3-adrenergic receptor family than to the other members of
the 5-HT receptor family. This helps to explain pharmacological results suggesting
that 5-HTla and 5-HTlb can bind certain adrenergic antagonists.
In the CNS, serotonin receptors are generally located post-synaptically. In
addition, 5-HTla, 5-HTlb and 5-HT Id are located on serotoninergic neurons
themselves and the stimulation of these so-called "autoreceptors" inhibits the
activity, the synthesis and the release of 5-HT (De Montigny et ah, 1992).
1.4 Some biological effects of serotonin
Numerous pharmacological studies have elucidated the role of 5-HT in the
modulation of a large number of stimulatory signals and in the coordination and the
organisation of appropriate behaviours. Particularly, it was suggested that 5-HT plays
a role in restraint of emotions such as fear, distress, depression and anguish (Vogt,
1982). Indeed, in several psychological disorders, sleep, circadian rhythms, mood,
food intake, thermoregulation and sexual behaviour are altered (Meltzer and Lowy,
1987) and these functions are highly related to disorders of the serotoninergic
system.
A role of 5-HT in the regulation of the mood was also strongly suggested. Studies
of depressed (Shopsin et ah, 1976; Delgado et al; 1990) or normal patients (Young et
ah, 1985; Smith et ah, 1987) have shown that decreased levels of 5-HT in the brain
are associated with mood disorders. Regimes low in tryptophan lead to slight
depression in normal patients (Young et ah, 1985; Smith et ah, 1987) and lead to
severe depression in patients already depressed before the regime (Smith et ah, 1987)
Another characteristic feature of depression is the alteration of sleep. A latency in
the state of sleep called rapid eye movement (REM) sleep is often observed in
depressed patients and this was proposed to be due to a decrease of serotoninergic
activity (Fornal and Radulavaki, 1983; Reyes et ah, 1983). However, the cholinergic
system may also be implicated in this symptom (Sitaram et ah, 1982) and REM
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alteration is observed in numerous psychiatric disorders not directly linked with
alteration of 5-HT levels.
The alterations of circadian rhythms (Wehr and Goodwin, 1981) and of
temperature regulation (Avery et ah, 1982) observed in some depressed patients was
suggested to be linked with perturbations of regulatory mechanisms in the
suprachiasmatic nuclei. The suprachiasmatic nuclei have been shown to be strongly
innervated by serotoninergic fibers (Moore et ah, 1981). In addition, links were
established between perturbation of serotoninergic systems and seasonal affective
disorders, which are characterised by frequent periods of hypersomnia and boulimia
in winter (Jacobson et ah, 1987).
5-HT also plays an important role in motor function (Modigh et ah, 1971),
memory (Altman et ah, 1984; Cross et ah, 1988) and aggression (Valzelli et ah,
1981; Cases et ah, 1995). The existence of a transgenic mouse strain in which high
levels of serotonin and aggression are associated provides further evidence for the
role of 5-HT in the regulation of this behaviour (Cases et ah, 1995).
2 The Dopaminergic system
For a long time, before the work of Carlson (Sweden, 1958), dopamine (DA)
was only considered as an intermediate metabolite of the noradrenaline (NA)
synthesis pathway. Because elevated DA levels were detected in the striatum even in
the absence ofNA, and because of its depletion due to reserpine (which antagonises
the neuronal storage of amines into vesicles) DA was finally suggested to play a role
as a neurotransmitter. Several studies have demonstrated its role as neurotransmitter,
and today DA is considered as one of the most important and well-known
neurotransmitters due to the diversity and importance of its functions and the number
of pathologies in which it is implicated.
2.1 Localisation
In the CNS, dopaminergic neurons are classically organised in five systems:
the tubero-infundibular and incerto-hypothalamic systems (A11-A14), the nigro-
striatal system (A9), the meso-limbic (A10), the meso-striatal (A10) and the meso-
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cortical (A10) systems (Bjorklund and Lindvall; 1984; 1986). The definition of these
systems relies on the knowledge of their main area(s) of projection(s).
Nigro-striatal and meso-striatal systems include DA neurons of the substantia
nigra (SN; A9) and of the ventral tegmental area (VTA; A10) which project to
several striatal areas (the caudate, the globus pallidus, the accumbens, the olfactory
tubercle and the stria terminalis). Meso-limbic and meso-cortical systems include
neurons of the VTA which project to the limbic (i.e.: septum, locus coeruleus,
habenula) and cortical areas. In addition, three discrete nuclei were described: A15
(dorsal and ventral preoptic areas), A16 (olfactory tubercle) and A17 (retina). Figure
1-3 provides a sagittal view of the different dopaminergic groups in adult rodent.
2.2 Metabolism
Like other aminergic neurotransmitters, DA does not cross the brain-blood
barrier. By contrast its precursor, tyrosine, crosses the brain blood barrier through an
energy-dependent uptake process common to large neutral amino acids. The
cytoplasmic enzyme, tyrosine hydroxylase (TH), catalyses the transformation of
tyrosine to L-dihydroxyphenylalanine (L-DOPA). Under basal conditions, TH is the
rate-limiting enzyme for DA synthesis and its physiological catalytic capacities are
maximal. After TH, AADC decarboxylates L-DOPA and forms DA. AADC is not a
rate limiting enzyme. After its synthesis, DA is actively concentrated by the vesicular
monoamine transporter into vesicles. In the vesicles DA is protected from the
oxidative activity of monoamine oxidases (MAOs) which could transform DA to
DOPAC.
Several mechanisms are involved in the elimination of DA in the synaptic
cleft: i) its uptake by DA terminals through specific DA transporters (Shimada et al.,
1991; Kilty et al., 1991; Giros and Caron; 1993), ii) its capture by neighbouring glial
cells, or iii) its inactivation by catecholamine-O-methyltransferase (COMT), into 3-
MT (3-methoxytyramine). The combination of COMT and MAO leads to the
formation ofhomovanylic acid (HVA). Figure 1-4 sums up these steps.




Figure 1-3 Dopaminergic cell groups within the rat brainstem. A, The two major
dopaminergic cell groups in the midbrain. The mesostriatal and mesolimbocortical
systems are located in A8 (retrorubral nucleus), A9 (substantia nigra), and A10 (ventral
tegmental area). B, Other dopaminergic cell groups of the central nervous system. Areas
A11-A14 are the diencephalic dopaminergic cell groups, including the
tuberohypophyseal incertohypothalamic and medullary periventricular neurons; area A15
includes cells in the dorsal and ventral preoptic areas and the hypothalamus; area A16
contains olfactory bulb and, area A17 the retinal dopaminergic neurons. (Adapted from
Cooper, Bloom, and Roth, 1986)


































Regulation of TH expression is relatively complex and differs between
species. In humans the TH gene gives rise to four TH mRNAs through alternative
splicing, resulting in four TH isoforms (Nagatsu, 1995). By contrast, in monkey two
TH isoforms are present, whereas in rat a single form of TH mRNA is detected. The
different forms of TH in human may be associated with differences in activity of the
enzyme, although this association remains unclear. TH function is determined by two
factors: changes in enzymatic activity (the rate at which the enzyme converts the
precursor into its product) and changes in the amount of the enzyme present. The
regulation of the enzymatic activity is due in part to the phosphorylation of the
enzyme which takes place at four different serine sites at the N-terminus of the
protein. These residues are phosphorylated differently by different kinases. A second
means of regulation of the enzymatic activity is through end-product inhibition:
catecholamines can inhibit the activity of TH through competition for the required
pterine cofactor of the enzyme.
An increased demand for catecholamine synthesis can be met by inducing TH
protein or by activating (by phosphorylation) the enzyme. For instance, increase in
NA synthesis in noradrenergic neurons of the locus coeruleus is accomplished
primarily by increasing gene expression. In contrast, TH mRNA levels do not vary in
dopaminergic neurons of the substantia nigra. In these neurons, TH synthesis is
changed primarily by altering existing enzyme activity (post-translational events).
(Glovinsky et al., 1976; Kumer and Vrana, 1996)
TH enzymatic activity requires the presence of a biopterin cofactor and Fe .
Because the levels of this cofactor are non-saturating under basal conditions, levels
of cofactor are significant in regulating TH activity. Indeed, a genetic defect in the
gene encoding GTP-cyclohydroxylase 1, the rate limiting enzyme in the synthesis of
the biopterin cofactor, has been associated with a neurological disorder called dopa-
responsive dystonia in which patients are impaired in specific movements (Ichinose
et al., 1994).
Recently, the study of the TH promoter has shown the existence of distinct
enhancer elements directing the region-specific expression of TH (Liu et al., 1997).
For instance, a hypothalamus regulatory domain and a midbrain-specific element
were located between -2.5 and -3.4kb and -0.8 and -5.5kb of the rat promoter
respectively (Sakurada et al., 1999).
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2.4 Receptors and transduction pathway
At least six types of DA receptors have been identified: Dl, D2a, D2b, D3,
D4, D5 and several isoforms exist for each receptor. All these receptors belong to a
superfamily of seven helix transmembrane receptors coupled to a G protein. Dl and
D5 are coupled with a Gs protein which increases cAMP by stimulating an adenylate
cyclase. Dl receptors are located in neurons of the striatum and D5 receptors are
located in cortical and hippocampal neurons. D2 and D4 receptors are located on
neurons of the limbic system, in the accumbens, the hippocampus, the cortex, the
caudate, the amygdala and the dopaminergic neurons of the substantia nigra. D2a
receptors are coupled with a Gi protein, which inhibits adenylate cyclase and D2b
receptors are coupled with a Gk protein, which stimulates the metabolism of
phosphatidylinositol. D2a receptors are located on axonal terminals and on the cell
bodies of dopaminergic neurons where they act as inhibitory autoreceptors. D3 and
D4 receptors are mostly expressed in the limbic system and in the cortex.
2.5 Some biological effects of dopamine
Dopaminergic interneurons projecting over very short distances exert a
neuromodulatory action on sensory input. This includes the interplexiform amacrine-
like neurons, which link inner and outer plexiform layers of the retina and the
periglomerular dopamine cells of the olfactory bulb which link mitral cell dendrites
in separated adjacent glomeruli. For instance, it was shown that odor learning
increases dopamine levels in the olfactory bulb, whereas odor deprivation increases
D2 receptor density present on olfactory nerve terminals (Coopersmith et al., 1991).
In "intermediate length systems" (tuberohypophysal, tuberoinfundibular
incertohypothalamic and periventricular systems) TH has been shown to be colocalised
with several transmitters including growth hormone-realising hormone (GNRH),
cholecystokinin (CCK), vasopressin (VIP), gamma aminobutiric acid (GABA/GAD),
neuropeptide Y (NPY), enkephalin (ENK) and oxytocin (OXT) and, to play a role in
the release of several transmitters (Tillet, 1991). The tubero-infundibular system
participates in the regulation of the release of prolactin, luteinizing hormone (LH)
and growth hormone. For instance, in this system, noradrenaline suppresses pulsatile
release of LH in ovariectomized females rats, but stimulates the LH secretion in
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oestrogen treated animals. During the preovulatory LH surge, noradrenaline and
adrenaline (from A1/A2 group) stimulate the activity of LHRH neurons (Weiner et
al., 1988). Dopamine (from A13/A14 groups) inhibits pulsatile release of LH with or
without steroids (MacKenzie et al., 1988). In contrast to LH secretion prolactin is
tonically inhibited by dopamine release from the tubero-infundibular system (Fuxe et
al., 1969). In turn dopaminergic neuron activity is influence by prolactin. DA has
also been directly implicated in promoting the release of vasopressin, oxytocin and
corticotropin releasing factor from the supraoptic nucleus and the periventricular
hypothalamic nucleus.
Systems formed by neurons projecting toward long distances, including the
nigro-striatal, meso-limbic and meso-cortical systems have been extensively studied
due to their implication in several diseases (see below). The nigro-striatal system is
implicated in the coordination of voluntary movements. Meso-limbic and meso-
striatal systems are implicated in the regulation of emotional behaviour, wakefulness
and the initiation of voluntary movements. The meso-cortical system participates in
cognition, attention, social behaviour and the organisation ofmemory
2.6 Dopamine and CNS pathologies
Parkinson's disease was the first illness associated with a lack of a specific
neurotransmitter. In 1817, James Parkinson described motor disorders generated by
an illness, which is nowadays associated with his name. Symptoms of Parkinson's
disease are best characterised by: i) rhythmic trembling while at rest, ii) difficulties
in the initiation of spontaneous movement (akinesia), iii) a very slow performance in
voluntary movements and iv) muscle rigidity (bradykinesia). In the sixties, by
studying the brains (post-mortem) of patients who died from Parkinson's disease,
Oleh Hornykiewicz found decrease levels of 5-HT, NA and most importantly DA in
those brains. Further, in 1966 Hornykiewicz demonstrated that brains of patients who
died of Parkinson's disease displayed a 90% loss of dopaminergic neurons of the
substantia nigra (Hornykiewicz, 1966). Extensive studies of human Parkinson's
disease and of animals with dopaminergic-depleting brain lesions show that
dopaminergic fibers of the nigro-striatal bundle are critical for initiation of voluntary
movement. The fibers appear to mediate a non-specific component of arousal that is
common to all motivated behaviours. The etiology of Parkinson's disease is
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complex. Several genetic or epigenetic predispositions have been pointed out as key
factors involved in the degeneration ofmesencephalic dopaminergic neurons.
The fact that antipsychotic drugs block several dopaminergic receptors
suggested that an excess of dopaminergic transmission could be associated with
some schizophrenic symptoms. Indeed, indirect evidence strengthens this idea. First,
the use of drugs increasing DA levels such as L-DOPA, cocaine or amphetamines
could lead in some cases to psychotic states which resemble to some extent paranoic
or schizophrenic states. Second, the post-mortem analysis of brains of patients
suffering from schizophrenia displayed an increase in D2 receptors in the caudate
and the accumbens (Kirch and Weinberger, 1986). This finding was corroborated by
positron emission tomography in living patients (Wong et al., 1986). In fact, several
models for schizophrenia in which DA plays a key role have been established. One
of them implicates a defect of meso-cortical activity in the frontal lobe leading to the
loss of the inhibitory feed-back of the frontal lobe on the meso-limbic system and
limbic areas (Weinberger, 1987).
3 The Noradrenergic and Adrenergic systems
NA and adrenaline (A) are the oldest neurotransmitters known. NA acts as a
neurotransmitter in the CNS and in the PNS and as an hormone in the adrenal. NA is
implicated in various functions from the control of blood pressure to arousal and
sleep.
3.1 Localisation
In the CNS, noradrenergic and adrenergic cell bodies are found in two main
locations: i) in the region of the pons, at the level of the locus coeruleus (LC) and
subcoeruleus (A5, A6, A7), ii) in the medulla at the level of the reticular nuclei (Al
and CI) and in the nuclei of the solitary tract (A2 and C2) (Moore and Bloom, 1979).
LC projects widely to the cortex, the hippocampus, the amygdala, the septum, the
thalamus, the hypothalamus and the medulla (Loughlin et al., 1986). Figure 1-5
provides a general overview of the main noradrenergic projections arising from the
LC. These neurons display an impressive number of collaterals. The noradrenergic
groups Al and A2 and their projections are partly mixed with the adrenergic groups
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Figure 1-5 Summary diagram of the projections of the locus coeruleus in the rat.
AP-VAB, ansa penduncularis-ventral amygdaloid bundle system; BS, brain stem; C,
cingulum; CC, corpus callosum; CER, cerebellum; CTT, central tegmental tract; CTX,
cerebral cortex; DPS, dorsal periventricular system; DTB, dorsal tegmental bundle; EC,
external capsule; F, fornix; H, hypothalamus; HF, hippocampal formation; LC, locus
coeruleus; ML, medial lemniscus; MT, mammilothalamic tract; OB, olfactory bulb; PC,
posterior commissure; PT, pretectal area; RF, reticular formation; S, septal area, SC,
spinal cord; SM, stria terminalis; T, tectum; TH, thalamus. (From Kandel, Schwartz, and
Jessel, 1991, third edition; adapted from Moore and Bloom, 1979).
(CI and C2). A1 and CI targets play an important role in the control of vegetative
functions (regulation of the blood pressure, the heart rate and respiration frequency,
of some neuro-hormonal secretions such as adrenocorticotrop hormones and growth
hormone).
3.2 Metabolism
A and NA are synthesised from tyrosine, which is actively taken up by
catecholaminergic neurons. Three enzymes: TH, AADC and dopamine-P-
hydroxylase (DBH) are necessary for the synthesis of NA. Finally the conversion of
NA to A is made by phenylethanolamine-N-methyltransferase (PNMT). The first two
steps are done in the cytoplasm and lead to DA synthesis. The final step for NA or A
synthesis takes place in the synaptic vesicles where DBH and PNMT are located. DA
is actively taken-up and concentrated into vesicles by the vesicular monoamine
transporter. Nerve terminals are depolarized by a calcium-dependent mechanism and
vesicular contents are released into the synaptic cleft (NA) or into the blood
(adrenal).
Several mechanisms are required for NA degradation. In the CNS, the most
important event is the specific re-uptake of NA by terminals: this is an active step
involving the specific NA transporter located on the membrane (Pacholczyk et al.,
1991). In neurons (pre or post-synaptic) or glial cells, MAOA and COMT degrade
NA to metabolites such as normetanephrin (NMN) and 3-methoxy-4-
hydroxyphenylglycol (MHPG). Figure 1-6 sums up the different steps involved in A
and NA degradation.
The regulation of DBH, like that of AADC, is less understood than that of
TH. However, it now appears that conditions that increase the activity of the locus
coeruleus noradrenergic neurons increase TH activity, DBH (rather than TH)
becomes saturated and is the rate limiting step in catecholamine synthesis (Scatton et
al., 1984). This results in the accumulation of DA and acidic dopamine metabolites,
which are then released from noradrenergic neurons.
3.3. Receptors and transduction pathway
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At least four types of receptors for NA have been identified: al, a2, (31 and
(32, with several isoforms for al (3), a2 (3), and (31 (2). These receptors belong to
the superfamily of receptors coupled with a G protein (Jonowski and Sulser, 1987). (3
receptors are positively coupled with a Gs protein, which stimulates adenylate
cyclase activity. They are expressed in the cortex and the cerebellum, pi receptors
are expressed in neurons whereas P2 receptors are expressed in glial cells, al
receptors are coupled with a Gp protein, which increases phospholipase C activity.
They are widely located in the brain (postsynaptically), in blood vessels (causing
vasoconstriction) and in the spleen. a2 receptors are negatively coupled with a Gi
protein, which inhibits adenylate cyclase activity. They are widely expressed in the
brain and are mainly presynaptic.
3.4 Some biological effects ofNA in the CNS
Biological effects of NA are mostly inhibitory: stimulation of the LC or
iontophoretic injections of NA induce a decrease of the spontaneous activity of
neurons. Conversely, NA potentiates the neuronal responses to auditory, visual and
nociceptive stimulations. NA amplifies signals coming from the periphery over the
background generated by the spontaneous activity of the neurons. This role is
important in attention and arousal. Conversely, LC is in relative rest when only
vegetative tasks or tasks related to species preservation are performed. During the
state of REM sleep, LC neurons are actively suppressed, and with the end of REM
sleep they show activation by novel sensory events. LC activation has been shown to
be positively correlated with arousal.
3.5 Depression and noradrenergic and adrenergic systems
Evidence for the role of NA systems in depression are not direct. Most
antidepressant drugs increase the half-life of monoamines, either by inhibiting their
uptake (imipramines), or by decreasing the degradation of monoamines (monoamine
oxidase inhibitors). Modifications in adrenergic receptors or in NA levels were
observed in depressed patients, but results are often contradictory. Recently, the
pharmacological administration of an antagonist of the a2 adrenoreceptor
(raclopride) with or without a D2/3 dopamine receptor antagonist (idazoxan) has
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shown the synergistic action of these two antagonists on cortical dopamine output
and has suggested a role for a2 adrenoreceptor antagonists in the treatment of
schizophrenia through its antipsychotic effects (Hertel et ah, 1999).
4 Monoamine oxidases
4.1 Introduction
Monoamine oxidases (MAOs; monoamine: 02 oxydoreductase; EC 1.4.3.4)
type A (MAOA) and type B (MAOB) are the major enzymes catalysing the oxidative
degradation of biological amines such as catecholamines and 5-HT in the CNS and
the PNS (liver, kidney, intestine). MAO also degrade xenobiotic amines such as
tyramine found in the food and p-phenylethylamine. MAO are flavoproteins located
in the external mitochondrial membrane (Weyler et ah, 1990).
In vitro, MAOA degrades preferentially 5-HT and is irreversibly inactivated
by clorgyline. In vitro, MAOB degrades preferentially P-phenylethylamine,
telemethylhistamine and benzylamine. MAOB is irreversibly inactivated by L-
deprenyl. In vitro, DA, NA, tyramine and tryptamine are common substrates for both
enzymes. In vivo, MAOA preferentially degrades 5-HT, NA and A, whereas MAOB
preferentially degrades DA, P-phenylethylamine, and telemethylhistamine in the
brain. In addition, the xenobiotic l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine
(MPTP) could be oxidised by MAOB into a neurotoxic product. In rat and monkey,
MPTP injections cause permanently symptoms observed in Parkinson's disease
(Strolin-Benedetti and Dostert; 1989; Srolin Benedetti et ah, 1991) and are used as a
model of this disease.
4.2 Localisation and organisation of genes coding for MAOA and MAOB
In human, mouse and probably most mammals, MAOs are located on the X
chromosome. In the mouse, the MAOA and MAOB genes are located in a region of
240 Kb and are organised in a "tail-to-tail" configuration with their 3' ends separated
by 50 Kb. The comparison of their genomic sequences showed that their exon-intron
organisation is identical. The hypothesis is that the two genes were derived from the
duplication of an initial ancestral gene (Grimsby et ah, 1991). Nucleotidic sequences
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show a very high homology between the two genes. In both genes, exon 12 encodes
for the sequence allowing the fixation of the flavine adenine dinucleotide (FAD), the
cofactor ofMAO activity.
Although the promoters of MAOA and MAOB are highly homologous (Shih
et al., 1993), the fixation sites for the transcription factors are not identical
suggesting that the two promoters have functionally diverged during evolution. This
would explain differences in their temporal expression and tissue distributions.
4.3 Tissue distribution ofMAOA and MAOB
Numerous studies have been done to characterise the tissue distributions of
MAO in several species including humans, primates, cats, sheeps, and rodents.
However, only few developmental data are available.
In human, MAOA and MAOB are co-expressed in most tissues, with the
exception of the placenta, which expresses only MAOA (Hsu et al., 1988; Grimsby
et al., 1990) and of the platelets and lymphocytes which only express MAOB (Bond
and Cundall, 1977). In the brain, MAOA is detected principally in noradrenergic
neurons whereas MAOB is detected principally in serotoninergic neurons (Thorpe et
al., 1987).
Luque et al. (1995) have recently shown that in the adult rat brain, the
location and level of MAO mRNA expression is in tight correspondence with the
quantity of MAO proteins. The highest level of MAOA expression is in
noradrenergic neurons. Low levels ofMAOA mRNA and protein are also reported in
serotoninergic and dopaminergic neurons in several species including rat (Kitahama
et al., 1994; Luque et al., 1995; Jahng et al., 1997). In addition, MAOA mRNA is
also detected in non-aminergic neurons of the hippocampus and the cerebral cortex
(Luque et al., 1995). MAOB mRNA and protein are principally located in
serotoninergic and histaminergic neurons, ependymal cells and Bergmann's glial
cells (Levitt et al., 1982; Kitahama et al., 1994; Luque et al., 1995; Jahng et al.,
1997). In addition, MAOB mRNA is also observed in non-aminergic neurons of the
hippocampus (CA1-2; Luque et al., 1995).
4.4 Temporal expression ofMAO
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The temporal expression of MAOA and MAOB are differently regulated
during brain development. For instance, in human foetal brain MAOA activity
precedes MAOB activity (Lewinsohn et ah, 1980) whereas MAOB activity is higher
than MAOA activity in adult brain (Garrick and Murphy, 1982).
In rodent brain, MAO activities first appear in the late stages of pregnancy
(Liu et ah, 1987). By using selective inhibitors ofMAOA or MAOB activities and
tyramine as the substrate, Mantel et ah (1976) were able to detected MAO activities
in extracts of embryonic rat brain (El 7). At this age, Mantel et ah (1976) have
estimated the level of MAOB activity to be only 2.5-3% of the total activity of
MAOA and MAOB. In mouse embryos, Melamed et ah (1990) have shown that
MAOB activity is extremely low. Interestingly, these authors have linked these
findings to developmental changes in MPTP sensitivity. MPTP damages
dopaminergic neurons of the substantia nigra and MAOB is necessary for the
activation of this toxin. When MPTP is injected to pregnant mice, a major decrease
of dopaminergic neurons is observed in the mother but not in the embryos. This
suggests that there is only a very low MAOB activity in the embryonic brain, which
could explain the resistance of embryos to MPTP (Melamed et ah, 1990).
Biochemical studies have shown that during the development of rodent brain,
MAOA and MAOB activities follow different expression patterns. MAOA activity
increases rapidly after birth and reaches a maximum by the fifteenth postnatal day
(PI5). At this age MAOB has only reached 30% of its maximal activity. In most
regions of the brain, MAOB reaches its maximum by P45 (Jourdikian et ah, 1975).
The studies of Diez and Maderdrut (1977), Yu and Hertz (1982) and Cao Danh et ah
(1984) have confirmed these results. In adult mice, in most brain regions, MAOA
activity is stable from the second to the twenty-fourth month of age. MAOB activity
increases during this period to reach a maximum at sixteen months of age (Strolin-
Benedetti et ah, 1991; Irwin et ah, 1992)
In humans, MAOA activity is very high by birth, then decreases rapidly
during the first two years of life, then remains stable during childhood and increases
again with age. By contrast, MAOB activity is very low at birth, remains stable
during childhood and increases progressively with age. The decrease of MAOA
activity during development correlates with studies showing that the 5-HIAA and
catecholamine metabolites are decreasing in the cerebrospinal fluid during the first
two years of human life (Anderson et ah, 1988). The rapid decrease of neuronal
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density associated with the increase of synaptic density (Huttenlocher, 1979) during
this period may account for this. The increase of MAOB activity during senescence
has been well established (Fowler et al., 1980; Strolin-Benedetti and Dostert, 1989).
Interestingly, it was suggested that this increase of MAOB could contribute to the
neuronal degeneration observed in Parkinson's disease (Knoll et al., 1987). Indeed,
MAOB antagonists are prescribed to Parkinson's patients (Suuronen et al., 2000). In
addition, the recent generation of a transgenic mouse strain lacking MAOB (Shih et
al., 1997) that is resistant to MPTP has clearly demonstrated the role ofMAOB in the
sensitivity to MPTP.
4.5 Monoamine oxidases and neurological and psychiatric disorders
The role of MAOB in psychiatric disorders has been studied extensively
(Fowler et al., 1982; Giller et al., 1982; Sandler et al., 1981; Von Knorring et al.,
1985; Zureick and Metzer, 1988). Most of these studies relied on measuring MAOB
activity in platelets (Murphy and Donelly, 1974) or on the observation of drug side
effects. Even though some results are contradictory, important studies have linked a
deficiency in MAOB in the platelets with some neurological and psychiatric
disorders. For instance, inherited alcoholism of type 2 is associated with a low
MAOB activity in the platelets (Oreland; 1993; Devor et al., 1993, 1994).
The role of MAOA in neurobiologic disorders has been less extensively
studied, for the reason that the diagnosis ofMAOA deficiency requires a skin biopsy
associated with fibroblast cultures (fibroblasts from normal patients possess a high
level of MAOA activity). Nevertheless, MAOA deficiency was not found in patients
suffering from delirium (Breakefield et al., 1980), schizophrenia (Giller et al., 1982),
autism or Gilles de la Tourette syndromes (Giller et al., 1980).
The first evidence showing a link between neurological disorders and MAO
deficiency were obtained by studying male patients carrying chromosomic deletions
in the region of the MAO genes. These genes are located in the same region as the
gene responsible for Norrie disease (Berger et al., 1992; Sims et al., 1992). The
deletion of the Norrie gene causes a recessive illness characterised by blindness and
progressive deafness sometimes associated with mild mental retardation (Warburg,
1966). Another form of this illness was characterised by severe mental retardation,
growth delay, hypotonic crisis, mental seizures and biochemical alterations of
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neurotransmitter metabolite levels in urine (Sims et al., 1989; Murphy et al., 1990;
Collins et al., 1992). Genetic analysis of the patients revealed that they were carrying
a deletion of the Norrie gene but also ofMAOA and MAOB genes (De la Chapelle et
al., 1985; Sims et al., 1989; Zhu et al., 1989).
Recently, the study of Brunner et al. (1993) has specifically associated
MAOA deficiency with behavioural alterations (Brunner et al., 1993a,b) in a Dutch
kindred. Indeed, four generations of males displayed the same behavioural alterations
(mental retardation and impulsiveness including a verbal aggressive behaviour,
aggressive attitudes and violence). In addition, these patients displayed biochemical
alterations in the level of several neurotransmitter metabolites in the urine. For
instance, they displayed a decrease of HVA, DOPAC, MHPG and 5-HIAA and an
increase of 5-HT, NMN and 3-MT.
Recently, studies of mice lacking the gene encoding MAOA (Cases et al.,
1995) allowed a deeper insight into the role of MAOA in development and
behaviour. MAOA deficient males displayed an aggressive behaviour. Interestingly,
preliminary results show that pharmacological treatments with
parachlorophenylethylamine (PCPA), a serotonin synthesis inhibitor, are sufficient to
reverse some aspects of the abnormal behaviour (I. Seif, unpublished results).
II Development of Monoaminergic systems
1 Genesis ofmonoaminergic neurons
The birth dates of discrete monoaminergic groups was investigated in several
. "i .
studies. In these studies, single or cumulative injections of H-thymidine (Lauder and
Bloom; 1974; Balan et al., 1996) or bromodeoxyuridine (BrdU) were used to label
cells undergoing division. Heavily labelled cells were considered to be precursors
that had not started to differentiate and that were undergoing S-phase at the time of
injection. Double immunolabelling for BrdU and TH or 5-HT or detection of the
radioactive 3H-thymidine followed by TH or 5-HT immunolabelling revealed the
monoaminergic phenotype of the labelled cells. It should be noted that most of these
studies were done in rat (there is a two day delay between the development of rat
embryos and mouse embryos; E12 rat in corresponds to E10 in mouse) and that these
authors considered El as the plug date.
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1.1 Serotoninergic neurons
The development of the serotoninergic system was first described by Olsen
and Seiger (1972; 1973) and later by Levitt and Moore (1978) in the rat embryo
using fluorescence histochemistry (Olsen and Seiger, 1972; Seiger and Olson, 1973,
Levitt and Moore, 1978). These studies provided topographic information concerning
the appearance and the development of the different components of the raphe nuclei
and their axonal projections. At the same time, the work of Lauder and her
collaborators initiated studies to date the time of genesis of the raphe nuclei in rat
embryos (Lauder and Bloom, 1974).
These studies have shown i) that raphe nuclei are generated between Ell and
El5 with a peak of genesis at El3, the dorsal raphe being generated earlier than the
median raphe (Lauder and Bloom, 1974), ii) that raphe nuclei are first detectable by
fluorescence histochemistry or by immunocytochemistry between E12 or E14 with a
precocity for the rostral group (B1-B7 complex), iii) that the onset of synaptogenesis
in the raphe nuclei is El9 and iv) that dorsal and medial raphe neurons contain
serotonin soon after they begin to differentiate and rapidly extend axons towards the
forebrain (Olson and Seiger, 1972). Table 1-1 sums up these findings.
1.2 Catecholaminergic neurons
Numerous studies have described the onset of TH expression in discrete
catecholaminergic populations in different vertebrate species (i.e.: Medina et al.,
1994 in sauropsides; Puelles and Medina, 1994, in chicks; Specht et al., 1977a,b in
rats and Puelles and Verney, 1998 in humans). These studies have shown that
catecholaminergic neurons start to express TH soon after they are generated. For
instance, dopaminergic neurons of the SN-VTA complex start to express TH soon
after they finish their last mitosis, while they are migrating to their final positions.
1.2. LDopaminersic neurons
TH-IR neurons of the substantia nigra are generated during a period
extending from El 2 to El 6 in rats with a peak of genesis at El 3 (Lauder and Bloom,
1974). TH-IR neurons of the retrorubral field and of the ventral tegmental area are
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Table 1-1 Development of serotoninergic neurons in the rat.
Serotonergic
Groups












B1 * o 0 P6
B2 * o 0 P6











B7 * o 0 ** E15 PI
B8 * o 0 ** ** E15 P3
B9 o 0 E15 none
The terminology described in Wallace and Lauder (1983) is used in
this table. The time of midline fusion was identified by Levitt and
Moore (1978). Several features of the development of serotoninergic
neurons are reported in this table: * the beginning of their mitosis,
(Lauder and Bloom, 1974), ** their peak of mitosis (Lauder and
Bloom, 1974), o the time of first observable fluorescence (Olson and
Seiger, 1972) and, Othe time of first detection with 5-HT
immunocytochemistry (Aitken and Tork, 1988; Konig et al., 1988).
generated simultaneously and a large majority of them (49% and 37% respectively)
are born before Ell (Bayer et al., 1995). In rodents, a gradient in the genesis ofTH-
IR neurons of the SN-VTA was reported, such that the more anterior and dorsolateral
neurons in the SN and the VTA are generated earlier than the posterior ventro-medial
neurons (Bayer et ah, 1995).
The birthdate of three CA groups, one located in the ventral thalamus (zona
incerta; Zi-A13) and two in the hypothalamus (periventricular nucleus and arcuate
nucleus) was studied by Balan et al. (1996). The authors showed that TH-IR neurons
originate between El2 and El3 in Zi, between E12 and El4 in the periventricular
nucleus and by El5 in the arcuate nucleus. In addition, they demonstrated a
hormone-independent sexual dimorphism in the genesis of these groups, prior to the
onset of a sex difference in androgen levels (El 6).
In the telencephalon, TH-IR periglomerular interneurons of the main
olfactory bulb are first generated by El 8 and from this age they continue to be
generated during the entire life of the animal by the subventricular zone of the lateral
ventricles (Luskin and Boone, 1994; Betarbet et al., 1996). By contrast, TH-IR
external tufted cells are generated locally in the ventricular zone of the olfactory bulb
between El3 and El8.
1.2.2 Noradrenergic neurons
In rat, noradrenergic neurons of the locus coeruleus are generated from El 1 to
El 3 with a sharp peak of genesis at El 2 (Lauder and Bloom, 1974)
2 Specification and determination of monoaminergic neurons
The understanding of monoaminergic neuronal differentiation and
specification rests on analysis of specific expression of transcription factors, or
secreted proteins and use of chemicals that can directly interfere with these two
steps. In the past few years, the mechanisms underlying the organisation of the
mouse brain have been extensively studied and data are now available on the
differentiation and specification ofmonoaminergic neurons of the PNS and CNS.
2.1 Patterning of the neural tube
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In the CNS, grafting experiments have demonstrated that neural progenitors
can acquire new identities if moved to ectopic locations (Alvarado-Mallart et al.,
1990; Gardner and Barald, 1991; Simon, 1995; Grapin-Botton et al., 1997). In
addition, transplantation and explant culture studies have confirmed the existence of
signalling centres that can change the fate of juxtaposed neuronal progenitors.
Signalling centres such as the dorsal ectodermal epidermis, roof plate, and notochord
have been shown to instruct cells along the dorso-ventral axis (Tanabe and Jessel,
1996), whereas signalling centres located in the prechordal plate, paraxial mesoderm,
midbrain-hindbrain boundary, and the anterior neural ridge can change cell fate
along the antero-posterior axis of the neural tube (Lumsden and Krumlauf, 1996;
Grapin-Botton et al., 1997; Muhr et al., 1997; Shimamura and Rubenstein, 1997,
Houart et al., 1998). Finally, secreted proteins and chemicals were shown to modify
cell fates in characteristic ways. For instance, Sonic hedgehog (Shh) and bone
morphogenetic proteins (BMPs) were shown to modify cell fates along the dorso-
ventral axis (Tanabe and Jessel, 1996) whereas the fibroblast growth factors, FGF2
and FGF8, retinoic acid, and wntl can change cell fate along the antero-posterior
axis (Crossley et al., 1996; Lumsden and Krumlauf, 1996; Shimamura and
Rubenstein, 1997).
In addition, gain-of-function experiments or conversely studies of transgenic
deficient mice have provided insight in the role of transcription factors necessary for
cell fate determination and specification.
2.2 Specification and determination of dopaminergic neurons
The nature of the signals that specify the fates and initial positions of
dopaminergic and serotoninergic neurons was directly addressed in several studies. It
was shown that the floor plate could induce the ectopic location ofDA neurons when
transplanted into both the midbrain and the rostral forebrain (Hynes et al., 1995a; Ye
et al., 1998) and that transplantation of the isthmus induces DA neurons in ectopic
ventrocaudal forebrain explants (Ye et al., 1998). Shh was shown to be in part
responsible for these inductions (Hynes et al., 1995b; Ye et al., 1998) and to act in a
dose and contact dependent fashion on the determination of cell fates. In addition, in
vitro addition of Shh blocking antibody to the explants prevents the appearance of
DA neurons in the forebrain (Ye et al., 1998). HNF3P, a Shh induced molecule, was
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also reported to be able to induce DA neurons ectopically (Sasaki and Hogan, 1994;
Hynes et al., 1995b). Finally, Ye et al. (1998) have shown that mesencephalic
dopaminergic neurons develop at sites where Shh and FGF8 intersect and that these
two molecules are necessary and sufficient for the expression of the DA phenotype in
normal mice. However, the role of Shh in early and late stages of dopaminergic
neuron differentiation may be different. Overexpression of Shh-N causes an increase
in TH only if expressed in proliferating cells prior to differentiation (Sakurada et al.,
1999). It is possible that the effect of Shh on dopaminergic neurons described by Ye
et al. (1998) reflects the differential expansion of precursors via the mitogenic effects
of Shh (Wechsler-Reya and Scott, 1999) or the effect of a ventral patterning
influence of Shh that acts primarily in proliferative versus postmitotic precursors (Ye
et al., 1998). Although Shh signalling is required beyond the final cell cycle in
cholinergic differentiation (Ericson et al., 1996), results obtained by Sakurada et al.
(1999) indicate that the later stages of dopaminergic neuronal differentiation may not
depend on the protracted presence of Shh.
Few transcription factors have been clearly implicated in the determination of
discrete dopaminergic populations. The specification of dopaminergic neurons of the
SN-VTA complex have been shown to depend on the expression ofNurrl and Ptx3.
Nurrl and Ptx3 are both specifically expressed in dopaminergic neurons of the SN-
VTA complex and are thought to participate in the same regulatory cascade event
(Zetterstom et al., 1997). Nurrl is an orphan receptor belonging to the nuclear
receptor superfamily (Law et al., 1992; Zetterstrom et al., 1996a) and Ptx3/Pitx3 is a
bicoid-related homeobox factor (Semina et al., 1997, 1998; Smidt et al., 1997). In
mice, Nurrl is protractedly expressed in the midbrain from El 0.5, just prior to the
appearance of TH (Zetterstrom et al., 1996a,b). Nurrl is not restricted to midbrain
(A8, A9 and A10) dopaminergic neurons and it is also expressed in All and A2
catecholaminergic neurons (Baffi et al., 1999). Nurrl-null mice display a specific
lack of midbrain dopaminergic neurons whereas Al 1 and A2 CA neurons are not
affected (Zetterstrom et al., 1997; Saucedo-Cardenas et al, 1998, Castillo et al.,
1998a) suggesting that Nurrl plays different regulatory roles in the different
catecholaminergic populations. In gain-of-function experiments, it was shown that
Nurrl is able to activate the transcription of the TH gene by binding a responsive
element within a region of the TH promoter necessary for midbrain specific
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expression. Interestingly, the action ofNurrl upon dopaminergic neurons was shown
to be independent of FGF8 and Shh signalling (Sakurada et ah, 1999). TH and Nurrl
expressions potentiated by the accumulation of cAMP (Tinti et ah, 1997; Castillo et
ah, 1997) and Shh inhibits adenylate cyclase suggesting that some of the TH-
repressing activity of Shh-N are mediated by the inhibitory pathway of protein kinase
A (Sakurada et ah, 1999). In mouse, Ptx3 expression starts in the ventral midbrain by
El 1.5, just after Nurrl expression and is exclusively and protractedly expressed in
mesencephalic dopaminergic neurons in rodent and human (Smidt et ah, 1997). In
addition, Ptx3 expression is decreased in SN-VTA neurons of human Parkinson
patients and in rat treated with 6-hydroxy-dopamine, an animal model for this disease
(Smidt et ah, 1997). Altogether, these results suggest that Ptx3 could play a specific
role in the development of SN-VTA neurons down-stream to Nurrl (Smidt et ah,
1997).
The specification of discrete dopaminergic populations located in the
paraventricular hypothalamus and the supraoptic nucleus have been shown to depend
on the expression ofSiml.
In addition, in Drosophila, the transcription factor islet has been shown to be
required for the expression of DA and 5-HT neurotransmitter phenotype (Thor and
Thomas, 1997). In islet loss-of-function mutants, TH expression is lost and a great
reduction in the number of 5-HT-IR neurons is observed. Interestingly, ectopic
expression of islet induces ectopic TH-IR cells but not ectopic 5-HT-IR cells.
2.3 Specification of serotoninergic neurons in the CNS
Both the specification of serotoninergic and dopaminergic neurons depends
on FGF8 and Shh (see above). However, the specification of serotoninergic requires
the additional presence of FGF4. Low levels (5ng/ml) of FGF4 and FGF2 can induce
ectopically 5-HT neurons in areas of the brain containing endogenous sources of Shh
and FGF8 (Ye et ah, 1998). Interestingly, the ectopic genesis of 5-HT neurons was
observed to the detriment of DA neurons suggesting that FGF4 can change the fate
of early neural progenitors (Ye et ah, 1998).
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Several mediators for Shh's effects have been identified in vertebrates, such
as the members of the Gli and Nkx families, and studies in Drosophila have pointed
out the necessity of several additional transcription factors.
A member of the Gli family (zinc finger family), Glil, which is expressed in
the midline neural plate from the stage of gastrulation, has been shown to act as a
target and mediator of Shh signalling in floor plate and ventral neuronal
differentiation (Lee et al., 1997). Misexpression of Glil protein (but not of Gli2 and
Gli3 proteins) in frog and mouse embryos leads to ectopic transcription of Shh and to
the ectopic differentiation of serotoninergic neurons (Hynes et ah, 1997; Lee et ah,
1997). Interestingly, Gli2 and Gli3 have been shown to participate in Glil regulation
(Ding et ah, 1998). Mainly, Gli3 and Shh repress each other whereas Gli2 and Glil
are targets for Shh signalling (Sasaki et ah, 1997; Ding et ah, 1998; Ruiz i Aetaba,
1998). It is possible that in the absence of Gli3, Shh territory would expand and
generate ectopic serotoninergic neurons, showing the requirement for Gli3 in the
mediation of Shh signalling. I have tested this hypothesis in Gli3 knockout mice but
found no ectopic serotoninergic neurons at any stage studied. Interestingly, it was
recently shown that shh expression is not ectopically activated in the brain of mice
lacking Gli3 suggesting that Gli3 fulfils a Shh-independent pathway (Theil et ah,
1999). This may explain my result.
Recently, the role of another transcription factor, Nkx2.2, in the genesis of a
subpopulation of serotoninergic neurons was also pointed out. Briscoe et ah (1999)
have shown that mice lacking Nkx2.2 display a specific loss of serotoninergic
neurons located adjacent to the floor plate but not of serotoninergic neurons of the
dorsal raphe. They showed that these serotoninergic neurons arise from Nkx2.2-
positive progenitors.
Studies on Drosophila have pointed to the requirement for four genes
encoding for transcription factors essential for the development of serotoninergic
neurons: the homeobox genes engrailed (en) and islet, the zinc-fmger-protein-
encoding gene huckenbein (hkb), and eagle (eg, a member of the steroid receptor
gene superfamily) (for review see Goridis and Brunet, 1999).
Lundell and Hirsh (1998) have shown that loss-of-function of eagle in Drosophila
leads to a dramatic reduction in the number of serotonin-producing neurons (Lundell
and Hirsh; 1998). The authors have demonstrated that eagle is necessary for the
maintenance of engrailed and Zinc-finger-2 expression in serotoninergic neurons.
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The en gene probably acts early in the lineage, as it is required for the proper
formation and development of the neuroblast from which 5-HT neurons are derived
in Drosophila. However, en is dispensable for 5-HT expression in neurons
expressing both eg and hkb. In fact the combined action of en and hkb is responsible
for the specification of the serotoninergic phenotype (Dittrich et al., 1997). Ectopic
expression of eg throughout the embryonic nervous system drives ectopic expression
of 5-HT in one or two cells in each segment of the Drosophila. In a hkb mutant
background, the number of these ectopic 5-HT neurons decreases dramatically
suggesting a co-operative effect of eg and hkb in the specification of serotoninergic
neurons (Dittrich et al., 1997).
2.4 Specification ofNoradrenergic neurons in the CNS and the PNS
Several groups of researchers have contributed very important insights into
the specification of noradrenergic neurons of the sympathetic ganglia in several
species. In chick, the work of Groves et al. (1995) has examined the expression of
transcription factors and their implication in the noradrenergic phenotype. They have
shown that sympathetic progenitor cells sequentially express the bHLH
transcriptional regulator Cash-1, Phox2, a paired homeodomain protein, GATA-2, a
zinc finger protein, and finally SCG10, a panneuronal membrane protein before
tyrosine hydroxylase. In addition, depletion experiments have shown that GATA-2,
Phox2 and TH, but not Cashl and SCG10, expressions depend on the presence of the
notochord. Together, these results suggest that the development of sympathetic
neurons involves multiple transcriptional regulatory cascades: one depending on
notochord or floor plate derived signals, involving Phox2 (renamed Phox2a) and
GATA2 which is assigned to the expression of the neurotransmitter phenotype; the
other independent of the notochord, involving CASh-1 which is assigned to the
expression of pan-neuronal properties (Groves al., 1995). The generation of mice
lacking Phox2a demonstrated the role of Phox2a in the differentiation of the
noradrenergic phenotype in the locus coeruleus, a subset of sympathetic and
parasympathetic ganglia and the Vllth, IXth, and Xth cranial sensory ganglia
(Valarche et al., 1993; Tiveron et al., 1996; Morin et al., 1997). In mice lacking
Phox2a, the transient expression of DBH in neuroblasts is abolished and the
expression of the GDNF receptor subunit c-ret is greatly reduced. Consequently,
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there is a massive increase of GDNF-dependent apoptosis in ganglion cells
(Oppenheim et al., 1995; Trupp et al., 1996; Morin et al., 1997). The overexpression
of Phox2 in chick neural crest culture leads in vitro to an apparent increase in number
of sympathoadrenergic cells and in vivo to the generation of additional neurons
expressing the noradrenergic markers, TH and DBH, and the cholinergic markers
ChAT and VAChT. New insight into the cascade of Phox2a expression was brought
by the work of Lo et al. (1998) showing that BMP2 and then MASH1 expression
were upstream of Phox2. Culture of neural crest stem cells in the presence of the
bone morphogenetic protein BMP2 leads to the induction of MASH1 expression
which in turn leads to Phox2a expression. Targeted mutation of Mashl showed that
Mashl is necessary for the development of all (except cranial sensory ganglia)
central and peripheral neurons that express permanently or transiently noradrenergic
traits (Hirsh et al., 1998). In mice lacking Mashl, Phox2a is abolished. In mice
lacking Phox2a, the expression of DBH is not abolished in all NA neurons and NA
neurons expressing Phox2b continue to express DBH. The regulation of DBH
through the Phox2 genes is thought to be direct since Phox2a and Phox2b bind to
regulatory elements of the DBH promoter and stimulate DBH promoter activity in
cultured cells. Interestingly, the overexpression of Phox2a in chick embryos has been
shown to result in ectopic TH expression (Goridis and Brunet; 1999).
3 Development and guidance of monoaminergic projections
The molecular signals that guide and confer target specificity on different
monoaminergic neurons are poorly understood. So far, only a few molecules have
been shown to play a direct role in dopaminergic axon guidance. Recently, the
receptor EphBl and its ligand ephrin-B2 have been shown to play a role in the
guidance of discrete dopaminergic projections of the SN and the VTA (Yue et al.,
1999). EphBl and ephrin-B2 are expressed in a complementary pattern in the
midbrain dopaminergic neurons and their targets (Yue et al., 1999) during the early
postnatal period, when dopaminergic innervation primarily occurs (Loizou, 1969;
1972; Coyle and Axelrod, 1972a,b; Olson and Seiger, 1972; Seiger and Olson, 1973).
EphBl is detected at high levels in the SN and not in the VTA and, complementarily,
its ligand is highly expressed in the developing striatum, the nucleus accumbens and
the olfactory tubercle and only weakly in the caudate putamen (Yue et al., 1999). In
addition, ephrin-B2 specifically inhibits the neuritic outgrowth and induces cell loss
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of SN but not VTA neurons (Yue et al., 1999). Together, these results suggest that
the interaction between EphBl and ephrin-B2 may result in an inhibitory signal that
restricts SN axons from innervating the ventromedial striatum and promotes cell
death in mistargeted neurons, thus contributing to the establishment of the
mesostriatal and mesolimbic pathways (Yue et al., 1999). In addition, in mice,
ephrin-B2 is upregulated after cocaine treatments (Yue et al., 1999) suggesting that it
could play a role in plasticity of the dopaminergic brain reward circuit and
consequently be involved in drug addiction mechanisms (Nestler et al., 1993; Hyman
andNestler, 1996).
Interestingly, it was suggested that the development of a transient
catecholaminergic phenotype could play a role in the maturation of brain circuitry.
Several neuronal populations have been described to transiently express tyrosine
hydroxylase. These neurons are mainly located in the telencephalon (piriform cortex,
neocortex, amygdala, bed nucleus of the stria terminalis, anterior olfactory nucleus,
and the inferior colliculus). Most of these neurons are only observed with TH but not
with AADC, DBH or PNMT immunocytochemistry and it is therefore possible that
these neurons use L-DOPA as a neurotransmitter. No signs of morphological
degeneration were reported in these neurons or in the surrounding tissues. In addition
the association of TH with somatostatin or substance P in these neurons suggests that
these neurons could progressively loose TH expression and remain somatostatin- and
substance P-immunoreactive. It is strongly suggested that the transient TH
immunoreactivity observed in those neurons could be associated with the maturation
of early limbic circuits (Jaeger and Joh; 1983; Verney et al., 1988).
4 Maturation and survival ofmonoaminergic neurons
Neurodegeneration of dopaminergic neurons in the ventral mesencephalon
projecting to the dorsal striatum (meso-striatal system) plays a major role in
Parkinson's disease. Thus the finding of candidate molecules able to promote the
survival capacities of dopaminergic neurons is a major area of investigation and hope
in the therapy of Parkinson's disease. Several factors have been implicated in
enhancing the late development of DA neurons. They could play a role in the
maturation, the late specification and the survival ofDA neurons.
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Cultured DA neurons are responsive to the serine protease thrombin, which
changes the length, the number of branches, and the pattern of neurites (Debeir et al.,
1998). Similarly, morphological changes could be induced in DA neurons by
members of the nerve growth factor protein family, by brain-derived neurotrophic
factor (BDNF), neurotrophin-3, neurotrophin-4/5, and by the members of the FGF,
TGF and GDNF families (Florger et al., 1998). Studies of mice deficient for the
TGFa gene revealed that these mice have a 50% reduction in the number of DA
neurons in the SN, but a normal complement of other midbrain DA neurons. This
indicates that TGFa may participate in the expansion or differentiation of this
particular subtype ofDA neurons (Blum; 1998).
Two members of the neurotrophic factor family, neurturin (NTN) and BDNF
have been shown to play important roles in the survival of mesencephalic
dopaminergic neurons. In vivo, neurturin, a glial cell-line derived neurotrophic
factor, protects dopaminergic neurons from lesion-induced degeneration and
increases the survival of embryonic DA neurons transplanted into postnatal rats
(Eggert et al., 1999; Rosenblad et al., 1999). In vitro, BDNF has been implicated in
the survival and differentiation of dopaminergic neurons. In vivo, mice
overexpressing BDNF in DBH positive neurons display a 52% increase of tyrosine-
hydroxylase positive neurons in the substantia nigra pars compacta (Alonso-Vanegas
et al., 1999). The authors suggest that an increased anterograde transport of BDNF
via the coerulo-nigral projection could rescue dopaminergic neurons from the
perinatal period of developmental cell death (Alonso-Vanegas et al., 1999).
In addition, several factors have been shown to influence the development,
survival and maturational state of DA neurons in vitro, such as the pituitary
adenylate cyclase-activating polypeptide (PACAP; Webber et al., 1998), neurotensin
(Sotty et al., 1998), oestrogen and progesterone (Kritzer and Kohama; 1998),
substance P (Futami et al., 1998), retinoic acid (Samad et al., 1997), and opioid
peptides (Tsao et al., 1998). However, little is known about the function of these
factors. They could participate in the late specification or serve as mitogenic or
survival factors for discrete DA progenitors.
Ill Development and organisation of the cerebral cortex
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1 Development of the cerebral cortex and cortical lamination
In mammals, the cerebral cortex is organised into six cortical layers. This
histological laminar appearance of the cerebral cortex is due to variations of cell
densities and of cell types throughout the thickness of the cortex. For instance, i)
afferents from the sensory thalamus stop in layer IV; ii) pyramidal neurons located in
the supragranular region of the cortex project to other cortical regions, including the
contra-lateral cortex; iii) layers V and VI project outside of the cortex, sending their
axons toward the thalamus, the striatum, the claustrum and the brainstem. In addition
to this laminar organisation, the cortex is divided into discrete areas more or less
well-defined (Figure 1-7). After the discredited works of the phrenologists of the
XVIII century, who tried to associate patriotic thoughts to discrete regions on the
cortical surface, numerous works followed. The works of de Broca and Wernicke on
language, studies of alterations due to genetic disorders (Clarke and O'Malley, 1969;
Blakemore, 1977) and more recently electrophysiological stimulations of specific
cortical regions have progressively confirmed the existence of cortical topographical
maps.
The main difference between the different cortical regions and that
determines their functional specificity is the origins of their afferents. The thalamus
is, by far, the major origin of cortical afferents. Both sensory organs (with the
exception of the olfactory system) and subcortical motor areas send their information
to one or several specific thalamic nuclei, which possess well-defined reciprocal
interconnections with specific cortical areas. For instance, the entirety of the rodent's
neocortex receives thalamic afferents (Caviness and Frost, 1980), and there is a
precise isomorphic correspondence between the topographical organisation of
thalamic nuclei and the organisation of cortical areas (Caviness et al., 1988).
In all mammals, the mechanisms of cortical neurogenesis appear to be the
same (Uylings et al., 1990). Neurons and glial cells originate in the telencephalic
neuroepithelium. As rapid cell division thickens the proliferative zone, the emerging
cortical structure progresses from a simple neuroepithelial sheet into a complex
laminar structure. The first step in this process involves the creation of a marginal
zone, a cell-sparse zone from which nuclei are excluded during interkinetic
movements in the epithelium (Marin-Padilla, 1978). Shortly thereafter, by the
thirteenth day of embryonic life (El 3) in the rat, the first neurons to be generated exit
the ventricular zone and form a single layer called the preplate. Together with the
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Figure 1-7 Cortical areas in rats. Rodent's isocortex is constituted by discrete
functional areas. These include the first (SI) and second (S2) somatosensory areas, the
more ventrally located ventral sensory area (PV), the primary motor area (Ml), the
primary auditory area (Al), the primary (VI) and secondary (V2) visual areas, the
supplementary motor areas (M2) and the premotor area (PM). The parietal rostral field
(PR) is included for orientation. Primary sensory areas appear in green in this schematic
representation (adapted from Northcutt and Kaas, 1995).
axons growing into the cortex, the axons of preplate neurons form the intermediate
zone, which separates the ventricular zone from the preplate. Collectively, these
axons pioneer the connections in both directions between the cortex and the
thalamus. The progressive thickening of the developing cortex continues in an
inside-out fashion (Lund and Mustari, 1977; Rakic, 1981) and a three-layered cortex
appears by El6. It is constituted by a ventricular zone containing proliferative cells,
the intermediate zone containing axons and migrating neurons, and the preplate
containing postmitotic neuronal precursors that will be subdivided later into the
subplate and the marginal zone (Marin-Padilla, 1978; Boulder Committee, 1970).
Then, the ventricular zone begins to produce neurons destined for different layers of
the cortex. These cells migrate through the intermediate zone and form the cortical
plate, a structure that splits the embryonic preplate into two domains: the marginal
zone (future layer I); and the subplate, a transient population of neurons that largely
disappears by programmed cell death in early postnatal life (Shatz et al., 1988).
Finally during the middle and the latter stages of neurogenesis (E21 in rat), a
subventricular zone containing mitotically active cells forms between the ventricular
zone and the intermediate zone. Figure 1-8 sums up these developmental steps.
Preplate neurons seem to play an important role during corticogenesis. They
are the first to express a large variety of receptors for several neurotransmitters
(Shatz et al., 1988), and to send axons outside of the cortex. In addition, the earliest
thalamic axons to penetrate the cortex accumulate under the subplate, over several
days in the rodent brain to a few weeks in primates (Rakic, 1977; Lund and Mustari,
1977; Shatz and Luskin, 1986). However in the somatosensory system of the rodent,
thalamic axons penetrate the deeper cortical areas without a waiting period (Catalano
et al., 1991).
An important issue in cortical development is the understanding of the
mechanisms leading to the specification of the cortical areas. According to the work
of Rakic (1988) and Reznikov et al. (1984), the cytoarchitectonic characteristics of
specific cortical areas are predetermined in the ventricular zone (Smart and
McSherry, 1982; Rakic, 1988). Others, like O'Leary (1989), have proposed that the
cortical plate is not predetermined and that the determination of specific cortical
areas is due to external signals. For instance, the arrival of topographically organised
thalamocortical axons in the sensory cortices would determine the characteristics of






















Figure 1-8 Stratification of the cerebral wall. Neurogenesis in the mouse neocortex
occurs from embryonic day El2 (left) to El7 (right). Cortical development begins with
the appearance of a population of cells along the lateral ventricle, known as the
ventricular zone (VZ; El2 mice mice). This population of cells gives rise to most of the
neurons and glial cells of the cerebral cortex. Once generated, neurons migrate towards
the pial surface and complete their differentiation in the cortical plate. Neurons for the
deeper layers of the cortex are generated and then migrate away form the VZ earlier than
the neurons destined for progressively more superficial layers. On E13-E14, the cerebral
wall is bilaminar consisting of the VZ and overlying primitive plexiform layer. CP,
cortical plate; IZ, intermediate zone; MZ, marginal zone; PPL, primordial plexiform
layer; SP, subplate; SVZ, subventricular zone (From Uylings et al., 1990).
described by O'Leary is the observation that the organisation of some sensory
cortical areas is tightly linked to the distribution of thalamocortical axons. This is
particularly well illustrated by the organisation of the primary visual cortex into
ocular dominance columns in the monkey (Hubel and Wisel, 1977) and by the
organisation of the primary somatosensory cortex into the barrel field in rodents
(Van der Loos and Woolsey, 1973). In addition, these cytoarchitectonic
characteristics only appear after the arrival of thalamocortical axons in the cortical
plate (Rakic, 1976; Jhaveri et al., 1991). The most convincing experiment in favour
of this hypothesis is that in which one cortical region was grafted into another
cortical area (Schlaggar and O'Leary, 1991). Presumptive embryonic rat visual
cortex grafted into the presumptive somatosensory cortex develops cytoarchitectonic
characteristics of the somatosensory cortex. In the same way, if this region is grafted
into a rostral cortical region not belonging to the somatosensory cortex, it will adopt
cytoarchitectonic characteristics of the host region (O'Leary and Stanfield, 1989).
Recently, the generation of mice lacking Gbx-2 whose thalamic differentiation is
disrupted and lack thalamocortical axons was used to provide a definitive answer on
the requirement for thalamocortical axons on neocortical regionalisation (Miyashita-
Lin et al., 1999). This study shows that despite the lack of thalamocortical
innervation, neocortical lamination and neocortical region-specific gene-expressions
(i.e.: cadherin-6, EphA-7, Id-2 and RZR-beta) developed normally. This study
provides the first evidence that cortical lamination is largely independent of thalamic
influence. However, it is likely that thalamic inputs regulates later steps in
neocortical development such as neuronal maturation, formation of neocortical
modules (such as barrels) and association cortices. Unfortunately Gbx-2 mutants died
at birth making it impossible to investigate the role of thalamic afferents on postnatal
neocortical development (Miyashita-Lin et al., 1999).
Studies on cortical development have shown that each developmental step in
its construction is plastic and consequently could be influenced by external signals
coming from the periphery. The nature of the signals is not known. One hypothesis,
that will be developed in Chapter II, is that cortical development could be controlled
or at least influenced by aminergic and thalamic afferents via the release of
neurotransmitters such as serotonin, dopamine, noradrenaline, glutamate and
acetylcholine.
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2 The somatosensory system
The following paragraph briefly summarises the numerous studies that have
elucidated the organisation of the rodent primary somatosensory cortex, a very
attractive system in which to study the formation and plasticity of the somatosensory
map.
2.1 Organisation of the somatosensory system
In rodents, the tactile hairs located on the snout, the lower hp, the paws and
the trunk are isomorphically represented in the primary somatosensory cortex in a
topographic map "the barrel field" (Van Der Loos and Welker, 1985; Van Der Loos
et al., 1991) where the size of the representation depends on the functional
importance of the receptor field (Figure 1-9). For instance, the main whiskers located
on the posterior snout are precisely organised into five parallel rows and each row is
constituted by four to height large whiskers. The most caudal whiskers are the largest
and the more thick; the caudal most are the smallest (Figure 1-10). Each whisker
receives a strong sensory innervation from the infra-orbital nerve.
Sensory information from the whiskers is conducted through a series of relays
to the somatosensory cortex. The successive relays are located in: i) the trigeminal
ganglion, ii) the trigeminal nuclei (the principalis, interpolaris and caudalis nuclei,
Erzurumulu and Jhaveri, 1992) and ii) the ventrobasal thalamic nucleus. Each relay,
with the exception of the trigeminal ganglion, maintains the precise topographical
organisation observed on the snout (Figure 1-11). In these nuclei, neurons are
organised in discrete structural units called barrelettes in the trigeminal nuclei (Ma,
1993) and barreloids in the ventrobasal (or ventro posterior) thalamic nucleus.
Barreloids project to the primary somatosensory cortex via thalamocortical axons.
This isomorphic representation is first established in the trigeminal nuclei.
2.2 The barrel field
De Vries first observed the barrel field, in 1912. After toluidine blue
coloration of preparations fixed in alcohol, De Vries reported the presence of "square
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Figure 1-9 Isomorphic organisation of the barrel field. On flattened preparations
stained for cytochrome oxidase each whisker located on the snout of the mice has a
unique and isomorphic representation in the somatosensory cortex of the animal. The size
of the representation depends on the functional importance of the barrel field. The
posteromedial barrel subfield (PMBSF) corresponds to the main whiskers located on the
snout. Whiskers located in the anterior snout (AS), lower lip (LL), hind paw (HP) and
forepaw (FP) are also represented in the barrel field. Note that the representation of the
main whiskers (PMBSF) which are the most important for the behaviour of the animal
proportionally occupy a larger brain area than the representation of the other tactile hairs.






Figure 1-10 Organisation of the whiskers on the face of the mice and of the barrels
in the cortex of the mice. Schematic representation of the organisation of the mystacial
vibrissae on the face and the barrel field in the first somatosensory cortex (SI). On the
face (top), the whiskers are arranged in the five principal rows labeled A-E from dorsal to
ventral, and numbered 1-4+ from caudal to rostral within the rows, with four straddler
whiskers located caudally between the principal rows and labeled a-8. This arrangement
is seen in the cortex (bottom), where each barrel is a cytoarchitectonically distinct area
that is one-to-one correspondence with a whisker on the animal's contralateral face. In
the barrel cortex, barrels for row E whiskers are anterior to those for row D whiskers, and
lower-numbered and straddler barrels are medial to higher-numbered barrels within a
row.
Figure 1-11 The five vibrissae-related maps of the trigeminal portion of the
somatosensory system of the rat. Three anatomically demonstrable maps are found in
the trigeminal complex of the brainstem of the rat which receives input from the
trigeminal ganglion (V ganglion). These are found the principal trigeminal nucleus (PrV),
the subnucleus interpolaris (Spl) and subnucleus caudalis (Spc) of the spinal trigeminal
nucleus. These brainstem nuclei in turn project into the contralateral thalamus where they
terminate in the medial portion of the ventral posterior nucleus (VPM), which contains
the fourth vibrissae-related map. During development, formation of the map in the ventral
posterior is dependent on an intact principal sensory nucleus, and not on other parts of the
trigeminal complex of the brainstem. The ventral posterior nucleus in turn projects into
the primary somatosensory cortex (SI). (From Killackey et al., 1995).
spaces" and "small islands" in layer IV of the cortical area that he described as "H2"
(De Vries, 1912). Then, rapidly the extensive studies of Droogleever Fortuny,
Lorente de No', Rose, Van Erp Taalman Kip and more recently Woolsey and Van
Der Loos, contributed to the precise description of the barrel field and to its scientific
popularity (Droogleever Fortuny, 1914; Lorente de No', 1922; Rose, 1929; Van Erp
Taalman Kip, 1938; Woolsey and Van Der Loos, 1970).
According to the work of Woolsey and Van Der Loos, which serves as a
reference today, the cytoarchitectonic organisation of layer IV of the primary
somatosensory cortex is called the "barrel field". On tangential sections stained for
Nissl, a barrel appears to comprise a ring of granular neurons (the wall) around a
sparse cell space (the hollow). Two neighbouring barrels are separated by a septum
(Figure 1-12).
In the barrel field, thalamocortical axons occupy the cell sparse hollows of
the barrels. They have been identified by the activity of several mitochondrial
enzymes. In 1968, Ladesky and Lierse first analysed the cortex of the mouse using
the activity of succinate dehydrogenase (SDH) and first described layer IV of the
somatosensory cortex as having blobs of high SDH activity and suggested that they
corresponded to the barrels. Today the activity of cytochrome oxidase and
acetylcholinesterase (O'Leary et ah, 1994; Broide et ah, 1996) is also extensively
used to visualise the peripheral related afferents.
In the barrel field, the "posteromedial barrel subfield" or PMBSF is the
cortical correspondence of the main whiskers on the snout. The barrels of the
PMBSF are organised in same five rows than the whiskers. The correspondence
between the PMBSF and the whiskers has been established by electrophysiology and
was extended to the entirety of the barrel field.
3 Influence of the thalamocortical and serotoninergic afferents on barrel field
formation.
The formation of the barrel field requires both thalamocortical afferents
coming from the ventrobasal thalamus and serotoninergic afferents coming from the
raphe nuclei. Thalamocortical axons are the first topographically organised
structures. Their organisation is determined during embryonic life (Erzurumlu and
Jhaveri, 1990; Schlaggar and O'Leary, 1994). The arrival of thalamocortical axons in
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the layer IV of the cortex is followed, one day later, by the arrival of serotoninergic
axons (Rhoades et ah, 1990; Blue et ah, 1991). Glial barriers form two to three days
after the arrival of thalamocortical axons (Jhaveri et ah, 1991; Rice and Van Der
Loos; 1977).
3.1 Influence of thalamocortical axons on the formation of the barrel field
Using acetylcholinesterase (ACh-E) activity, Schlaggar and O'Leary (1994)
and Broide et al. (1996) have examined the emergence of the somatosensory map in
the rat cortex. They described the existence of a dense region of ACh-E activity in
layer VI of the developing somatosensory cortex by E20 rapidly followed at E21 by
the separation of the main domains of the representation (the snout, the paws and the
trunk). At the end of P0, the rows are distinguished in the cortical plate. Then,
thalamocortical axons project from the deep cortical plate into layer IV of the
somatosensory cortex following a radial trajectory developing rapidly a barrel-like
organisation (Agmon et al., 1993; 1995). By PI, thalamocortical axons reach their
neuronal targets in presumptive layer IV.
The use of lipophilic dyes has defined the timing of thalamocortical
development and shown that thalamocortical axons develop without a waiting period
in the rodent cortex (Senft and Woolsey, 1991a; Agmon et al., 1993). The precise
morphology of individual thalamocortical axons has shown their precise degree of
addressage since E16 (Catalano et al., 1991; Agmon et al., 1993). Thus, there is a
strong correlation between the arrival of thalamocortical axons and the emergence of
the blobs ofACh-E enzymatic activities.
The study of the topographical organisation of the thalamocortical axons in
the adult rat brain was first performed by Lorente de No' His work has defined the
existence of two types of thalamocortical axons i) the "non-specific thalamocortical
axons" sending collaterals in the white matter ii) the specific thalamocortical axons
characterised by a dense plexus of collaterals restricted to a small area of layer IV
(Lorente de No', 1949). Recently, Jensen and Killackey (1987a) have described the
morphological organisation of thalamocortical axons of the somatosensory cortex
(Figure 1-13). They have shown that i) their plexus extends into layer III and, rarely,
into layer II, ii) the size of their arborisations depends on the region of the
somatosensory cortex and on the whisker-barrel relation, iii) thalamocortical axons
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Figure 1-12 Organisation of granular neurons in the barrel field. In the layer IV of
the somatosensory cortex granular neurons form cylindrical aggregates called "barrels".
On flattened preparation stained for Nissl, barrels (B) appear as ring of granular neurons
"the wall" (white arrows) separated by cell spare regions "the septae "(thin black arrows).
Inside the barrel is the "hollow" (h). Scale bar is 100 pm. (From Woolsey and Van der
Loos, 1970).
which have a large area of projection in the tangential plane belong to the PMBSF.
Previous studies have also shown that the number of neurons in a barrel depends on
the number of myelinated axons innervating the corresponding barrel (Killackey,
1973; Killackey and Leshin, 1975; Lee and Woolsey, 1975, Welker and Van Der
Loos, 1986).
3.2 Influence of serotonin on the formation of the barrel field
Several studies have shown that cholinergic and aminergic projections are
necessary for normal cortical development. Cholinergic alterations lead to alterations
of the cytoarchitectonic organisation of the cortex (Hohmann et ah, 1988a) and pre-
or postnatal lesions in dopaminergic and noradrenergic afferents lead to alterations in
the cortical dendritic trees or in the kinetics of cortical synaptogenesis (Ebersole et
ah, 1981; Loeb et ah, 1987; Parnavelas and Blue, 1982).
The role of serotonin on cortical development has been addressed in several
studies. These studies were motivated in part by the description of a "transient
serotoninergic hyperinnervation" observed in rodent sensory cortices (Fujimiya et al.,
1986; Rhodes et al., 1990; Bennett-Clarke et al., 1991; Blue et al., 1991). Indeed,
Fujimiya et al. (1986) reported the presence of strong immunolabelling for serotonin
in the murine somatosensory cortex during the first ten days of postnatal life (PI to
P10; with a maximum around P5). They proposed that the diffuse serotoninergic
innervation observed at birth becomes progressively organised into barrels and
disappears after P10. At the same time, D'Amato et al. (1987) observed the same
transient hyperinnervation in the rat and showed the presence of sites of uptake of
serotonin in the somatosensory cortex. Recent studies have shown that this
hyperinnervation is due to the uptake and the storage of serotonin by thalamocortical
axons (Lebrand et al., 1996) and that this phenomenon could be generalised to all
sensory cortices (Cases et al., 1998). Figure 1-14 illustrates these observations.
These observations suggest a role for serotonin in the formation of the
somatosensory cortex. In addition, during the transient serotoninergic
hyperinnervation period, 5-HTlb receptors (Leslie et al., 1992; Bennett-Clarke et al.,
1993), the serotonin transporter and the vesicular monoamine transporters are
expressed (Lebrand et al., 1996; Hansson et al., 1996) by thalamic neurons.
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Figure 1-13 Individual reconstructed terminals of thalamocortical afferents. Normal
terminal arbors of animals of various ages from PI (first day after birth) to aaulthoood
are illustrated. In addition, terminal arbors of normal adults found in the anterolateral
(A.L.) portion of the surface map of the body, where small rostral vibrissae are
represented, and from the posteromedial (P.M.) portion of the map, were the large caudal



















Figure 1-14 Serotoninergic hyperinnervation of the barrel field: observation and
interpretation. A, During a transient period (P0-P8), barrels display a strong and
transient 5-HT-immunolabelling. 5-HT-immunolabelling is strongest by P5-P7 and
rapidly decrease to completely disappear by P10. Adult mice show no remaining 5-HT-
immunolabelling in the somatosensory cortex. B, SERT is expressed from E15 to P10 in
the somatosensory cortex. C, SERT is able to uptake 5-HT released by serotoninergic
terminals and also by thalamocortical axons (to a lower extent). 5-HT is then transported
into vesicles by the vesicular monoamine transporter type 2 (YMAT2). The model
proposed to explain the so-called "transient serotoninergic hyperinnervation of the
somatosensory cortex" is now based on this recent finding rather then on a progressive
degeneration of the serotoninergic terminals.
Surprisingly, lesions of the serotoninergic systems had only few effects on
barrel field formation and organisation. Permanent lesions of the serotoninergic
system by pharmacological injection of 5,7-DHT at birth induced only a delay in the
apparition of the barrel field (Blue et ah, 1991; Osterheld-Haas et ah, 1994) and a
20% reduction in the size of the barrels (Bennett-Clarke et ah, 1994). These results
suggest that serotonin does not play an instructive role but rather a modulatory or
trophic role in barrel field formation.
Is an excess of serotonin during the period of formation of sensory cortices
playing an instructive role in the barrel field formation? Recently, a transgenic mouse
line deficient for the gene encoding MAOA was generated (Cases et ah, 1995; Cases
et ah, 1996) and shown to display increased levels of serotonin during a period
covering the critical period of barrel field formation and alterations of the
organisation of the somatosensory cortex (Figure 1-15). Studies on dissociated
thalamic neurons have recently shown that serotonin can increase the growth of
thalamic neurites (Lotto et ah, 1999). It is possible that 5-HT could act by enhancing
the production of neurotrophic factors (Whitaker-Azmitia and Azmitia, 1989;
Whitaker-Azmitia et ah, 1990) or by reducing the production of factors that inhibit
growth. But it is also possible that serotonin is related to the modulation of neuronal
activity in the developing cortex. In this case, its action upon 5-HTlb receptors, that
are expressed on glutamatergic thalamic axons (Bennett-Clark et ah, 1993), could
mediate strong presynaptic inhibitory effects upon thalamocortical transmission
(Rhoades et ah, 1994). In MAOA-knockout mice it is possible that excessive
amounts of serotonin could result in a functional silencing of thalamic neurons,
which would be reversed when 5-HT levels are normalised. This possible role of an
excess of 5-HT on barrel field formation is still speculative since a clear effect of
neuronal activity on the formation of the barrel field has not been clearly
demonstrated (review in O'Leary et ah, 1994).
It is interesting to note that a similar transient hyperinnervation was described
from the noradrenergic neurons of the locus coeruleus in the mouse parietal cortex
(Lidov et ah, 1978; Lidov and Molliver, 1982a,b; Levin et ah, 1988) suggesting that
NA stimulation could also play a modulatory role in the formation of cortical
organisation. In addition, lesion of the catecholaminergic system by pharmacological
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Figure 1-15 Schematic representation of the barrel field in wild type and MAOA-
knockout mice. In wild types, thalamocortical axons arborize in layers VI and IV and
granular neurons are clustered into barrels in the layer IV of the somatosensory cortex.
Barrels are separated by septa containing the extracellular matrix protein, tenascin. In
MAOA-knockout mice, thalamocortical axons and granular neurons are not clustered into
barrels and boundaries of tenascin are lacking.
that observed after 5,7-DHT lesion. This strongly suggests a role for catecholamine
in the development of the barrel field. MAOA-knockout mice display also an excess
of NA during the period of barrel field formation which was shown not to be
responsible for the altered formation of the barrel field (Cases et ah, 1996).
Catecholaminergic innervation may participate in the formation of other cortical
regions.
4 The somatosensory system and plasticity
4.1Plasticity of the somatosensory system
The organisation of the somatosensory system is dependent on the integrity of
the peripheral system during development (Van Der Loos and Woolsey, 1973;
Woolsey, 1990). Each synaptic level from the periphery to the cortex can be altered
in neonates (Killackey et ah, 1976; Belford and Killackey, 1979a,b, 1980; bates et
ah, 1982). Early thalamic lesions (Wise and Jones, 1978), or lesions of peripheral
receptors by section of the infraorbital nerve or by cauterisation of the whiskers from
P0 to P5 (Belford and Killackey, 1980; Jeanmonod et ah, 1981; Jensen and
Killackey, 1987b), lead to permanent alteration of the barrel field. Thalamic lesions
and lesions of the infraorbital nerve reduce the thickness of the layer IV and induce
fusion in the row of the PMBSF (Wise and Jones, 1978, Jensen and Killackey,
1987b, Rhoades et ah, 1990).
4.2 Plasticity of the somatosensory system versus that of the visual system: a role for
activity?
Classically, the cat visual system and the rodent somatosensory system have
been confronted in considering the process involved in their plasticity. The plasticity
of the visual system is dependent on activity whereas for the somatosensory system
there is no direct evidence to show the same dependence. Contrary to what is
observed in the visual system, blockade of afferents (Henderson et ah, 1992) or of
cortical activity in the somatosensory system (Chiaia et ah, 1992; 1994a,b) by
tetrodotoxin (TTX), or with D-2-amino-5-phosphovalerate (APV; an N-methyl-D-
aspartate (NMDA) antagonist; Schlaggar et al., 1993), do not lead to
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cytoarchitectonic alterations of the somatosensory cortex. However, Fox et al. (1996)
have recently shown that electrophysiological properties of the barrel field were
modified after APV treatment, the receptor field of each whisker was enlarged
tangentially both in layers IV and II/III (Fox et al., 1996).
The difference between these two systems could be explained on the basis of
the results of several experiments. First, spontaneous and evoked activities are
stronger in the cat visual system than in the rodent somatosensory system
(Armstrong-James, 1975; Chiaia et al., 1994a). It is possible that the blockage or
decrease of activity in a system where the spontaneous activity is low is less
important than in a system where activity is more intense. Secondly, ocular
dominance columns in cats form over a longer period (ten postnatal weeks) than the
barrel field (3 postnatal days). Therefore, in rodent the postnatal blockade of activity
can have only a short period of action upon barrel field formation. However, several
studies have explored this idea and the blockade of activity (with TTX or NMDA
antagonist) in hamster, in which the period of barrel field formation is longer (2
weeks), has no effect on barrel field representation (Chiaia et al., 1994a).
Interestingly, mice lacking the NMDA-R1 receptor lack the characteristic
topographical organisation of the first sensory relay in the trigeminal ganglion (Li et
al., 1994). Unfortunately, these mice die at birth and they provide no real information
on the formation of the somatosensory system.
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Chapter Two:
Influence of serotonin on specific developing structures:
Effects of monoamine oxidase a inhibition on barrel formation




ON SPECIFIC DEVELOPING STRUCTURES
Effects of monoamine oxidase A inhibition
on barrel formation in the mouse somatosensory cortex:
Determination of a sensitive developmental period
I Abstract
Genetic inactivation of monoamine oxidase A (MAOA) in mice with a
C3H/HeJ genetic background causes a complete absence of barrels in the
somatosensory cortex. Likewise, in normal C3H/HeJ mice, pharmacological
inhibition ofMAOA during the first postnatal week causes permanent alterations of
the barrel field. To further determine the sensitive period during which
developmental alterations of the barrel field can be produced in normal mice, I
administered the MAOA inhibitor clorgyline to mice of the outbred strain OF1 for
various time periods between embryonic day 15 (E15) and postnatal day 7 (P7). The
optimal dose and schedule for clorgyline administration (10mg/kg/8h) was selected
after testing different protocols of drug administration. High-pressure liquid
chromatography measures of brain serotonin (5-HT) showed three to eight-fold
increases during the periods of clorgyline administration. Perinatal mortality was
increased and weight gain was slowed between P3 and P6. Cytochrome oxidase and
Nissl stains showed a disorganised barrel field in P10 or adult mice treated with
clorgyline during the periods E15-P7 or P0-P7: barrels did not form in the anterior
snout representation, and the posteromedial barrel subfield (PMBSF) displayed
various fusions of barrels, both along and across barrel rows. Administration of
clorgyline from PO to P4 caused similar though less severe barrel field alterations,
indicating that MAOA inhibition continues to be effective on barrel development
after P4. However, when started on P4, administration of clorgyline caused no
detectable abnormalities. Similarly, treatment from El5 to PO caused no observable
changes. In the cases with barrel field alterations, a rostral to caudal gradient of
changes was noted: rostral barrels of the PMBSF were most frequently fused and
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displayed an increased size tangentially (P0-P4 treated pups). Within SI, the area of
the trigeminal representation was increased (10-20%) in the most affected cases
(E15-P7 and P0-P7 treated pups), while the thickness of layer IV was reduced by 10-
20%.
Altogether, these results indicate that MAOA inhibition, resulting in
increased brain levels of brain 5-HT, affects barrel development during the entire
first postnatal week but that there is a sensitive period for this effect between P0 and
P4. The rostral to caudal gradient of changes in the barrel field parallels known
developmental gradients in the sensory periphery and in the maturation pattern of
thalamocortical afferents. The observed barrel fusions reflect a reduced clustering of
thalamic afferents, that could correspond to a default in the initial segregation of
these fibers at the time when they contact their cortical targets and/or to a continued
exuberant growth, after they have reached these targets, which overrides the
tangential domain that is normally devoted to individual whiskers.
II Introduction
1 Trophic role of monoamines
5-HT, DA and acetylcholine influence, in vitro, the growth of their targets
(Haydon et al., 1984; McCobb et al., 1988; Lipton and Kater, 1989). This is either an
inhibitory or a stimulatory regulation depending on the developmental stage, of the
secondary messengers implicated, the presence of glial cells and of the method of
administration.
In Heliosoma, 5-HT and NA directly applied to their targets inhibit neurite
outgrowth and increase the intracellular concentration of Ca2+ (Lipton and Kater,
1989). In larvae of Heliosoma, 5-HT depletion by 5,7-DHT causes an increase of
dendritic outgrowth among the cellular targets of 5-HT, suggesting that
serotoninergic afferents inhibit the growth. However, 5-HT can initiate neurite
outgrowth from a sub-population of neurons (Goldberg and Kater, 1989). It was
suggested that the nature (inhibitory or stimulatory) of 5-HT's effect was directly
dependent on the developmental stage of the target cells and on their intracellular
concentration of Ca2+. Acetylcholine also inhibits neurite outgrowth when it is
directly applied to appropriate neurons, but could also inhibit the inhibitory effects of
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5-HT on target cells by acting on the intracellular concentration of Ca2+ and the
resting membrane potential (Lipton and Kater; 1989).
Glial cells can influence the effect of neurotransmitters on other neurons. Neurite
outgrowth is inhibited by micromolar concentrations of 5-HT applied to dissociated
cultures of cortical (Sikich et al., 1990) and raphe neurons. Like 5-HT, DA inhibits
cortical and retinal neurite outgrowth (McCobb et al., 1998). These inhibitory effects
of 5-HT and DA have been associated with the activation of 5-HTla and D1
receptors respectively (Lankford et al., 1988; Santos Rodrigues and Dowling, 1990;
Todd, 1992). However, in cortical or hippocampal organotypic cultures, neural
differentiation and synaptogenesis are stimulated by the same concentration of 5-HT
and a proliferation of glial cells is also observed (Lauder, 1990). The presence of
glial cells in organotypic cultures versus dissociated cultures can account for the
opposite effect of 5-HT. Glial cells can release neurotrophic factors in response to
monoamines. Astrocytes bear a large variety of monoaminergic receptors (Lauder
and McCarthy, 1986) and send neurotrophic signals for afferent neurons (Qian et al.,
1992: Liu and Lauder, 1992a). Neuronal activity and monoamines could regulate the
synthesis and the release of growth signals. Indeed, interactions between glial cells
and neurons transmit some neurotrophic functions during development.
The trophic interactions between neurons and glial cells are best exemplified by
the regulation of the protein SI00(3. This protein captures the calcium and functions
like a growth factor for serotoninergic neurons (Whitaker-Azmitia, 1992). During the
development of the serotoninergic system, interactions between the neurons of the
raphe and glial cells bearing the 5-HTla receptors induce the release of S100(3.
S100P is released by glial cells on serotoninergic neurons of the raphe and along the
serotoninergic pathways (Van Hartesfeldt et al., 1986; Bledsoe and Zhou, 1992). 5-
HTla agonists induce the release of S100P by astrocytes and serotoninergic
outgrowth (Liu and Lauder, 1992b). After 5-HTla stimulation, APMc is activated
and the transcription of S100P is initiated. This is due to the presence of a CRE
responsive element on the promoter of the gene coding for S100p. In addition, AMPc
is increased in glial cells treated with 8-OH-DPAT (Liu and Lauder, 1982b). It is
possible that the release of monoamines from developing axons stimulates, in vivo,
the release of neurotrophic factors from glial cells. Then, the expression of specific




2.1 Role of serotonin on development of serotoninergic neurons
Several in vitro and in vivo experiments have demonstrated that alteration of 5-
HT levels are critical for the development of serotoninergic neurons. In vitro, 5-HT
regulates the growth of serotoninergic neurons of the raphe in a dose-dependant
fashion (Lauder et al., 1990; Whitaker-Azmitia et ah, 1990). 5-HT is also able to
initiate and to auto-amplify its own synthesis. This was shown in hypothalamic
cultures (De Vitry et ah, 1986). In vivo evidence of the role of 5-HT in its own
development was given by the characterisation of Drosophila mutants unable to
synthesise serotonin (Budnik et ah, 1989). These mutants display an aberrant growth
of their serotoninergic projections (Budnik et ah, 1989). In addition, rats treated with
5-MT, a 5-HT agonist, displayed abnormal growth of their serotoninergic axons
(Whitaker-Azmitia, 1992).
2.2 On the development of other structures
2.2.1 Lack ofserotonin
The alteration of the serotoninergic system is also deleterious to the
development of its targets systems. PCPA injections into pregnant rats or mice
induce 5-HT depletion in the embryonic neurons of the raphe. This depletion is
followed by a delay in the neurogenesis of areas normally receiving precociously
serotoninergic afferents (Lauder et ah, 1990). This effect is transmitted by a variety
of serotoninergic receptors (Hellendahl et ah, 1992) and their number seems to be
modulated by 5-HT. Indeed, PCPA or 5-MT treatment during pregnancy alters the
level of 5-HT receptors expressed postnatally.
2.2.2 Excess ofserotonin
The effect of an excess of 5-HT on barrel field formation was clearly
established in MAOA-knockout mice (Cases et ah, 1996). During the sensitive
period of barrel field formation, MAOA-knockout mice display an increase in 700-
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900% of serotonin levels whereas NA levels, which are also affected in this mouse
strain, display only a 35-70% increase. In addition, pharmacological treatment with
a-MPT, an inhibitor of catecholamine synthesis, during the first postnatal week
caused no cortical alterations, whereas reduction of 5-HT synthesis by administration
of PCPA restored the normal development of the barrel field. The phenotype of
MAOA knockout mice is best characterised by a fusion of the barrels in each main
domain of the barrel field representation and an alteration of the organisation of the
periphery related afferents. Granular neurons of layer IV are not organised into
barrels but in a continuous and homogeneous band. Thalamocortical axons are not
segregated in layers VI and IV of the barrel field. In the somatosensory area, layer IV
displayed a 20% decrease of its thickness whereas the total cortical thickness is
unchanged and the total size of the barrel field is increased by 20%. In layer IV,
tenascin immunoreactivity is decreased. Interestingly, trigeminal and thalamic relays
display no obvious alteration in their organisation and thalamocortical axons bear 5-
HTlb receptors as normal. These alterations are summarised in figure 1-15.
3 Effects of monoamine oxidase A inhibition on barrel formation in the mouse
somatosensory cortex: Determination of a sensitive developmental period
A number of mechanisms underlying the formation and plasticity of cortical
sensory maps have been uncovered by studying the barrel field in the rodent
somatosensory cortex. The appeal of this system for developmental analyses lies in
the fact that its precise topographical organization can be readily visualised: the
peripheral tactile receptors associated with the whiskers are isomorphically
represented as discrete elements called barrelettes in the sensory relays of the
brainstem, barreloids in the thalamic relay, and barrels in the primary somatosensory
cortex (SI). In SI, barrels form clear units in layer IV, consisting of a ring of
granular cells that surrounds a cell-sparse hollow containing the clustered terminal
arbors of thalamic neurons (Woolsey and Van der Loos, 1970; Jensen and Killackey,
1987a). The crucial role of the sensory periphery in the formation of barrels was
demonstrated early on. Lesioning a row of whiskers early in postnatal development
causes defective formation of barrels in the corresponding cortical representation
(Van der Loos and Woolsey 1973; Woolsey and Wann, 1976; Belford and Killackey,
1980; Jeanmonod et al., 1981). Conversely, the presence of additional whiskers on
the snout induces additional barrels to form in the cortex (Welker and Van der Loos,
1986). However, the nature of the signal conveyed by the periphery is still unclear
since blockade of neural activity with tetrodotoxin or bupivacaine does not alter
barrel formation (Chiaia et al., 1992; Henderson et al., 1992; Chiaia et al., 1994).
Nevertheless, normal glutamatergic neurotransmission appears to be necessary for
the refinement of topographic order in the thalamocortical projection, since whisker-
related patterns fail to develop in the brainstem, thalamus, and cortex of mice
genetically deficient for the key subunit of the N-methyl-D-aspartate (NMDA)
receptors (Li et al., 1994; Iwasato et al., 1996), and since pharmacological blockade
of NMDA receptors in normal SI disrupts the topographic refinement of the
thalamocortical projection and the functional columnar organization of barrels (Fox
et al., 1996).
Recently, defective formation of barrels has been shown to occur, despite the
presence of normal peripheral receptors, in two other strains of mice. One strain is
characterized by a spontaneous mutation, named "barrelless", located on the
proximal segment of chromosome 11 (Welker et al., 1996). The other strain has a
serendipitous knockout for the gene encoding monoamine oxidase A (MAOA)
located on the X chromosome (Cases et al., 1995). In these two strains of mice, the
tangential clustering of thalamocortical afferents is lacking and granular neurons in
layer IV do not form the characteristic rings. An excess of brain serotonin (5-HT)
amounts during early postnatal development appears to be responsible for the
abnormalities in the MAOA knockout mice, since lowering 5-HT amounts in the
brain of developing pups allows normal barrels to form in SI (Cases et al., 1996).
Excess of 5-HT could alter two components of the normal developmental processes
that underlie cortical barrel formation: the ingrowth of thalamocortical fibers and the
differentiation of cortical neurons in layer IV. In mice, thalamocortical fibers reach
the cortical anlage as early as embryonic day 15 (El5), invade the deep cortical
layers (V-VI) in late embryonic life (Catalano et al., 1996), and the cortical plate
around birth (postnatal day 0, P0) (Senft and Woolsey, 1991 a,b; Agmon et al.,
1993), reaching the nascent layer IV in the lower cortical plate by P2. Barrel-like
periodicities of the thalamocortical afferents become detectable on P3 (Senft and
Woolsey, 1991 a,b; Agmon et al., 1993) and are soon accompanied by changes in the
distribution of the layer IV neurons: in Nissl-stained tangential sections, barrels first
appear by P3.5 as oval-shaped patches of decreased packing density of perikarya.
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Clear ring-like arrangements of granular neurons are observed by P5 (Rice and Van
derLoos, 1977).
Although the exact targets of 5-HT in this intricate developmental process
remain to be determined, there are strong arguments for a direct effect of 5-HT on
the thalamocortical neurons originating from the ventrobasal (VB) thalamic nuclei.
Serotonin receptors of the 5-HTib subtype are transiently located on VB terminals in
the somatosensory cortex (Bennett-Clarke et ah, 1993) and pre-synaptically inhibit
the excitatory thalamocortical transmission, at least in vitro in brain slices (Rhoades
et ah, 1994). Furthermore, developing VB neurons transiently express the genes
encoding the serotonin transporter (SERT) and the vesicular monoamine transporter
(VMAT2). As a result, 5-HT is taken up and stored in thalamocortical axons
innervating SI (Lebrand et ah, 1996), giving the picture of a dense 5-HT-positive
innervation of the barrel field during the first postnatal week (Fujimiya et ah, 1986;
D'Amato et ah, 1987; Rhoades et ah, 1990; Blue et ah, 1991; Lebrand et ah, 1996).
In the present study, I sought to obtain more precise information on the
sensitive period during which increased levels of brain 5-HT are affecting barrel
development. In previous work, focusing on the absence of barrels in MAOA
knockouts, I had shown that in wild-type C3H/HeJ mice, transient pharmacological
inactivation of MAOA with clorgyline from P0 to P6 caused important and
permanent barrel field abnormalities (Cases et ah, 1996). The purpose of the present
study, performed on another strain of mice, the outbred OF1 strain, was to compare
the extent of changes following a variety of clorgyline dosages and schedules in
prenatal and early postnatal life and to provide a more detailed analysis of the pattern
of barrel field abnormalities. I also analyzed the general physiological effects of the
pharmacological treatments, to determine whether any observed alterations of the
barrel field could be related to effects of MAOA inhibition on overall growth and
development of the mice.
Ill Material and methods
1 Animals
Experiments were carried out on mice of the outbred strain OF1. All animal
procedures were conducted in strict compliance with approved institutional
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protocols, and in accordance with the provisions for animal care and use described in
the "Scientific procedures on living animals ACT 1986". The day of birth was
counted as postnatal day 0 (PO).
2 Pharmacological treatments
Clorgyline (5, 10, or 30 mg/kg; Sigma-Aldrich, M-3778, France) or
physiological saline were administered intraperitoneally to pregnant dams and
subcutaneously to mouse pups using a 30-gauge needle. Injections were given either
daily or every 8 hours over the following developmental periods: E15-P0, E15-P7,
P0-P4, P4-P7, and P0-P7 (Fig. II-l). The first injection at PO was made 4 to 8 hours
after delivery. Each day, surviving pups were numbered and weighed. The total
number of OF1 mice that were treated with the different dosages and schedules is
indicated in Table II-1.
3 Biochemical analysis
Embryos (El9) and P7 pups treated for various times with clorgyline (10
mg/kg/8h) or saline were decapitated after cold-anesthesia, three hours after the dams
or the pups received their last injection. PO pups born form treated mothers were
killed in the same way but in this case the delay with the last clorgyline injection to
the mother was uncertain (between 3 and 10 hours). In addition, P3 pups were killed
3.5, 8, and 24 hours after a single clorgyline injection (10 mg/kg). The brains were
rapidly frozen in liquid nitrogen, and kept at -80°C. After homogenization of the
whole brains, 5-HT, 5-hydroxyindoleacetic acid (5-HIAA), and tryptophan (Trp)
amounts were measured with high-pressure liquid chromatography (HPLC) and
fluorometric detection (Kema et al., 1993).
4 Histology
For Nissl and cytochrome oxidase (CO) stains, most animals were killed at
P8 and P10 (Table II-1). Some treated mice were killed as adults (2 months). Mice
were deeply anesthetized with ether at P8 and P10, and with chloral hydrate (0.5
g/kg) as adults, and perfused transcardially with 4% paraformaldehyde in 0.1M
54
Periods of clorgyline treatments









Figure II-l Schedules of clorgyiine treatment. The different schedules of clorgyiine
treatment used in the present study are indicated with bars along a time-scale that marks
the days of pre- and postnatal development.
Table II-l. Clorgyline and saline treated pups and dams used in the different experiments in this report.
Treatment Dose Interval Period of the treatment Dams PO Animals Ages
(mg/kg) between pups Analysed
injections n n n










clorgyline 30 24h E15- ->P7 2 24 7 P8, P15
clorgyline 5 8h E15- ->P7 2 16 P8, P15
clorgyline 10 8h E15- ->P7 7 60 9 P8, P10
'Experiment 2: Varying the period of clorgyline administration
clorgyline 10 8h P0 >P7 50 17 P0,P10,
Adults
clorgyline 10 8h P0-AP4 3 16 P10
clorgyline 10 8h El 5 >P0 3 15 11 P10
clorgyline 8h P4->P7 2 24 P10
Animals that have been used for biochemical analyses are not counted in this Table. 1 For all these
periods saline-treated controls (n = 6) were analyzed in parallel with the clorgyline-treated mice.
phosphate buffer (pH 7.4). After perfusion, brains were removed from the skull and
weighed. One hemisphere was separated from the rest of the brain by a section
through the internal capsule and flattened between two glass slides separated by
spacers. The rest of the brain was kept as one block. Blocks were postfixed overnight
in the same buffered paraformaldehyde and cryoprotected in 30% sucrose phosphate
buffer. Serial, 40 micron-thick, frozen sections were obtained in the coronal or
tangential planes. Alternate series of sections were used for CO, as described by
Wong-Riley and Welt (1980), and Nissl (0.025% thionine in acetate buffer pH 5.5).
5-HT immunocytochemistry (rat monoclonal antibody from Harlan-Sera-lab,
clone YC5/45, 1:50; Consolazione et ah, 1981) was performed on frozen sections
from animals killed at P0 and P7, as previously described in Lebrand et al. (1996).
5 Histological analysis
Barrels were examined in Nissl- or CO-stained coronal sections, and the
entire barrel field was reconstructed from serial CO-stained tangential sections. The
outlines of the CO-dense clusters (barrels, abnormally shaped barrels, or fused
barrels) were drawn using a camera lucida and the drawings from consecutive
sections were aligned using blood vessels. Reconstructions from four to six animals
were made for each administration schedule at 10 mg/kg/8h clorgyline.
From the reconstructions made with the x6.3 objective, I determined the total
number of CO-dense clusters (barrels, abnormally shaped barrels, and fused barrels)
in the posteromedial barrel subfield (PMBSF). To evaluate the topographical
distribution of changes, the number of normal barrels were counted: a ) along the 5
longitudinal rows (A to E) of the PMBSF; b) along the eight transversal arcs (1-8) of
the PMBSF (see Rice and Van der Loos, 1977 for the nomenclature). The most
caudal barrels a, P, y, 8, that straddle barrel rows, were not counted in this scheme.
The surface area covered by the PMBSF and the anterior snout (AS) was
outlined on reconstructions made with the x2.5 objective and measured using a
morphometric software (Image Tool, The University of Texas Health Science Center
in San Antonio). The surface area of individual barrels was measured from
reconstructions made with the xlO objective. Only unfused barrels in B1-B4, C1-C5,
and D1-D5 in P0-P4 saline- or clorgyline-treated mice could be evaluated.
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The thickness of cortical layers II-IV and layers II-VI were measured in Nissl-stained
coronal sections, using an eyepiece graticule (xlO objective). The thickness of layer
IV was measured in CO-stained coronal sections (xl6 objective). Measurements
were taken along a line perpendicular to the pial surface, at two different levels: one
in the PMBSF, (level -1 posterior and -3.1 lateral to the Bregma), and the other in
AS, (level +0.7 anterior and -3 lateral to the Bregma).
IV Results
1 Optimization of clorgyline dosage regime
I determined the minimal dose and frequency of administration of clorgyline
capable of producing major alterations in the formation of the barrel field. After each
of the various protocols listed in Table II-l (Experiment 1), the barrel field was
examined with Nissl and CO stains at P8. I started with a 5 mg/kg daily injection of
clorgyline, a dose known to acutely inhibit MAOA activity by nearly 100% in adult
rats and which does not produce obvious behavioral alterations (Green and Youdim,
1975; Sleight et al., 1988). After daily administrations from E15 to P7, a few
abnormally shaped barrels were observed in CO-stained coronal sections (4 out of 14
pups). Increasing the daily dose to 30 mg/kg did not produce more substantial
modifications of the barrel field. Taking into account the higher rate of MAOA
synthesis in pups (Nelson et al., 1979; Samsa et al., 1979), I then increased the
frequency of clorgyline administration. Treating animals from El5 to P7 with 5
mg/kg/8h of clorgyline produced alterations in rostral barrels but had little effect on
the posteromedial barrel subfield (PMBSF). The 10 mg/kg/8h regime led to constant
and severe abnormalities throughout the barrel field. The following report will
therefore mainly deal with the latter dosage regime.
2 General developmental and behavioral effects of clorgyline administration
In mothers treated from El5 to P0 (5 mg/kg/24h or 10 mg/kg/8h), I observed
no effects of the clorgyline treatment on the duration of pregnancy, nor on the
survival and weight increase during pregnancy (Fig. II-2A). However, the size of the
litters, evaluated 4 to 8 hours after delivery, was reduced by 30% (Fig. II-2B)
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saline 10 mg/kg/8h5 mg/kg/24h
Treatments
Figure II-2 General developmental effects of clorgyline administrations. A, Weight
increase in gram units (gr.) during pregnancy in dams injected with saline (filled circles,
n = 5) and 10 mg/kg/8h clorgyline (open circles, n = 7). Mean ± SEM. B, Litter size at
birth in mice treated with saline (n = 7), 5 mg/kg/24h clorgyline (n = 3), or 10 mg/kg/8h
clorgyline (n = 7) from El 5 to P0. Mean ± SEM. C, Survival of pups receiving injections
of saline (filled circles) or 10 mg/kg/8h clorgyline from El 5 to P7 (open squares) or from
P0 to P7 (open circles). D, Weight increase in gr. of 10 mg/kg/8h clorgyline-treated pups
from 6 litters (open circles) versus saline-treated pups from 5 litters (filled circles).
Injections were administered during the P0-P7 period. Mean ± SEM. Significant
differences between groups (p < 0.05; Student's t test) are indicated with an asterisk* in
(B) and (D).
reflecting an increased perinatal mortality. Mortality of clorgyline-treated pups was
considerably increased during the subsequent 4 days of postnatal life (Fig. II-2C)
with a survival rate at P7 of 30% and 36% in the E15-P7 and P0-P7 administration
schedules, respectively. Surviving clorgyline-treated pups aged P3-P6 displayed a
slight, temporary retardation of their growth curve relative to controls, but their
growth returned to normal at P7 (Fig. II-2D). Clorgyline-treated pups displayed some
of the behavioral abnormalities described in the MAOA knockout pups (Cases et al.,
1995) such as agitation, trembling, hunched posture, increased righting time (15-20
seconds, instead of 1 second in controls), and abnormal rooting reflex. However,
these behavioral alterations were less intense and were no longer observable 24 hours
after the last injection. By contrast, saline-treated pups showed no changes in
survival, weight gain, and behavior compared to non-injected animals.
Clorgyline-treated dams, contrary to saline-treated dams, showed almost
constantly increased locomotor activity and excitability, even after the end of the
treatment, which were probably due to the long-lasting effects of clorgyline in adults
(Maitre et al., 1976). This could explain in part the high mortality rate of the pups
observed in the E15-P7 group. Nursing and nurturing defects have also been noted
previously when rat pups were treated with inhibitors ofMAOs (IMAOs) (Whitaker-
Azmitia et al., 1994).
3 Biochemical abnormalities
To evaluate the duration ofMAOA inhibition provoked by the administration
of clorgyline, I measured the amounts of 5-HT and its metabolite, 5-HIAA, 3.5, 8,
and 24 hours after a single subcutaneous injection at P3 (10 mg/kg) (Fig. II-3A). As
judged by the reduction in the amounts of 5-HIAA, MAOA inhibition was maximal
3.5 hours after the injection (55% reduction from controls) and a partial recovery was
observed by 8 hours (20-25% reduction from controls). 5-HT amounts were
increased by three-fold 3.5 and 8 hours after the injection.
Repeated injections of clorgyline (10 mg/kg/8h) over the P0-P7 period led to
a more complete inhibition of MAOA. There was a larger increase in 5-HT (eight¬
fold; Fig. II-3B), a larger decrease in 5-HIAA (80% reduction; Fig. II-3C), and a 6%
increase in tryptophan levels (not shown). Pharmacological inhibition with clorgyline






























































Figure II-3. Serotonin levels in the brains of clorgyline-treated pups compare to wild
types. A, Whole brain amounts of serotonin (5-HT; shaded bars) and 5-
hydroxyindolacetic acid (5-HIAA; cross-hatched bars) in P3 pups after a single 10 mg/kg
clorgyline injection. Pups were killed 3.5, 8, or 24 hours later (n = 5 for each point).
Saline-treated controls were killed at the beginning, t = 0 (n = 3), and at the end of the
experiment, t = + 24 hours (n = 3), and no difference was observed between these two
control groups, which are pooled in the first histogram. Values are expressed in
picograms per milligram of wet brain and represent the mean ± SEM. Asterisk indicates
that the results are statistically significant (p < 0.005; Student's t test). B, 5-HT and C, 5-
HIAA amounts in whole brains of mice receiving repeated injections of saline (filled
bars) or 10 mg/kg/8h clorgyline (shaded bars) following the E15-P7 schedule. Measures
were performed at E19 (n = 12), PO (n = 4), and P7 (n = 7). In graphs A and B, all values
of the clorgyline-treated group were statistically different from controls (p < 0.005;
Student's / test).
in PO pups born from treated mothers the amounts of brain 5-HT were four-fold
higher than in controls, while 5-HIAA was reduced by 70%, or 50% of the controls
(Fig. II-3C).
4 5-HT immunostaining
5-HT immunostaining at P7 was increased in the brainstem, diencephalon,
and cerebral cortex of P0-P7 clorgyline-treated pups. This increase was also visible
in PO pups bom from clorgyline-treated mothers. In tangential sections of the
cerebral cortex of P7 clorgyline-treated pups, 5-HT immunolabeling was markedly
increased in SI, as well as in the primary auditory and primary visual cortices. In SI,
the frontiers between cortical barrels were blurred (Fig. II-4B).
5 Effects on the barrel field
The patterning of the barrels was diversely affected by the different schedules
of clorgyline administration. In animals that had received clorgyline treatments only
during the embryonic period E15-P0, cortical barrels had a normal appearance on
CO- and Nissl-stained coronal sections. On reconstructions from CO-stained
tangential sections, the organization of SI was similar to that of controls (Figs. II-5A
and II-5B). Barrels and other characteristic CO-dense elements were distinguished in
the four main domains of SI: the PMBSF, AS, the lower lip (LL), and the forepaw
(FP). They normally have different aspects and sizes in these different parts: they are
largest and quadrangular in the PMBSF, smaller and roughly circular in the caudal
part of AS, have a stripe-like organization in the rostral part of AS, and are the least
sharply defined in LL and FP, where ovoid blobs are visible.
Severe alterations of the barrel field were observed in all pups that received
clorgyline from El5 to P7 or from PO to P7. On CO-stained coronal sections, barrels
were distinguished only in a few cases: large patches with blurred outlines were
observed in the most caudal part of the PMBSF (Fig. II-6E). Tangential
reconstructions of SI were made in 12 cases. In AS, barrels or stripes were
completely absent in 11 cases, and in one case showed a few disorganized clusters.
In LL, CO-positive clusters or blobs were completely lacking in 8 cases (Figs. II-5C
and II-5D). In the PMBSF, some barrels were visible in all the cases but there were
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Figure II-4 5-HT immunostaining in tangential sections of the flattened cortex at P7.
A, In saline-treated pup, moderate 5-HT immunostaining delineates SI with a barrel
pattern visible in the PMBSF and AS; the auditory cortex (Al) is also visible. B, In P0-P7
clorgy line-treated pup, 5-HT immunostaining is more intense, obliterating the normal
pattern of some barrels in SI. An artefactual crack on this section is indicated with an
asterisk (*) Scale bar = 330 pm.
Figure II-5 Representative reconstructions of SI were made from complete series of
cytochrome oxidase (CO)-stained tangential sections of flattened cortex. A, In a
saline-treated pup, the different regions of the somatosensory representation are indicated:
the large mystachial vibrissae (PMBSF), the anterior snout (AS), the lower lip (LL), and
the forepaw (FP); these regions are separated by large septa. Each division is subdivided
into barrels and stripes. B, Embryonic clorgyline injections (E15-P0) have no effects. C
and D, Severe alterations are seen in protracted postnatal clorgyline treatments. A
complete barrel fusion is seen in the AS and partial row-fusions (open arrow) or arc-
fusions (closed arrow) are visible in the PMBSF. E, Early postnatal clorgyline
administration (P0-P4) causes barrel disorganization and fusions in the LL, AS, and to a
lesser extent in the PMBSF. F, P4-P7 clorgyline injections have no visible effects on
formation of barrels in the different subfields.
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Figure II-6 Gradual alterations of the cortical barrels according to the period and
the duration of the clorgyline treatment. A, Normal barrels are visible as blobs of
increased CO activity or B, as clustered granular cells in layer IV, surrounding a cell
sparse hollow, with Nissl staining. C, In P0-P4 clorgyline-treated pups, barrels appear
larger than in controls on CO stains and D, are less clearly defined cytoarchitecturally on
Nissl stains. E, In P0-P7 clorgyline-treated pups, increased CO activity and F, granular
neurons form a continuous band in layer IV. Scale bar = 320 pm.
fusions of barrels within a given row, mainly in row A, or along the barrel arcs,
mainly between the rostral barrels of rows C, D, and E (Fig. II-7). Nissl-stained
coronal sections did not show the characteristic clusters in layer IV of SI (Fig. II-
6B); instead, granular neurons formed a uniform band with a moderate packing
density (Fig. II-6F). These cortical alterations were not accompanied by any obvious
abnormalities in the barrelette or barreloid patterns of the lower sensory stations (Fig.
II-8). Furthermore, cortical changes were permanent, as no barrels were
distinguished on CO- and Nissl-stained coronal sections from four adult mice that
had been treated with 10 mg/kg/8h of clorgyline from P0 to P7 (Figs. II-9A and II-
9B).
Less severe alterations of the barrel field were visible in P0-P4 clorgyline-
treated pups. In coronal sections, clustered CO-stained blobs were observed in the
caudal PMBSF (Fig. II-6C) and also occasionally in coronal sections, though the
anterior part of the barrel field. These CO-clusters had irregular shapes and blurred
contours. Tangential reconstructions of SI were done in 6 cases. In AS, barrels were
completely lacking in only one case, the other 5 cases displaying barrel-like CO-
positive clusters, albeit with a disorganized appearance compared to controls (Fig. II-
5E). In LL, segregation as blobs was absent in 4 cases. In the PMBSF, barrels were
always distinguishable, but with some barrel fusions similar to those previously
described, along arcs or rows (Fig. II-5E, and Fig. II-7). Nissl-stained coronal
sections through SI revealed a disorganized distribution of granular cells in layer IV;
with periodic differences in cellular density (Fig. II-6D), suggesting that some
architectonic differentiation had occurred.
In P4-P7 treated pups, barrels appeared to be normal on coronal sections, and
in all the 5 reconstructed cases, all PMBSF barrels could be identified, and barrels
were found in AS (Fig. II-5E). In the case illustrated, the patterning of AS differs
slightly from controls, but this is difficult to interpret because there are some
variations in the patterning of this subfield in normal animals.
To provide a quantitative comparison of the effect of these different
treatments, I counted the total number of CO-positive clusters as well as the number
of clearly formed barrels in the PMBSF (see Materials and Methods). These counts
confirmed that clorgyline had more potent effects when administered during the El 5-
P7 and P0-P7 periods, rather than just during the P0-P4 period, while a prenatal
treatment did not significantly augment clorgyline's deleterious developmental effect
59
Figure II-7 Pattern of barrel field alterations caused by MAOA inhibition viewed on
CO-stained tangential sections. A, Reconstruction of SI in a control case killed at P10,
showing the different trigeminal subfields, PMBSF, AS, and LL as well as the hindpaw
(HP) and forepaw (FP) representations. The 5 rows in the PMBSF are indicated with
letters from A to E, and the first five barrel arcs are indicated with numbers. B, E15-P7
clorgyline-treated mouse killed at P8: note the lack of barrels or CO-positive clusters in
AS, LL, and FP. In the PMBSF, the most rostral barrels are lacking with arc-like fusions
of barrels along arc 4 (C4, D4, and E4) and 5 (arrow). A row-like fusion is also visible
along row A (open arrow). C, A similar pattern of barrel field alterations is visible in
another case that received a clorgyline treatment from PO to P7 and was killed at P8. D,
higher magnification of C. Scale bar = 320 pm.
Figure II-8 Normal patterning in the lower stations of the somatosensory pathway,
in P10 pups. Different relays of the somatosensory pathway are shown with CO activity
(A-D) and Nissl (E, F). Barrelettes have similar staining and distribution patterns in the
trigeminal nucleus principalis of (A) controls, and (B) P0-P7 clorgyline-treated-pups.
Barreloids have similar staining and distribution in the ventrobasal thalamic nucleus of
(C, E) controls and (D, F) P0-P7 clorgyline-treated pups. Scale bar = 320 pm.
A
Figure II-9 Permanent alterations of layer IV in a two-month-old mouse treated with 10
mg/kg/8h clorgyline from PO to P7: granular neurons observed with Nissl staining (the
asterisk indicates a displaced fragment of the choroid plexus) (A) and CO activity (B)
form a continuous band in layer IV instead of clustered granular cells (Fig. 7A) or blobs
of increased CO activity (Fig. 7B). Scale bar = 640 pm.
(Table II-2). Furthermore, counts of the number of the normally formed barrels along
the rows and arcs confirmed the impression of a topographical distribution of the
barrel alterations: the reduction in the number of barrels was most severe in row A.
Row B, which is formed of four caudal barrels in the normal PMBSF, appeared to be
relatively spared by clorgyline treatments. Normal barrels were also less frequent
within rostral barrel arcs, comprizing arcs 3 to 8, in the E15-P7 and P0-P7
clorgyline-treated pups, and arcs 5 to 8 in the P0-P4 clorgyline-treated pups (Table
II-3). Barrel straddlers (a,p,y, 5), not included in the counts appeared to be fused in
about half the clorgyline-treated cases (El 5-07, P0-P7, and P0-P4).
6 Morphometry
Brain weights were similar in P0-P7 clorgyline-treated (308 ± 30 mg) and
controls (310 ± 7 mg) P10 mice. On Nissl-stained coronal sections, neither the
thickness of cortical layers II-VI, nor the thickness of the layers (II-IV) were
significantly changed by any of the treatments (Table II-4). By contrast, the thickness
of layer IV, measured as the reactive CO-dense zone, was reduced by 10-20% (Table
II-5).
The surface area comprising the PMBSF and AS in the tangential sections, showed a
significant 10-20% increase in the P0-P7 and E15-P7 clorgyline-treated pups, but
appeared unchanged with the E15-P0, P0-P4, and P4-P7 treatments (Fig. II-10A).
Measurements of the individual barrel areas were done in the P0-P4 clorgyline-
treated pups, considering only the unfused barrels that could be identified in rows B,
C, and D. Significant increases in size were noted for barrels C3 to C5 and D3 to D5,
whereas changes were non-significant for the more caudal barrels CI, C2, Dl, and
D2 and for barrels B1 to B4 (Fig. II-10B). Measurements of individual barrel areas in
the P4-P7 treated mice showed no significant difference with controls. Such
measures were not feasible in the other treated groups because of the frequency of
fusioned barrels.
V Discussion
The present study shows that pharmacological inhibition of MAOA activity
during development irreversibly alters the formation of barrels in the mouse
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Table II-2 Number of CO positive clusters (normal barrels, abnormal shaped barrels,
and fused barrels) and number of clearly defined barrels that can be identified in the
PMBSF of P10 pups treated with saline or clorgyline (10 mg/kg/8h) during different
periods. These counts were obtained from flattened reconstructions. Mean ± SEM.
Asterisk indicates a statistical difference with the control group (* p < 0.05; Student's
t test). Circles indicates a statistical difference between the different clorgyline
schedules and the P0-P7 treated group (° p < 0.05; Student's t test).
saline clorgyline
P0-P7 E15-P0 E15-P7 P0-P7 P0-P4 P4-P7
(n = 5) (n = 5) (n = 4) (n = 5) (n = 6) (n = 4)
CO-clusters in the 30 29.5 17 19.4 23.8 29.7






30 29.5 12.3 14 19 29.7





Table II-3 Topographical distribution of barrel alterations. Number of clearly
defined barrels along rows and arcs of the PMBSF as identified on complete SI
reconstructions. Analysis was done in P10 pups treated with saline or clorgyline (10
mg/kg/8h). Values represent the mean ± SEM of n cases. Asterisk indicates a statistical
difference with the saline group (** p< 0.01, * p < 0.05; Student's t test).
saline clorgyline
P0-P7 E15-P0 E15-P7 P0-P7 P0-P4 P4-P7
(n = 5) (n = 6) (n = 4) (n = 5) (n = 6) (n = 4)
Rows







B 4 4 4 4 4 4






















1 5 5 4.3 ±0.9 4.4 ±0.5 4.5 ±0.6 5
2 5 5 4 4.4 ±0.5 4 ±0.7 5






















7 2 2 0 0 0.5 ±0.7
*
2
8 1 1 0 0 0.2 ±0.3
*
1
Table II-4 Cortical thickness in P10 pups treated with saline or
clorgyline (10 mg/kg/8h) during different periods. Measures were
obtained from Nissl-stained coronal sections at the level -1 mm
posterior, -3.1 mm lateral to the Bregma. Mean ± SEM.




saline P0-P7 467 ± 20 1195 ±34
(n=3)
clorgyline E15-P0 413 ±32 1023 ±22
(n=6)
clorgyline P0-P4 410 ±39 1088 ±90
(n=6)
clorgyline P0-P7 462 ±24 1169 ±64
(n=6)
Table II-5 Thickness of cortical layer IV in P10 pups treated with
saline or clorgyline (10 mg/kg/8h) during different periods.
Measures were obtained from CO-stained coronal sections at two
different stereotaxic levels: -1 mm posterior and -3.1 mm lateral, and
+ 0.7 mm anterior and -3 mm lateral, to the Bregma. Mean ± SEM.
Treatment Period of Thickness of layer IV (pm) at
(number of treatment level to the Bregma
pups)
-1 ; -3.1 mm +0.7; -3 mm







































D1 D2 D3 D4 D5
Figure 11-10. Morphometric analysis of the barrel field of clorgyline-treated pups.
A, Area of the PMBSF plus the AS measured on CO stains from pups treated with
saline (n = 4) or 10 mg/kg/8h clorgyline during different periods: E15-P0 (n = 6), P0-
P4 (n = 6), P4-P7 (n = 5), P0-P7 (n = 6), and El 5-P7 (n = 4). ** = p < 0.005, *= p <
0.025 (Student's t test). B, Histograms representing the area of individual CO-stained
barrels after saline (n = 4) and P0-P4 clorgyline treatment (n = 6). * indicates
significant differences (p < 0.05; Student's t test) between saline- and clorgyline-
treated pups.
somatosensory cortex. The degree of cortical abnormality is strongly related to the
time period during which MAOA activity is inhibited, with a sensitive period during
the first 4 days of postnatal life, but with more pronounced effects when MAOA
inhibition is maintained throughout the first postnatal week.
1 Pharmacological blockade of MAOA activity: evaluation of the present model
and comparison with MAOA knockout mice
Monoamine oxidases (MAOs) are key enzymes in the degradation pathway of
monoamines. Two MAOs exist in the brain, MAOA and MAOB (review in Weyler
et al., 1990). Although closely related in their gene structure (Shih, 1991), MAOA
and MAOB differ in several characteristics: MAOA is abundant in noradrenergic
neurons (Luque et al., 1995; Jahng et al., 1997), has a preferential affinity for 5-HT,
and is selectively inhibited by clorgyline, whereas MAOB is abundant in
serotoninergic neurons and glial cells, has a lower affinity for 5-HT, and is
selectively inhibited by deprenyl. Compounds that inhibit MAOA exhibit
antidepressant activity (review in Tipton, 1989). In rodents, developmental studies
have shown that MAO activity in the brain appears early in ontogeny, by El5
(Bourgoin et al., 1977), with MAOA activity initially predominating over MAOB
(Mantle et al., 1976). By PI5, MAOA is maximal, whereas MAOB activity reaches
50% of adult values (Jourdikian et al., 1975).
In a transgenic mouse line characterized by the deletion of exons 2 and 3 of
the gene encoding MAOA, and resulting in the absence of measurable MAOA
activity, I observed a peculiar developmental abnormality in the primary
somatosensory cortex, where layer IV cortical neurons and afferent thalamic fibers
failed to organize in barrels (Cases et al., 1995; 1996). Similar though less extensive
alterations were produced when the corresponding wild-type mice (inbred strain
C3H/HeJ) were treated with the MAOA inhibitor clorgyline (Cases et al., 1996). In
order to generalize these findings, an important first step was to show that similar
effects could be obtained in other mouse strains. In the present study, abnormalities
in barrel formation were observed after MAOA inhibition in the OF1 mouse strain. I
found that these alterations were similar to those observed in the C3H/HeJ mice.
However, in parallel unpublished studies, I observed variations of the effects of
MAOA inhibition among different mouse strains. In F1 hybrids between the
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C57BL/6 and C3H/HeJ strains, clorgyline treatments from PO to P7 induced only
minor changes in the AS field, while treatment from PO to P4 produced no visible
cortical alterations (T. Vitalis and O. Cases, unpublished observations).
Correspondingly, MAOA knockouts with a C57BL/6 genetic background, obtained
by repeated backcrossing, have some, ill-defined barrels in the caudal PMBSF (I.
Seif and P. Gaspar, unpublished observations). This suggests that according to the
mouse strain, factors that modulate the levels or effects of 5-HT are differently
regulated. Indeed, amounts of MAOs (Voitenko, 1992), tryptophan hydroxylase
(Knapp et al., 1981; Daszuta et al., 1984; Kulikov et al., 1995), 5-HT receptors, 5-HT
transporter, as well as the number of serotonergic raphe neurons (Daszuta and
Portalier, 1985) appear to differ among inbred mouse strains.
The milder severity of alterations in clorgyline-treated mice as compared with
MAOA knockouts with identical genetic background could be due to incomplete
inhibition of MAOA. Incomplete inhibition ofMAOA might be particularly critical
during specific periods such as the perinatal period. Clorgyline is an irreversible
inhibitor ofMAOA and the duration of its effects is linked to its elimination and the
rate of synthesis of MAOA, with a replacement rate in MAO activity varying from
24 hours in rat or mouse pups (Nelson et ah, 1979; Samsa et ah, 1979), to 10-12 days
in adult rats (Maitre et ah, 1976). Present observations indicate that a partial recovery
ofMAOA activity occurs as soon as 8 hours after a single clorgyline administration
at P3. Thus, although chronic administration of clorgyline every 8 hours resulted in a
near-complete inhibition of MAOA at P7, as reflected by the increased levels of
brain 5-HT that mirrored those observed in the MAOA knockouts, there could be
fluctuations in these levels. For instance, at PO, brain levels of 5-HT increased four¬
fold in pharmacologically treated versus nine-fold in MAOA knockouts, probably
reflecting the difficulty of drug administrations during the perinatal period. A
continuous mode of administration of clorgyline, such as afforded by minipumps,
would be needed to evaluate the importance of these fluctuations. A critical threshold
of brain 5-HT may exist, above which cortical abnonnalities occur. Below such a
level, compensatory mechanisms might be active: for instance other
neurotransmitters could antagonize the effects of 5-HT, or changes in number or
affinity of 5-HT receptors and monoaminergic transporters could dampen the effects
of 5-HT increase. Such compensations would become ineffective when the brain is
overwhelmed with large amounts of 5-HT.
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The present protocol is potentially flexible and could be applied to other
useful experimental species, such as rats or felines, to determine whether similar
effects of MAOA inhibition on the formation of cortical maps can be observed. The
variability of effects observed between different mouse strains is however an
indication that interspecies differences are to be expected.
2 Period sensitive to MAOA inhibition: relationship to stages in barrel field
development
The present pharmacological study, together with previous observations in
the MAOA knockout mice, allows me to narrow down the sensitive period during
which MAOA inhibition can alter the development of barrels.
In the rodent trigeminal system, the formation of the cortical map and its
differentiation into barrels results from a precisely timed sequence of events, which
can be separated into three main epochs. The first period corresponds to the
formation of a topographic map of the VB in the cortex. During fiber outgrowth, VB
axons maintain a strictly ordered topography (Molnar and Blakemore, 1995;
Catalano et al., 1996) that is in register with the peripheral topography initiated in the
trigeminal nerve and transmitted to the trigeminal nerve nuclei and to the VB
(Erzurumlu and Killackey, 1983). All these processes which occur during embryonic
life are not affected by MAOA inhibition. Indeed, clorgyline treatments during
embryonic life caused no visible effects and did not increase significantly the
postnatal effects ofMAOA inhibition (comparison of E15-P7 with P0-P7 clorgyline
treatments). Accordingly, in MAOA knockouts, inhibition of 5-HT synthesis during
postnatal life (P0-P6) suffices to reverse the barrel field abnormalities (Cases et
al.,1996). Furthermore, the topographic organization of the thalamocortical
projection, revealed with anterograde tracers in adult MAOA knockouts, appeared to
be normal (Cases et al.,1996).
The second major step is the formation of periphery-related clusters in SI.
This process seems to be dictated by a tendency of thalamic terminal axons carrying
information from a functional group of peripheral receptors (large vibrissa, sinus
hair, or digits) to cluster together, first in layer VI, then in layer IV, where they
induce the characteristic cellular ring-like cytoarchitectonic differentiation (Rice and
Van der Loos, 1977; Senft and Woolsey, 1991 a,b; Agmon et al., 1993). These
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processes which occur essentially during the first 4-5 days of postnatal life appear to
be most affected by the clorgyline treatments. Indeed, clorgyline treatments during
the first five days of life sufficed to cause alterations in the barrel field while
clorgyline treatments after P4 caused no visible changes of the barrels. This time
limit coincides with that disclosed for the effects of lesions of peripheral receptors
(Woolsey and Wann, 1976; Belford and Killackey, 1980; Jeanmonod et al., 1981)
indicating that the cytoarchitectonic differentiation of granular neurons in layer IV is
an irreversible process once it has been initiated. The exact step that is disrupted by
excess 5-HT during this 4-day period remains to be determined.
The third and last phase of barrel development extends until probably P21
and is characterized by the functional maturation of the barrels, coinciding with an
extensive collateral arborization of the thalamic axonal arbors within the confines of
a given barrel (Agmon et al., 1993). A corresponding maturation of the cortical
targets occurs with extensive dendritic remodeling, formation of dendritic spines and
synapses (White et al., 1997). The general resultant of these cellular events is a
growth in the size of individual barrels and in the total area of SI (Rice and Van der
Loos, 1977; Riddle et al., 1992). I could not detect a clear effect of clorgyline
treatments between P4 to P7. However, the histological methods used in the present
study do not allow me to monitor more subtle developmental events that could be
affected by the excess of brain 5-HT, such as the fine topographic arrangement of
thalamocortical afferents. For instance, early sensory deprivation, or application of
an NMDA-receptor antagonist, to the cortex, caused no cytoarchitectonic changes of
the barrel field although electrophysiological studies demonstrated the presence of
topographically inappropriate thalamic projections (Fox, 1992; Fox et al., 1996).
An observation for which I have as yet no clear interpretation is that barrel
field changes were more important when MAOA inhibition was maintained until the
end of the first postnatal week rather than just during the first five postnatal days.
This difference could be interpreted as resulting from a delay in the cellular
processes of barrel formation, that could still be re-initiated when MAOA inhibition
ceases at P4, but not when it ceases at P7. However, in other experimental situations
where a delay in barrel formation was observed, such as caused by 5-HT neurotoxins
(Blue et al., 1991; Osterheld-Haas et al., 1994; Osterheld-Haas and Hornung, 1996),
or protein malnutrition (Vongdokmai et al., 1980) a normal barrel field eventually
formed, whereas the patterning of the barrel field remained abnormal after P0-P4
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clorgyline treatments. The synergism of P4-P7 clorgyline treatments with the P0-P4
treatment could indicate that there are some later effects of 5-HT on barrel
development, but that these become apparent only when primed by an early effect
during the initial stages of barrel development.
3 Gradients of changes in the barrelfield
Barrel alterations in the representation of the whisker pad were not uniformly
distributed, effects were more marked in the rostral fields where the small vibrissae
are represented than in the posterior field where the large caudal vibrissae are
represented. Indeed, barrel fusions were more frequent in the AS representation and
in the rostral part of the PMBSF, where significant enlargments of « intact»
individual barrels was also seen. Exceptions to this general trend were the largest and
caudal-most barrels (a, P, y, and 5), which were frequently fused.
Several hypotheses can be proposed to explain this phenomenon. The
sequence of development of the face vibrissae proceeds from ocular to nasal and this
temporal sequence is replicated at least at the level of the trigeminal nerve and the
brainstem (Erzurumlu and Killackey, 1983). A caudal to rostral sequence of
emergence of periphery-related patterns has also been described in the
somatosensory cortex. This can be seen in the ACh-E preparations of Schlaggar and
O'Leary (1994), where barrel-like patterning is visible in the PMBSF before it
emerges in AS. Using 5-HT immunostaining, that also reveals the thalamocortical
afferents, Rhoades et al. (1990), described a clear caudal to rostral sequence of fiber
clustering in SI. Later in development, boundary patterns of cortical glia
(McCandlish et al., 1989) and markers of synaptogenesis (Stettler et al., 1996), were
described as following a similar gradient of maturation. In this view, excess 5-HT
would have more pronounced effects on the rostral, relatively immature thalamic
fibers compared with the more mature caudal ones, and the fact that I were not able
to disrupt the caudalmost barrels even when administering clorgyline before birth,
could be due to an unsufficient MAOA inhibition during late embryonic and early
postnatal life.
These gradients should also be considered in the context of a difference in the
geometry and function of the peripheral receptors that are mapped in the caudal
versus the rostral parts of SI: the large vibrissae mapped in the PMBSF are more
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widely separate on the snout than the anterior sinus hair of the AS. Large PMBSF
vibrissae could thus be expected to be functionally autonomous and to have
asynchronous activity compared to their neighbours. This would provide a larger
drive for segregation of afferents than in the case of the small AS vibrissae. If excess
5-HT, antagonizes this process, one could therefore have more visible effects in the
AS than in the PMBSF. This hypothesis derives from the general hypothesis that
activity-dependent mechanisms are regulating the segregation of sensory afferents
following the principle that "cells that fire together wire together" (review in Shatz,
1990).
4 Mechanisms of MAOA inhibition
It is important to consider whether the effects of clorgyline on barrel field
development are due to a general effect on growth, since clorgyline administration
caused a deficit in weight gain between P3 and P6. This is an unlikely explanation
however, because protein malnutrition in mice causes only a two-day delay in the
development of the barrels and in the sensitive period to neonatal vibrissal damage
(Vongdokmai et ah, 1980), and not a persistent absence of barrels as observed in this
study.
Despite the ignorance about the precise mechanism of 5-HT action in the
developing somatosensory thalamocortical system, the developmental pattern of
expression of 5-HT receptors in this system should be a good indication of the
potential cellular targets of 5-HT.
In the cortex, pyramidal cells in layers II-III express functional 5-HT2
receptors during development and their activation reduces gap junction coupling
(Rorig and Sutor, 1996). Scattered cortical neurons have been shown to express 5-
HT3 receptor gene (Tecott et al. 1995). However, these neurons would constitute
unlikely targets in the process of barrel formation within layer IV, and it has not yet
been determined whether layer IV neurons or glia express any 5-HT receptors,
during the sensitive period of barrel development.
On the other hand, developing VB thalamic fibers express both SERT
(Lebrand et al., 1996) and 5-HTiB receptor subtype between El5 and P10 (Lebrand
et al., in preparation). SERT causes 5-HT to accumulate in large excess in VB
neurons when MAOA is inhibited (Cases et al.,1998) and thereby, could cause an
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abnormal development. Indeed, an abnormal tangential distribution of the
thalamocortical fibers in the clorgyline-treated mice was presently visualized with 5-
HT immunocytochemistry. Excessive stimulation of the presynaptic 5-HT]B receptor
subtype might cause a complete inhibition of the excitatory neurotransmission in the
thalamocortical circuit, interrupting any activity-dependent mechanism that could be
responsible for the segregation of the thalamocortical axons. Alternatively, activation
of the 5-HTib receptor subtype or internalization of 5-HT might also have a direct
trophic action on axonal growth, that would mask the underlying segregation
processes.
Indirect clues on the mechanisms underlying 5-HT's effects may be drawn
from comparing the effects of MAOA inhibition with that of different types of
lesions. The fact that 5-HT has no instructive effects per se on barrel formation is
demonstrated by the early lesions of the 5-HT system that cause no disruption in the
general patterning of the barrel field (Blue et al., 1991; Bennett-Clarke et ah, 1994,
Osterheld-Haas et ah, 1994). On the other hand, these studies suggest that 5-HT may
have a trophic effect on thalamocortical and barrel development. In neonatal rat
pups, 5,7-dihydroxytryptamine (5,7-DHT) or fenfluramine administration caused a
decrease in the tangential area covered by individual barrels in the PMBSF (Bennett-
Clarke et ah, 1994; 1995) and a delay in the laminar differentitation of layer IV was
noted in 5,7-DHT treated mice (Osterheld-Haas and Hornung, 1996). These findings
are however hampered by the possibility that 5-7 DHT could have a direct toxic
effect on the developing thalamic neurons, because it may be taken up in these
neurons by SERT.
5-HT could be acting as a modulator of peripheral influences derived from
the periphery. Lesions of the infraorbital nerve (ION), the trigeminal branch that
supplies the whisker pad, produce effects similar to that of MAOA inhibition in that
there is loss of the characteristic thalamocortical clustering and a lack of
cytoarchitectonic differentiation in layer IV. However, the pattern of PMBSF
alterations resulting from such lesions differed: the deprived territory appeared
atrophic and disorganized with a main outline of the 5 barrel rows (Jensen and
Killackey, 1987b; Killackey et al., 1994) (Figure 11-11). By contrast, clorgyline
treatment during the sensitive period results in barrel fusions, both within and across
rows with a general trend for hypertrophy as there was an increase in the size of the
trigeminal representation, or of individual barrels. Furthermore, MAOA inhibition
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Figure 11-11 Schematic representation of the barrel field (PMBSF and AS) pattern after
MAOA inhibition, in comparison with reported changes after infraorbital nerve
transection (Killackey et al., 1994), and with described patterns of thalamocortical
afferents in PO rat pups (redrawn from Schlaggar and O'Leary, 1994).
caused no visible alterations in the trigeminal nerve nucleus and VB, contrary to the
effects of lesions (Killackey et al., 1994; Durham and Woolsey, 1984). These
different patterns of alterations could indicate that peripheral lesions interrupt a
trophic influence originating from the peripheral receptors whereas excess 5-HT does
not. Anterograde transport of neurotrophic molecules from the periphery has been
recently demonstrated in the chick developing visual system (Von Bartheld et al.,
1997) and could well exist in the rodent somatosensory system, as suggested by
recent observations (Wilkinson et al., 1996; Chiaia et al., 1996). In this respect, the
effects of 5-HT may be viewed as being limited to the distalmost component of this
ascending sensory pathway, which is the synaptic interaction of ingrowing terminals
with their maturing cortical targets. Direct evidence derived from
electrophysiological studies, pharmacology, single axonal reconstructions, and




Importance of TrkB signalling
in themurine somatosensory cortex
CHAPTER THREE:
IMPORTANCE OF TRKB SIGNALLING IN THE MURINE
SOMATOSENSORY CORTEX.
I Abstract
In this chapter, I show that the catalytic trkB tyrosine kinase receptor is
strongly expressed in layer IV of the somatosensory cortex from PO to P10. This
period corresponds to the sensitive period of establishment of both granular neurons
and thalamocortical axons in barrels. To elucidate if trkB has a role in these
processes, I have analysed the somatosensory thalamocortical system in mice lacking
trkB. I show that trkB is not essential in the clustering of granular neurons in barrels,
although thalamocortical axons display subtle morphological alterations, expanding
abnormally in layer II-III but not tangentially. This suggests that cortical trkB
signalling participates in the fine clustering of thalamocortical axons.
I also wanted to evaluate the effects of trkB signalling in MAOA knockout
mice. MAOA knockout mice display both an abnormal exuberant tangential
thalamocortical projection and an abnormal clustering of granular neurons in layer
IV. I showed that trkB mRNA levels are normal in MAOA knockout mice,
suggesting that abnormal expression of trkB is not essential in the phenotype
displayed by MAOA knockout mice. Interestingly, the lack of trkB in MAOA
knockout mice induced a much more expanded tangential thalamocortical projection
as revealed by 5-HT, SERT and VMAT2 immunolabelling. In addition, MAOA-trkB
double knockout mice displayed also an abnormal vertical expansion of SERT
immunolabelling in layers II-III, similar to those observed in trkB knockout mice.
These results suggest that the mechanisms inducing the abnormal phenotypes in
MAOA knockout mice are independent of trkB, although knock out of both genes
can act synergistically.
Interestingly, MAOA-trkB double knockout mice displayed a much better
survival rate than trkB knockout mice. However, similar reductions in body and
brain weights and cortical thickness between both strains were observed by P8.5. I
have also compared the cell death in the CNS of MAOA-trkB double and trkB
knockout mice. I showed decreased numbers of pyknotic profiles in specific brain
regions of MAOA-trkB knockout mice compared to trkB knockout mice. This
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suggests that increasing monoamines (5-HT and NA) levels in the brain of trkB
knockout mice prevents or delays the cell death of discrete neuronal populations such
as the accumbens and cingulate cortex.
II Introduction
Excess of 5-HT affects late events in the development of the somatosensory
thalamocortical system, such as the morphology of axonal terminals and dendritic
processes or migration of cortical neurons. Candidate molecules that may be affected
are unknown. In this chapter, I have explored the hypothesis that 5-HT could directly
or indirectly modulate the actions of trophic factors, such as neurotrophins, in the
somatosensory thalamocortical system. Second, I have tested whether the signalling
through one of the neurotrophin receptor, TrkB, is requiered for the effects of excess
5-HT. Neurotrophins are trophic factors expressed in the CNS and have a wide
spectrum of effects, such as neuronal survival, axonal guidance or neurite outgrowth.
A hypothesis tested in this chapter is that an excess of 5-HT could induce an excess
of "neurotrophic effects" that lead to an abnormal exuberant growth of thalamic
fibers in the somatosensory cortex.
1 Neurotrophins and their receptors
Several neurotrophins have been identified, all of which are able to promote
the survival of a large range of neuronal populations: nerve growth factor (NGF;
Levi-Montacini, 1987), brain-derived neurotrophic factor (BDNF; Barde et al.,
1982), and neurotrophins 3 (NT-3; Ernfors et al., 1990) and 4/5 (NT-4/5; Berkemeier
et al., 1991; Hallbook et al., 1991). Neurotrophins act through membrane receptors
whose activation leads to a cascade of intracellular phosphorylations. Three high
affinity receptors have been identified, and belong to a family of tyrosine kinase
proteins. TrkA binds preferentially NGF, TrkB binds both BDNF and NT-4/5 with
the same affinity and TrkC binds preferentially NT-3 (Barbacid, 1994). In addition, a
low affinity receptor, p75, which binds all the neurotrophins with the same affinity
has been identified (Chao, 1994).
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2 Neurotrophins and critical periods during sensory development
Several observations suggest that neurotrophins play important roles in the
control of developmental plasticity; for instance, exogenous supply of neurotrophins
counteracts the effects ofmonocular deprivation and dark rearing, and blocking their
activity prevents the formation of ocular dominance columns. They can modulate
synaptic transmission and, like NMDA receptors, their expression is developmentally
regulated and dependent on electrical activity (Caleo et ah, 1999; Berardi and Maffei,
1999). This reciprocal regulation between neurotrophins and neural activity may
provide means by which active neuronal connections are selectively strengthened.
Indeed, neurotrophins seem to require the presence of electrical activity in order to
exert their effects (McAllister et ah, 1999). Particularly compelling evidence for this
comes from Caleo et al. (1999), who have shown that NGF signalling via trkA
receptor must be coupled with afferent electrical activity to prevent the effects of
molecular deprivation. In addition, there is clear evidence that neurotrophins control
the duration of the critical period; in fact, they are the first molecules for which a
causal relation has been established between their action and the duration of critical
periods in mammals. The first evidence came from the finding that blockade of
endogenous NGF through the use of antibodies prolongs the duration of the critical
period, an effect similar to that of dark-rearing (Domenici et al., 1994). Very
recently, in an elegant study using transgenic mice that overexpress BDNF in the
forebrain, Huang et al. (1999) have found accelerated visual development and early
cessation of synaptic plasticity that is enabled by LTP in the visual cortex. These
findings suggest that BDNF controls the time course of the critical period by
accelerating the maturation of GABAergic inhibition.
To summarise, BDNF regulates GABAergic inhibitory intemeurons
(Carnahan and Nawa, 1995), potentiates GABA release (Sala et al., 1995), and
mediates the activity-dependent regulation of synaptic inhibition (Rutherford et al.,
1998). In addition to these actions, BDNF has been repeatedly found to affect
excitatory transmission; also, modulation of NMDA responses by BDNF has been
recently suggested (Carmignoto et al., 1997; Levine et al., 1998).
3 Neurotrophins and the somatosensory system
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In the somatosensory cortex, several studies have shown that neurotrophins
can rapidly modulate activity-dependant stimulation; for instance in adult rats, levels
of BDNF mRNA in non-GABAergic neurons are increased after sensory stimulation
of the whiskers (Rocamora et al., 1996). In addition, exogenous supply of BDNF to
the surface of the somatosensory cortex leads to a decrease in the size of the
receptive field of a whisker and to a decrease in the amplitude of cortical activity-
dependent signals (Prakash et ah, 1996). It is important to note that mice deficient for
trkA, trkB, trkC, p75, BDNF or NT4/5 display no obvious alteration of the barrel
field (Henderson et al., 1995).
4. TrkB signalling in the neocortex
The effects of trkB signalling on the development of neocortical neurons has
been of particular interest due to the correlation between the spatial and temporal
patterns of expression of the trkB receptor and its ligands during corticogenesis, and
the known effects of trkB activation on neuronal survival and function in vitro.
Immunocytochemical and in situ hybridisation analyses have shown that expression
of trkB receptors and/or ligands are increased during corticogenesis. TrkB activation
has been shown to influence the survival (Nawa et ah, 1994), differentiation
(McAllister et ah, 1995, 1997; Horch et ah, 1999), connectivity (Katz and Shatz,
1996) and neurotransmitter release (Wang and Poo, 1997) of neocortical neurons
both in vivo and in vitro. Finally, one well known action of trkB in developing
neocortical neurons is the regulation of dendritic growth (Yacoubian and Lo, 2000).
Together, these findings led to the hypothesis that trkB signalling may be critical for
neocortical neuronal development.
Determining the effects of the deletion of trkB on neocortical neuronal
survival, differentiation, and function has been difficult with mutant mice alone due
to the neonatal lethality caused by the trkB gene deletion. While gross anatomical
analysis of trkB knockout mice suggests normal neocortical cytoarchitecture within
neonatal mice (Silos-Santiago et ah, 1997), other studies point to a significant
increase in apoptotic cell death and reduced cell numbers in layer II/III, V, and VI of
the developing mutant cortex (Alcantara et ah, 1997). Recently, subtle anatomical
abnormalities have been observed in mutant cortex such as reduced survival and
neurite outgrowth in vitro, and delayed neuronal migration and differentiation in vivo
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(Gates et al., 2000). Limitations on the importance of trkB in neocortical
development are potentially confounded by unrelated cranofacial sensory and
suckling defects that greatly reduce the health and postnatal lifespan ofmutant mice.
This early death occurs before the more superficial neocortical layers II/III and IV
fully develop, and before the processes of axon pathfmding, fiber pruning and
synaptogenesis in the neocortex are complete. Recently, this problem has been
circumvented obtaining viable conditional trkB knockout mice. In these mutant mice,
only layer V neurons display a lack of trkB. Following trkB deletion in layer V
pyramidal cells, their dendritic arbors are altered, and cortical layers II/III and V are
compressed, after which there is an apparent loss of mutant neurons expressing the
transcription factor SCIP but not of those expressing Otxl (Xu et al., 2000). Taken
together, this shows that trkB is required for the differentiation and maintenance of
specific populations of cells in the developing and adult neocortex.
5 Aim of the work
In this chapter, I wanted to show if trkB signalling has a role in the critical
period of the somatosensory thalamocortical system. In the first place, I studied the
spatio-temporal pattern of catalytic trkB during the critical period of the
somatosensory thalamocortical system. Then, I characterised subtle alterations in the
somatosensory cortex of trkB knockout mice. Moreover, I wanted to know if there
was a link between 5-HT and trkB signalling in the alterations displayed by MAOA
knockout mice. The basic hypothesis would be that 5-HT could regulate a trkB-
promoted outgrowth of thalamic fibers in the somatosensory cortex. First, I obtained
the pattern of expression of trkB in MAOA knockout mice to evaluate if 5-HT could
act on the transcription of this molecule. Then, I obtained MAOA-trkB double
knockout mice to see if the alterations observed in MAOA knockout mice were
unchanged.
II Material and methods
1 Mice
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trkB knockout mice were generated with a targeted mutation in the tyrosine
kinase domain (Klein et ah, 1993). trkB knockout mice were maintained on a mixed
C57/B16-Svl29 genetic background. MAOA knockout mice displayed a deletion of
exon 2 and 3 in the gene encoding MAOA (Cases et ah, 1995). MAOA knockout
mice were originally obtained and maintained on a C3H/He genetic background.
Mice double knockout for trkfi and MAOA were obtained in the F2 progeny from
crosses between females heterozygous for MAOA and trkB and males hemizygous
for MAOA and heterozygous for trkB. trkB knockout, MAOA knockout and wild
type mice were obtained from the same crosses. Genitors and pups were genotyped
for trkB and MAOA mutations. For trkB genotyping, the same primers as previously
described by Klein et al. (1993) were used. For MAOA genotyping, two couples of
primers were used. The first couple was used to detect the presence of the transgene
(5': CTCAGAAGTCGGATCTGAT in the H2-Kb and 3':
CAGTAGATTCACTACCAGTC in the interferon-P gene). The other couple of
primers corresponded to a sequence that is only present in the normal allele (5':
GATTCTCTCCTATTGTCTCTG and 3': AAAGACAGTTGTGAAGCCTCA).
2 Immunocytochemistry and histochemistry
Postnatal mice were analysed at postnatal day 0 (PO) and P8.5 (the day of
birth was counted as PO). Pups were anaesthetised and fixed in 4% paraformaldehyde
in 0.12M phosphate buffer, pH 7.4. All mice were perfused transcardially and
postfixed in fresh fixative overnight. After perfusion, brains were removed from the
skull and weighed. One hemisphere was separated from the rest of the brain by a
section through the internal capsule and flattened between two glass slides separated
by spacers. The rest of the brain was kept as one block. Blocks were postfixed
overnight in the same buffered paraformaldehyde and cryoprotected in 30% sucrose
phosphate buffer. Serial, 40 pm-thick, frozen sections were obtained in the coronal
or tangential planes. Alternate series of sections were used for CO, as described by
Wong-Riley and Welt (1980), and Nissl (0.05% thionine in acetate buffer pH 5.5).
5-HT immunocytochemistry (rat monoclonal antibody from Harlan-Seralab, clone
YC5/45, 1:20 to 1:50; Consolazione et al., 1981) was performed on frozen sections
as previously described in Lebrand et al. (1996). VMAT2 (1:4000, Phoenix
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Immunochemicals) and SERT (1:2000, Calbiochem) immunocytochemistries were
also performed on sections from P8.5 animals.
3 In situ hybridisation for trkB
trkB cRNA probes, corresponding to the tyrosine kinase domain of the
protein were used (Klein et al., 1993). The plasmid was linearised with BamHl for
antisense RNA synthesis by T7 polymerase and with EcoRI for sense RNA synthesis
by T3 polymerase. The in vitro transcription was carried out using the Promega kit
and probes were labelled with 35S-UTP (>1000 Ci/mmol; Amersham). In situ
hybridisation for cRNA probes was performed on fresh frozen brain sections (15 pm
thick). Tissue sections were postfixed for 15 mn in 4% paraformaldehyde, washed in
PBS, acetylated, washed in PBS, dehydrated, and air-dried. Sections were covered
with hybridisation buffer containing 5xl04 cpm pf1 of the 35S-trkB probes (12.5
pl/section), and then incubated overnight in a humid chamber at 48°C. Washes were
then performed as previously described in Fontaine and Changeux, 1989.
Autoradiograms were obtained by apposing the sections to hyperfilms (P-max,
Amersham) for several days. Autoradiographic films were developed in D19
(Kodak) for 3 min at 20°C, and fixed in A14 (Ilford) for 5 min. For histological
analyses, the slides were dipped in photographic emulsion (NTB2, Kodak) and
exposed for about 10 days. After development of the emulsion, the sections were
counterstained with cresyl violet.
4 Morphometric analysis
Counts. Coronal sections stained for Nissl (one section out of three) were analysed
using a 20x objective and a millimetric eyepiece. The number of pyknotic nuclei was
counted in the cingulate cortex (Cing), restrosplenial cortex (Rsg), striatum (Str),
Accumbens (Acb), ventrobasal thalamic nucleus (VB), somatosensory cortex (SI)
and superior colliculus (Coll). Counts were performed in 5 to 7 sections per animal
(100,000 pm fields per section for each region). Values derived from trkB and
MAOA-trkB double knockout mice were compared with those of the various
controls using an unpaired Student's t test.
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Neuronal size. For determination of neuronal cross-sectional areas, profile of neurons
in layer V (somatosensory cortex) of trkB, MAOA-trkB double knockout and wild
type mice (P8.5, 4 animals each, 30 neurons per animal) were drawn using camera
lucida tracing. Areas were quantified with Image Tool software (The University of
Texas Health Science Centre in San Antonio).
Areas. Trigeminal ganglion and facial nuclei of wild type, trkB knockout and
MAOA-trkB double knockout mice were outlined using a camera lucida. Areas of
the trigeminal ganglion and facial nucleus were estimated using the Image tool
software (The University of Texas Health Science Centre in San Antonio). One
section out of three was analysed from two pups of each genetic background
(analysis of additional animals would be necessary for statistical analyses).
5 Cortical analysis
The barrel field was analysed from sections obtained from tangentially
sectioned hemispheres. Reconstruction of the PMBSF was obtained either from CO-
reacted sections or from 5-HT- reacted sections (Vitalis et ah, 1998-Chapter II). The
thickness of cortical layers II-IV and layers II-VI were measured in Nissl-stained
coronal sections, using an eyepiece graticule (xlO objective). The thickness of layer
IV was measured in CO-reacted coronal sections (xl6 objective). Measurements
were taken along a line perpendicular to the pial surface, at two different levels: one
in the PMBSF, (level -1.94 posterior and -3.1 lateral to the Bregma), and the other in
AS, (level -0.82 anterior and -3.1 lateral to the Bregma).
Ill Results
1 TrkB expression in MAOA knockout mice during the critical period of barrel
field formation
In order to test whether high levels of 5-HT were playing a role in modulating
the expression of trkB in the cortex and the thalamus, I first analysed trkB mRNA
expression in wild type and MAOA knockout mice. This study was mainly
conducted during the period of barrel field formation at P0, P4, P6 and P15. In situ
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hybridisations with riboprobes corresponding to the tyrosine kinase domain of trkB
in wild type and MAOA knockout pups showed that MAOA knockout mice
displayed a normal pattern of trkB expression in the ventrobasal thalamic nucleus
and somatosensory cortex. In the isocortex and allocortex, most neurons were
strongly labelled at birth. This expression progressively decreased during
development. Interestingly, trkB expression was high in layer IV of sensory cortices
from PO to P10. In SI, trkB was expressed in a barrel-like pattern from P4 to P7 (Fig.
III-l). Then, the distribution of trkB was diffuse all cortical layers, except layer I. In
the thalamus, the ventrobasal thalamic nucleus displayed low to moderate levels of
expression at PO, P4 and P7. From PI5, levels of trkB expression were low. These
results are in agreement with previous studies done in rat (Masana et al., 1993). At
the level of the cortex and the thalamus, similar patterns and levels of trkB
expression were observed in MAOA knockout mice (data not shown).
These results failed to reveal any striking differences in trkB levels between controls
and MAOA knockout mice during postnatal development (P0-P15). I decided to test
the hypothesis that trkB is requiered for MAOA phenotype by generating mice
double knockout for trkB and MAOA.
2 General development of MAOA-trkB double knockout mice
MAOA-trkB double knockout and trkB knockout mice and their various
controls were obtained in the F2 progeny from crosses between females
heterozygous for both MAOA and trkB and males hemizygous for MAOA and
heterozygous for trkB. The size of the litter and the weight of pups of the different
genotypes were evaluated prior to perfusion, at PO and P8.5. At PO, the size of the
litter was similar to controls (10 ± 1.3 pups; values are mean ± SEM) with a normal
sex ratio. MAOA-trkB double knockout and trkB knockout mice were obtained with
an expected frequency and there was no statistical difference in pup's weights
(MAOA-trkB, 1.2 g ±0.2, n=6; trkB, 1.1 g ±0.1, n=5; MAOA, 1.2 g ±0.1, n=5;
wild type, 1.3 g ± 0.2, n=5). By P3, a reduction of 20% in weight was observed for
both MAOA-trkB double knockout and trkB knockout pups. Few pups died around
this age. By P8.5, most trkB knockout mice had died whereas MAOA-trkB double
knockout mice survived (n-13 litters analysed). Surviving trkB and MAOA-trkB
double knockout pups displayed both a reduction in body weight (MAOA-trkB, 2.3 ±
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Figure ni-1 Coronal section of a P7 pup showing trkB
expression at the level of the somatosensory cortex. White
arrow point to lower layer IV. Scale bar = 600 pm.
0.3 g, n=14; trkB, 2.5 ± 0.2 g, 11=4; MAOA; 5.2 ± 0.4 g, n=10; wild type, 5.5 ± 0.6 g,
n=10) and in brain weight (trkB-MAOA, 0.26 ± 0.03 g, n=14; trkB, 0.22 ± 0.02 g,
n=4; MAOA; 0.31 ± 0.02 g, n=10; wild type, 0.32 ± 0.03 g, n=10).
trkB knockout mice died as a result of feeding problems due probably to the
increased cell death observed in the central (facial motor nucleus) and peripheral
(trigeminal) nervous system (Klein et al., 1993). Since 5-HT has been shown to have
a survival- and growth-promoting role for some neuronal populations, it is
conceivable that subsets of cells, which die in trkB knockout mice, are at least
temporally rescued by elevated levels of serotonin in the brain. I have investigated
this possibility. Evidence for this role will be presented later.
3 Deficiency of trkB in MAOA knockout mice does not rescue the alterations of
the barrel field observed in MAOA knockout mice
3.1 Abnormal organisation of granular neurons
In wild type mice, the structural differentiation of layer IV neurons into
barrels is visible with Nissl staining as cylindrical shaped aggregates (Fig. 111-2^4).
Barrels consist of a dense ring of granular neurons surrounding a hollow (area of less
cell density) and are separated by septae. This cytoarchitectonic differentiation
occurs normally in trkB knockout mice (Fig. 111-25). In contrast, MAOA-trkB
double knockout mice display the same cortical alterations as those previously
described in MAOA knockout mice (Fig. III-2C,D). The granular cells in layer IV do
not cluster into barrels but instead form a continuous band with homogeneous
density (Cases et al., 1996 and present study).
3.2 Cortical thickness
As measured on coronal sections of P8.5 mice at the level of the
posteromedial barrel subfield (PMBSF) and the anterior snout (AS), the thickness of
layers II-IV and layers II-VI displayed a significant reduction in trkB and MAOA-
trkB double knockout mice (Table III-l). Layers II-IV were the most affected layers
and the reduction was more severe in the anterior region of the brain. At this level,
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Figure TTT-2 A-D, Organisation of granular neurons in layer IV of the somatosensory
cortex in P8.5 (A) wild type, (B) trkB knockout, (C) MAOA knockout and (D) MAOA-
trkB double knockout mice. A-D, Black arrow points to lower layer IV. Note that both
(A) wild type and (B) trkB knockout mice show a discrete clustering of granular neurons
in the layer IV of the somatosensory cortex whereas (C) MAOA knockout and (D)
MAOA-trkB double knockout mice do not. Note also the slight decrease in the cortical
thickness of (B) trkB and (D) MAOA-trkB double knockout mice. Scale bar = 640 pm.
the thickness of Layers II-IV displayed a 25% reduction in trkB knockout mice and a
18% reduction in MAOA-trkB double knockout mice compared to wild types.
3.3 Cytochrome oxidase histochemistry
Cytochrome oxidase (CO) histochemistry allows the visualisation of neurons
with heightened metabolic activity in the centre of the cortical barrels. At this level,
CO is localised mainly in dendrites of cortical neurons, but also in axon terminals
(Wong-Riley et al., 1980). In trkB knockout mice, the intensity of CO activity was
similar than that of wild types (Fig. 111-3^,5). Barrels were observed in the entirety
of the barrel field, in the representations corresponding to the main whiskers
(PMBSF), tactile hairs located on AS, the lower lip, the hind paw and the fore paw.
However, there was a 26%-29% reduction in the area of the barrel field
representation. This decreased area was proportional to the reduction of the size of
the flattened hemisphere, suggesting that the reduction of the barrel field area was
due to hypotrophism. Individual barrels displayed similar shrinkage in proportion to
the entire barrel field representation (wild type: B2 length, 280 pm ± 2.3, n=5; B2
width, 190 pm ± 1.8, n=5; B1-B4 length, 840 pm ± 4.6, n=5; A1-A4 width, 730 pm
± 5.0, n=5; trkB knockout: B2 length, 200 pm ± 2.3, n=4; B2 width, 150 pm ± 2,
n=4; B1-B4 length, 650 pm ± 4.5, n=4; A1-A4 width, 550 pm ± 5.0, n=4). In
MAOA knockout mice, the somatosensory map was profoundly modified as
previously reported (Cases et al., 1996 and Fig. III-3Q. Most of the PMBSF and AS
representations were fused, with only separations maintained between the AS, the
lower lip and the fore paw, the trunk and the hind paw. In the mixed genetic
background used in this study, there was a variation in the intensity of the phenotype.
In most cases, some barrels located in the PMBSF and blobs of CO activity
corresponding to the fusion of several barrels in PMBSF and in AS were identified.
Differences in phenotype displayed by MAOA knockout mice were previously
reported depending on the genetic background (Vitalis et al., 1998). In double
knockout mice, the intensity of CO activity was greatly reduced in the cortex
compared to wild type, trkB or MAOA knockout mice (Fig. III-3). On coronal
sections, the lower part of layer IV displayed a stronger CO activity that
progressively faded in the upper part of layer IV. No barrels could be identified on















Figure III-3 A-D, Flattened sections of P8.5 (A) wild type, (B) trkB knockout, (C)
MAOA knockout, and (D) MAOA-trkB double knockout mice stained for cytochrome
oxidase (CO). A, B, Note blobs of cytochrome (CO) oxidase activity in the posteromedial
barrel subfiled (PMBSF) and the anterior snout representation (AS) in (A) wild type and
(B) trkB knockout mice. C, Section showing a complete blurring of the AS representation
and a remainder of barrel-like organisation in the PMBSF of a MAOA knockout pup. D,
Section showing a complete lack of barrel and barrel-like CO blobs in the PMBSF and
AS representations of a MAOA-trkB double knockout pup. Note also the decrease in CO
activity. Scale bar = 960 pm.
Table III-l Cortical thickness in wild type, MAOA knockout, trkB
knockout and MAOA-trkB double knockout pups aged P8.5. Measures
were obtained from Nissl-stained coronal sections at two different
stereotaxic levels: -1.94 mm posterior and -3.1 mm lateral, and -0.82
mm anterior and -3.1 mm lateral, to the Bregma. Mean ± SEM.
Genotype Thickness of cortical layers (pm)
II-IV II-VI
-0.82 -1.94 -0.82 -1.94
Wild type 403 ± 16 386 ±17 1122 ± 30 1071 ±50
(n = 4)
MAOA-KO 395± 20 360 ± 25 1100 ±40 1091 ±30
(n = 4)
trkB-KO 305 ± 7 305 ±21 937 ±15 935 ± 50
(n = 4)
MAOA-trkB-DKO 328 ± 15 303 ± 20 1024 ±27 943 ± 36
(n = 8)
representation were difficult to identify precisely in most cases (Fig. III-3Z)).
However, separations between the anterior snout, the lower hp and the fore paw, the
trunk and the hind paw were visible in the cases presenting a sufficient CO activity.
These alterations appeared similar, although more severe than those observed in
MAOA knockout mice of the same genetic background.
3.4 Abnormality of 5-HT immunolabelling
Thalamic neurons do not synthesise 5-HT but accumulate exogenous 5-HT
through 5-HT high affinity uptake sites located on thalamocortical axons and
terminals from E15 to P10 (Lebrand et al., 1996). I have taken advantage of this
transient mechanism to specifically visualise and compare thalamocortical axons in
trkB knockout and MAOA-trkB double knockout mice. On flattened 5-HT
immunolabeled sections, trkB knockout mice have normally individualised barrels in
the PMBSF (Fig. \\l-AA,B) and AS representations. In MAOA knockout mice, strong
5-HT immunolabeling delineates the three sensory cortices. In the somatosensory
cortex, the barrel field representation is blurred although in several cases few barrels
and blobs of immunolabeling remained (Fig. III-4C), similarly to what was observed
with CO activity (see above). In MAOA-trkB double knockout mice, the barrel field
representation was altered more than in MAOA knockout mice (Fig. III-4D).
Interestingly, the 5-HT immunostaining of the presumptive auditory and
somatosensory cortices were fused whereas limits between the primary visual cortex
and the sensory or the auditory cortices were defined in most cases (Fig. III-4Z)).
Moreover, on coronal sections, 5-HT immunolabeling extended abnormally in layers
II-III, (Fig. III-5) below the region of CO activity. This suggested that either
thalamocortical axons extended abnormally far radially in proportion to the thickness
of the cortex in layers II-III and tangentially in layer IV or that 5-HT was abnormally
released from thalamocortical axons or serotoninergic varicosities in layers II-III and
IV.
3.5 Abnormality of SERT immunolabeling
The serotonin transporter is specifically expressed on thalamocortical arbors
from E15 to P10 (Lebrand et ah, 1998). At P8.5, in the wild type cortex, a dense
80
Figure III-4 A-D, Flattened sections of P8.5 (A) wild type, (B) trkB knockout, (C)
MAOA knockout and (D) MAOA-trkB double knockout mice stained for 5-HT. A, The
primary sensory cortices (visual, VI; auditory, Al; somatosensory, SI) are delineated and
in SI, barrels are individualised. B, Sections of trkB knockout mice showing VI and
normally segregated barrels in the PMBSF. AS do not appear on this plane of section. C,
Section of MAOA knockout mouse showing VI, Al, SI. Note the presence of clusters
corresponding to fused barrels in PMBSF (black arrow). D, Section of MAOA-trkB
double knockout mouse showing a complete fusion of 5-HT immunolabelled regions. A-
D, Note the similar reduction in the size of the flattened cotex in both (B) trkB knockout
and (D) MAOA-trkB knockout mice compared to (A) wild type or (C) MAOA knockout
mice. Scale bar = 700 pm.
MAOA-KO MAOA-trkB-DKO
Figure III-5 A, B, Coronal section of P8.5 (A) MAOA knockout and MAOA-trkB
double knockout mice immunolabeled for 5-HT. A, Coronal section of a MAOA
knockout pup showing three distinct areas displaying strong 5-HT-immunolabeling in
layer IV: in the premotor cortex (dorsal), the primary somatosensory cortex (medial) and,
the primary auditory cortex (ventral). Note that 5-HT-immunolabeling is strongest in
layer IV. Note also 5-HT immunolabeling in layer VI which mirrors the 5-HT-
immunolabeling in layer IV. B, Coronal section of a MAOA-trkB double knockout pup
showing an homogeneous band of 5-HT immunolabeling in layer IV and an extension of
the staining in upper layers II-III. Note also 5-HT immunolabeling in layer VI which
appears as a single band of staining. Scale bar = 640 pm.
network of SERT-immunolabeled terminals was visible in the primary
somatosensory cortex (SI), the secondary somatosensory areas (S2, PV and PR), the
auditory (Al) and the primary visual (VI) areas. In SI, barrels were clearly
delineated in PMBSF, AS, FP, HP and LL. In trkB knockout mice, tangential
sections of flattened cortex showed that sensory cortices were normally
immunolabeled and barrels were clearly defined in SI similarly to what was
observed with 5-HT immunolabeling (see above). Interestingly, on coronal sections
SERT-immunolabeled thalamocortical axons showed abnormal extensions in layers
II-III (Fig. III-6). In MAOA knockout mice, SERT and 5-HT immunolabeling
showed similar alterations (see below): a blurring of the barrel field representation on
flattened sections and a decrease in the thickness of SERT immunolabeling on
coronal sections (Fig. III-6Q. In MAOA-trkfi double knockout mice, SERT
immunolabeling partially mirrored 5-HT immunolabeling (Fig. III-6D). On flattened
sections, the auditory and somatosensory cortices were fused as observed with 5-HT-
immunolabeling showing that thalamocortical axons extended abnormally in the
tangential plane. On coronal sections, there was also a relative increase in the
thickness of SERT immunolabeling, expanding radially in layers II-III. Together,
these results show that trkB knockout mice have subtle alterations of thalamocortical
projections. Moreover, thalamocortical alterations are increased in MAOA-trkB
double knockout mice compared to MAOA or trkB knockout mice both in the radial
and tangential plane indicating that the lack of trkB signalling and excess of 5-HT act
synergistically on thalamocortical axonal morphology.
3.6 Organisation of the sensory relays
Previous studies have shown that the lower stations of the somatosensory
system, the barrelettes, in the brainstem and the barrelloids, in the ventrobasal
thalamic nuclei were normally organised in MAOA knockout mice (Cases et al.,
1996). No alterations in their organisation were observed in trkB knockout and
MAOA-trkB double knockout mice (Fig. III-7).
4 Do 5-HT excess prevents cell death induced by a lack of trkB ?
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Figure III-6 A-C, Coronal sections ofP8.5 (A) wild type, (B) trkB knockout, (C) MAOA
knockout and, (D) MAOA-trkB double knockout pups immunolabeled for SERT. A,
Section of wild type pup showing SERT immunolabeled barrels. B, SERT
immunolabeled barrels appear larger and slightly extended radially in trkB knockout pup.
C, In MAOA knockout mouse, SERT immunolabeling appears as a band of staining
which is restricted to layer IV. D, In MAOA-trkB double knockout pup, SERT
immunolabeling defines a homogeneous band that extends radially in layers II-III. Scale
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Figure III-7 A-C, Normal organisation in barreloids in the thalamus, of (A) wild type,
(B) trkB knockout, (C) MAOA knockout and, (D) MAOA-trkB double knockout P8.5
pups. Barreloids are shown with cytochrome oxidase activity. Barreloids have similar
distribution in the ventrobasal thalamic nucleus of (A) wild type, (B) trkB knockout,
(C) MAOA knockout and (D) MAOA-trkB double knockout pups. Scale bar = 320 pm.
trkB knockout mice display severe neuronal deficits in the peripheral nervous
system (Klein et al., 1993) and an increased apoptosis in the central nervous system
of several brain regions (Alcantara et al., 1997). Serotonin is regarded as a strong
candidate molecule having a role in the maturation and survival of several neuronal
populations (Lauder, 1993). Since MAOA-trkB double knockout mice displayed an
increased survival, I have tested whether the increase in 5-HT levels could prevent or
delay the cell death of specific populations affected in trkB knockout mice (Klein et
al., 1993; Alcantara et al., 1997).
I have analysed Nissl-stained sections of P8.5 animals and counted the
number of pyknotic nuclei in several brain regions (accumbens, caudate putamen,
cingulate cortex, somatosensory cortex, retrosplenial cortex, ventrobasal thalamic
nucleus, ventral lateral geniculate thalamic nucleus and superior colliculus). Pyknotic
nuclei were extremely shrunken, dark, and surrounded by an almost absent
cytoplasm, suggesting that they corresponded to apoptotic cells. I found that wild
type and MAOA knockout mice displayed a similar number of pyknotic nuclei in
most of these brain areas. A significant increase in cell death of both trkB knockout
and MAOA-trkB double knockout mice was observed in these areas (Fig III-8).
However, a significantly lower number of pyknotic nuclei was counted in the
accumbens and the cingulate cortex ofMAOA-trkB double knockout mice compared
to trkB knockout mice (Fig III-8). The location of pyknotic profiles was similar in
trkB knockout and MAOA-trkB double knockout mice. They were randomly
distributed in the accumbens, striatum and ventrobasal thalamic nucleus. However, in
the superior colliculus they were mainly located in the stratum zonale and superficial
grey layer. In the somatosensory cortex, pyknotic profiles were mainly located in
layers II-III and layer V. In the cingulate and retrosplenial cortex, they were mainly
located in upper layer II and lower layer VI.
Preliminary data obtained from newborn pups show a similar reduction in the
size of the facial nucleus and trigeminal ganglion in trkB knockout and MAOA-trkB
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Figure III-8 Number of pyknoetic nuclei in different brain regions of wild type,
MAOA knockout, trkB knockout and MAOA-trkB double knockout P8.5 pups.
No significant differences were obtained between wild type and MAOA knockout
mice. A significant increase in cell death in both trkB knockout and MAOA-trkB
double knockout mice was observed in the different regions analysed (except for the
VLG) compare to wild type mice (p< 0.05, Student's / test). A significant lower
number of pyknotic nuclei was observed in the accumbens and the cingulate cortex
in MAOA-trkB double knockout mice compare to trkB knockout mice (* p< 0.05,
Student's / test).
Acb: accumbens; Cing: cingulate cortex; Cpu: caudate putamen; Col: superior
colliculus; Rsp: retrosplenial cortex; SI: primary somatosensory area; VB:
ventrobasal thalamic nuleus; VLG: ventral lateral geniculate thalamic nucleus.
1 Analysis of trkB deficiency on somatosensory thalamocortical development
This study reports that trkB is strongly expressed by layer IV neurons from
PO to P7, suggesting a potential role of trkB in the establishment of the
somatosensory cortex. The period of the strongest trkB expression corresponds to the
critical period of differentiation of immature neurons arranged homogeneously in the
cortical plate (prospective layer IV) into mature neurons arranged in barrels. The
known effects of trkB in the developing cortex are numerous, including neuronal
survival (Alcantara et al., 1997; Xu et ah, 2000), dendritic growth (Yacoubian and
Lo, 2000) and the control of the expression of LTP (Sermasi et ah, 2000). It has been
already reported that the deficiency in trkB does not increase cell death (Alcantara et
ah, 1997) and does not alter the development of granular neurons in barrels
(Henderson et ah, 1995). This study confirms that the development of the
topographic arrangement of granular neurons into barrels is not affected in trkB
deficient mice. Indeed, despite an increased expression of trkB during the first
postnatal week, no significant increase in cell death is observed in the somatosensory
cortex of trkB knockout mice. In a preliminary study, I looked at the dendritic
morphology of granular neurons using mGluRV immunoreactivity. mGluRV is
transiently located on dendrites of granular neurons, forming clear barrels from P4 to
P9 (Munoz et ah, 1999). Data indicate that dendritic organisation is grossly altered in
trkB knockout mice. To have further details of the dendritic morphology adopted by
granular neurons in trkB knockout mice, I would like to use fluorescent marker/gene-
transfer method. This method allows the labelling of individual neurons in slices of
the cortex in vitro (Lo et ah, 1994). Then using a Neurolucida system, the dendritic
morphology can be reconstructed and compared to normal or mutant cases.
Moreover, as judged by SERT- and 5-HT-IR, thalamocortical axons are
subtly altered in trkB mutant mice. Indeed, somatosensory thalamocortical axons are
arranged in barrels but display a surprisingly vertical expansion in the superficial
layer II/III rather than a tangential expansion in layer IV. Since trkB is only very
slightly expressed in somatosensory thalamic neurons, this suggests that the
alteration of thalamocortical axons is induced by the lack of trkfi in cortical cells.
2 Role of an excess 5-HT and trkB signalling deficiency
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MAOA knockout mice display increased 5-HT levels during the early
postnatal period (Cases et al., 1995) and this excess alters permanently the clustering
in barrels of both granular neurons and thalamocortical axons (Cases et ah, 1996;
Vitalis et ah, 1998). I have tested the hypothesis that these alterations could be
related to an alteration in trkB signalling. In first place, I have determined the levels
of trkB mRNAs in the somatosensory thalamocortical system. No changes ofmRNA
expression was observed in the cortex or the thalamus of MAOA knockout mice.
Second, since it has been reported that BDNF and trkB signalling play crucial roles
in the regulation of the serotoninergic phenotype both in vitro (Gaiter and Unsicker,
2000a,b) and in vivo (Lyons et ah, 1999; Mamounas et ah, 2000), I have verified that
trkB deficiency did not induce low number of serotoninergic neurons or low 5-HT
levels in trkB knockout mice. Interestingly, the lack of trkB does not induce dramatic
changes in the number of serotoninergic neurons or 5-HT levels, suggesting that in
vivo trkB signalling is not crucial at least for the early development and
differentiation of serotoninergic neurons. The number of serotoninergic neurons in
MAOA-trkB double knockout mice is normal but 5-HT levels are similar to those
displayed by MAOA knockout mice (complete study in progress). Surprisingly, the
consequences of excess 5-HT in the somatosensory thalamocortical system of
MAOA-trkB double knockout mice are not similar to those displayed by MAOA
knockout or trkB knockout mice alone. Whereas the abnormal homogenous band of
granular neurons in layer IV is present in MAOA-trkB double knockout, as in
MAOA knockout mice, thalamocortical axons display a much more widely
tangential and vertical expansion. Indeed, sensory thalamocortical axons of auditory
and somatosensory cortices overlap and have abnormally invaded tangentially the
premotor and limbic areas. Radially, sensory thalamocortical axons have invaded the
superficial layers II/III. Thus, the lack of trkB signalling worsens the MAOA
phenotype at least at the level of thalamocortical projections in the cortex. The
mechanisms underlying this increased alteration are unknown and may be related to
a lack of cortical neurons to release a trkB-induced factor facilitating the clustering
of thalamocortical axons. This trkB-induced factor could be also per se insensitive to
5-HT levels. Then, deficiency in trkB signalling alone induces subtle changes in
thalamocortical projections and excess of 5-HT alone induces only a limited
tangential expansion. However, when these two alterations are together, they can act
synergistically to produce a totally aberrant pattern, as observed in MAOA-trkB
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double knockout mice. I would like also to look at the dendritic morphology adopted
by granular neurons in trkB knockout, MAOA knockout, MAOA-trkB double
knockout and wild type mice. To do that, I will use the same methods described
above (mGluRV immunoreactivity and fluorescent marker/gene-transfer).
3 Excess 5-HT has potential recovery effects in cell death of specific populations
The analysis of mice lacking TrkB has illustrated the critical role of TrkB
signalling in the generation and/or survival of a variety of sensory neurons in the
peripheral nervous system (Klein et al., 1993; Minichiello et al., 1995; Schimmang et
al., 1995, Pinon et al., 1996). More recently, Alcantara et al. (1997) have
demonstrated that TrkB signalling plays a similar role in the central nervous system.
Their study showed that trkB knockout mice undergo a period of increased cell death
during early postnatal life in various cell populations. Interestingly, the authors
correlated the onset of cell death with the peak of expression of the catalytic trkB
tyrosine kinase receptor observed during the second postnatal week (Dugich-
Djordjevic et al., 1993; Knusel et al., 1994). My study confirmed this finding and
extended the analysis to other brain regions such as the accumbens, the cortex or the
collicullus. Interestingly, MAOA-trkB double knockout mice display a substantial
recovery from cell death in specific brain regions such as the accumbens or the
cingulate cortex. This suggests that increased levels of 5-HT can prevent the
increased cell death observed in specific brain regions of mice lacking TrkB. Indeed,
serotonin is regarded as a strong candidate for a molecule having a role in the
maturation and survival of several neuronal populations (Lauder, 1993). For instance,
serotonin promotes the differentiation and the survival of glutamatergic neurons in
organotypic slice cultures of the developing cerebral cortex (Dooley et al., 1997;
Lavdas et al., 1997). 5-HT acts upon specific high affinity receptors and it has been
shown that some of them can support cell survival (Dooley et al., 1997; Gaiter and
Unsicker, 2000). Then, one can think that in some cases 5-HT could act in synergy




of monoamine oxidase A and monoamine oxidase B
CHAPTER FOUR:
DEVELOPMENTAL EXPRESSION OF
MONOAMINE OXIDASE A AND MONOAMINE
OXIDASE B
This study was performed in collaboration with Drs. P. Gaspar and O. Cases
(INSERM U106, Paris, France) and with Dr. J. Shih (University of Southern
California, California). These collaborators have cloned the MAOA and MAOB
probes and have performed additional in situ hybridizations, some of which are
shown in this report (Drs. P. Gaspar and O. Cases). They have also generated and
characterised in vitro the specificity of the MAOB antibody (Dr. J. Shih) used in this
study.
I Abstract
Monoamine oxidase A (MAOA) and B (MAOB) are key players in the
inactivation pathway of monoaminergic transmitters and of xenobiotic amines.
Although there is a wide literature about MAOA and MAOB location in adults,
nothing is known concerning the localisation of both enzymes during development.
This present study combines in situ hybridization, histochemistry and
immunocytochemistry to locate precisely MAOA and MAOB in the developing
nervous system.
I found that MAOA expression is tightly linked to the noradrenergic
phenotype. MAOA is expressed early (from embryonic day 12) in all noradrenergic
and adrenergic neurons in the hindbrain and peripheral nervous system, as well as in
neurons that transiently express the noradrenaline synthesising enzyme, dopamine-p-
hydroxylase: the autonomic motor nuclei of the hindbrain, and the sensory ganglia of
cranial nerves. By El2, MAOA is also expressed in the serotoninergic neurons of the
raphe, soon after they start producing 5-HT. Then, during early postnatal life,
serotoninergic neurons shift progressively from MAOA to MAOB expression. I also
found that most dopaminergic groups, as well as neurons that display a transient
tyrosine hydroxylase phenotype, express MAOA. Besides its link with histaminergic
neurons, this study points out that MAOB is expressed in most forebrain cholinergic
neurons, in the septum, the striatum, the ventral pallidum, and the tegmental nuclei.
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MAOB-expressing neurons were also detected in structures that did not contain
monoaminergic or cholinergic neurons such the accumbens or the thalamus. MAOB
expression was also associated with non-neuronal cells such as the ventricular
ependymal cells and astrocytes. In addition, I found two novel localizations of
MAOB: i) in the olfactory placode and olfactory epithelium where MAOB is
expressed from E10 to adulthood, and ii) in astrocytes at the spinal and cranial nerve
interface between the CNS and PNS, where the period of MAOB expression
coincides with the period of crossing and arborization of nerves into the CNS.
II Introduction
Monoamine oxidase A (MAOA) and B (MAOB) are membrane-bound
mitochondrial flavoproteins that oxidatively deaminate a broad range of biogenic
amines, including monoaminergic neurotransmitters in neurons, glial cells, and other
cell types (Weyler et al., 1990; Shih, 1997). In CNS, MAOs are thought to be
involved in maintaining low cytosolic and extracellular levels of monoamines, and in
preventing various natural substrates from accumulating in monoaminergic neurons
to act as false neurotransmitters. In rodent brain, MAOA mainly metabolises
monoaminergic neurotransmitters such as serotonin (5-HT), dopamine (DA),
noradrenaline (NA) or adrenaline (A) whereas MAOB mainly metabolises trace
amines such as tyramine or p-phenylethylamine (Strolin-Benedetti and Dostert,
1992). These functions could be particularly important during development since the
lack of MAOA causes enhanced levels of 5-HT and NA during embryonic and early
postnatal life (Cases et al., 1995; Lajard et al., 1998) and an abnormal development
of the somatosensory (Cases et al., 1996; Vitalis et al., 1998) and visual systems
(Upton et al., 1999).
MAOA and MAOB have been localised in rodent, cat, primate, and human
adult brain by a variety of techniques, including immunohistochemistry (Levitt et al.,
1982; Westlund et al., 1985; 1988), histochemistry (Kitahama et al., 1994), enzyme
autoradiography (Saura et al., 1992; 1996), and in situ hybridisation (Luque et al.,
1995; Jahng et al., 1997). Generally, MAOA is most abundant in (nor)adrenergic
neurons, moderate in serotoninergic neurons and very low in histaminergic neurons
(Luque et al., 1995; Jahng et al., 1997) whereas MAOB is most abundant in
histaminergic and serotoninergic neurons (Levitt et al., 1982; Saura et al., 1992;
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Luque et al., 1995; Jahng et al., 1997). Surprisingly, MAOs are also present in non-
aminergic cell populations. Indeed, MAOA is abundant in neurons of the cerebral
cortices, the hippocampal formation and the cerebellar granule cell layer whereas
MAOB is abundant in non-neuronal cells such as astrocytes, Bergmann glial cells or
circumventricular organs (Luque et al., 1995). So far no developmental studies have
been done and indirect evidence derived from studies in MAOA knockout mice
suggests that MAOA could be expressed in other locations during development.
Indeed, during embryonic and early postnatal life, 5-HT immunolabeling is
considerably increased in MAOA knockout mice, compared to wild type mice, not
only in monoaminergic neurons, but also in a number of structures that transiently
express the serotonin transporter (SERT) (Cases et al., 1998, Lebrand et al., 1998).
This indicates that, in normal conditions, 5-HT is internalized in non-aminergic
neurons where it could be rapidly degraded.
In this study, in situ hydridization, histochemistry and immunocytochemistry
were combined to study the developmental distribution of MAOA and MAOB in
CNS. MAOA expression started by E12 and increased dramatically in embryonic
life. By birth, MAOA expression decreased sharply and the adult pattern of
expression was reached by P10. MAOB expression appeared later, by E14 and
increased progressively to reach the adult pattern of expression by PI5. I found two
striking characteristics of MAOA distribution in embryonic and early postnatal life.
The first is its association with a (nor)adrenergic phenotype: MAOA is expressed in
all neurons that permanently or transiently express dopamine-P-hydroxylase, the
biosynthetic enzyme ofNA and A. The second is its association with a serotoninergic
phenotype: MAOA is strongly expressed in all serotoninergic neurons. From birth,
MAOA expression progressively decreased to reach a minimum by P10. In the
meantime, MAOB expression increased progressively in serotoninergic neurons to
reach a maximum by P10. This study corroborates mostly the documented locations
of MAOA and MAOB in adults, i.e.: in dopaminergic neurons and in the
hippocampus for MAOA and in histaminergic neurons and in astrocytes for MAOB.
In addition, I have shown new and interesting locations of MAOA and MAOB, such
as astrocytes at the interface between the CNS and the PNS from E12 to P4, during
the entire period when peripheral nerves enter into the CNS, or in the olfactory
epithelium thoughout life.
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Ill Material and methods
1 Animals
Experiments were carried out on Ell, E12, E14, E15, E16, E17, and E18
embryos and PO, P4, P7, P10, P13, P21 and 5-months-old C3H/He and MAOA
knockouts (Cases et al., 1995). The day of the vaginal plug was counted as El, and
the day ofbirth as PO.
2 In situ hybridization
Partial murine cDNAs encoding from exon 1 to exon 8 of MAOA and
MAOB were amplified by RT-PCR, cloned into the pCRII-TOPO vector (Invitrogen,
Carlsbad, USA) and verified by sequencing. The plasmid containing MAOA was
linearised with Hindlll (Amersham, IL) for antisense RNA synthesis by T7 RNA
polymerase (Boehringer-Mannheim) and the plasmid containing MAOB was
linearised with EcoRV (Amersham) for antisense RNA synthesis by SP6 RNA
polymerase (Boehringer-Mannheim). For whole mount in situ hybridization (ISH),
antisense digoxigenin (DIG)-labelled riboprobes for MAOA and MAOB were
produced using a DIG-RNA labelling kit (Boehringer-Mannheim), following the
manufacturer's instructions. For radioactive ISH, antisense riboprobes were labelled
with 35S-UTP (Amersham). Mice were sacrified by deep anesthesia and brains were
immediately removed and frozen in isopentane. Coronal and sagittal sections (20
pm) were cut on a cryostat, collected onto SuperFrost slides and stored at -80°C until
ISH. Tissue sections were post-fixed for 15 minutes in 4% paraformaldehyde,
washed in PBS, acetylated, washed, dehydrated in ascending alcohols and air-dried.
Sections were covered with hybridation buffer (50% formamide, 10% dextran
sulfate, 4 X SSC, 1 X Denhardf s solution, 10 mM dithiotreitol, 0.5 mg/ml sonicated
denatured herring sperm DNA and 1.5 ng/ml RNA total) containing riboprobes
(500,000 cpm/slide) and then incubated overnight in a humid chamber at 48°C.
Washes were then performed as previously described (Fontaine and Changeux,
1989). Sections were dehydrated, air-dried and exposed onto Kodak-MR films
(Eastman-Kodak, Rochester, NY) at room temperature for 1-4 days. For histological
analyses, slides were dipped in NTB-2 radioautographic emulsion (Eastman-Kodak)
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and exposed at 4°C for up to 1 week. Emulsion-dipped slides were counterstained
with Nissl.
Levels of MAOA mRNA expression were estimated on emulsion-dipped
slides. High, moderate and weak levels of expression were distinguished as
exemplified: i) the locus coeruleus displayed strong level of MAOA mRNA
expression (Fig. IV-1), ii) the substantia nigra displayed moderate level of MAOA
mRNA expression at P10 (Fig. IV-4Q and iii) the facial and trigeminal nuclei
displayed low level ofMAOA mRNA expression at PO (Fig. IV-6C).
3 Immunocytochemistry
To identify monoaminergic neurons, I used antibodies to 5-HT (1:50; rat
monoclonal; Harlan), tyrosine hydroxylase (1:5000; rabbit polyclonal; gift from A.
Vigny), aromatic amino-acid decarboxylase (1:1000; rabbit polyclonal; Protos
Biotech, New-York, NJ), and dopamine-(3-hydroxylase (1:1000; rabbit polyclonal;
Protos Biotech, New-York, NJ). Anaesthetised animals were transcardially perfused
with saline followed by 4% paraformaldehyde in PB. Whole embryos or brains were
post-fixed 2-5 days in the same fixative and cryoprotected in 30% sucrose in PB.
Serial coronal sections (50 prn) were cut on a freezing microtome and immediately
processed for immunocytochemistry as previously described (Cases et al., 1996). In
brief, sections were washed in PB, incubated 1 hr in PBS+ (0.1M PBS with 0.2%
gelatine and 0.25% Triton X-100). Sections were incubated sequentially with the
primary antibodies (24 hrs at 4°C), PBS+ (30 min), secondary antibodies
(biotinylated goat anti-rat; biotinylated swine anti-rabbit; 1:200; DAKO, Denmark)
(2 hrs at room temperature), PBS+, streptavidin-biotin-peroxidase complex (1:200;
Amersham) (2 hrs at room temperature) and finally reacted with a solution
containing 0.02% diaminobenzidine, 0.6% nickel ammonium sulfate (Carlo Erba),
and 0.003% H2C>2 in 0.05M Tris buffer, pH 7.6. All sections were mounted on
TESPA-coated slides, air-dried overnight, dehydrated, and coverslipped in DePeX.
4 Histochemistry ofMAOA and MAOB activities
El2 and El3 embryos were fixed for 2 hours by immersion in an ice-cold
mixture of 1.5% paraformaldehyde and 1.5% glutaraldehyde in PB. Older embryos
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were perfused transcardially with 0.9% saline followed by the same ice-cold fixative
and lh post-fixation. Pups and adults were perfused with a mixture of 1%
paraformaldehyde and 1% glutaraldehyde. Brains were removed and cryoprotected
overnight in 30% sucrose in PB at 4°C. Serial sections were cut (50-60 pm) on a
freezing microtome, collected in cold PB, and processed immediately. MAO
activities were revealed according to Dunning et al. (1997). Briefly, sections were
rinsed three times for 1 min each in PB, preincubated for 15 min in 50 mM Tris
buffer pH 7.6, incubated for 4 hr to 24 hr at 22-25°C in a solution containing 0.07%
tyramine-HCl (Sigma), 0.005% diaminobenzidine-HCl, 0.05% horseradish
peroxidase Type II (Sigma), 0.065% sodium azide and 0.6% nickel sulfamate
(Aldrich, Germany) in 50 mM Tris buffer, pH 7.6. During the entire procedure,
sections were kept in the dark and gently agitated. Since the specific inhibitor of
MAOB, L-deprenyl (Research Biochemicals, Natick, MA), can partially inhibit
MAOA activity, I used MAOA knock-outs to determine the minimal concentration
of L-deprenyl necessary to inhibit completely the remaining MAOB activity.
5 Characterisation of a novel polyclonal MAOB antibody and
immunocytochemistry for MAOB
To determine the location of MAOB in several populations, I used a specific
polyclonal antibody raised against the full length of the mouse MAOB protein (clone
110-1). This antibody was obtained in collaboration with Dr. J. Shih (University of
Southern California, California) and Drs. P. Gaspar and O. Cases (INSERM U106,
Paris). The specificity of the antibody was confirmed on western blot by Dr. J. Shih
and collaborators. In addition the staining obtained on sections from wild type mice
and MAOA knockout mice was compared. I found no difference in the location of
the protein in wild type and MAOA knockout mice showing that in vivo the antibody
was likely to recognise only type B monoamine oxidase. However, MAOA knockout
mice may not be perfect controls since a truncated protein corresponding to exon 1 of
the MAOA gene could still be generated in these mice (Cases et al., 1995; I. Seif,
personal communication). The rabbit polyclonal MAOB antibody (1:2000) was used
as described in "3 Immunocytochemistry". Double labeling for MAOB and 5HT (rat
monoclonal anti-5HT, 1:30, Harlan-Sera-Lab) or MAOB and GFAP (mouse
monoclonal anti-GFAP, 1:200, Sigma) were performed on free floating sections.
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Sections were incubated overnight at room temperature with two primary antibodies
diluted in PBS+. Then, sections were washed in PB and incubated for 1 hr with two
secondary antibodies (TRITC anti-mouse antibody, 1:200, molecular probe or Cy3
anti-rat antibody, 1:200, Sigma and FITC anti-rabbit antibody, 1:200; Molecular
Probe).
IV Results
The location of MAOA and MAOB mRNA expressions was determined
during embryonic and postnatal development. The nomenclature is taken from
Paxinos et al. (1994) for embryonic stages and from Franklin and Paxinos (1994) for
postnatal ages.
1 MAOA and MAOB mRNA expressions in classical monoaminergic neurons
The neuronal populations described in the following paragraph were reported
to express permanently the monoamine synthesizing enzymes, tyrosine hydroxylase
(TFt), dopamine-P-hydroxylase (DBH), tryptophan hydroxylase (TpOFl), or histidine
decarboxylase (HDC).
1.1 Noradrenergic and Adrenergic cell groups
By El2 a strong MAOA mRNA expression was already detected in most of
the noradrenergic and adrenergic cell groups: A4, A5, the locus coeruleus (A6), the
locus subcoeruleus (A6s), C3 and Al/Cl and A2/C2 complexes (Al and CI, and A2
and C2 are located in similar anatomical regions; this does not allow there complete
distinction; Jacobowitz and Abbott, 1998) (Table IV-1, Fig. IV-1). Then, MAOA
mRNA expression remained very high during all embryonic and postnatal life (Fig.
IV-1). In the PNS, by E12, all noradrenergic neurons of the sympathetic ganglia
already displayed a strong MAOA mRNA expression. By far, MAOA mRNA
expression was the highest in noradrenergic neurons of the CNS and PNS.
MAOB mRNA was not detected in noradrenergic and adrenergic neurons in
normal mice at any age studied.
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Table IV-1 Locations of MAOA mRNA expression in monoaminergic neurons during development
Labeling intensity of neurons at pre- and postnatal ages
Location E12 E14 E16 E18 PO P4 P7 P10 Adults
















A16 Olfactory bulb - +
A 15v Supraoptic n. ...
A14 Dorsomedial hyp. n. - - -
A14 Paraventricular n. 4-
A13 Zona incerta +
A10 Ventral tegmental area ...
A9 Substantia nigra ...
Histaminergic group ...._ +
- - - nd + +
+ 4- nd nd - -
















Intensity of the labeling at prenatal and postnatal ages according to locations in the brain: -
+++ high; nd not defined.
none; + weak; ++ moderate ;
Figure IV-1 Coronal sections of (A) El2 embryo and (B) PO and (C) P15 postnatal
pups showing MAOA expression in noradrenergic neurons of the locus coeruleus. A-
C, The white arrow points to the locus coeruleus. A, Note the strong intensity of the
signal as early as El2. B, Open arrows point to the periaqueductal gray that display
a low level of MAOA expression. C, Double white arrows point to the locus
subcoeruleus. Scale bar: A, 2mm; B,C, 1mm.
1.2 Serotoninergic cell groups
Strong MAOA mRNA expression was first detected by El 2 near the midline
where serotoninergic neurons are normally located (Fig. IV-2 and Table IV-1). By
E14, all serotoninergic neurons displayed strong MAOA mRNA expression (Fig. IV-
2, Fig. IV-5R and Table IV-1). This expression remained high until P0-P4, when
MAOA mRNA expression decreased to reach a minimum from PI5 (Fig. IV-2 and
Table IV-1). The decrease of MAOA mRNA expression was heterogenous in 5-HT
neurons since some neurons in the dorsal raphe retained MAOA mRNA expression
whereas 5-HT neurons in caudal raphe nuclei (B1-B3) stopped expressing MAOA
(Table IV-1).
Low MAOB mRNA expression was first detected in caudal and rostral
serotoninergic neurons by E12 (Fig. IV-1CL4 and Table IV-2). Then MAOB mRNA
expression increased progressively to reach a maximum by P10. MAOB mRNA
expression remained strong during the entire postnatal period (Fig. IV-3A,C and
Table IV-2).
1.3 Dopaminergic cell groups
The isthmic neuroepithelium, a region where midbrain dopaminergic neurons
of the substantia nigra-ventral tegmental (SN-VTA) complex are generated,
displayed moderate MAOA mRNA expression from E12 (data not shown). By PO,
low levels of MAOA mRNA expression were seen at the level of the SN(A9)-
VTA(AIO) complex (Fig IV-3A.B and Table IV-1). Then, MAOA mRNA
expression increased progressively to reach a maximum by P4 (Table IV-1). This
expression remained stable during all postnatal life in SN-VTA neurons (Fig. IV-4C
and Table IV-1). Low to moderate MAOA mRNA expression was also detected in
several other dopaminergic cell groups: in the ventral thalamus at the level of the
zona incerta (A13) from E16, in the hypothalamus at the level of the paraventricular
nucleus from E16 and the dorsal medial hypothalamic nuclei (A14) from El8, and in
the telencephalon at the level of the supraoptic nucleus (A15v) from P10 (Table IV-
1). In the olfactory bulb, A16 dopaminergic external tufted cells displayed a strong
MAOA mRNA expression from E16 (Fig. IV-4D,E) and A16 dopaminergic
periglomerular interneurons from PO (Table IV-1).
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Figure IV-2 Coronal sections of (A) E12 and (B) E14 embryos and of (C) PO pups
showing MAOA expression in serotoninergic neurons of the B4-B9 complex. A-C, Open
arrows point to serotoninergic neurons and filled arrows point to noradrenergic neurons
of the locus coeruleus. A, Note that MAOA expression is already intense and mainly
located in postmitotic neurons, in close proximity with the proli ferating region of the B4-
B9 complex (white open arrow). B, White open arrows point to serotoninergic neurons,
that have migrated away from their region of genesis. C, Note the general decrease in
MAOA expression in serotoninergic neurons in comparison to (A) and (B). Note also the
relative decrease of MAOA expression in serotoninergic neurons versus noradrenergic
neurons. Scale bar = 2mm.
Figure IV-3 A-C, Coronal sections of P21 pups showing MAOB mRNA expression
(A,B) in serotoninergic neurons of (A) the dorsal (RD) and median (MnR) raphe nuclei
and (B) the magnus (RMg) and pallidus (RP) raphe nuclei and (C) in histaminergic
neurons {white arrow) in the tubero-mammilar region. Scale bar: A,B, 2mm; C, 1mm.
Figure IV-4 Coronal sections of (A,B) PO, (C) P10 and (D) El6 animals showing
MAOA expression in dopaminergic cell groups of the (A-C) substantia nigra (SN)-
ventral tegmental area (VTA) complex and (D) in the olfactory bulb. A, White arrow
points to the SN-VTA where a low level ofMAOA expression is seen. B, More caudal
section than shown in (A). White arrow points to the dorsal part of the VTA which
displays a higher level of MAOA expression. C, White arrow points to the VTA that
expresses moderate level of MAOA expression. Arrowheads point to dopaminergic
neurons of the SN. D, White arrow points to the mitral cell layer where dopaminergic
external tufted cells are located. E, Bright field photomicrograph of the section shown in
(D) pointing to the mitral cell layer (black arrow). Scale bar: A-C, 1mm; D,E, 0.5mm.
Table IV-2 Location of MAOB mRNA expression in monoaminergic and cholinergic neurons during
development
Labeling intensity of neurons at pre- and postnatal ages
E12 E14 E16 E18 PO P4 P7 P10 Adults










A 15v Supraoptic n. ++
Preoptic area
Cholinergic groups
Chl-Ch3, - - - - -++++++
Ch5-Ch6 ..... + +++
Ch7 - ++++ ++ ++++++ ++
Striatum, Ventral pallidum - - - -++++++++
Intensity of the labeling at prenatal and postnatal ages according to locations in the brain: - none; + weak; ++ moderate ;
+++ high.
From P10, moderate MAOB mRNA expression was only detected in
dopaminergic neurons located in the supraoptic (A15v) and preoptic areas (Table IV-
2).
1.4 Histaminergic cell group
Scattered neurons displaying a low MAOB mRNA expression were first
detected by PO in the caudal hypothalamus (Table IV-2). By P4, these neurons
displayed moderate MAOB mRNA expression and were clearly distributed at the
level of the tubero-mammillary nucleus, they corresponded to histaminergic neurons
(Table IV-2). Then MAOB mRNA expression remained very high in histaminergic
neurons (Fig. IV-3C). Interestingly, a weak MAOA mRNA expression was detected
in few histaminergic neurons from P4 (Table IV-1).
1.4 Melatoninergic cell group
From El6, melatoninergic cells of the pineal gland displayed already moderate
MAOB mRNA expression (Table IV-2) in parallel with a strong tryptophan
hydroxylase expression (data not shown). Then MAOB mRNA expression increased
to reach a maximum by PO and remain high throughout life (Table IV-2).
2 MAOA mRNA expression in neurons displaying a transient monoaminergic
phenotype
The neuronal populations described in this following section are not classified
as classical monoaminergic cell groups but have been shown to express transiently at
least one particular monoamine synthesizing enzyme.
2.1 Transient TH-expressing neurons
I and others have reported that during development discrete neuronal
populations express transiently the catecholamine synthetisizing enzyme, tyrosine
hydroxylase (TH). Indeed, transient TH-expressing neurons have been located in the
cortex (Berger et al., 1985), piriform cortex (Vitalis et al., 2000), amygdala (Verney
et al., 1988 ; Vitalis et al., 2000), or inferior colliculus (Jaeger and Joh, 1983; Vitalis
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et al., 2000). I showed that some of these transient TH-expressing neurons display a
parallel transient MAOA mRNA expression. In the developing amygdala, neurons of
the central, medial and cortical amygdaloid nuclei display both a moderate TH
immunoreactivity and a weak to moderate MAOA mRNA expression from E16-E18
to P0-P4 (Fig. IV-5D-F and Table IV-3). In the developing mesencephalon, neurons
in the inferior colliculus displayed a weak TH immunoreactivity and a moderate
MAOA mRNA expression from E14 to E16 (Fig. IV-5H-C and Table IV-3).
2.2 Transient DBH-expressing neurons
It has been reported that motor neurons of the hindbrain express transiently
DBH (Tiveron et al., 1996) but not TH (unpublished results) from E12 to birth. From
El2-16 to P0-P4, a weak to moderate MAOA mRNA expression was detected in
motor neurons of the oculomotor, trochlear, trigeminal motor, abducens, facial,
ambiguus, dorsal motor vagus, and hypoglossal nuclei (Fig. IV-6 and Table IV-3). In
facial and ambiguus motor nuclei low levels of MAOA mRNA expression were
observed protractedly (Fig. IV-6F and Table IV-3).
2.3 Transient DBH and TH-expressing neurons
Cranial sensory ganglia serving the trigeminal (Vth), facial (Vllth),
glossopharyngeal (IXth), and vagus (Xth) have been reported to express transiently
during embryonic development selected catecholaminergic traits, such as TH or
DBH expression or NA uptake (Son et al., 1996). Interestingly, cranial sensory
neurons expressed also moderate to strong levels ofMAOA mRNA from El2 to at
least birth (Table IV-3). Low to moderate MAOA mRNA expression was also found
from E12 to at least P0 in sensory neurons of the dorsal root ganglia (Table IV-3).
3 MAOB mRNA expression in discrete cholinergic populations
Cholinergic neurons are found in seven major projections systems (Ch), and
at least three major areas containing intrinsic neurons, contained wholly within the
CNS. Earlier reports have shown that cholinergic neurons of the pedunculopontine
tegmental (Ch5) and laterodorsal tegmental (Ch6) (Ikemoto et al., 1999), and small
cholinergic interneurons intrinsic to the caudate-putamen (Nakamura et al., 1993)
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Figure IV-5 MAOA expression in neurons displaying a transient tyrosine hydroxylase
(TH) immunoreactivity in the (A-C) inferior colliculus and the (D-F) amygdala. A,
MAOA expression and B, TH immunoreactivity at the level of the caudal inferior colliculus
at E14. A,B, arrows point to individual neurons at the same level. C, Higher magnification in
box inset in (B), arrows show small and lightly stained TH-immunoreactive neurons. D,
MAOA expression and E-F, TH immunoreactivity in the developing amygdala at PO. D,
MAOA expression is located at the level of the medial cortical amygdaloid nucleus {arrow),
the central nucleus {arrowhead) and the basal cortical amygdaloid nucleus {double arrow).
E, Numerous TH-immunoreactive neurons are located in the central nucleus {arrowhead), F,
the medial cortical amygdaloid nucleus {arrow), and the cortical amygdaloid nucleus
{double arrow). Scale bar: A,B,E,F, 2mm; C, 0.5mm; D, 3mm.
Figure IV-6 MAOA expression in motor neurons of the hindbrain. A, B Sections of E14
embryos showing strong MAOA expression in (A,B) the facial nucleus (7n) and (B) the
dorsal motor vagus (10n) and the hypoglossal nucleus (12n). B, Note also MAOA
expression in serotoninergic neurons of the B1-B3 complex (B1-B3). C-E, MAOA
expression in sections from new born pups, note the decrease of MAOA expression in
motor neurons in comparison to (A-B). C, MAOA expression at the level of the
trigeminal motor nucleus (5n) and the facial nucleus (7n). Note also MAOA expression in
adrenergic neurons of the A5 group (A5). D, MAOA expression at the level of the dorsal
motor vagus and the neighbouring adrenergic group C2 (C2), the ambiguus (Amb) and
the adrenergic group CI (CI). E, moderate MAOA expression in the hypoglossal nucleus
(12n). F, Section of P15 pups showing protracted MAOA expression in the facial
nucleus. Arrowheads point to serotoninergic neurons of the B1-B3 complex. Scale bar:
A,B, 2mm; C-E, 1mm; F, 0.5mm.
Table IV-3 Location of MAOA mRNA expression in neurons expressing transiently a
catecholaminergic phenotype
Labeling intensity of neurons at pre- and postnatal ages
Location E12 E14 E16 E18 PO P4 P7 P10 Adults
(n = 3) (n = 3) (n = 3) (n = 3) (n = 3) (n = 3) (n = 4) (n = 4) (n = 2)
TH-positive
Central n. of amygdala - - + + + + - - -
Medial amygdaloid n. - - - -H- ++ - - - -
Cortical amygdaloid n. - - - + + - - - -
Inferior colliculus - ++ ++ - - - - - -
DBH-positive
Oculomotor n. - - + + + - - - -
Trochlear n. - - + + + - - - -
Trigeminal motor n. - + ++ ++ + - - - -
Abducens n. + ++ ++ ++ ++ + - - -
Hypoglossal n. + ++ ++ ++ + + - - -
Dorsal motor vagus n. + -H- ++ ++ + + - - -
Facial n. + ++ ++ ++ ++ + + + +
Ambiguus n. - + + ++ ++ + + + +
TH-positive and DBH-positive
Cranial sensory ganglia
V, VII, IX, X ++ +++ I I I +++ +++ -H- nd nd nd
Dorsal root ganglia +++++++ ++ -H- nd nd nd
Intensity of the labeling at prenatal and postnatal ages according to locations in the brain: - none; + weak; ++ moderate ;
+++ high; nd not defined.
display MAOB activity. I confirmed these findings by in situ hybridization and
extended the notion of MAOB location in cholinergic neurons by showing MAOB
mRNA expression in additional cholinergic groups (Table IV-2).
From P4, weak MAOB mRNA expression was found in cholinergic neurons of
Ch5 and Ch6 (Table IV-2). In the basal telencephalon, large cholinergic neurons in
the medial septal nucleus (Chi), vertical limb of the diagonal band of Broca (Ch2)
and horizontal limb of the diagonal band of Broca (Ch3) displayed moderate MAOB
mRNA expression from P4 (Table IV-2). In the epithalamus, the medial habenular
nucleus (Ch7) displayed strong MAOB mRNA expression from E14 (Table IV-2).
Moderate MAOB mRNA expression was also detected in small cholinergic
interneurons of the striatum and ventral pallidum by PO (Table IV-2).
4 MAOA and MAOB mRNA expression in non-aminergic neuronal populations
The neuronal populations described below never express transiently the
monoamine synthesizing enzymes, TH, TpOH, DBH, HDC or L-amino acid
decarboxylase.
4.1 Telencephalon
From E12 to El6, low MAOA mRNA expression was found throughout the
ventricular and subventricular zone of the neocortical, striatal, amygdal and pallidal
anlages (Table IV-4). Then MAOA mRNA expression became restricted to discrete
neuronal populations. Low MAOA mRNA expression was detected from E16 in the
cortical plate and the hippocampal formation (Table IV-4). In the cortex, MAOA
mRNA expression was stronger in layer VIb and V (Fig IV-6 and Table IV-4). In the
hippocampal formation MAOA mRNA expression was located at the level of the
CA1-CA3 fields, the strongest expression being in CA3 (Fig. IV-8 and Table IV-4).
From El6, the ventral part of the basal amygdaloid nucleus displayed low levels of
MAOA mRNA expression (Table IV-4).
Low MAOB mRNA expression was detected by PO in the basal telencephalon,
particularly at the level of the medial and lateral nucleus accumbens shell. In these
structures MAOB mRNA expression progressively increased to reach maximal levels
in adults.
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Table IV-4 Location of MAOA and MAOB expressions in non-monoaminergic neurons and
glial cells during development
Labeling intensity at pre- and postnatal ages
Location E12 E14 E16 E18 PO P4 P7 P10 Adult





svz-vz + + +
Cortical plate - + + +
Layer VI b + + + + + +
Layer V + + + + + +
Piriform Cortex - + ++ ++ ++ ++
Anterior olfactory n. + + + + + +
LGE-MGE
SVZ-VZ + + + -
Hippocampus
SVZ-VZ - + + +
CA1 + + + - - - -
CA3 ++ ++ ++ ++ ++ ++ ++
Amygdala
Basal amygdaloid nucleus 4- + + + + + +
Diencephalon
Zona incerta, caudal part + + + + + -
Habenula - + ++ ++ ++ ++ ++ ++ ++
Paraventricular th. n. - + + + + + +
Lateral dorsal th. n. - . nd nd nd + +
(sub)Parafascicular th. n. - + + + + + +
Central th. system - + + + + + +
Rhomboid n., Reuniens n. - + + + + + +
Ventromedial hyp. n. - + + + + - -
Brainstem
Ventral Cochlear n. - . + nd nd nd nd
Lateral Vestibular n. - - + nd nd nd nd
Solitary tract n. - ++ ++ ++ ++ ++ ++ ++ ++
MAOB
Neuronal cells
Accumbens - . + + ++ ++ +++
Lateral habenula - . + + ++ ++ +++
Paraventricular th. n. - . + + ++ ++ +++
Central th. system - - - + ++ ++ ++
Rhomboid n., Reuniens n. - - - + + + +
Ventral th. system - - - + + + +
Non-neuronal cells
Nerve entry zone ++ +++ +++ +++ ++ + - - -
Astrocytes - - - + ++ +++ +++
Circumventricular organs - - + ++ +++ +++ +++
Intensity of the labeling at prenatal and postnatal ages according to locations in the brain: - none; + weak; ++ moderat
+++ high.; nd not defined.
Figure IV-7 MAOA expression in the developing cerebral cortex. A, MAOA expression
in a El8 embryo showing a moderate expression in lower layer IV, upper layer V and in
the pia. B, MAOA expression in a P15 pup. Note the strongest MAOA expression in
lower layer VI and layer V. Scale bar: A, 0.25mm; B, 0.5mm.
Figure IV-8 MAOA mRNA expression in thalamic nuclei. A, Coronal section of El 8
embryo showing MAOA expression in the thalamus: in intralaminar thalamic nuclei
(central (CL), central median (CM), paraventricular (PV) and intermediate dorsal
thalamic nuclei (IMD) thalamic nuclei), the rhomboid (Rh), the reuniens (Re), and the
ventral medial (VM) thalamic nuclei. Note also MAOA expression in the hippocampus
with higher levels of expression in CA3, the habenula (Hb), the amygdala with higher
level of expression in the central (Ce) and the anterior amygdala (AA) and in the
trigeminal ganglion (V). B-D, Coronal sections of PI 5 pups showing protracted MAOA
expression in thalamic nuclei. B, Rostral section showing MAOA expression in the
lateral dorsal (LD), paraventricular (PV) and intermediate thalamic nuclei (IMD). Note
also the strong and protracted MAOA expression in CA3. C, more caudal section
showing MAOA expression in intralaminar thalamic nuclei (paracentral (PC), CM and
PV), Rh and Re and the medial habenula (MHb). D, Caudal section showing MAOA
expression in the parafascicular (PF) and subparafascicular (SPF) thalamic nuclei and in
the zona incerta (ZI). Scale bar: 2 mm.
i
Figure IV-9 MAOB mRNA expression at the level of the thalamus and
habenula. A, Coronal section of a El 8 embryo showing MAOB mRNA expression
in the fimbria and the mastocytes. Note also MAOB mRNA expression in the
habenula (Hb) and the trigeminal ganglion (V). B, Coronal scetion of a P21 pup
showing MAOB mRNA expression in the habenula and thalamic nuclei: in the
paraventricular (PV), the paracentral (PC) and central median (CM) and, in the
rhomboid (Rh) and reuniens (Re) thalamic nuclei. Scale bar = 2mm.
4.2 Diencephalon
In the epithalamus, the habenula displayed low MAOA mRNA expression by
E14. From E16, the entire medial habenula displayed moderate MAOA mRNA
expression (Fig. IV-8 and Table IV-4). From El8, low MAOA mRNA expression
was detected in the paraventricular thalamic, the lateral dorsal, the
(sub)parafascicular, the rhomboid and reuniens nuclei and in discrete nuclei of the
central system (central, central median and paracentral) (Fig. IV-8 and Table IV-4).
From E18-P0, strong MAOB mRNA expression was detected in the lateral
habenula (El8; Fig. YV-9A) and paraventricular thalamic nucleus (PO). From P4, the
rhomboid and reuniens nuclei and all dorsal thalamic nuclei of the central and ventral
systems (ventroanterior, ventromedian, ventrolateral, and ventroposterior) displayed
low to moderate MAOB mRNA expression (Fig. TV-9B and Table IV-4).
From El8 to P7, the ventromedial hypothalamic nucleus displayed low
MAOA mRNA expression (Table IV-4). From E18 to P10, low MAOA mRNA
expression was also detected in the caudal zona incerta (Fig. IV-8 and Table IV-4).
4.3 Brainstem
From El8, MAOA mRNA was detected in the periaqueductal central grey
(Fig. IV-15) and the nucleus of the solitary tract (Table IV-4). In the superior
colliculus, the stratum zonale contained low levels ofMAOA mRNA from PO (Table
IV-4). Low levels of MAOA mRNA expression were also detected by PO in the
ventral cochlear and the lateral vestibular nuclei (Table IV-4).
5 Non-neuronal cells
5.1Glial cells
From E12 to P4, cells at the interface between the CNS and the PNS
displayed strong MAOB mRNA expression (Fig. IV-10A and Table IV-4). The
nature of the cells is not clear but might correspond to astrocytes. From El4, glial
cells of the tectal glia limitans displayed strong levels ofMAOB mRNA. From E12,
there was a strong MAOB mRNA expression in the olfactory epithelium (Fig. IV-
105). From El4, ensheating astrocytes of the olfactory nerve and olfactory bulb
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Figure IV-10 MAOB mRNA expression in glial cells. A, MAOB mRNA expression at
the interface between the CNS and the PNS at the level of nerve V (V). Note also MAOB
mRNA expression in serotoninergic neurons of the raphe median (MnR). Arrows point to
MAOB mRNA expression in several cartilages. B, Coronal section showing MAOB
mRNA expression in the olfactory epithelium (Oe). Note also MAOB mRNA expression
in the liver. Scale bar = 4mm.
nerve layer expressed high levels ofMAOB. From El7 the fimbria display high level
of MAOB (Fig. IV-9A). Finally, astrocytes displayed moderate MAOB mRNA
expression in all brain regions from P0-P4.
5.2 Ependymocytes and circumventricular organs
A moderate level of MAOB mRNA expression was detected from E17 in all
circumventricular organs: the subfornical and subcommissural organs, the area
postrema and the choroid plexus. Then MAOB mRNA expression increased to reach
a maximum by P7. A high level ofMAOB mRNA expression was also detected from
P4 throughout all ventricular ependyma (Table IV-4).
5-3 Blood vessels
From E15, blood vessels displayed low levels of MAOA mRNA expression
in all brain regions. MAOB mRNA was never detected in blood vessels. This is in
contrast to what was reported in rat in which MAOB but not MAOA is expressed in
blood vessels (Kitahama et ah, 1994).
6 MAO activity
I used clorgyline, a selective inhibitor of MAOA, and deprenyl, a selective
inhibitor ofMAOB, to determine the specific pattern ofMAOA and MAOB activity
during development. I used MAOA knockouts to determine the minimal
concentration of deprenyl necessary to inhibit completely the remaining MAOB
activity. I found that 10"7 M deprenyl was sufficient to inhibit MAOB activity. I
found also that 10"7 M clorgyline was sufficient to block MAOA activity. On the
whole, I found a good spatio-temporal correlation between MAO activity and MAO
mRNA expression, especially with noradrenergic, serotoninergic, histaminergic,
melatoninergic, and some dopaminergic neurons where MAO proteins are largely
concentrated into cell bodies and dendrites and allow a clear visualisation (Arai et al.,
1986 and Figure IV-11). However, exceptions were found such as SN-VTA neurons
that never displayed MAO activity. Cholinergic neurons also displayed a good
spatio-temporal correlation between MAOB mRNA and MAOB activity. I found
also a rather good spatio-temporal correlation between MAO activity and MAO
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Figure IV-11 MAO activity in aminergic, histaminergic and thalamic neurons.
A, Sagittal section of a El4 embryo showing strong MAO activity in serotoninergic
neurons (RD, MnR, RMg), in noradrenergic neurons of the locus coeruleus (LC), in
the mammilary body (mm) and the choroid plexus (chp). Open arrows point to
individual blood vessels. Note that numerous blood vessels display MAO activity. B,
Coronal section of a P4 pup showing MAO activity in histaminergic neurons in the
tubero-mammilar region (hist), in the habenula (Hb) and in several intralaminar
thalamic nuclei (PV, CL, IMD, PC, CM). CL, central lateral; CM, central median,
MnR, raphe median nucleus; PC, paracentral; RD, Raphe dorsal; RMg, Raphe
magnus nucleus. Scale bar: A, 3mm; B, 4mm.
mRNA in non-monoaminergic neurons and neurons displaying a transient
monoaminergic phenotype. For instance, TFI-IR neurons of the inferior colliculus
displayed MAOA activity until E14 and neurons of the thalamic intralaminar system
by P4 (Fig. IV-11). However, I failed to detect any MAO activity in the hippocampus
or cortex. Finally, an excellent spatio-temporal correlation was found between
MAOB activity and MAOB mRNA in non-neuronal cells (Fig. IV-12).
7 MAOB immunocytochemistry
I have used MAOB immunocytochemistry to determine the cell types containing
MAOB. The complete analysis of the cellular and subcellular locations of the MAOB
protein is not completed. Some preliminary results are presented below.
So far I was able to show that most serotoninergic neurons express MAOB as
early as El4. At this age MAOB immunolabeling was more intense in neurons that
had migrated away from their area of genesis (Fig. IV-13). The difference of
intensity in MAOB labelling was maintained throughout development. The high
intensity of the signal obtained could be attributed to the long life of the protein and
to its accumulation. In other neuronal populations there was a good correlation with
in situ hybridization and activity.
MAOB labelled numerous astroglial and glial cells that were scattered all
over the brain. Double labelling for GFAP and MAOB revealed that MAOB was an
earlier and more general marker for astrocytes than GFAP. MAOB was observed in
numerous astrocytes as early as El7 and was also observed in astrocytes that were
not GFAP-positive (i.e.: at the level of the fimbria) (Fig. IV-14).
V Discussion
I provide here the first description of the developmental localisation of
MAOA and MAOB. Unexpectedly, in serotoninergic neurons I found that MAOA is
the principal enzyme of degradation of serotonin in embryonic ages whereas MAOB
is the principal enzyme of degradation in postnatal ages. In addition, I report that
there is a transient expression of MAOA in proliferating neuroepithelia and in
several non-monoaminergic structures, a notion that is of importance to comprehend
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Figure IV-12 A, Sagittal section of E12 embryo showing a strong MAO activity at
the level of the olfactory epithelium (oe). B, Coronal section ofE14 embryo showing
MAO activity in the olfactory epithelium and the olfactory nerve (olf). C, Coronal
section of E14 embryo showing strong MAOA activity at the interface between the
CNS and the PNS at the levels of nerves VIII, V and VII. D, Sagittal section ofEl 7
embryo showing MAO activity in individual cells in the ganglion of the nerve X
(lOGn). Scale bar: A, 1mm; B, 4mm; C, 2mm; D, 0.5mm.
Figure IV-13, Please see following page for figure legend
Figure IV-13 Colocalisation of MAOB and 5-HT in sagittal section of E14
embryo. A, 5-HT and MAOB are colocalised in both B1-B3 (ventral) and B4-B9
(medial) serotoninergic complexes. B-C", Higher magnification of areas pointed out
in (A) showing (B,C) MAOB-immunolabeled serotoninergic neurons, (B',C') 5-HT
immunolabeled neurons, (B",C") the overlay of (B and B') and (C and C')
respectively. B-C", Arrows and filled arrows point to single neurons. Note that most
serotoninergic neurons contain MAOB. Note also that in both serotoninergic groups
(B1-B3) and (B4-B9) some serotoninergic neurons contain lower levels of MAOB
than others. B-C", Arrows point to serotoninergic neurons displaying a strong
MAOB immunolabeling. C-C', Filled arrows point to serotoninergic neurons
displaying a less strong MAOB immunolabelling. Note that these neurons are closer
to their area of genesis than those displaying higher level ofMAOB immunolabeling.
Scale bar: A, 1mm; B-B", 0.4mm; C-C", 0.3mm.
Figure IV-14 Please, see figure legend on the following page
Figure IV-14 Colocalisation of MAOB and GFAP at the level of (A-C) the
fimbria and (D-F) the hippocampus. A-A", Coronal section of a P15 pup showing
immunolabeling for (A) MAOB, (A') GFAP and (A") the overlay. Note that the
ventral part of the fimbria is immunolabeled for MAOB but not for GFAP. B,
Coronal section of El7 embryo showing a strong MAOB immunolabeling but no
GFAP immunolabeling. Please, see FigIV-9A for the location of the fimbria on
coronal section. C, Fligher power of the region pointed in (A") showing an astrocyte
double labelled for MAOB and GFAP (<double arrow) and another astrocyte
displaying a single label for MAOB (arrow). D, Coronal section of a PI 5 pup double
labelled for MAOB and GFAP. E,F, Higher power of the areas pointed by the (E)
large arrow and (F) thin arrow in (D) respectively, showing astrocytes
immunolabeled for MAOB and GFAP. Scale bar: A-B, 0.5mm; C, 0.2mm; D, 1mm;
E,F, 0.3mm.
Finally, beside its important role in scavenging monoamines by non-neuronal cells,
this study shows a surprising coexistence ofMAOB in cholinergic neurons.
1 MAOA expression is linked to the noradrenergic phenotype
Previous localization studies in the adult have shown that in all species
studied, humans (Westlund et ah, 1985), cats (Kitahama et ah, 1994) and rats (Luque
et ah, 1995), MAOA is most abundantly expressed in noradrenergic neurons of the
central and peripheral nervous system. In this study, I show that typical
noradrenergic neurons express MAOA soon after they differentiate by embryonic
day 12. Interestingly, MAOA is also transiently expressed in neurons that display a
transient noradrenergic phenotype such as motor nuclei of the brainstem and Vth,
Vllth, IXth and Xth cranial sensory ganglia. All these nuclei express the biosynthetic
enzyme ofNA, DBH (Tiveron et ah, 1996) during the same developmental period as
MAOA, suggesting that both genes could be co-regulated. Interestingly, recent
studies have implicated two transcription factors, MASH1 and Phox2a, in the control
of (nor)adrenergic differentiation (Morin et ah, 1997; Hirsch et ah, 1998). In
particular, Phox2a has been shown to be a positive regulator of the DBH gene
(Zellmer et ah, 1995) and inactivation of Phox2a leads to a complete agenesis of
neurons that display either a permanent or a transient noradrenergic phenotype: the
LC and parasympathetic ganglia are absent, while the cranial sensory ganglia and the
superior cervical ganglion are atrophic or altered (Morin et ah, 1997). It is tempting
to speculate that, in addition to its control of the DBH gene, Phox2a could be a
positive regulator of the MAOA gene in (nor)adrenergic cell groups. Surprisingly,
the other biosynthetic enzymes of NA, tyrosine hydroxylase and L-DOPA
decarboxylase, are not expressed in motor nuclei suggesting that either NA could be
produced from DA by specific uptake ofDA or DBH could have another substrate.
2 MAOA is the principal degradative enzyme of serotonin in serotoninergic
neurons during early development
Previous descriptions done in rat adult brain have already shown a moderate
MAOA mRNA expression in some serotoninergic neurons (Luque et ah, 1995). This
study confirms this observation in mice. Interestingly, MAOA is also strongly
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expressed in all serotoninergic neurons during early development. MAOA is
expressed and active in all serotoninergic neurons soon after they differentiate and
start producing 5-HT. Serotoninergic neurons start producing 5-HT when neurons are
still in the process of migrating to their final destination (E10-E12 in mice, present
study; E12 to E14 in rats, Lauder and Bloom, 1974, Lidov and Molliver, 1982a).
Concomitantly, serotoninergic neurons express SERT (Schroeter and Blakely, 1996),
and VMAT2 (Hansson et ah, 1998, Lebrand et al. 1998). Thus, soon after they are
generated, developing serotoninergic neurons are already able to produce, store,
release, uptake and degrade 5-HT. Unexpectedly, with respect to previous
observations in adults (Levitt et ah, 1982), serotoninergic neurons express strongly
MAOA during embryogenesis and early postnatal life. The shift toward the adult
pattern begins by PO, when serotoninergic neurons start to co-express MAOA and
MAOB. MAOB gene expression then increases progressively, while MAOA gene
expression decreases to reach low levels in adult serotoninergic neurons. Since
MAOA degrades more efficiently 5-HT than MAOB, the predominant presence of
MAOA in serotoninergic neurons during embryonic life could be important for
regulating the levels of this amine. Indirect evidences for this are the high levels of 5-
HT during embryonic development and the progressive decrease of these high levels
during early postnatal development in mice lacking MAOA (Cases et ah, 1995 ;
Lajard et ah, 1999) and the fact that 5-HT levels are unchanged in mice lacking
MAOB (Grimsby et ah, 1997). It will be important to know whether similar
mechanisms occur in humans. MAOA deficiency has been associated with mild
mental retardation and behavioural abnormalities (Brunner et ah, 1993a,b) whereas
MAOB deficiency has not been associated with behavioural alterations. This
suggests that the same mechanisms could be conserved in humans.
3 MAOB in cholinergic neurons
Earlier reports have already shown the existence of MAOB in subsets of
cholinergic neurons (Nakamura et ah, 1993; Ikemoto et ah, 1999) and identified
MAOB-expressing cells in regions containing cholinergic neurons (Ikemoto et ah,
1997). This study shows the striking expression of MAOB in most of forebrain
cholinergic neurons. Only cholinergic neurons of the basalis nucleus of Meynert
(Ch4) do not display MAOB expression. Despite no biochemical data upon the
specificity of MAOB to acetylcholine, it appears very unlikely that acetylcholine
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represents a substrate for MAOB. The more likely explanation would be the
elimination of trace amines that interfere with acetylcholine synthesis or storage in
vesicles, although the nature of these trace amines remains unknown. Alternatively,
MAOB could degrade monoamines such histamine or serotonin internalised with
their own receptors. In the cytoplasm, monoamines could interfere with acetylcholine
storage by acting upon the vesicular acetylcholine transporter that display a
substantial resemblance with vesicular monoamine transporters (Roghani et ah,
1994). However, in vitro studies have shown that monoamines are not transported by
the vesicular acetylcholine transporter (Clarkson et ah, 1993). Although the role of
MAOB in cholinergic neurons remains speculative, its inhibition could be of
importance in neurodegenerative conditions involving cholinergic neurons such as
Alzheimer's disease or even aging. In Alzheimer's disease, several trials have shown
the benefit of the MAOB inhibitor, deprenyl used in a low dosage; in particular it
improves cognition (Birks and Flicker, 2000). Interestingly, there is a 40% decrease
in MAOB activity in the brains of smokers and smoking has been shown to protect to
some extent against Alzheimer's disease (Fowler et ah, 1996). The mechanisms
inducing neuroprotection by MAOB inhibition are not known but could include a
delay in cell death (Magyar et ah, 1998; Paterson and Tatton, 1998).
4 MAOB as a multipurpose scavenger
In the adult brain MAOB has been shown to be located to all ependymal and
astroglial cell populations and this pattern is already present during development. I
found that MAOB mRNA expression in the ventricular ependymal system, and the
circumventricular organs (plexus choroid, subcommissural organs, area postrema,
and pineal gland), appeared on the day of birth and increased progressively until
adulthood. The known physiological role of MAOB in these structures is to protect
the CNS from trace amines present in the cerebrospinal fluid (Levitt et ah, 1982;
Willoughby et ah, 1988; Saura et ah, 1992). Astrocytic expression ofMAOB had the
same temporal pattern of expression, starting after birth. In astrocytes the role of
MAOB might be dual: i) in the vicinity of monoaminergic nerve terminals, it could
degrade transmitters taken up, by the glial cells and ii) throughout the brain, it could
inactivate trace amines in the extracellular space. Recent reports have shown that
astrocytes are capable of high-affinity 5-HT uptake (Bel et ah, 1997) and possess a
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facilitated diffusion system for dopamine (Hosli and Hosli, 1997). In addition to
these known locations, I found two novel and interesting locations of MAOB during
development. MAOB was intensely expressed in the developing cranial and spinal
nerve entry zones, in a very particular population of cells, that are most likely
astrocytes (Golding et ah, 1997; Golding and Cohen, 1997). It is tempting to
speculate that, at this transitional zone between the CNS and the penetrating nerves
these cells produce MAOB to prevent amines of the cerebrospinal fluid from
penetrating into the CNS. MAOB expression in this area is transient, from E10 to P4,
a period when cranial and spinal nerves cross the nerve entry zones to arborize into
the CNS (Golding et ah, 1997; Golding and Cohen, 1997). It has been shown that
regenerating axons are able to cross the dorsal root entry zone when a dorsal root is
crushed neonatally whereas they fail to re-enter the spinal cord when the crush is
effected one week postnatally (Carlstedt, 1985; Carlstedt et al., 1987). This temporal
coincidence suggests that MAOB could be used as a marker of astrocytic
permissivity at nerve entry zones. The other new localization of MAOB uncovered
by the present analysis is the expression in the olfactory epithelium. The olfactory
epithelium is exposed to a variety of xenobiotic chemicals, including odorants,
pheromones and airborne toxic compounds. Recently, several novel, highly
abundant, olfactory-specific biotransformation enzymes have been identified: the
cytochrome P-450olf (Nef et al., 1990), the olfactory UDP-glucoronosyl transferase
(Lazard et al., 1990) and glutathion-S-transferase (Rama-Krishna et al., 1992). These
enzymes are particularly important in the rapid termination of odorant signals and
detoxification (Thornton-Manning et al., 1997). It is tempting to speculate that the
physiological role of MAOB in the olfactory epithelium might also be the
termination of aminergic odorant signals and the detoxification of a broad range of
airborne amines. Interestingly, all these enzymes have an exceptionally high activity
in the olfactory system, comparable or even higher to that measured in the liver. The
increasing popularity of the nose as a route of drug administration and the increased
incidences of nasal tumour associated occupations makes the study of MAOB as a
xenobiotic-metabolising enzyme of the nasal cavity an important are of health-
related research. Interestingly in humans DA is metabolised by MAOB whereas in
rodents it is oxidised by MAOA (Neff and Yang, 1974). As a consequence, increased
oxidation of dopamine (DA) by MAOB may be associated with the loss of
dopaminergic neurons in the substantia nigra, which underlies Parkinson's disease.
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Indeed, patients with Parkinson's disease have elevated MAOB activity in striatal
astroglial cells, and the MAOB inhibitor, deprenyl, delays the progression of
symptoms (Knoll et al., 1989). However, it has been suggested that deprenyl may




Search formolecules that could influence the development of
monoaminergic systems-!-:
A role for the trancription factor pax6?
CHAPTER FIVE :
SEARCH FOR MOLECULES THAT COULD INFLUENCE
THE DEVELOPMENT OF MONOAMINERGIC SYSTEMS:
A ROLE FOR THE TRANSCRIPTION FACTOR PAX6?
Note that in this study the word specification should be read TH-specification
I Abstract
In the central nervous system, the lack of the transcription factor Pax6 has
been associated with early defects in cell proliferation, cell specification and axonal
pathfinding of discrete neuronal populations. In this study, I show that Pax6 is
expressed in discrete catecholaminergic neuronal populations of the developing
ventral thalamus, hypothalamus and telencephalon. In mice lacking Pax6, these
catecholaminergic populations develop abnormally: those in the telencephalon are
reduced in cell number or absent whereas those in the ventral thalamus and
hypothalamus are greatly displaced and densely packed. Catecholaminergic neurons
of the substantia nigra (SN) and the ventral tegmental area (VTA) do not express
Pax6 protein. Nevertheless, mice lacking Pax6 display an altered pathfinding of SN-
VTA projections: instead of following the route of the medial forebrain bundle
ventrally, most of the SN-VTA projections are deflected dorso-rostrally at the
pretectal-dorsal thalamic transition zone and in the dorsal thalamic alar plate.
Moreover, some catecholaminergic neurons are displaced dorsally to an ectopic
location at the pretectal-dorsal thalamic transition zone. Interestingly, from the
pretectal-dorsal thalamic to the dorsal thalamic-ventral thalamic transition zones,
mice lacking Pax6 display an ectopic ventral to dorsal expansion of the
chemorepellant/chemoattractive molecule, Netrin-1. This may be responsible for
both the altered pathway of catecholaminergic fibers and the ectopic location of
catecholaminergic neurons in this region.
II Introduction
1 The transcription factor Pax6
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Pax6 is a member of the Pax gene family, which has nine members (Dressier
et ah, 1988; Walter and Gruss, 1991). All share a conserved paired box-sequence
which encodes a protein that binds the DNA and influences its transcription (Kessel
and Gruss, 1990). These transcription factors are highly conserved during evolution.
The same DNA-binding motif has been identified in a variety of organisms such as
zebrafish (Krauss et ah, 1991a,b; Puschel et ah, 1992), chicken (Goulding et ah,
1992), nematodes, frog, turtle, mouse and human (Dressier et ah, 1988; Burri et ah,
1989). The paired sequence of the mouse and the human Pax6 genes share 90%
homology. In addition, the sites of splicing in both the paired domain and the
homeodomain are conserved in different species of vertebrates suggesting that
vertebrate Pax6 genes are homologues.
Interestingly, in vitro studies have shown that Pax6 can bind and transactivate
its own promoter (Plaza et al., 1993). Pax6 is able to stimulate Pax6-responsive
reporter constructs in transient transfection assays and this response is critically
dependent on Pax6 concentration (Czemy and Busslinger, 1995). Few genes have
been identified as candidate targets for Pax6. Chalepakis et al. (1994) have identified
three in vitro binding sites of Pax6 in the promoter region of the neural cell adhesion
molecule LI suggesting that Pax6 could play a direct role in regulating LI. In vitro,
the gene coding for the neural cell adhesion molecule NCAM, several Pax genes and
crystallin genes (Witsow and Piatigorsky, 1988) have also been shown to be direct
targets ofPax6.
Mutations of the Pax genes have been associated with three congenital
disorders in humans: mutations in PAX2 with autosomal dominant renal
abnormalities, and optic colobomas (Sanyanusin et al., 1995); mutations in PAX3
with Wardenburg's syndrome type 1 and Klein-Wardenburgh syndrome (Baldwin et
al., 1992, Hoth et al., 1993; Morell et al., 1992); and mutations in PAX6 with aniridia
(Ton et al., 1991).
The role of Pax6 in the developing nervous system is far from completely
understood. However, several studies have shown its direct role on eye induction, on
nose and craniofacial development, in the dorso-ventral organisation of the spinal
chord (Ericson et al., 1997) in the specification of neuromeric boundaries (Stoykova
et al., 1996) and in thalamic development (Stoykova et al., 1996; Warren and Price,
1997). All these events (which represent a non-exhaustive list) are altered in the
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several strains of mice and rat lacking Pax6. Unfortunately, the lack of Pax6 is lethal
and mice lacking Pax6 die at birth limiting the possible analysis of the role of Pax6.
In the mouse, Pax6 is expressed from E8.5 (Walther and Gruss, 1991;
Grindley et ah, 1995) and its expression is protracted in several region of the
developing brain. Interestingly, Pax6 is protractedly expressed in regions known to
contain a high concentration of dopaminergic neurons such as: the olfactory bulb, the
amygdala, the zona incerta and the paraventricular hypothalamic region (Stoykova
and Gruss, 1994). In addition, Pax6 expression was reported in the isthmus, the
presumptive region of mesencephalic dopaminergic neuron genesis and decribed in
P45 mouse brain in the region of the substantia nigra (pars reticulata and pars lateral)
(Stoykova and Gruss, 1994).
The pattern of Pax6 expression led me to further analyse the possible co-
localisation of Pax6 and tyrosine hydroxylase, the rate-limiting enzyme for
cathecholamine synthesis. I also wanted to assess the possible deleterious effect of
the lack of Pax6 on catecholaminergic neurons by studying the genesis and
development of catecholaminergic neurons in mice lacking Pax6.
2 Defects of tyrosine hydroxylase-immunoreactive neurons in the brains of mice
lacking the transcription factor Pax6
Catecholaminergic neurons (dopaminergic, noradrenergic and adrenergic)
express the rate-limiting biosynthesis enzyme, tyrosine-hydroxylase (TH), as soon as
they are generated, allowing a relatively easy study of their development. Recently, a
neuromeric model for catecholaminergic (CA) neuronal development has been
proposed in several species, including lizard (Medina et al., 1994), chick (Puelles
and Medina, 1994) and human (Puelles and Verney, 1998). In this model, it is
proposed that permanent or transient CA neurons are generated in or near the region
that they occupy in the adult, rather than being generated at a few localized sources
and distributed through migration (Olson and Seiger; 1972). As a consequence,
complex CA entities such as the substantia nigra (SN), the ventral tegmental area
(VTA) or the incerto-hypothalamic axis (Hokfelt et al., 1984) are generated along
several neuromeric components. Despite the apparent anatomical diversity of
noradrenergic (NA) and dopaminergic (DA) neurons, it appears that their early
specification relies on a small number of molecules. For instance, essential
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transcription factors such as Mashl, Phox2a and Phox2b have been implicated in
controlling the specification of all noradrenergic neurons (Pattyn et al., 1997; Hirsh
et ah, 1998). It appears that the two secreted molecules sonic hedgehog (SHH) and
fibroblast growth factor 8 (FGF8) are critical for the specification of DA neurons,
and the stereotypic location of most DA neurons along the antero-posterior and
dorso-ventral axes is defined by the integration of these two signals (Ye et ah, 1998;
Hynes et ah, 2000).
Gene expression studies have shown that the transcription factor Pax6 is
transiently expressed in areas containing discrete CA neurons in the mesencephalon,
the ventral thalamus, the hypothalamus (Stoykova and Grass, 1994), and the
olfactory bulb (Dellovade et ah, 1998). Pax6 is a member of a highly conserved gene
class and encodes a transcription factor containing a paired domain and an
homeodomain (Callaerts et ah, 1997). The spatiotemporal expression of Pax6, from
E8.5 to adulthood, suggested that Pax6 plays key roles in central nervous system
development (Walther and Grass, 1991; Stoykova and Grass, 1994). Indeed, mice
lacking Pax6 display early defects in axonal pathfinding (Mastick et ah, 1997), in the
specification of several prosomeric transition zones (Grindley et ah, 1995, 1997;
Stoykova et ah, 1996), in cell proliferation (Warren and Price, 1997), in the
specification ofmotor (Ericson et ah, 1997) and diencephalic (Stoykova et ah, 1996)
cell subtypes and in cell migration (Caric et ah, 1997; Brunjes et ah, 1998;
Engelkamp et ah, 1999).
In the present study, I first defined the localisation of the Pax6 protein in TH-
immunoreactive (TH-IR) populations during development. I then investigated the
role of Pax6 in these populations by looking at their development in mice lacking
Pax6. I found that developing TH-IR neurons of the ventral thalamus (zona incerta),
hypothalamus (paraventricular nucleus), olfactory bulb and basal telencephalon
(anterior olfactory nucleus, piriform cortex, anterior amygdala and olfactory
tubercle) display high levels of Pax6 protein during a critical period of their
development. Despite severe positional alterations, diencephalic and hypothalamic
TH-IR neurons were identified in mice lacking Pax6, showing that Pax6 is not
necessary for their specification. In contrast, TH-IR neurons were greatly reduced in
number in the basal telencephalon and the remaining olfactory bulb. In addition, I
found ectopic TH-IR neurons distributed ventro-dorsally along the pretectal-dorsal
thalamic transition zone, and that TH-IR fibers and fibers immunoreactive for the
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cell adhesion molecules NCAM (neural cell adhesion molecule) and LI were
misguided in this zone and in the dorsal thalamic alar plate. Interestingly, this region
displayed an increased and ectopic expression of the SHH induced
chemorepellant/chemoattractive molecule Netrin-1 (Leonardo et ah, 1997a;
Lauderdale et ah, 1998) which might contribute to its having altered cues for cell
migration and axonal navigation.
Ill Material and methods
1 Animals
The original small-eye (Pax6sey) mutation arose spontaneously in a stock
called "CSR" and was subsequently out-crossed. The genetic background of the
small-eye strain used in this study was derived from the outbred Swiss background.
The mating of Pax6sey/+ (small-eye heterozygotes) was confirmed by the presence of
a vaginal plug the following morning. This was designated embryonic day 0.5
(E0.5). Experiments were carried out on El 1.5, E12.5, E13.5, E14.5, E16.5, E17.5
and El8.5 embryos. Embryos were dissected from deeply anaesthetised mothers into
cold phosphate buffered saline (PBS) on ice and examined under a dissecting
microscope. Homozygous Pax6sey/Pax6sey embryos were easily distinguished by
their absence of eyes and characteristic craniofacial phenotype of foreshortened
upper jaw (Hogan et ah, 1986). From E12.5, heterozygotes (Pax6sey/+) were
distinguished by the characteristic appearance of their iris lacking its inferior margin
(Kaufman et ah, 1995). In each experiment, wild type and Pax6sey/Pax6sey embryos
were obtained from the same litter. Some additional experiments were also carried
out on embryos, postnatal and adult mice of the Swiss genetic background. Animal
procedures were conducted in strict compliance with approved institutional protocols
and in accordance with the provisions for animal care and use described in the
"Scientific procedures on living animals ACT 1986". In all the experiments, adult
mice were anaesthetised with 0.3 ml 25% urethane injected intraperitoneally.
2 Immunocytochemistry
El 1.5, E12.5 and E13.5 embryos were fixed by immersion in 4%
paraformaldehyde in 0.1M phosphate buffer pH 7.6 (PB). Embryos from E14.5 to
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El9.5 and postnatal mice were perfused transcardially with saline followed by 4%
paraformaldehyde in PB. Whole embryos or brains were post-fixed for 2-5 days in
the same fixative and cryoprotected in 30% sucrose in PB. Serial coronal or sagittal
sections (40 pm) were cut on a freezing microtome and immediately processed for
immunocytochemistry as previously described (Cases et al., 1996). In brief, sections
were incubated with the primary antibodies diluted in PBS+ (0.1M PBS with 0.2%
gelatine and 0.25% Triton X-100) overnight at 4°C. Rabbit polyclonal anti-TH
antibodies (1:8000; a kind gift of A.Vigny or 1:800; Protos Biotech, New-York),
rabbit polyclonal anti-calretinin antibody (1:10000: Swant, Switzerland), rabbit
polyclonal anti-calbindin antibody (1:20000; Swant), rat monoclonal anti-Ll
antibody (1:50; Roche-Diagnostics, USA) and rat monoclonal anti-NCAM antibody
(1:50; Roche-Diagnostics) were used. Biotinylated goat anti-rabbit and biotinylated
goat anti-rat (1:200; DAKO, Denmark) were used as secondary antibodies and were
revealed with a streptavidin-biotin-peroxidase complex (1:200; Amersham, UK).
Sections were then reacted with a solution containing 0.02% diaminobenzidine,
0.6% nickel ammonium sulfate, and 0.003% H2O2 in 0.05M Tris buffer, pH 7.6
(DAB-Ni). From these sections, the total number of TH-IR neurons in A14PAVH
and the diameters of randomly selected TH-IR neurons (n = 20) were measured in
A14PAVH from El7.5 wild type (n = 4) and Pax6sey/Pax6sey (n = 4) embryos.
3 Double Pax6 and TH immunocytochemistry
Whole embryos (El 1.5, E12.5, E14.5, E16.5, E17.5 and E18.5) and dissected
postnatal (P0, P2, P4 and P9) and adult brains (5 week- and 16 week-old) were
immediately frozen in isopentane (-40°C) and stored at -80°C until sectioning.
Coronal and sagittal sections (10 to 14 pm) were cut on a cryostat and processed the
same day. Sections were dried at room temperature, fixed 10 min in methanol-
acetone (1/1; -20°C), dried 15 min at room temperature, hydrated 5 min in PBS, and
blocked 15 min in a solution containing 2% bovine serum albumin, 2% sheep serum,
7% glycerol and, 0.2% Tween-20 (BS). Sections were then incubated overnight at
room temperature with three different antibodies: a rabbit polyclonal anti-TH
antibody (1:5000; a kind gift of A. Vigny) and two mouse monoclonal anti-PAX6
antibodies (AD1.5.6 and AD2.35; 1:50 in embryos and 1:30 in adults; Engelkamp et
al., 1999) diluted in BS. Sections were washed in PBS 0.2% Tween-20 (PBST) and
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incubated 1 hr with secondary antibodies (TRITC anti-mouse antibody, 1:200;
Vector Labs, and FITC anti-rabbit antibody, 1:200; Sigma) diluted in PB. Sections
were washed in PBST and analyzed with a Leica confocal microscope (Leica TCNS,
Germany). In addition, alternate sections immunostained with anti-TH antibody or
anti-PAX6 antibody or Nissl-stained were analyzed in parallel.
4 Morphometric analysis
Free floating sections (45 pm) were processed for TH immunocytochemistry
as described above, except that immunolabeling was revealed using a FITC anti-
rabbit antibody (1:200; DAKO). Propidium iodide, a nuclear dye (1:10000;
Molecular Probes, USA), was added during the last 10 minutes of incubation with
the secondary antibody. This analysis was carried out on sections obtained from four
wild type and four Pax6sey/Pax6sey embryos. In each case, 7 sections from wild type
embryos and 5 sections from Pax6sey/Pax6sey embryos taken through the zona incerta
(Zi) and the dorsomedial hypothalamic (DMH) nucleus were selected. By confocal
microscopy (Leica TCNS, Germany), each section was re-sectioned into serial 7 pm-
thick sections. To estimate the volume of A13 and A14DMH in wild type and
Pax6sey/Pax6sey embryos, the surface area of these nuclei in each section was
measured using LEICA TCNS software. For each brain, volumes were obtained by
multiplying each area by the thickness of tissue between sections and summing the
values. To estimate cell densities in A13 and A14DMH, the same sections were
analysed. In the areas defined by TH-immunoreactivity, all propidium-labelled nuclei
and all cells with a visible TH-immunostaining were counted and the averages of
total cell density and of TH-IR neuronal density (per mm ) were calculated for each
nucleus. From these sections, the diameters of randomly selected TH-IR neurons (n -
30) were measured in A13 and A14DMH in wild type and Pax6sey/Pax6sey embryos
using the same software.
5 Proliferation of tyrosine hydroxylase neurons
Pregnant mice were injected with a single dose of bromodeoxyuridine (BrdU;
25mg/kg in sterile saline i.p.) on E9.75, E10.5, El 1.5 and E12.5 and were killed
when embryos reach E17.5. Embryos were perfused transcardially with saline
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followed by 4% paraformaldehyde in PB, brains were dissected, post-fixed overnight
in the same fixative and cryoprotected in 10% sucrose in PB. Brains were embedded
in a solution containing 7% gelatine and 10% sucrose and frozen in isopentane.
Alternate coronal sections (20 pm) were cut on a cryostat and processed for
sequential immunolabeling. Half of the alternate sections were reacted for both TH
and BrdU. Sections were first processed for TH immunocytochemistry as described
above except that only DAB was used (0.03% DAB, 0.01% hydrogen peroxide in
0.1M PBS). Then, sections were washed in TBS (0.09% NaCl, 50mM Tris, pH 7,6),
incubated 8 min in 1M HC1 at 60°C, washed 4 min with tap water, rinsed in TBS,
incubated 10 min in 20% rabbit serum in TBS and finally incubated overnight with a
solution containing mouse anti-BrdU (1:200; Becton-Dickinson, Maryland) in 20%
rabbit serum-TBS. Sections were washed in TBS, incubated for 2hr with a
biotinylated rabbit anti-mouse (1:200; DAKO) in 20% rabbit serum-TBS, washed in
TBS, incubated with a streptavidin-biotin-peroxidase complex (1:200; Amersham)
for 2 hr at room temperature and revealed with the DAB-Ni protocol (see above).
The other half was Nissl-stained. To estimate the number of BrdU-labelled cells, a
minimum of 6 sections taken through Zi and DMH were selected. On each section,
A13 and A14DMH were identified and the number of TH-IR neurons heavily
labelled (HL; defined as having more than 50 % of the nucleus immunolabeled) for
BrdU was estimated using 40x and lOOx objectives. Only heavily labelled cells were
counted since they would have been generated at the time of BrdU administration,
whereas many lightly labelled cells would have been the products of further
progenitor cell divisions (Gillies and Price, 1993). For each age of BrdU injection,
wild type (n = 4) and Pax6sey/Pax6sey (n = 4) embryos were obtained from at least 2
independent litters. In addition, the total number of TH-IR neurons in A13 and
A14DMH was estimated from these sections in wild type (n = 6) and Pax6sey/Pax6sey
(n = 6) embryos.
6 Nissl staining and counterstaining
Complete series of parasagittal and coronal paraffin sections (10 pm)
obtained from El 1.5, E12.5, E14.5, E16.5 and E18.5 wild type and Pax6sey/Pax6sey
embryos were Nissl-stained in a solution containing 0.05% thionin in acetic acid (pH
5.5).
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7 In situ hybridization
El 1.5, E12.5, E13.5, E14.5, E16.5 and E19.5 wild type and Pax6sey/Pax6sey
embryos were dissected in PBS, fixed and cryoprotected overnight in 4%
paraformaldehyde-30% sucrose. 80-100 pm thick-sections were obtained on a
freezing microtome, washed in PBS 0.1% Tween-20 (PTW), dehydrated 20 min in
methanol and rehydrated in PTW before hybridization. Hybridization was performed
as described in Henrique et al. (1995). Briefly, sections were treated with proteinase
K (10 mg/ml) for 10 min, rinsed in PTW, fixed for 20 min in 4% paraformaldehyde-
0.2% glutaraldehyde, rinsed in PTW, rinsed in the hybridization medium (50%
formamide, 1.3XSSC, 50 mM EDTA, 0.2% Tween-20, 10% CHAPS, 100 mg/ml
heparin) at room temperature until the sections settled and rinsed in the hybridization
medium (HM) at 65°C before hybridization. Sections were then hybridized
overnight at 65°C with digoxigenin-labeled (Roche Diagnostics) riboprobes for
Netrin-1 (a kind gift of M. Tessier-Lavigne; EcoRI, T3: antisense; SacI, T7: sense)
or Pax6 (a kind gift of S. Saule; PstI, T3: antisense; Hindlll, T7: sense). The
following day, sections were rinsed in HM (2 X 30 min, 65°C), washed in a 1:1
mixture of HM and MABT (100 mM maleic acid, 150 mM NaCl, pH 7.5, 0.1%
Tween-20) for 10 min at 65°C and 15 min at room temperature, incubated for 1 hr in
MABT with 2% blocking reagent (Roche Diagnostics) and incubated 4 hr in MABT
with 2% blocking reagent and 20% of heat-treated sheep serum (MABT+) and
finally incubated overnight with anti-digoxigenin antibody conjugated with alkaline-
phosphatase (1:2000; Roche Diagnostics) in MABT+. Sections were washed in
MABT for 4 hr and in NTMT (100 mM NaCl, 100 mM Tris-HCl pH 9.5, 50 mM
MgCh, 0.1% Tween-20) for 20 min before the enzymatic color detection with the
NBT/BCIP substrate (Roche Diagnostics).
8 Nomenclature
On the basis of gene expression domains and anatomical features
(constrictions in the neural wall and regions of low cell density), the brain has been
subdivided into neuromeres. The rhombomeric and mesencephalic organisation have
been described by Lumsden (1990), Krumlauf (1994) and Guthrie (1996) and the
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prosomeric organisation has been described in Rubenstein et al. (1994) and Puelles
(1995). Eight consecutive rhombomeres (rl-r8), the isthmus (Is) and the
mesencephalon (mes) are identified in the rhombencephalon and midbrain. Note that
rhombomere 1 and isthmus are represented as a single entity (rl-Is) in this scheme.
According to the prosomeric model, the forebrain is subdivided into six transverse
domains called prosomeres (pl-p6). The diencephalon develops in prosomeres 1-3
(pl-p3) and the secondary prosencephalon (hypothalamus, preoptic areas and its
hyper-alar extension, the telencephalon) develops in p4-p6. In addition, these
transverse domains are subdivided dorso-ventrally into roof plate, alar plate, basal
plate and floor plate or prechordal plate (from p4; Shimamura at al., 1995).
Telencephalic organisation refers also to the work of Fernandez et al. (1998). The
anatomical description refers to the atlas of the developing rat brain (Paxinos; 1991),
the atlas of the mouse brain (Franklin and Paxinos, 1995) and the chemoarchitectonic
atlas of the developing mouse brain (Jacobowitz and Abbott, 1998). To describe the
permanent TH-IR cell groups (Al to A17), I have mainly used the nomenclature of
Hokfelt et al. (1984) and Jacobowitz and Abbott (1998). The description of the
distribution ofTH-IR neurons in the hypothalamus and preoptic regions also refers to
the work of Ruggiero et al. (1984) and Foster (1994). A14 complex was subdivided
into subgroups relative to their main anatomical locations. In addition, some transient
TH-IR neuronal populations have already been described in the developing central
nervous system (Jaeger and Joh, 1983; Verney et al., 1988; Nagatsu et al., 1990).
IV Results
1 Neuromeric location of TH immunoreactive groups in E14.5 wild type
embryos
So far, no description of the neuromeric location of permanent and transient
TH-IR groups is available in developing mice despite the increasing references to the
neuromeric organisation of the brain (Bulfone et al., 1993; Rubenstein et al., 1994;
Puelles, 1995; Shimamura et al., 1995; 1997). In this study I first provide a
comprehensive neuromeric location of the different TH-IR groups in El4.5 wild type
mice. At this age, most of the permanent TH-IR groups (Al to A17; Hokfelt et al.,
1984) occupy their definitive position, some transient TH-IR groups are detected and
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Figure V-l Please, see figure legend on the following page.
Figure V-l Determination of the neuromeric organisation of TH-IR neurons in E14.5
wild type embryos. Sagittal sections stained for Nissl (A) or immunoreacted for calbindin
(B) or calretinin (C) have provided the prosomeric landmarks used for the determination of
the segmental organisation of TH-IR groups as shown in (D-F). A, The section shows
constrictions in the neural wall and regions of low cell densities associated with prosomeric
boundaries. Arrowheads indicate, from caudal to rostral, the isthmic constriction, the
caudal limit of the posterior commissure (PC) at the mesencephalic (mes)-pl boundary, the
fasciculus retroflexus (fr) at the pl-p2 boundary (in p2), and the stria medullaris (stm) at
the p3-p4 boundary. The dotted line represents the angle used for coronal sectioning. B,
Calbindin immunoreactivity shows the posterior commissure in the roof of pi, the nucleus
of the posterior commissure (NPC) in pi, the dorsal thalamus (DT) in p2 alar plate, and
thalamocortical axons (tc) running through p3 alar plate. The asterisk marks a strong
immunoreactive hypothalamic region in p5 and p6 basal plate. The septum (SE) and
olfactory bulb (OB) are also strongly immunoreactive. C, Calretinin immunoreactivity
shows the posterior commissure, the subthalamic nucleus (Sut) in p4 basal plate, the
thalamic eminence (EMT) in p4 alar plate and the retrochiasmatic area (RCH) in p6 basal
plate. The septum (SE) is also strongly immunolabelled. D-F, The prosomeric boundaries
(<continuous black lines) and basal-alar limit (dotted lines) are deduced from the adjacent
sections stained for calretinin or calbindin. Note that B, C, E are alternate sections. D,
Medial section showing a subgroup ofAll organised along the fasciculus retroflexus and
the A9-A10 complex. Note that A9 is located in the basal plate and extends from mes to p2
whereas A10 is located in the floor plate and extends from the isthmic (AlOi) region to p3.
E, A more lateral section than shown in (D) showing A11 extending from mes to p2 and
the diencephalic and hypothalamic groups: A13 in p3, A14 in p4 and RCH and anterior
preoptic (POA) areas in p6. F, A lateral section shows additional groups in the
hypothalamus (A14 subgroups in p5 basal and alar plates) and in the telencephalon (A15).
AB: anterobasal nucleus; Is: isthmus; LGE: ganglionic eminence, lateral part; LL: lateral
lemniscal area; MA: mammillary region; mes: mesencephalon; MGE ganglionic eminence,
medial part; mlf: medial longitudinal fasciculus; mtg: mammillotegmental tract; OR: optic
































































TableV-lPlease,sefigurle endotheo lowingpag .
Table V-l Mapping of the main TH-IR groups in E14.5 mouse brain. The same
neuromeric criteria as those applied to describe the early neuromeric TH-IR neurons in
human embryos (Puelles and Verney, 1998) were used here. According to the models
described in Lumsden (1990), Krumlauf (1994), Rubenstein et al. (1994), Puelles (1995),
Guthrie (1996), see also "Material and Methods: Nomenclature", the different
neuromeres are individualised by longitudinal and transverse black bars and the different
histogenetic fields are labelled in black capitals. The optic recess is marked with a black
circle. In this scheme, the different TH-IR groups are mapped and appear in blue or red.
Groups displaying a transient tyrosine-hydroxylase immunoreactivity are labelled with a
superscript "t". Each subgroup was labelled according to its location; for instance, the
isthmic component of A10 is labelled AlOi where "i" stands for the isthmus, except for
the transient TH-IR groups located in the piriform cortex (pir), the anterior amygdala
(AA) and the olfactory tubercle (OT) which appear in the intermediate telencephalic
territory (ITA), the region from which they are supposed to be derived (Fernandez et ah,
1998). TH-IR groups displaying Pax6 immunoreactivity appear in red. TH-IR groups not
displaying Pax6 immunoreactivity appear in blue.
A1-A17: catecholaminergic groups; AB: anterobasal nuclei; ACB: nucleus accumbens;
ACX: archicortex; AEP: entopeduncular area; AH: anterior hypothalamus; AP: alar plate;
BP: basal plate; BST: bed nucleus of stria terminalis; C1-C3: putative adrenergic groups;
CB: cerebellar primordium; CGEL: caudal ganglionic eminence, lateral part; CGEM:
caudal ganglionic eminence, medial part; DMH: dorsal medial hypothalamic nucleus;
DT: dorsal thalamus; ET: epithalamus; FP: floor plate; HCC: hypothalamic cell cord; IC:
inferior colliculus; Is: isthmus; LGE: lateral ganglionic eminence; LL: lateral lemniscus;
MA: mammillary region; mes: mesencephalon; MGE: medial ganglionic eminence; OB:
olfactory bulb; pl-p6: prosomeres; PC: posterior commissure; PAVH: paraventricular
hypothalamic nucleus; PEP: posterior entopeduncular area; PF: prechordal floor plate;
POA: anterior preoptic area; POP: posterior preoptic area; PP: prechordal plate; PTECT:
pretectum; rl-r8: rhombomeres; RCH: retrochiasmatic nucleus; RP: roof plate; SCH:
suprachiasmatic nucleus; SPV: supraoptic/paraventricular region; EMT: thalamic
eminence; TECT: midbrain tectum; TU: tuberal hypothalamic region; VT: ventral
thalamus.
the neuromeric limits are still visible. The topological landmarks necessary for the
description of the neuromeric organisation were obtained by studying alternate
sections stained for Nissl (Fig. V-\A) or for several differentiation markers,
principally, the two calcium-binding proteins calbindin (Fig. V-l.fi) and calretinin
(Fig. V-1C) which display complementary immunoreactive patterns (Jacobowitz and
Abbott, 1998, and Figure V-l). The neuromeric location of the main discrete TH-IR
groups is shown in Figure V-lD-F and detailed in Table V-l. The description of TH-
IR groups that did or did not display Pax6 immunoreactivity in wild type mice is
presented within this framework (see below and Table V-l).
2 Colocalisation of Pax6 and TH immunoreactivities
2.1 TH immunoreactive neurons displaying Pax6 immunoreactivitv (Table V-l)
Pax6 immunoreactivity was detected in three dopaminergic groups of the
forebrain. In the alar plate of the ventral thalamus, a subpopulation (around 40%) of
TH-IR neurons of the zona incerta (A13) displayed a strong and transient Pax6
immunoreactivity from El2.5 to P9 (Fig. \-2D,E). This subpopulation corresponds
to the body of A13. In the hypothalamus, TH-IR neurons of the magnocellular part of
the hypothalamic paraventricular nucleus displayed transient Pax6 immunoreactivity
from El4.5 to P2 (A14PAVH in Table V-l; data not shown). TH-IR neurons of the
supraoptic nucleus (A15v) display also a transient Pax6 immunoreactivity from P0 to
P9 (Table V-l; data not shown). In the telencephalon, transient TH-IR neurons
located in the anterior olfactory nucleus (A16AON) displayed Pax6
immunoreactivity from E14.5 to E18.5 (Table V-l; data not shown). Transient TH-
IR neurons of the piriform cortex, the olfactory tubercle and the anterior amygdala
display Pax6 immunoreactivity from E14.5 to El8.5 (Fig. V-2 G-I). In the olfactory
bulb (A160B), TH-IR external tufted cells displayed Pax6 immunoreactivity from
E14.5 and TH-IR periglomerular interneurons from El 8.5 (Fig. V-2J,K and Tablel).
2.2 TH immunoreactive neurons not displaying Pax6 immunoreactivitv (Fig. V-2 and
Table V-l)
Noradrenergic (A1-A7) and adrenergic (C1-C3) neurons of the brainstem
never displayed Pax6 immunoreactivity (Tablel). Dopaminergic neurons of the
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Figure V-2 Please, see figure legend on the following page.
Figure V-2 Pax6 protein expression in discrete developing TH-IR groups.
Sections through the A8-A10 complex (A-C), the diencephalon and the
hypothalamus (D-F), and the telencephalon (G-K) were double immunostained
with antibodies to TH (green; cytoplasmic staining) and Pax6 (red; nuclear
staining). A-C, Absence of Pax6 and TH colocalization in SN-VTA (A9-A10)
complex and the retrorubral field (A8). A, The sagittal section shows a lack of
Pax6 immunoreactivity in the developing SN-VTA of E12.5 embryo. Note the
strong Pax6 immunolabeling of the deep mesencephalic nucleus (DPMe). B, The
coronal section shows Pax6 immunoreactive cells {short arrows) in close
proximity with TH-IR neurons of the dorsal part of the SN in El6.5 embryo. C,
The coronal section shows Pax6 immunoreactive cells in the retrorubral field
close to A8 neurons. D, The coronal section shows the colocalisation of TH and
Pax6 in A13 neurons of the zona incerta in the ventral thalamus. E, Higher
magnification of the box shown in (Z)) showing individual double immunolabeled
cells (white arrows). Note the presence of TH-IR neurons (A13d) that do not
express Pax6 {white arrowhead). F, The coronal section shows the lack of Pax6
immunoreactivity in A14DMH neurons of the hypothalamus. G, Coronal section
showing Pax6 immunoreactive cells in the basal telencephalon, Pax6
immunoreactive cells are located in the anterior amygdala {large arrowhead) and
the region of the piriform cortex {small arrowhead). Note Pax6 immunoreactive
cells also in the cerebral cortex, hypothalamus and ventral thalamus. H, Higher
magnification of {G) showing individual double labelled neurons at the level of
the anterior amygdala. I, Higher magnification of (G) showing individual double
labelled neurons at the level of the piriform cortex {arrows). J, K, Coronal
sections of the olfactory bulb. J, TH-IR external tufted cells display a strong Pax6
immunostaining in E15.5 embryo {small arrow). K, Both TH-IR periglomerular
neurons and TH-IR external tufted cells in A16 display Pax6 immunoreactivity at
PO. Scale bar: A, G, 6 mm; B, C, 4 mm; D, F, J, 1 mm; E, 0.25 mm; H, 0.12 mm;
I, 0.5 mm, K, 5mm.
ventral tegmental area (AlOi, A10m, AlOpl, A10p2 and, A10p3) in the floor plate,
of the substantia nigra (A9m, A9pl and, A9p2) and of the retrorubral field (A8) in
the basal plate, and of A11 complex (A1 lm, A1 lpl, A1 lp2) in the alar plate did not
display Pax6 immunoreactivity throughout development (Fig. V-2A-C). In the
hypothalamus, the TH-IR groups listed below did not display Pax6 immunolabeling
at any stage of development: the lateral hypothalamic nucleus (A141), the medial
preoptic area (POA and A14d), the arcuate nucleus (A12). In the telencephalon, TH-
IR neurons of the bed nucleus of the stria terminalis (A15d) did not display Pax6
immunoreactivity. Although no colocalization of TH and Pax6 was observed in TH-
IR neurons of the dorsal medial hypothalamic nucleus (A14DMH, Fig. V-2F), Pax6
was expressed in the neuroepithelium ofA14DMH during its period of genesis (from
E9.75 to E12.5; see below).
3 An overview of defects in Pax6sey/Pax6sey embryos
From El0.5 to El4.5, Pax6sey/Pax6sey embryos displayed a delay in their
growth. A marked difference in their crown-rump length was observed at El 1.5
(wild type: 4.8 ± 0.3 mm, n = 15; Pax6sey/Pax6sey: 3.8 ± 0.33 mm, n = 15). By El4.5
wild type and Pax6sey/Pax6sey embryos displayed no significant difference in their
crown-rump length (wild type: 11.7 ± 0.07 mm, n = 30; Pax6sey/Pax6sey: 11.1 ± 0.1
mm, n = 30). By El7.5 brain weights were similar in wild type and Pax6sey/Pax6soy
embryos (wild type: 0.76 ± 0.07 g, n = 30; Pax6sey/Pax6sey: 0.74 ± 0.06 g, n = 25).
TH-IR groups that did or did not display Pax6 immunoreactivity were
described in Pax6sey/Pax6sey embryos within the same framework used above (see
Figure V-3 for a general overview at E14.5). I observed several alterations in both
Pax6-expressing TH-IR populations and TH-IR neurons that did not express Pax6,
such as SN and VTA neurons. Noradrenergic (A1-A7) and adrenergic (C1-C3)
neurons, and mesencephalic dopaminergic neurons of A8, which did not express
Pax6 (Table V-l), displayed no delay and appeared normally organised in
Pax6sey/Pax6sey embryos. The following description will focus on TH-IR groups
displaying alterations.
4 Defects in Pax6 immunoreactive components of the incerto-hypothalamic axis
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Figure V-3 Determination of the presumptive neuromeric organisation of TH-IR
groups in E14.5 Pax6sey/Pax6sey embryos. Nissl-staining (A) and immunolabelling for
calbindin (B) or, calretinin (C) have provided prosomeric landmarks used for the
determination of the segmental organisation of TH-IR groups (D). A, The sagittal section
shows constrictions in the neural wall and regions of low cell densities associated with
neuromeric boundaries. From caudal to rostral, arrowheads point to the isthmic
constriction and the presumptive, pl-p2, p2-p3 and p3-p4 boundaries. Thin arrows point
to the presumptive p2-p3 and p3-p4 boundaries. Arrows point to the presumptive pl-p2,
p2-p3, p3-p4 and p4-p5 boundaries. The dotted line represents the angle used for coronal
sectioning. B, The sagittal section immunoreacted for calbindin shows a normal medial
longitudinal fasciculus (mlf), retrochiasmatic (RCH) and anterobasal (AB) areas, and
septum (SE). The black star indicates the lack of clustering of the presumptive dorsal
thalamus and the lack of thalamocortical axons. C, Sagittal section immunoreacted for
calretinin shows normal immunoreactivity in the thalamic eminence (EMT), the stria
medullaris (sm) and the subthalamic nucleus (Sut) in p4. D, The sagittal section
immunoreacted for TH shows numerous groups and complexes: All, A9-A10 and in
anterobasal and preoptic (POA) areas. The limit between mes and pi is not indicated
since this neuromeric limit is altered in the mutant (Mastick et al., 1997). Scale bar: A-D,
4 mm.
The incerto-hypothalamic axis (Bjorklund et al., 1975) includes TH-IR
neurons of A11-A14. In this structure in normal animals, TH-IR neurons appear
fused together along an axis extending from the mesencephalon to the anterior
hypothalamus. In this structure, TH-IR neurons are arranged either in discrete nuclei
(A12, A13, A14PAVH and A14DMH) or in a periventricular position (All,
A14Periv). A13 and A14PAVH express Pax6 transiently during development
whereas Al 1, A12, A14DMH, A14Periv and A141 do not express Pax6.
4.1 Cell generation
In El 1.5 wild type embryos, it was possible to identify scattered TH-IR
neurons in the ventral thalamus at the level of the primordium of A13 and a few
medium-sized TH-IR neurons of the A14 complex in p4 and p5. These cells were
more numerous by E12.5 (Fig. V-4^). In Pax6sey/Pax6sey embryos, the A13 and A14
primordia appeared with a two-days delay (Fig. V-4A,B) and, when they did first
appear, they contained fewer TH-IR neurons than in wild type embryos (50%
reduction estimated). This delay did not persist: by El 7.5 the total numbers of TH-IR
profile counts in mutants and wild types were similar in A13 (n = 600 ± 65, from 6
wild types; n = 524 ± 60, from 6 mutants; values are means ± SEM), in A14DMH (n
= 510 ± 40, from 6 wild types; n = 486 ± 60, from 6 mutants) and in A14PAVH (n =
40 ± 4, from 4 wild types; n = 38 ± 3, from 4 mutants). Since the mean diameters of
TH-IR neuronal cell bodies were similar in wild type (A13, n = 10 pm ± 0.7;
A14DMH, n = 11 pm ± 0.7; A14PAVH, n = 12 pm ± 0.9; values are means ± SEM
from 30 TH-IR neurons from 4 wild types) and Pax6sey/Pax6sey embryos (A13, n =
11 pm ± 0.6; A14DMH, n = 10.5 pm ± 1.0; A14PAVH, n = 11.5 pm ± 0.4, values
are means ± SEM from 30 TH-IR neurons from 4 mutants), this indicates that there
is no difference in TH-IR cell number in these structures.
Although Pax6 is expressed in differentiated TH-IR neurons of A13 and
A14PAVH but not A14DMH, Pax6 is expressed during the time of genesis of all
these TH-IR populations. I have investigated a possible delay in cell generation of
the cells destined for these groups in Pax6sey/Pax6sey embryos. Cell proliferation was
studied by analyzing BrdU incorporation into S-phase cells and visualizing them at
E17.5 using anti-BrdU and anti-TH antibodies (Fig. V-4C-F). To identify the
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Figure V-4 Please, see figure legend on the following page.
Figure V-4 Delay in the appearance of a TH phenotype in A13 and A14DMH
is not due to a cell proliferation defect. A, B, Sagittal sections of E12.5 wild
type (A) and Pax6sey/Pax6sey (B) embryos immunolabelled for TH. A, arrow points
to the A13 and A14 primordia. B, The black asterisk indicates the presumptive
location of the A13 and A14 primordia in the mutant; note the lack of TH-IR
neurons in these regions. C-F, Double immunolabeling for TH and BrdU ofEl 7.5
wild type (C,D) and Pax6scy/Pax6scy embryos (E,F) at the level of A13. BrdU was
injected on El0.5. D, F, Arrows point to TH-BrdU double labelled neurons. G, H
Histograms showing similar mean percentages (± SEM) of TH-IR neurons darkly
labelled for BrdU in A13 (G) and A14DMH (H) in wild type (white bars) and
Pax6sey/Pax6sty (black bars) El7.5 embryos following injections of BrdU on
E9.75-E12.5. Scale bar: A, B, 2 mm; C, E, 0.5 mm; D, F, 0.1 mm.
injection was applied at four different developmental stages: E9.75, E10.5, El 1.5
and, El2.5. The number of BrdU-TH-positive cells and TH-positive cells was
determined on coronal sections at El7.5. The labelling index was calculated as the
percentage of the total number of TH-positive cells that were BrdU-TH-positive. In
wild type embryos, A13 and A14DMH are generated from E9.75 to El 1.5 with a
peak at El0.5 (White bars, Fig. V-4G,H). In Pax6sey/Pax6sey embryos, the labelling
index following each injection was unchanged and no delay was observed (Black
bars, Fig. V-4G,H) suggesting that cell generation is unaffected in A13 and
A14DMH.
4.2 Positional alterations
In wild type embryos, A13, A14DMH and A14PAVH were populated by
large TH-IR neurons and appeared fused with each other from E14.5 (Fig. V-1A, Fig.
V-5A.Q. In Pax6sey/Pax6sey embryos, A13, A14DMH and A14PAVH appeared
greatly disjoined and abnormally shaped (Fig. V-5E-G). In wild type embryos, three
distinct A13 subgroups were observed from E16.5 (Hokfelt et al, 1984): a dorsal
group (A13d), a lateral group (Fig. V-5B; A13L) and a medial group (A13) (Fig. V-
5B). In Pax6sey/Pax6sey embryos, only two subgroups were identified in A13; they
were displaced laterally from the third ventricle and appeared as a ventral round
shaped group (Fig. V-5E,F) and as a dorsal group (Fig. V-5F). The presumptive
A14PAVH was observed more rostrally, as a small nucleus densely packed with few
TH-IR neurons (Fig. V-5G). The presumptive A14DMH group was laterally
displaced and organised as an ovoid shaped nucleus (Fig. V-5E,F).
4.3 Cellular segregation
In wild type embryos, the structures of the incerto-hypothalamic axis, Zi,
DMH and PAVH are each composed of several neuronal groups with different
phenotypes, such as TH, neurotensin, or vasopressin neurons. In these structures,
TH-IR neurons are mixed with other cell types that do not express TH (Fig. V-6A).
In Pax6sey/Pax6sey embryos, TH-IR neurons constituting A13, A14DMH and
A14PAVH appeared more highly clustered (Fig. W-6B). As described above, the
total number of TH-IR neurons in A13, A14DMH and A14PAVH are the same in the
wild type and Pax6scy/Pax6sey embryos (Fig. V-6C-F). However, the volume
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Figure V-5 Please, see figure legend on the following page.
Figure V-5 Alterations of the incerto-hypothalamic axis in El8.5
Pax6sey/Pax6sey embryos. Coronal sections are shown for wild type (A-D) and
Pax6sey/Pax6sey (E-H) embryos and are organized from caudal (top) to rostral
(bottom). A-C, The components of the incerto-hypothalamic axis, A13,
A14PAVH and A14DMH appear fused together in wild type embryos. The
medial forebrain bundle is also indicated in A-D and F-H (large unlabelled
arrows). A, Arrow indicates TH-IR neurons of the A14DMH complex. B, TH-IR
neurons of A13 are divided in three distinct groups: a dorsal group (A13d), a
lateral group (A13L) and a medial group A13 (A13). C, Arrow indicates TH-IR
neurons of the paraventricular hypothalamic nucleus (A14PAVH). D, Rostral
section at the level of the anterior commissure showing TH-IR neurons located in
the medial preoptic nucleus (MnPo), the striato-hypothalamic nucleus (StHy) and
the anterobasal region (AB). E-G, In Pax6sey/Pax6scy embryos, the components of
the incerto-hypothalamic axis are completely disjoined and display abnormally
high packing of the neurons. E, Arrows indicate A13 and A14DMH. Open arrows
indicate abnormally located TH-IR fibers originating from the SN-VTA. F,
Arrows indicate A13 and A14DMH. Projections from A14DMH to the area of the
arcuate nucleus-median eminence are abnormally highly fasciculated. G, H,
Arrows indicate the location of A14PAVH, StHy, the anterior medial preoptic




























Figure V-6 Increased cellular segregation of TH-IR neurons in A13 and
A14DMH of mice lacking Pax6. TH was revealed with fluorescein-coupled
antibodies (green in A and B) and nuclei were revealed on the same sections with
propidium iodide (red in A and B). Pictures show the addition of two confocal
images acquired simultaneously with a two-channel excitation beam. A, In A13 in
the wild-type embryo, TH-IR neurons were mixed with non TH-IR neurons. B, In
Pax6sey/Pax6sey embryo, TH-IR neurons of A13 appeared more densely clustered
and more segregated from the non TH-IR neurons. C, Histogram shows the
estimated volume occupied by TH-IR neurons in A14DMH and A13 in wild type
{white bars) and Pax6sey/Pax6sey (black bars) embryos. D, Histogram shows that
the mean cell density of propidium-positive nuclei in A14DMH and A13 was
similar in wild type (white bars) and Pax6sey/Pax6sey (black bars) embryos. E,
Histogram shows a significant increase of the percentage of TH-IR neurons
compared to the total number of propidium-positive nuclei in A14DMH and A13
of Pax6sey/Pax6scy embryos. F, Histogram shows a significant increase in the
density of TH-IR neurons in A14DMH and A13 in Pax6sey/Pax6sey embryos. C-F,
Significant differences with Student's t-test between groups are indicated: *P <
0.05; **P < 0.01. Scale bar: A, B, 0.75 mm.
occupied by A13 and A14DMH was smaller in Pax6sey/Pax6sey embryos (Fig. V-6C).
Interestingly, whereas the mean cellular density was similar between wild type and
Pax6sey/Pax6sey embryos (Fig. V-6D), the cellular density of TH-IR neurons in these
structures was higher in Pax6sey/Pax6sey embryos (Fig. V-6F), indicating a higher
segregation of TH-IR neurons in these structures as estimated by the increased
percentage of TH-IR neurons within them (Fig. V-6E). TH-IR neurons were more
clustered or less mixed with cell types that did not express TH. This suggests altered
adhesive properties of cells composing the Zi and DMH in Pax6sey/Pax6sey embryos.
5 Defects of TH immunoreactive neurons in the telencephalon of Pax6scy/Pax6se>
embryos
In wild type embryos, from E14.5, TH-IR neurons were observed at the level
of the bed nucleus (A15d; Fig. W-1A) and the anterior olfactory nucleus (A16AON;
Nagatsu et al., 1990; Fig. V-8C). In Pax6sey/Pax6sey embryos, A15d was greatly
reduced in cell number (Fig. V-7C), whereas A16AON was absent by E14.5 (Fig. V-
8G). In wild type embryos, TH-IR neurons were also observed in the olfactory bulb
as soon as E16.5 (Fig. V-8D). Based on their age, large soma size and the location in
the developing glomerular layer, these neurons probably correspond to external
tufted cells. By El8.5, a large number of TH-IR neurons were observed in the
glomerular layer of the olfactory bulb, corresponding to both external tufted cells
and the earliest population of periglomerular interneurons. In Pax6sey/Pax6scy
embryos, from El6.5, only a few lightly labelled TH-IR neurons were observed at
the level of the residual olfactory bulb (Fig. V-8G). Evidence for the development of
a residual olfactory structure is provided by calretinin and calbindin
immunoreactivities (Fig. V-8E,F). In this structure, TH-IR neurons were scattered
but differentiated: they were large with angular shapes and short processes probably
corresponding to the external tufted cells (Fig. V-8H). The reduction in the mutant of
TH-IR neurons in A15d (Fig. V-7C) and A16 (Data not shown) persisted in older
Pax6sey/Pax6soy embryos. No small TH-IR neurons corresponding to the
periglomerular interneurons were observed in older Pax6sey/Pax6sey embryos.
In wild type embryos, from E16.5, TH-IR neurons were observed at the level





Figure V-7 Defects of the telencephalic TH-IR neurons in Pax6sey/Pax6sey embryos.
Coronal sections through the basal telencephalon and hypothalamus of El4.5 (A, C) and
El8.5 (B, D) wild type (A, B) and Pax6sey/Pax6sey (C, D) embryos. A, The section shows
both the transient TH-IR neurons of the piriform cortex (pir) and the permanent TH-IR
groups of A15v and A15d in continuation with A14d. Note the location of the medial
forebrain bundle (mfb). B, High magnification of the pir-A15v area. C, The section
shows a reduced A15d still in continuation with A14d. The black star indicates the lack
of pir-A15v at the presumptive level of the rhinal fissure. D, The lack of pir-A15v
persists in older age embryos (black star). The large asterisk indicates the abnormal swirl
ofTH-IR fibers at the medial forebrain bundle (mfb). Scale bar: A-E, 2 mm.
Figure V-8 Delay and diminution in the number of A16 neurons in the anterior
olfactory nucleus and the residual olfactory structure of Pax6sey/Pax6sey embryos.
Sagittal (A-C) and coronal (D-H) sections are shown for E14.5 (A-C, E-G) and E16.5
(D, H) wild type (A-D) and Pax6sey/Pax6sey (E-H) embryos. Alternate sections are
immunostained for calbindin (A, E), calretinin (B, F) or TH (C, F). A, Calbindin
immunoreactivity labels short axon cells of the olfactory bulb. B, Calretinin
immunoreactivity labels mitral and tufted cells of the olfactory bulb. C, Arrows
indicate neurons of A16 in the anterior olfactory bulb in A16AON. D, Section
showing TH-IR external tufted cells in the olfactory bulb of E16.5 wild type embryo.
E, Calbindin immunoreactivity strongly labels cells that may correspond to short axon
cells. F, Calretinin immunoreactivity strongly labels cells that may correspond to the
mitral and tufted cells of the remaining olfactory bulb. G, TH-IR neurons are absent in
the remaining olfactory structure of El4.5 Pax6sey/Pax6sey embryo. E-G Arrow points
to the residual olfactory structure. H, High magnification shows scattered TH-IR
neurons with short processes (arrows) in the residual olfactory bulb of El6.5
Pax6sey/Pax6sey embryo. Scale bar: A-C, E-G, 2 mm; D, H, 1 mm.
lack of the anterior commissure, TH-IR neurons were observed at the presumptive
level of the strio-hypothalamic nucleus (Fig. V-5H).
In addition, transient TH-IR neurons were observed in the piriform cortex
(nearby to A15v, Fig. \-lA,B) from E14.5 to El8.5 and in the anterior amygdala
(data not shown) and olfactory tubercle (data not shown) from E16.5 to E18.5 in
wild type embryos. In Pax6scy/Pax6sey embryos, TH-IR neurons were rare round and
pale (n = 15 ± 4, values are mean ± SEM from 4 mutants; n = 90 ± 10, values are
mean ± SEM from 4 wild types) at the presumptive level of the anterior amygdala.
By El8.5, TH-IR neurons were not detected and no pyknotic profiles were observed
in this region. This suggests that these neurons were generated and had progressively
lost their ability to maintain TH expression. TH-IR neurons were never observed in
the presumptive olfactory tubercle, the piriform cortex (Fig. V-1C,D) and the
neighbouring hypothalamic A15v (Fig. V-7C) and at any age studied in
Pax6sey/Pax6sey embryos.
6 Defects in TH immunoreactive groups not expressing Pax6
6.1 Defects in the SN-YTA (A9-A10) and A11 complex
In wild type embryos, from El 1.5 to E13.5, TH-IR neurons of the
primordium of the ventral tegmental area (AlOi, AlOm, AlOpl, A10p2 and, A10p3)
and of the substantia nigra (A9m, A9pl, and A9p2) migrate radially from their
proliferative zones to more superficial positions (Kawano et al., 1995). These cells
are shown in Figure V-9A. In Pax6sey/Pax6sey embryos, by El 1.5, TH-IR neurons of
A9m and A9pl and of A10m and AlOpl were normally radially organised
suggesting that they were normally migrating to their ventral positions (data not
shown). At this age, TH-IR neurons of A10p2 and A10p3, in the p2-p3 floor plate of
the mutants, were less numerous than in wild type (75% reduction estimated). By
E12.5, whereas sagittal medio-lateral sections of wild type embryos showed that the
oldest TH-IR neurons ofA9pl and A9p2 were oriented caudo-rostrally in pi and p2,
in Pax6sey/Pax6sey embryos, very few radially oriented TH-IR neurons were observed
on medial-most sections in mes, pi, p2 and p3. Strikingly, in medio-lateral and
lateral sections TH-IR neurons of A9 were abnormally positioned along the




Figure V-9. Developmental defects of the SN-VTA complex in Pax6sey/Pax6sey
embryos. A, Sagittal section showing the developing SN-VTA complex of E12.5 wild
type embryo. Arrowheads indicate the radially oriented TH-IR neurons from mes to p3.
Note that TH-IR neurons of A10 in p3 (A10p3) display a less intense immunoreactivity.
B, Coronal section of El8.5 wild type embryo showing the characteristic topographical
"inverted fountain-like" organisation of the SN-VTA complex. C, D, Medial (C) and
lateral (D) sagittal sections of E18.5 wild type embryo showing the organisation of the
SN-VTA complex. E, Sagittal section of the developing SN-VTA complex in E12.5
Pax6sey/Pax6sey embryo showing the abnormal topographical organisation of TH-IR
neurons in pi and p2 {small arrowheads). Small arrows point to A10p3. Large
arrowheads point to radially migrating TH-IR neurons. F, The coronal section shows the
abnormal topographical organisation of the SN-VTA complex in an El8.5
Pax6sey/Pax6sey embryo. B, F, Curved arrows emphasise the topographical organisation of
dopaminergic neurons of the SN and the main direction of their neuropils. G, H, Medial
(G) and lateral (H) sagittal sections ofEl 8.5 Pax6sey/Pax6sey embryo. The arrows point to
TH-IR neurons abnormally located along the pl-p2 border and in p2. C, D, The black
star indicates the lack of TH-IR neurons in wild type embryo at the corresponding
location where ectopic TH-IR neurons are seen in the mutant. Scale bar: A, E, 2 mm; B,
F, 1 mm; C, D, G, H, 0.5 mm.
In wild type embryos, the number of radially oriented TH-IR neurons detected in the
vicinity of the ventricular surface gradually decreased by E13.5. By E14.5, most A9
and A10 neurons had reached their final locations in more superficial positions of the
ventral floor plate and basal plate, respectively, and were oriented parallel to the
ventral pial surface. From El 6.5, TH-IR neurons of the A9 complex displayed their
characteristic "inverted fountain" pattern (Hanaway et al., 1971; Kawano et al.,
1995). This arrangement was even more striking in embryos of older stages (Fig. V-
9B). Strikingly, in Pax6sey/Pax6sey embryos, from E16.5, defects in the topography of
A9 neurons were accentuated at the pl-p2 border and, in p2, A9 did not show its
characteristic "inverted fountain" organisation (compare Fig. V-9F and Fig. V-9B).
On sagittal sections TH-IR neurons accumulated abnormally at the pl-p2 border in
Pax6sey/Pax6sey embryos (Compare Fig. V-9C with Fig. V-9G and, Fig. V-9D with
Fig. V-9H). Taken together, these results suggest defects in the migration of TH-IR
A9 and A10 neurons in the mutant.
6.2 TH-IR fiber pathway alterations in Pax6scy/Pax6scy embryos
In wild type embryos, by El 1.5, nigrostriatal and mesocortical fibers
originating from A9 and A10 followed the pathway of the medial forebrain bundle
(mfb) in mes, pi, p2, p3, and p4 basal plate. By El4.5, nigrostriatal fibers terminated
in the lateral portion of the caudate-putamen (Fig. V-10H) whereas mesocortical
fibers continued rostrally to reach the prefrontal cortex and the striatum by El5.5. In
addition, a few TH-IR fibers originating from A10 were observed running along the
fasciculus retroflexus toward the epithalamus (Skagerberg et al., 1984). By El8.5,
the caudate-putamen and the globus pallidus were homogeneously labelled and a
denser band of terminals was visible under the external capsule (Fig. V-10A1).
Mesocortical fibers emerged from mfb entered the olfactory tubercle or ramified into
the ventral lateral part of the nucleus accumbens (Fig. V-10A1). The remaining
mesocortical TH-IR fibers turned dorsally to enter the medial, prefrontal, and
anterior cingulate cortices (Schlumpf et al., 1980; Verney et al.,1982; Voorn et al.,
1988, and present study).
In Pax6sey/Pax6sey embryos, by El 1.5, most TH-IR fibers did not follow the
pathway ofmfb. Fibers were misguided along the presumptive pl-p2 transition zone
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Figure V-10 Alterations of TH-IR fibers pathway in Pax6sey/Pax6sey embryos.
Sagittal (A-J) and coronal (K-L) sections are shown for wild type (A, K) and
Pax6sey/Pax6sey (B-J; L) embryos. Embryos were sectioned at El 1.5 (B-D), E14.5
(A, E-J) and El 8.5 (K, L). Large arrows indicate the direction of the fibers. A,
Large arrow indicates the direction of the medial forebrain bundle (mfb), the
major fiber pathway originating from TH-IR neurons of the SN-VTA complex. B,
The sagittal section shows early alterations of TH-IR fiber pathway. C, D Small
arrowheads point to growth cones. C, Higher magnification of area outlined in
(.B), showing that most of the TH-IR fibers are abnormally deflected dorsally
following the presumptive pretectal-dorsal thalamic boundary. D, Higher
magnification of area outlined in (B) shows that some TH-IR fibers are not
deflected dorsally. E, A lateral section shows a high number of fibers from the
SN-VTA complex misguided in the diencephalic alar plate (arrow). F, A medio-
lateral section of Pax6sey/Pax6sey embryos indicating neurons of the SN and their
projections. Arrow indicates some TH-IR neurons of the SN that are not
misguided. G, A medial section shows TH-IR fibers looping in the roof of the
diencephalon (arrow). H, I, J, are higher magnifications of (E, G, F) respectively.
H, Reconstruction of TH-IR fiber pathway. K, The coronal section shows the
main projecting areas of TH-IR fibers, the striatum (ST), the nucleus accumbens
(ACB) and the olfactory tubercle (OT). L, TH-IR fibers terminated normally in
the striatum and the nucleus accumbens of Pax6sey/Pax6seyembryo. The black star
indicates a lack of terminals in the olfactory tubercle. Scale bar: A, E-G, K, J, 4
mm; B, 2 mm; C, H-J, 1 mm; D, 0.5 mm.
originating from the more rostral and ventro-medial neurons of the A9-A10 complex
followed the pathway of the presumptive mfb (Fig. V-1(1D), although they only
reached p4 by E12.5. By E14.5, misguided TH-IR fibers looped in the roof of p2,
plunged medio-laterally following the presumptive p2-p3 border and turned rostro-
ventrally in p3 basal plate to reach and follow the pathway of the presumptive mfb in
p4 and p5 (Fig. V-10E-J). In addition, few TH-IR fibers looped rostrally in
presumptive p2 alar plate (Fig. V-10E,G). In their ascending and descending
courses, TH-IR fibers appeared abnormally highly fasciculated (Fig. V-10H). At the
presumptive level of the internal capsule and the optic tract, TH-IR fibers swirled
just before they entered the caudate putamen (Fig. W-1D). From El8.5, at least some
TH-IR fibers reached the same rostral levels as observed in wild type embryos,
although the number of terminals was greatly reduced, particularly in the olfactory
tubercle (Fig. V-10Z,).
7 General fiber pathway alterations in Pax6scy/Pax6scy embryos
Using the neuronal cell adhesion molecules NCAM and LI as general
markers ofmost axonal pathways, I analyzed whether alterations of TH-IR axons in
the presumptive diencephalon were a selective defect of catecholaminergic fibers or
a general defect of all ascending and descending fibers.
NCAM (from El 1.5 to E13.5) and LI (from E14.5) immunoreactivities
revealed most of the fiber pathways travelling in the diencephalon. In wild type
embryos, the posterior, pretectal and tectal commissures, the fasciculus retroflexus
and the stria medullaris were labelled with NCAM (Fig. V-l If?) or LI (Fig. V-l 1E).
In addition, the zona limitans intrathalamica (Zli) at the p2-p3 boundary displayed
NCAM immunoreactivity from El 1.5 to E13.5 (Fig. V-l IB).
In Pax6sey/Pax6seyembryos, fibers travelling medially followed a normal
trajectory in the basal plate of the rhombencephalon, mes, pi, p2 and p3 whereas
fibers located laterally in basal plate and alar plate were misguided at the
presumptive pl-p2 transition zone and in p2 alar plate (Fig. V-l 1D,F). In p2, most of
the LI immunoreactive fibers were highly fasciculated into several straight and
parallel bundles (Fig. V-l IF). In the roof of p2, most fibers looped and descended at
the presumptive p2-p3 limit.
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Figure V-ll Alterations of specific fiber pathways in Pax6sey/Pax6seyembryos.
Sagittal sections are shown for El2.5 wild type (A, B) and Pax6sey/Pax6sey (C, D)
embryos. Nissl-stained sections (A, C) are shown in parallel with sections immunoreacted
for NCAM (B, D). A, C, The sagittal section shows constrictions and regions of low cell
densities associated with prosomeric boundaries. A, C, Arrows indicate, from caudal to
rostral, the mes-pl boundary and the pl-p2 boundary. B, NCAM immunoreactivity
reveals ascending and descending fibers of the posterior commissure (pc), the fasciculus
retroflexus (fr), the stria medullaris (sm) and thalamic axons. A cellular labelling also
reveals the zona limitans intrathalamica (Zli). D, A remaining pc is distinguishable in pi
but most of the fiber tracts are misguided in the diencephalon {white arrowhead). E, F
Sagittal sections immunoreacted for LI are shown for El8.5 (E) wild type and (F)
Pax6sey/Pax6sey embryos. E, The sagittal section shows the posterior commissure (pc) in
the caudal part of the pretectum and the fasciculus retroflexus (fr) at the pretectal-dorsal
thalamic transition zone. F, The sagittal section shows aberrant fiber pathways in the
pretectal and dorsal thalamic alar plate {between the arrows). Note that fibers travelling
in the lower part of the basal plate and in the floor plate maintain a normal trajectory.
Scale bar: A-D, 4 mm; E, F, 8 mm.
8 Altered expression of the chemorepellent/chemoattractive molecule Netrin-1
in Pax6scy/Pax6scy embryos
In Pax6sey/Pax6sey embryos, from El 1.5, the developmental expression of
Netrin-1 was roughly normal in the rhombencephalic and mesencephalic floor plate,
along the floor of the fourth ventricle and along the wall of the lateral ventricle (Fig.
V-12). From E13.5, Netrin-1 was normally expressed in the striatum and from E14.5
in the vicinity of the SN-VTA complex (Eivesey and Hunt, 1997; Fig. V-12A,C).
However, an abnormally high and expanded expression of Netrin-1 was observed
from the presumptive pl-p2 transition zone to the p2-p3 transition zone. Instead of
being expressed in the ventral part of the diencephalic basal plate and in the zona
limitans intrathalamica (Fig. V-12Q, Netrin-1 expression was expanded in all the
basal plate and the most ventral part of the presumptive alar plate (Fig. V-12D). This
altered Netrin-1 expression persisted and was correlated with increased and
expanded expression of SHH previously reported (Grindley et al., 1997; and data not
shown). The comparison of the pattern of Netrin-1 expression with TH-IR
immunoreactivity (compare Fig. V-12D and Fig. V-10E,H) showed that TH-IR
fibers and neurons seemed orientated abnormally toward the increased and ectopic
Netrin-1 expression located at the pretectal-dorsal thalamic transition zone.
V Discussion
The results obtained in normal mice are in good agreement with previous
comparative analyses on catecholaminergic systems in sauropsides (Medina et al,
1994) and humans (Puelles and Verney, 1998). The main TH-IR neurons clearly
arise independently along the whole brain axis. Table V-l shows the resulting
topological map of these groups. This mosaic pattern strongly suggests that this
phenotype is generated by the combinatorial effects of regionally expressed
transcription factors, such as Pax6, and diffusable morphogens such as SHH or
FGF8. Differences between groups of TH-IR neurons may be caused by differences
in the factors they express and the signals they receive.
It has been suggested that the transcription factor Pax6 could be a good
candidate for controlling the proliferation, specification, or the maintenance of




Figure V-12 Alteration of Netrin-1 expression in the diencephalon of Pax6sey/Pax6sey
embryos. Coronal (A, Q and sagittal (B, D) sections of E14.5 (B, D) and E16.5 (A, C)
wild type (A, B) and Pax6sey/Pax6sey (C, D) embryos. A, In the mesencephalon, Netrin-1 is
expressed at the level of the SN-VTA complex. B, The sagittal section shows Netrin-1
expression in the floor of the fourth ventricle and in the basal plate ofpi, p2 and p3. Note
also a weak expression along the zona limitans intrathalamica (Zli). C, The coronal
section shows a normal Netrin-1 expression at the level of the SN-VTA complex. D, In
the diencephalon, Netrin-1 expression is increased and expanded dorsally. Arrows
indicate the dorsal expansion in the ventral and dorsal thalamic alar plates, mes:
mesencephalon. Scale bar: A, C, 4 mm; B, D, 2 mm
1998). This study indicates that discrete catecholaminergic populations in the
diencephalon, the hypothalamus and the basal telencephalon express Pax6, either
permanently or transiently. By analysing mice lacking Pax6, I show that Pax6 is not
necessary for the specification and time of generation of diencephalic and
hypothalamic dopaminergic neurons but is needed for the normal packing and
segregation of these cells. The lack of Pax6 leads also to a virtual absence of TH-IR
neurons in the basal telencephalon. I also describe non-cell autonomous defects
among dopaminergic neurons of the SN-VTA complex: some are abnormally located
and the medial forebrain bundle, the major ascending pathway of dopaminergic
neurons, is misrouted.
1 Dopaminergic populations expressing Pax6
1.1 Diencephalic and hypothalamic TH-IR neurons : cell adhesion defect
The neuroepithelium of prosomeres 3, 4 and 5 expresses Pax6 during the time
of genesis of diencephalic and hypothalamic TH-IR neurons. This study indicates
that differentiated TH-IR neurons of A13 and A14PAVH continue to express Pax6
until the first postnatal days whereas A14DMH does not. In mice lacking Pax6, these
populations differentiate but display a one to two days delay in their appearance.
Since previous studies have shown abnormally low proliferative rates in the entire
diencephalic alar plate ofmice lacking Pax6 (Warren and Price, 1997), I looked for a
delay in the genesis of two of these TH-IR groups (A13 and A14DMH). My results
indicate no significant delay in genesis in A13 and A14DMH and no reduction in cell
number of TH-IR neurons in A13, A14PAVH and A14DMH. It is unlikely that Pax6
is required for the specification and the regulation of proliferation of TH-IR neurons
in these groups.
In mice lacking Pax6, A13, A14PAVH and A14DMH TH-IR neurons display
an increase in cell density, suggesting altered adhesive properties. Previous studies
have suggested that Pax6 regulates the expression of adhesion molecules such as R-
cadherin (Matsunami and Takeichi, 1995; Stoykova et al., 1997). In mice lacking
Pax6, there is a loss of R-cadherin expression in areas in which this gene is normally
co-expressed with Pax6 (Stoykova et al., 1997). Moreover, it has been shown that the
segregation normally observed in aggregates of cortical and striatal cells in an in
vitro assay is lost in mice lacking Pax6 (Stoykova et al., 1997). This could be
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explained by a model in which loss of Pax6 disrupts the Ca -dependent adhesive
mechanisms involving R-cadherin, thereby increasing cell mixing and leading to
some of the morphological disruptions observed in the mutant. Interestingly, TH-IR
neurons in A13, A14PAVH and A14DMH do not display a particular scattering or
increased cell mixing, as might be expected, but paradoxically they are more densely
packed in roundish cell clusters. I suggest that the selective loss of some adhesion
molecules (such as R-cadherins) may alter the balance between heterophilic and
homophilic interactions in such a way that some cells may have reduced ability to
adhere to other types of cells and may have a tendency to adhere more strongly to
cells of their own type.
1.2 Telencephalic populations: cell migration/ maintenance defect
In the olfactory bulb, Pax6 is expressed from El5.5 in TH-IR external tufted
cells and from El8.5 in TH-IR periglomerular interneurons. In mice, external tufted
cells are born between El3 and El8 (Hinds; 1968a,b) and proliferate in the
ventricular zone of the olfactory bulb. In mice lacking Pax6, I observe rare TH-IR
neurons in the region of the olfactory structure whose onset of TH expression and
morphology correspond to those expected for external tufted cells. This suggests that
Pax6 is important for the specification of external tufted cells in the olfactory bulb.
Proliferation defects may account for the low number of external tufted cells.
Alternatively, since mice lacking Pax6 fail to develop a nasal olfactory epithelium,
this dramatic reduction could be due to the lack of induction by primary olfactory
afferents. Indeed, it has been shown that activity-dependent processes from primary
olfactory nerves are necessary for the initiation and maintenance of TH expression
(McLean and Shipley, 1988; Baker and Farbman, 1993; Cigola et al., 1998).
In contrast to external tufted cells, periglomerular cells are born from El8 and
arise along the anterior subventricular zone (Hinds, 1968a,b; Betarbet et al., 1996)
from which they migrate in a large subventricular stream to the main olfactory bulb
(Alvarez-Buylla, 1997). In mice lacking Pax6, no TH-IR periglomerular interneurons
are observed in late embryos or neonatal pups. Interestingly Pax6sey/+ heterozygote
mice display a dramatic and specific decrease of TH-IR periglomerular interneurons
whereas external tufted cells are preserved (Dellovade et al., 1998). This reduction
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has been correlated to a progressive diminution in primary afferents (Dellovade et
al., 1998).
Pax6 is strongly and transiently expressed in all TH-IR neurons of the
piriform cortex, olfactory tubercle and anterior amygdala. Recently, it has been
suggested that cells populating these structures may be derived in part from a
transient structure, the intermediate telencephalic territory (ITA), located at the
transition zone between the neocortex and the lateral ganglionic eminence. Pax6 is
expressed (from E12.5 to E14.5) in both proliferating cells and cells located near or
in migrating neurons of the lateral cortical migratory stream derived from ITA
(Fernandez et al., 1998; unpublished results). When cells reach their targets, most of
them express Pax6 during the formation of the different structures of the basal
telencephalon. In mice lacking Pax6, ITA is dramatically altered: radial glial
fascicles do not form at the cortical-ganglionic eminence transition zone, the normal
expression of R-cadherin and the extracellular matrix molecule tenascin-C is lost and
an ectopic expression of Dlxl is found (Stoykova et al., 1997; Gotz et al., 1998).
Interestingly, cellular migration in the lateral cortical migratory stream occurs in
Pax6sey/Pax6sey embryos, although cells fail to stop in their final locations in the basal
telencephalon and continue to migrate to the pial surface of the brain (Brunjes et al.,
1998). I observe that the transient TH-IR neurons of the piriform cortex, the anterior
amygdala and the olfactory tubercle are decreased in number and fail to maintain TH
expression in Pax6sey/Pax6sey embryos. I suggest that the absence of TH
immunoreactivity in these cells may be due to the failure of TH induction or
maintenance of TH expression in these migrating neurons that do not recognize a
"stop signal " in the basal telencephalon. Whereas proliferative defects may account
for the absence of TH-IR neurons, BrdU studies suggest a normal proliferation from
the lateral ventricles (data not shown; Brunjes et al., 1998).
2 Defects in catecholaminergic populations not expressing Pax6
Although TH-IR neurons of the SN-VTA complex, from the isthmus to p3,
never display Pax6 immunoreactivity, I show in mice lacking Pax6 an abnormal
location of TH-IR neurons and an altered pathway of catecholaminergic fibers along
the pretectal-dorsal thalamic transition zone and in the alar plate of the dorsal
thalamus. The abnormal location of TH-IR neurons might be due to either an ectopic
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genesis induced by altered expression of morphogenetic molecules or to an altered
migratory behavior induced by changes in the navigational environment.
2.1 Ectopic genesis ofTH-IR neurons
Pax6sey/Pax6sey mice display an early abnormal ventral to dorsal expansion of
expression of the signaling secreted morphogen SHH and the SHH-induced gene, the
winged helix transcription factor hepatocyte nuclear factor 3(3 (HNF-3(3) at the level
of the pretectal-dorsal thalamic transition zone and in the alar plate of the dorsal
thalamus (Grindley et al., 1997; unpublished observation). There is evidence that
HNF-3p, SHH and FGF8 create induction sites for TH-IR neurons along the dorso-
ventral axis (Hynes et al., 1995b; Wang et al., 1995; Ye et al., 1998; Sasaki and
Hogan, 1994; Hynes et al., 1995a). It is possible that the early ectopic SHH and
HNF-3P expression domains in Pax6sey/Pax6sey mice induce ectopic
catecholaminergic neurons. Additional experiments will be required to answer this
question.
2.2 Changes in navigational environment
Clearly a complex set of attractive and repulsive guidance molecules are
provided in the environment. Ectopic expression of SHH or FGF8 could induce an
ectopic expression of guidance cues such as netrin, ephrin, semaphorin, or slit
proteins, leading to the misrouting of growth cones or defects in cellular migration.
For instance, it has been shown recently that ectopic expression of Hedgehog
molecules induces ectopic Netrin-1 expression in the CNS of zebrafish embryos
(Lauderdale et al., 1998). In mice lacking Pax6, the early ventral to dorsal expansion
of SHH (Grindley et al., 1997) coincides with the ventral to dorsal expansion of
Netrin-1 along the pretectal-dorsal thalamic transition zone and in the dorsal
thalamus. Netrin-1 is a laminin-related secreted protein with critical roles in axon
guidance (Leonardo et al., 1997a) and cell migration (Przyborski et al., 1998; Bloch-
Gallego et al., 1999) which induces either attractive or repulsive responses,
depending on the netrin receptor expressed. Activation of DCC family receptors
(DCC and neogenin in vertebrates) produces attraction (Fazeli et al., 1997; Ming et
al., 1999) whereas activation of UNC5 family receptors (UNC5H1, UNC5H2, and
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UNC5H3) produces repulsion (Ackerman et al., 1997; Leonardo et al., 1997b).
Normally, TH-IR neurons of the SN-VTA complex migrate in two phases, first
radially along tenascin-bearing glial processes and, secondly, tangentially giving the
SN its characteristic "inverted fountain" shape (Hanaway et al., 1971; Kawano et al.,
1995). In Pax6sey/Pax6sey embryos, the radial migration of SN-VTA neurons occurs
normally along tenascin-bearing glial processes (unpublished results). Later, the
rostral pretectal SN-VTA neurons are disorientated at the pretectal-dorsal thalamic
transition zone near the expansion ofNetrin-1 expression and ectopic TH-IR neurons
in the dorsal thalamus are disorientated and appear to be migrating away from the
expanded Netrin-1 expression. The SN-VTA neurons in the mesencephalon and the
caudal pretectum display a normal orientation, suggesting a normal tangential
migration.
Nearly all SN-VTA projections are also misrouted at the pretectal-dorsal
thalamic transition zone. Instead of following the medial forebrain bundle ventrally,
SN-VTA projections are deflected rostro-dorsally away from the expanded Netrin-1
expansion. Taken together, this suggests that Netrin-1 has a chemorepulsive activity
on both the tangential migration and the pathfinding of SN-VTA neurons.
In conclusion, this study indicates that Pax6 is directly or indirectly involved
in the adhesion and migration of discrete catecholaminergic populations and the
maintenance of their phenotype. Second, Pax6 has a primordial role in determining
the correct navigational environment for early diencephalic axonal pathfinding.
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Chapter Six:
Search formolecules that could influence the development of
monoaminergic systems-II-:
a role for netrin-1 ?
CHAPTER SIX:
SEARCHING FOR MOLECULES THAT COULD INFLUENCE THE
DEVELOPMENT OF MONOAMONERGIC SYSTEMS-II:
A ROLE FOR NETRIN-1?
I Abstract
First, this study confirmed that Netrin-1 is expressed in the floor plate ofmes-
p3 where mesencephalic dopaminergic neurons are generated and later on in the
vicinity of dopaminergic neurons of the substantia nigra (SN) and ventral tegmental
area (VTA). Furthermore, I showed for the first time that numerous SN-VTA
dopaminergic neurons coexpress protractedly tyrosine hydroxylase (TH), the rate
limiting enzyme for DA synthesis, and Netrin-1.
Then, I investigated whether Netrin-1 plays a role in the axon guidance
and/or neuronal migration of discrete dopaminergic populations of the SN and VTA.
VTA explants obtained from E14 embryos co-cultured in the presence of a gradient
of Netrin-1 showed a slight but significant increase in neurite outgrowth toward the
source of Netrin-1 whereas explants from E14 SN, E17 SN or E17 VTA did not. In
parallel, the analysis of El5 Netrin-1 knockout mice showed a reduction in the
density of TH-IR fibers at the level of the olfactory tubercule, a major target that
expresses high levels of Netrin-1. Together this suggests that, in vivo, Netrin-1 could
play a role in promoting outgrowth of VTA projections. In vitro, SN and VTA
explants showed no neuronal migration toward a source of Netrin-1. However,
Netrin-1 knockout embryos and pups (E15-P0) displayed ectopic TH-IR neurons in
mes-p3. At the moment, it is difficult to attribute to Netrin-1 a role in the migratory
behavior of SN-VTA neurons. Netrin-1 could act early by guiding specific
subpopulations of dopaminergic neurons and/or later in the maintenance of
dopaminergic neurons. Interestingly, mice lacking the Netrin-1 receptor, deleted in
colorectal cancer (DCC) displayed larger numbers of SN and VTA TH-IR neurons
indicating a potential role for DCC and Netrin-1 in the survival of SN-VTA neurons.
Additional experiments such as BrdU injections in mice lacking DCC or
Netrin-1 would be required to support those findings.
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II Introduction
1 Role of Netrin-1 in axonal guidance
Netrins are secreted molecules closely related in structure to the non-
diffusible molecule laminin-1. Netrins mediate long-range attraction and repulsion of
axons. They were identified as proteins that can mimic the diffusible outgrowth-
promoting activity of floor plate cells on commissural axons (Kennedy et ah, 1994).
Netrin-1 is produced by floor plate cells, and is believed to be present in the spinal
cord in a decreasing ventral-to-dorsal gradient that attracts commissural axons to the
ventral midline of the spinal cord (Kennedy et al., 1994; Serafini et ah, 1996).
Interestingly, Netrin-1 also appears to function as a long range repellent (Colamario
et ah, 1995; Tucker et ah, 1996). Thus, netrins appear to guide axons in both dorsal
and ventral directions in the neural tube. Netrins are the vertebrate homologs of the
UNC-6 protein of the nematode Caenorhabditis elegans, which plays similar roles in
the nematode (Hedgecock et ah, 1990; Wadsworth et ah, 1996).
Interestingly, Netrin-1 is expressed in the region of the ventral tegmental area
and substantia nigra (Livesey and Hunt, 1997), suggesting that dopaminergic neurons
located in these areas could be influenced in their migration or in their axonal
projections.
The action of Netrin-1 is mediated by cell membrane receptors. So far, five
Netrin-1 receptors have been identified, neogenin and DCC (deleted in colorectal
cancer), and three members of the UNC-5 family (Unc5Hl, Unc5H2 and, Unc5H3).
Neogenin and DCC are expressed in the region where mesencephalic dopaminergic
neurons are differentiating from E12 to adults (Livesey and Hunt; 1997), whereas
only Unc5H2 is transiently expressed in the basal mesencephalon (Leonardo et ah,
1997). So far, no colocalisations of TH and Netrin-1 or any of these receptors have
been reported.
Thus, it is highly possible that DCC, neogenin and/or Unc5H2 mediate
several actions of Netrin-1 on mesencephalic dopaminergic neurons but what are
these effects?
2 Role of Netrin-1 in neuronal migration
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Recently, Netrin-1 has been implicated in neuronal migration. Bloch-Gallego
et al. (1999) have shown that the expression of Netrin-1 and several Netrin-1
receptors, DCC, neogenin and a member of the Unc5 family, was consistent with a
possible role of netrins in directing the migration of precerebellar neurons from the
rhombic lip. Their analysis of mice deficient in Netrin-1 revealed a decrease in the
number of inferior olivary neurons (Bloch-Gallego et al., 1999). In addition, they
showed that ablations of the midline lead to a fusion of two olivary masses
suggesting that the floor plate may function as a specific stop signal for inferior
olivary neurons. Together, these studies demonstrate a requirement for Netrin-1 in
the migration of inferior olivary neurons. Interestingly, the authors also support the
idea that Netrin-1 plays a direct or indirect role in the survival of inferior olivary
neurons.
In addition, the study of a natural mutant deficient for Unc5H3 (rem mutant)
has shown a direct role of Unc5H3 in the neuronal migration occuring in cerebellar
development. Rem mutants display, from E13.5, an ectopic location and
accumulation of granule cells and Purkinje cell precursors (Przyborski et al., 1998).
This suggests that the establishment of the rostral cerebellar boundary may rely on
chemorepulsive signalling events requiring UNC5H3 and Netrin-1. In mice lacking
Pax6, Unc5H3 is absent in the cerebellar granule cells and these mice display similar
cerebellar alterations to those described in rem mutants (ectopic granule cells in the
inferior colliculus).
To conclude, Netrin-1 is involved in other mechanisms than axonal guidance
such as neuronal migration or survival.
3 A role for Netrin-1 in the migration and axonal guidance of dopaminergic SN-
VTA neurons?
Because i) Netrin-1 is expressed in the ventral tegmental area and the
substantia nigra (Livesey and Hunt, 1997) and because ii) I reported that altered
Netrin-1 expression was associated with abnormal topographical organisation of SN-
VTA neurons and their projections in mice lacking Pax6, I wanted to investigate the
role ofNetrin-1 in the development ofmesencephalic dopaminergic neurons.
The role of netrin-1 has been assessed in vivo by studying the phenotype of
mice lacking Netrin-1. I have also developed in the laboratory of Dr. Linda Richards
(The University of Maryland, Baltimore) an in vitro approach by co-culturing SN-
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VTA explants with EBNA-293 cells expressing Netrin-1 (Keino-Mazu et al., 1996). I
have also tried to find the receptor mediating the effects of Netrin-1. DCC appeared
to be a good candidate since it has been shown that DCC is expressed in the SN-
VTA complex (Shu et al., 2000). The time-course of expression of DCC and the
phenotype ofmice lacking DCC were studied for these reasons.
Ill Material and methods
1 Animals
Netrin-1 knockout mice and their control littermates were analysed at
embryonic day (E) E14, E15, E16, and E17 and postnatal day 0 (P0). DCC knockout
pups were also analysed at P0. Both strains were maintained on a C57/B16 genetic
background.
2 Immunocytochemistry
Embryos were perfused transcardially with saline followed by 4%
paraformaldehyde in PB. Brains were postfixed for 2-5 days in the same fixative and
cryoprotected in 30% sucrose in PB. Serial coronal or sagittal sections (40 pm) were
cut on a freezing microtome and immediately processed for immunocytochemistry as
previously described (Chapter II). Some brains were also embedded in a solution
containing 3% agarose and cut in the coronal plane (40 pm) using a Leica vibratome.
In brief, sections were incubated with the primary antibodies diluted in PBS+ (0.1M
PBS with 0.2% gelatin and 0.25% Triton X-100) overnight at 4°C. Rabbit polyclonal
anti-TH antibodies (1:200, Pel-Freez; 1:800, Protos Biotech, New-York), rabbit
polyclonal anti-calretinin antibody (1:10000: Swant, Switzerland), rabbit polyclonal
anti-calbindin antibody (1:20000; Swant), rabbit anti-neurofilament (1:50000,
DAKO, Denmark), rabbit polyclonal anti-(3galactosidase (1:50000, DAKO), rat
monoclonal anti-tenascin (1:20000, Sigma, USA) and rat monoclonal anti-Ll
antibody (1:50, Roche-Diagnostics, USA) were used. Biotinylated goat anti-rabbit
and biotinylated goat anti-rat (1:200; DAKO) were used as secondary antibodies and
were revealed with a streptavidin-biotin-peroxidase complex (1:200, Amersham,
UK). Sections were then reacted with a solution containing 0.02% diaminobenzidine,
0.6% nickel ammonium sulfate, and 0.003% H2O2 in 0.05M Tris buffer, pH 7.6
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(DAB-Ni) or with a solution containing 0.04% diaminobenzidine, and 0.003% H2O2
in PBS (DAB).
3 In situ hybridization
In situ hybridization for Netrin-1 was either performed on 80-100 pm thick
sections that were obtained on a freezing microtome or on 10 pm thick-paraffin
sections. Sections were processed for in situ hybridization as described in Chapter V.
4 Sequential in situ hybridization for Netrin-1 and immunolabelling for TH
In situ hybridization for Netrin-1 was performed on 10 pm thick-paraffin
sections as described in Chapter V. Sections were then rinsed in PBS and directly
processed for TH immunolabelling as described above. TH immunolabelling was
revealed with DAB.
5 Collagen gel assays and quantification
5.1 Explant cultures:
Experiments were carried out on E14 and El 7 mouse embryos of the C57/B16
background. Brains were removed from the skull, embedded in 3% low melt agarose
diluted into Leibovitz's L-15 medium (GIBCO, USA) supplemented with 10%
glucose (Sigma) (L15+) and sectioned into 300 pm thick coronal sections. The
substantia nigra and ventral tegmental area were dissected out from these sections
and collected in L15+. The delineation of regional boundaries of the SN, VTA and
striatum was performed according to Jacobowitz and Abbott (1998). A cut was made
in the lateral top region of the explants as an indication of the topographic orientation
of the explant (Fig. VI-1). Explants were co-cultured at a distance of 200 to 600 pm
with aggregates of EBNA-293 cells stably transfected with a construct encoding
netrin-1-c-myc, or with a construct encoding c-myc alone (Keino-Masu et al., 1996).
Explants were embedded into a solution containing 40% dialysed rat-tail collagen
(Collaborative Biomedical Products, USA), 50% matrigel (Collaborative Biomedical
Products), 5% lOx MEM (GIBCO), 7.5% Na2C03, and cultured in DMEM/F-12




Figure VI-1 Schematic drawing illustrating the origin and dissection of the explants
chosen in the co-culture experiments. A, B, The dotted lines indicate the sections made
to isolate the explants and the numbers indicate the order of sectioning. A, Schematic
representation of a section from which explant containing dopaminergic neurons of the
substantia nigra (SN, red) or the ventral tegmental area (VTA, green) were obtained.
Note that the shape of the section and the location of the red nucleus were useful
indicators of the SN and VTA areas. B, Schematic representation of a section from which
striatal explant were obtained. The blue dots represent the area ofNetrin-1 expression.
incubator at 37°C. Netrin-1 expression was previously reported to be obtained in a
gradient over a distance of about 300-400 prn away from the EBNA-293 aggregates
after 2 days in similar conditions (Alcantara et al., 2000).
5.2 Analysis and quantification
Explants were photographed and fixed at 4°C in 4% paraformaldehyde
diluted in PBS. Some explants were micro-injected with 1 pi of a solution containing
10% of Dil (Dil was diluted in N-N-dimethyl formamide, Sigma) using a
picospritzer apparatus. Dil was allowed to diffuse until entire explants were labelled.
For quantification, explants were scanned using a Leica confocal microscope and the
halo of outgrowth was divided into four quadrants as illustrated in figure VI-2. To
determine the preferential direction of the outgrowth, the longest axons (to a
maximum of 10) were measured in each quadrant and for each explant.
IV Results
1 Netrin-l expression in the region of the developing SN-VTA complex
Netrin-1 expression is detected in the area of differentiation of SN-VTA
dopaminergic neurons as soon as E12.5 (Livesey and Hunt; 1997). At this age few
dopaminergic neurons co-expressed TH and Netrin-1 (data not shown). By E14, the
ventral tegmental area displayed a strong Netrin-1 expression. Co-expression of
Netrin-1 and TH was observed in numerous TH-IR neurons in the VTA (Fig. VI-3).
By El 7, Netrin-1 expression increased in SN. At this age, at the level of the SN-VTA
complex, Netrin-1 expression was observed in subsets of dopaminergic neurons
located close to the midline and the basalmost region of mes. By P4, most
dopaminergic neurons in SN-VTA complex (estimated 75%) co-expressed TH and
Netrin-1. Netrin-1 was also expressed by non-TH-IR cells in the vicinity of SN-VTA
dopaminergic neurons at all ages studied (Fig. VI-3). This pattern of expression was
protracted in adults (data not shown). This suggests that Netrin-1 could play several
roles during the development of SN-VTA TH-IR neurons: in their proliferation,





Figure VI-2 Schematic representation of a co-culture explaining how the
explants were analysed. The explant is divided into four quadrants and the halo
of outgrowth was analysed in three of them: one facing the transfected cells
(face), one opposite to the transfected cells (opposite) and an intermediate one
(lateral). Concentric circles symbolize the distances from the edges of the
explant (100 jam, 200 urn and 300 pm and more).
Figure VI-3 Netrin-1 expression at the level of the SN-VTA: in dopaminergic
neurons and in the vicinity of dopaminergic neurons. A, Strong expression of
Netrin-1 in the VTA (large arrow) and low expression ofNetrin-1 in the SN (thin
arrow) of E14 embryo. B-D, Colocalization of Netrin-1 expression (blue) and
tyrosine hydroxylase immunoreactivity (TH-IR, brown) in El4 embryo. B, Arrow
points to low level ofNetrin-1 expression in SN. C, Colocalisation ofNetrin-1 and
TH-IR in dopaminergic neurons of the VTA. D, Higher magnification of the box
shown in (C). Black arrows point to dopaminergic neurons coexpressing Netrin-1
and TH and white arrows point to cells expressing only Netrin-1. E-F, Alternate
coronal sections of the substantia nigra of a P4 pup stained for (E) TH (brown-red)
and (F) TH and Netrin-1 (blue). F, Black arrow points to Netrin-1 expression
located in the vicinity of dopaminergic neurons of the substantia nigra. Scale bar:
A, 3.5 mm; B, C, 1.2 mm; D, 0.1 mm; E, F, 0.5 mm.
in adults (Livesey and Hunt; 1997 and data not shown) indicating a potential role in
survival and plasticity of dopaminergic neurons.
Target neurons in the basal telencephalon (caudate-putamen, accumbens, and
olfactory tubercle) also expressed high levels of Netrin-1 during their period of
innervation by SN-VTA neurons, suggesting that Netrin-1 produced by striatal
neurons could be used as a chemo-attractant for SN-VTA TH-IR neurons.
Conversely, it is also possible that Netrin-1 produced by dopaminergic neurons could
be used to guide striato-nigral projections toward the mesencephalon.
2 Co-culture experiments
In vitro experiments with El7 striatal explants cultured alone or co-cultured with
El7 SN or El7 VTA or Netrin-1 secreting cells showed no neurite outgrowth.
However, numerous cells were seen migrating radially out of the striatal explants in
all the conditions tested. A similar result was obtained with E14 striatal explants
facing E14 SN, E14VTA or Netrin-1 secreting cells. It is difficult to conclude from
these experiments whether I failed to optimise the culture conditions necessary to
obtain striatal outgrowth or whether striatal projections are not attracted by a gradient
of Netrin-1. However, this suggests that Netrin-1 is not playing a crucial role in the
initial establishment of striato-nigral projections.
I have also tested whether the neurite outgrowth of SN or VTA neurons from E14
or E17 embryos was affected by a maintained gradient ofNetrin-1. I found that E17
SN and VTA explants displayed little neurite outgrowth (a few short processes) and
that they showed no selective outgrowth toward Netrin-1 secreting cells. I considered
that the failure to observe significant neurite outgrowth was due to the old stage of
the explants. Indeed, dopaminergic neurons of the SN-VTA complex have already
established a mature pattern of innervation in their targets (striatum and olfactory
tubercle) by El7. I have therefore repeated my experiments using younger tissues
obtained from E14 embryos, ages at which SN-VTA projections start to reach their
telencephalic targets. At E14, VTA explants displayed a significant increase of
neurite outgrowth directed towards Netrin-1 secreting cells compared to control cells
(Fig VI-4) whereas SN explants did not. The neurites were thin and straight. This
suggests that developing projections of VTA neurons could be directed or attracted,







Figure VI-4 Schematic representation showing the outgrowth observed in
VTA explants cultured with (A) control cells or with (B) cells secreting
Netrin-1. Data of all explants (Controls, N=ll; Netrin-1, N=ll) are added
together to give the diagram above. Blue dots show the distribution of the growth
cones of the longest axons (with a maximum of 10 axons counted per quandrant
and per explant). A, Note that there is no selectivity in the direction of growth
from VTA explants cultured with control cells. B, Note that there is a significant
(yj, P< 0.01) increase in the number of axons and their length from VTA explants
co-cultured with Netrin-1 secreting cells.
Using the same experimental paradigm, I tested the migratory behaviour of
SN or VTA neurons toward Netrin-1 secreting cells. I found no migration of
dopaminergic neurons toward Netrin-1 secreting cells in these experimental
conditions. It is therefore unlikely that SN-VTA neurons require Netrin-1 for their
migratory behaviour. However, it is possible that the conditions required to observe
SN-VTA neuronal migration was not reached in my experiments. For instance, it is
possible that endogenous secretion of Netrin-1 in the explants would prevent the
establishment of a gradient of Netrin-1 in these co-cultures.
3 Analysis of dopaminergic neurons and fiber pathways in Netrin-1 knockout
mice
I used Netrin-1 knockout mice to test whether, in vivo, Netrin-1 could play a
role in the guidance of dopaminergic neuronal projections arising from the SN and
the VTA and in the migration of these neuronal populations.
3.1 Altered topographic organisation of mesencephalic and diencephalic
dopaminergic neurons in Netrin-1 knockout mice
In wild type embryos, by El 5, TH-IR neurons of the SN-VTA complex have
reached their final superficial position. SN neurons are located in the basal plate of
mes-p2 and VTA neurons are located in the floor plate of mes-p3 (Vitalis et al.,
2000). By E15, SN neurons are migrating tangentially and start to display their
characteristic "inverted fountain" pattern (Hanaway et ah, 1971; Kawano et ah,
1995). In mes, pi and p2, TH-IR neurons are also located along the third ventricle
(Al 1), the floor of the aqueduct (AlOdc) and in the retrorubral field (A8).
From El5, the earliest age analysed, Netrin-1 knockout mice displayed an
ectopic location of several TH-IR neurons (Fig. VI-5). Coronal sections of Netrin-1
knockout newborns showed the existence of ectopic TH-IR neurons (n= 1115 and
1145 neurons estimated from 2 pups) in mes, pi, p2 and p3. Ectopic TH-IR neurons
were located dorsally to A8, A9 and A10 and laterally to Al 1 and AlOdc (Fig. VI-6).
In some sections, ectopic neurons were abnormally located around the red nucleus
(Fig. VI-6). Their morphology resembled those adopted by the most differentiated




Figure VI-5 Topographical alterations of tyrosine-hydroxylase neurons in
E15 Netrin-1 knockout embryo. A, Coronal section of a E15 wild type embryo
at the level of the SN-VTA complex. Arrow points to dopaminergic neurons of
the substantia nigra (SN). B, Coronal section of a El5 Netrin-1 knockout embryo
at a similar level than shown in (A). Arrows point to ectopically located TH-IR
neurons. Scale bar = 0.5 mm.
Figure VI-6 Normal pathfinding of the medial forebrain bundle and ectopic
location of tyrosine-hydroxylase neurons in the pretectum and the
mesencephalon of Netrin-1 knockout mice. A, B, Coronal sections showing the
pathfinding of the medial forebrain bundle (mfb) in wild type (A) and Netrin-1
knockout mice (B). Note that there is no obvious alteration in the organisation of the
mfb. C-F, Coronal sections of the (C, D) substantia nigra and the ventral tegmental
area or (E, F) the retrorubral field in (C, E) wild type mice and (D, F) Netrin-1
knockout mice. C, E Short arrows point to A11 neurons. D, F, Stars point out the
region were All neurons are normally located in wild type mice. Note the reduction
ofAll neurons in Netrin-1 knockout mice. Long arrows point to ectopic tyrosine-
hydroxylase neurons in Netrin-1 knockout mice. D, Note that ectopic tyrosine-
hydroxylase neurons are in close contact with the substantia nigra. Scale bar = 2 mm.
(Fig. VI-6). These ectopic neurons never displayed the morphology adopted by A10
neurons at the age studied (small and roundish appearance). Their long processes
were mostly oriented laterally toward the dorsal part of the SN and sometimes
medially toward A11 neurons. Fewer A11 TFI-IR neurons were observed in Netrin-1
knockout mice compare to wild type mice (wild type, n=1026 and n=1050; Netrin-1
knockout, n=357 and n= 390 values were obtained from 2 wild type and 2 Netrin-1
knockout mice). At this stage of the analysis, I can not be sure of the identity of these
TFI-IR neurons but from their location, morphology and number it is highly possible
that they could belong to A8, A9 or/and A11 groups.
It has been reported that tenascin-bearing glial processes may guide SN-VTA
neurons while they migrate radially and that LI- and neurofilament-bearing neuronal
processes could support the tangential migration ofSN-VTA neurons (Kawano et ah,
1995; Ohyama et ah, 1998). I have analysed the pattern of expression of these
molecules in Netrin-1 knockout mice. I found no gross alteration in tenascin-, LI - or
neurofilament immunoreactivity in the mesencephalon of Netrin-1-knockout mice
(data not shown).
Interestingly, the analysis of the location of cells that would normally express
Netrin-1 in Netrin-1 knockout mice (using immunolabeling for (3-Gal) revealed a
dorsal expansion of the P-Gal/Netrin-1-positive region, the region where SN-VTA
neurons are generated (Fig. VI-7). It is therefore conceivable that, in Netrin-1
knockout mice, some TH-IR positive neurons are generated too far from cues that
would normally guide them (i.e.: tenascin-bearing processes, see also figure VII-3)
and therefore appear ectopically located later on. Additional analysis of their genesis
and cell lineage would be required.
3. 2 Analysis of SN-VTA fibers pathway in Netrin-1 knockout mice
In wild type mice, mesocortical fibers reached the prefrontal cortex and the
striatum by El5. In addition, a few TH-IR fibers originating from A10 were observed
running along the fasciculus retroflexus toward the epithalamus (Skagerberg et ah,
1984). By El8.5, the caudate-putamen and the globus pallidus were homogeneously
labelled and a denser band of terminals was visible under the external capsule.
Mesocortical fibers emerged from mfb, entered the olfactory tubercle or ramified












Figure VI-7 A-D, Coronal sections of (A,B) El5 embryo heterozygote for
Netrin-1 mutation and (C, D) El 5 Netrin-1 knockout embryo at the level of the
floor of the aqueduct and the ventral tegmental area (VTA). Sections are
immunostained for (3Gal which reveals the location ofNetrin-1 expressing cells.
B, D Higher magnification of boxes shown in (A) and (C) respectively. Arrows
point to the dorsal limit of strong [3Gal immunolabeling. Note that (3Gal
immunolabeling extends more dorsally in (D) than in (B). Scale bar: A,C, 1 mm;
B,D, 0.25 mm.
TH-IR fibers turned dorsally to enter the medial, prefrontal, and anterior cingulate
cortices (Schlumpf et al., 1980; Verney et al., 1982; Voorn et ah, 1988, and present
study). By P0, cortical and septal regions started to display a more refined
innervation. In the septum, TH-IR innervation was mostly refined to the lateral and
lateral-dorsal regions. The innervation of the cingulate cortex was denser in regions
lateral to the indusium griseum, above the corpus callosum (data not shown).
In Netrin-1 knockout mice, TH-IR fibers originating from the SN and the
VTA display minor alterations in the telencephalon whereas they appeared normal in
other brain regions. By El5, Netrin-1 knockout mice displayed a decrease in TH-IR
fiber density in the ventral pallidum, mainly at the level of the olfactory tubercle
(Fig. VI-8). By El7, Netrin-1 knockout mice showed a 34% reduction in the
thickness of olfactory tubercle (OT) as revealed by TH immunoreactivity (TH-IR-
OT) and pGal immunoreactivity (PGal-IR-OT) (wild type: TH-IR-OT, 280 pm +/- 8
pm; pGal-OT, 210 pm +/- 16 pm; Netrin-1 knockouts: TH-IR-OT, 180 pm +/- 8 pm,
PGal-OT, 160 pm +/- 20 pm, values are mean +/- SEM of four wild type and four
Netrin-1 knockout mice- TH-IR-OT is a measure of the thickness of the TH-IR fibers
at the level of the olfactory tubercle and pGal-OT is a measure of the thickness of the
PGal-immunopositive region of the olfactory tubercle). This difference was no
longer observed at P0, suggesting that Netrin-1 may have an early outgrowth
promoting effect on VTA projections toward the olfactory tubercle in vivo. However,
it is also possible that this defect is secondary to an hypomorphism of the region and
to the lack of anterior commissure. By P0, TH-IR fiber alterations were observed in
the innervation of the septum and cingulate cortex where fibers appeared tangled
instead of being organised in parallels (data not shown). This alteration is probably
secondary and due to the lack of the corpus callosum and the abnormal formation of
Probst's bundles in the septum. Taken together, this suggests that Netrin-1 is not
essential to the axonal guidance of SN-VTA TH-IR neurons. However, Netrin-1 may
have an outgrowth promoting effect on VTA projections innervating the olfactory
tubercle.
3 Analysis of mice lacking DCC
DCC is protractedly expressed at the level of the SN-VTA (Gad et al., 1997),





























Figure VI-8 A, D, Coronal sections at the level of the olfactory tubercle of E17 (A) wild
type (C) Netrin-1 heterozygote and (B,D) Netrin-1 knockout embryos. Sections were
immunostained for (A,B) tyrosine hydroxylase or for (C,D) pGal which reveals the
location ofNetrin-1 expressing cells. A, B, Coronal sections showing the decrease in the
density of tyrosine hydroxylase immunoreactive fibers in the olfactory tubercle of (B)
Netrin-1 knockout embryo in comparison to (A) wild type embryo. Arrow points to the
olfactory tubercle. C, D, Arrows define the thickness of the olfactory tubercle. Note the
reduction in the thickness of the olfactory tubercle in (E) Netrin-1 knockout embryo in
comparison to (D) Netrin-1 heterozygote embryo. Scale bar = 1 mm.
regulation of DCC expression (Volenec et al., 1998), suggesting that DCC is
expressed by dopaminergic neurons. In addition, it has been recently reported that
DCC is transiently expressed from E15 to El7 in the nigrostriatal bundle (Shu et al.,
2000) and mesocortical fibers (data not shown). This suggests that DCC could be a
good candidate in mediating the role ofNetrin-1 in dopaminergic neurons.
I have tested whether DCC- and Netrin-1-knockout mice displayed similar
alterations. Like Netrin-1 knockout mice, mice lacking DCC displayed no gross
alterations in SN-VTA projections and I have observed similar alterations to those
displayed by Netrin-1 knockout mice. By contrast, DCC-knockout mice displayed
only few ectopic TH-IR neurons in mes-p2 which were located dorsally to A10.
Interestingly, we found that DCC knockout mice displayed an increased number of
SN and VTA TELIR neurons as judged by the higher density and higher surface
occupied by the SN-VTA complex (Figure VI-9). However, additional experiments
such BrdU injections would be necessary to provide a quantitative analysis of this
phenotype.
V Discussion
1 Expression of Netrin-1 in dopaminergic neurons of the A9-A10 complex
The roles of the morphogen sonic hedgehog (Shh) in the spinal cord have
been well described: SHH protein is first produced by the notochord and induces the
formation of the floor plate in the ventral midline of the neural tube, which then goes
on to express Netrin-1 (Ingh, 1995; Placzek, 1995). At the level of the midbrain, Shh
has been implicated in the differentiation of dopaminergic neurons (Hynes et al.,
1995; Wang et al., 1995; Wu et al., 1999). It is conceivable that the expression of
Netrin-1 by nigral and ventral tegmental dopaminergic neurons reflects the role of
Shh in their development. In this view, Netrin-1 expression could be regarded as an
early marker of differentiation of SN-VTA dopaminergic neurons. In this study, I
pointed out that a subset of A9-A10 dopaminergic neurons, mostly located in VTA,
express Netrin-1. This suggests that dopaminergic neurons of the A9-A10 complex
are not equally influenced by Shh while they are generated, and that Netrin-1
expression in specific dopaminergic neurons may provide additional qualities to
these neurons, such as those involved in migration, axonal outgrowth or survival.
139
+/+ TH

















Figure VI-8 A, D, Coronal sections at the level of the olfactory tubercle ofEl 7 (A) wild
type (C) Netrin-1 heterozygote and (B,D) Netrin-1 knockout embryos. Sections were
immunostained for (A,B) tyrosine hydroxylase or for (C,D) (3Gal which reveals the
location ofNetrin-1 expressing cells. A, B, Coronal sections showing the decrease in the
density of tyrosine hydroxylase immunoreactive fibers in the olfactory tubercle of (B)
Netrin-1 knockout embryo in comparison to (A) wild type embryo. Arrow points to the
olfactory tubercle. C, D, Arrows define the thickness of the olfactory tubercle. Note the
reduction in the thickness of the olfactory tubercle in (E) Netrin-1 knockout embryo in
comparison to (D) Netrin-1 heterozygote embryo. Scale bar = 1 mm.
2 Role of Netrin-1 in neuronal migration
Several studies have pointed out the role of Netrin-1 in the migration of
different neuronal populations in non-vertebrates (Chan et ah, 1996) and vertebrates
(Block-Gallego et ah, 1999; Alcantara et ah, 2000). Dopaminergic neurons have a
biphasic migratory behavior, first they migrate radially from the proliferative
(ventricular) zone to the superficial zone of the midbrain and then they migrate
tangentially from caudal to rostral. The radial migration starts from E10.5 to finish
roughly by El3.5 whereas the tangential migration starts from E14 to finish by El7.
In early developmental stages from E12 to El4, I found a strong expression of
Netrin-1 both in the proliferative zone where SN-VTA neurons are generated and in
the marginal zone where postmitotic SN-VTA neurons are migrating radially from
the ventricular zone to the superficial zone. From El5, Netrin-1 expression decreased
strongly in the proliferative and radial migration zone whereas Netrin-1 expression
increased in the regions of tangential migration. It is conceivable that Netrin-1
controls both the radial and tangential migration of newly generated postmitotic
neurons away from the germinal zones. My in vitro experiments with E14 and El7
explants failed to support a role for Netrin-1 in the migratory behavior of SN-VTA
neurons. Additional co-culture experiments performed with younger explants
including germinal zones would be required to fully answer this question. In
addition, it is possible that the endogenous expression of Netrin-1 in the explants has
prevented the gradient of Netrin-1 established from the EBNA-Netrin-1 aggregates
in co-cultures, leading to the failure of SN-VTA neurons to migrate toward Netrin-1
secreting cells. The use of explants obtained from Netrin-1 knockout mice would
prevent such artefacts from happening. Interestingly, in mice lacking Netrin-1, I
found ectopic TH-IR neurons in the midbrain. The existence of these ectopic TH-IR
neurons could originate from either an abnormal migratory behavior of some
dopaminergic neurons or an abnormal increase of the proliferative zone that could
induce supernumerary TH-IR neurons. Interestingly, Netrin-1 knockout mice
displayed a normal expression of Shh and HNF3-P, two molecules able to induce the
generation of dopaminergic neurons. Taken together, my results suggest that Netrin-




The data obtained from my in vitro assay show that El4 VTA explants
display an increase and preferential axonal outgrowth towards Netrin-1 secreting
cells. This suggests that Netrin-1 could play a role as a guidance molecule for TH-IR
fibers from the VTA to their target tissues or alternatively that Netrin-1 could play an
outgrowth-promoting role on dopaminergic neurons of the VTA. It is believed that in
vivo, Netrin-1 mediates its effects locally rather than over long distances. Since
Netrin-1 is expressed in the target tissues but also all along the pathway of the medial
forebrain bundle where most dopaminergic projections are travelling it is
conceivable that Netrin-1 could guide VTA fibers which express DCC. My data
support also the possibility of an outgrowth promoting effect of Netrin-1. Indeed, the
number of growth cones facing the transfected cells is increased if the cells were
transfected with Netrin-1 rather than c-myc alone. However, the nature of the VTA
projections affected by Netrin-1 has not been identified in these experiments and it
would be crucial to do it.
Netrin-1 and DCC knockout mice display an overall normal organisation of
TH-IR fibers travelling along the medial forebrain bundle and the fasciculus
retroflexus. Alterations in the organisation of TH-IR terminals are only seen in the
ventral pallidum, septum and cingulate cortex and they are most likely secondary to
the lack of the anterior commissure and corpus callosum and the abnormal presence
ofProbst's bundles in the septum. This suggests that Netrin-1 and DCC are not likely
to play a major role in the initial guidance of TH-IR fibers in the brain. However, this
study does not present the quantitative data necessary to provide a definite answer
and it is possible that terminals reaching the specific targets of the SN or VTA (i.e.:
the olfactory tubercle) are reduced in number. Finally, this study shows that other
molecules than Netrin-1 are playing roles in the guidance ofTH-IR fibers.
Since Netrin-1 is protractedly expressed in adults, it is also possible that
Netrin-1 could be important in the plasticity of the dopaminergic system (i.e.: in the
plasticity of the dopaminergic brain reward circuit).
4 Neuronal survival and DCC
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In the midbrain, DCC is expressed from El3.5 in postmitotic dopaminergic
neurons (Gad et al., 1997; Volonec et al., 1998). Interestingly, this period
corresponds to the tangential migration, axonal guidance and survival of
dopaminergic neurons. Interestingly, DCC knockout mice displayed no gross
alterations in TH-IR fiber pathway or migratory behavior. However, DCC knockout
showed an obvious increase in the number of SN-VTA dopaminergic neurons at PO
suggesting a role for DCC either in the cell proliferation or the cell survival of these
dopaminergic populations. DCC is a candidate tumour-suppressor gene (Fearon and
Pierceall, 1995). Indeed, loss of DCC expression has been associated with
tumorigenicity of several tissue types (i.e.: colon, uterus; Schmitt et al., 1998)
including brain (Ekstrand et al., 1995). Furthermore, reestablishment of DCC
expression in tumours cells has been shown to suppress tumorigenicity (Kato et al.,
2000). One mechanism by which DCC could have its tumor suppressor activity
would be that DCC induces apoptosis when engaged by Netrin-1. DCC is a caspase
substrate and mutation of the site at which caspase-3 cleaves DCC suppresses the
pro-apoptotic effect ofDCC completely (Mehlen et al., 1998). Apoptosis in SN-VTA
dopaminergic neurons has only been reported to occur postnatally, from P2 (Jackson-
Lewis et al., 2000) and so far there is no evidence for embryonic cell death in SN-
VTA dopaminergic neurons. Interestingly, the caspase-3 pathway has been shown to
be implicated in early cell death of SN dopaminergic neurons (Jackson-Lewis et al.,
2000). Altogether, this suggests that DCC could participate in the regulation of SN-
VTA dopaminergic neuron cell number throught the caspase-3 pathway. Further
experiments such caspase-3 localisation or BrdU injections in DCC knockout mice






I Chapter II and Chapter III
In Chapter Two, I showed that an excess of serotonin during the critical
period P0-P4 was sufficient to produce permanent thalamocortical and cortical
alterations of the barrel field. This demonstrates that a transient rather than a
permanent excess of serotonin (as observed in MAOA-knockout mice) produces
these permanent alterations. Moreover, soon after this study had started, colleagues
showed that sensory thalamic neurons were able to take up and store 5-HT,
reinforcing the idea of a primordial role of serotonin during the development of the
thalamocortical system.
The targets that mediate the effects of serotonin in the thalamocortical
somatosensory system are still not clearly defined and much work has to be done to
elucidate the molecular and cellular mechanisms through which serotonin acts. So
far, several targets have been identified and a few mechanisms could be proposed.
1 5-HT action mediated through 5-HT receptors and 5-HT transporter
1.1 Presynaptic action
5-HT could act presynaptically on two main targets: the 5-HT IB receptor
subtype and the plasma membrane serotonin transporter (SERT). Both are expressed
by thalamic neurons and are located at the level of the axonal arbors during the
critical period of barrel field formation.
5-HT1B is a member of the seven transmembrane domains family and is
coupled to a Gi protein. Its activation by 5-HT inhibits the adenylate cyclase activity
leading to a decrease in cAMP levels. Physiologically, 5-HT1B activation leads to a
decrease of neurotransmitter release (i.e. 5-HT or acetylcholine). In the
thalamocortical system, 5-HT1B activation could lead to a decrease in glutamate
release. Indeed, electrophysiological studies have shown that glutamate release was
decreased by applying 5-HT or 5-HT IB antagonists in the bath of a thalamocortical
preparation in vitro (Rhoades et al., 1994). In vivo, 5-HT1B knockout mice display a
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normal barrel field and recently, mice double knockout for MAOA and 5-HT1B have
been generated. MAOA-5HT1B double knockout mice display both a normal barrel
field and an excess of 5-HT (as observed in MAOA knockout mice), indicating a
direct role of 5-HT1B in mediating the effects of 5-HT excess (Salichon et al.,
submitted). Moreover, it has been shown that adenylate cyclase 1 knockout mice
display a barrelless phenotype. Taken together, this indicates that 5-HT acting on 5-
HT1B modulates in vivo the release of glutamate by inhibiting the cAMP
transduction pathway (Fig. VII-1). It is not known presently what targets are
involved in this transduction pathway.
SERT and VMAT2 are also transiently expressed by thalamocortical axons.
SERT takes up 5-HT from extracellular space to intracellular cytosol. Then, 5-HT is
stored into vesicles through VMAT2. It is possible that 5-HT could be released by
thalamocortical axons after budding of the vesicles. 5-HT could act locally on
presynaptic (5-HT1B) and postsynaptic targets. The role of SERT in the formation of
the barrel field is important since SERT knockout mice display a barrelless
phenotype. This could be explained by the fact that 5-HT is not cleared from the
synaptic cleft and could act in a long lasting time on 5-HT1B receptors. Moreover, it
is unlikely that VMAT2 plays an important role in SI formation since VMAT2
knockout mice did not display alteration in the barrel field organisation (O. Cases,
unpublished observations).
1.2 Postsynaptic action
So far, no 5-HT receptors have been identified in SI layer IV cells. At least 5-
HT1A, IB, ID, 2A and 2C are not expressed in SI layer IV cells during the critical
period (O. Cases, unpublished observation). In addition, mice knockout for 5-HT2A,
IB, 1A, 5A, and 5B have a normal barrel field organisation (J.P. Hornung,
unpublished observations). However, other 5-HT receptor subtypes are still to be
studied such as the 5-HT3 or 5-HT2B.
Moreover, it has been described that cortical astrocytes display a low affinity
uptake for serotonin. This study was done in vitro and there is no evidence for such a
mechanism in vivo.




Figure VII-1: Please, see figure legend on the following page
Figure VII-1: A, Action of glutamate on granular neurons. Glutamate (Glu)
can act via the metabotropic glutamate receptor type V (mGluR5), the NMDA
receptor and AMPA receptor that are expressed by granular neurons during the
critical period. B, Presynaptic action of 5HT on thalamocortical axons.
5HT1B receptors are transiently expressed on thalamocortical axons, 5HT
action is to inhibit adenylate cyclase 1 (AC1). Inhibition of AC1 leads possibly
to the inhibition of glutamate (Glu) release through the cAMP transduction
pathway. 5HT uptake through the serotonine transporter (SERT) and storage
through the vesicular monoamine transposter type 2 (VMAT2) leads to the
accumulation of 5HT that could be released.
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(1) N. Salichon, I Seif et al., personal communication; (2 and 3) P. Gaspar, O. Cases et al., personal
communication; (4) Welker et al., 1996; (5) Maier et al., 1999; (6) Iwasato et al., 2000; (7) Hannan
et al., submitted.
The hypothesis is that 5-HT inhibits presynaptically the release of glutamate
(Figure VII-1). Glutamate acts on three families of receptors: the AMPA, the NMDA
and the metabotropic glutamate receptors. The AMPA and NMDA receptors are
ionotropic types. Metabotropic glutamate receptors (mGluRs) are coupled to G
proteins and mediate slow action of glutamate through modulation of second
messenger pathways. It has been shown that granular neurons express during the
critical period the AMPAR, the NMDAR1 and R2 subunits and mGluRland R5
subtypes. Both mGluRl and mGluR5 stimulate phosphatidyl inositol hydrolysis and
mobilisation of Ca2+ from intracellular stores. Group I-mediated PI hydrolysis is
enhanced in early development (Casabona et al., 1997) and mGlurla and mGluR5
expression is differentially regulated during the same time period (Romano et al.,
1996). In the kitten primary visual cortex, peaks in mGluRl and mGluR5 expression
and in mGluR-mediated PI turnover overlap the critical period of development (Reid
et al., 1997). Hence, mGluRs may make a substantial contribution to the activity-
dependent establishment of somatopic patterns of representation in the developing
central nervous system. Mice lacking mGluR5 have recently been shown to lack
granular neuronal clustering (J.P. Hornung, unpublished observation and Hannan,
submitted). In addition, it has been shown that mGluR5 mediates the activation of
phospholipaseC-pi (PLCpi) and that mice lacking PLCpi display similar alterations
than those observed by mGluR5 knockout mice (P. Kind, personal communication
and Hannan et al., submitted).
Intense NMDAR1 immunoreactivity is also present in layer IV during the critical
period and recent data show that conditional knockout mice for NMDAR1 in the
cortex display altered granular neurons clustering (Iwasato et al., 2000).
In conclusion, glutamate is necessary to the clustering in barrels of granular neurons.
Cytoplasmic or membrane targets of mGluR5 or NMDA activation have not been
identified so far.
3 5-HT action mediated through other mechanism
In addition, several expression studies have also pointed out that several
molecules are expressed in a barrel-like pattern either transiently or permanently
(Table VII-1). Several knockout mice have been done to explore the involvement of
these molecules in barrel field formation (Table VII-2). None of these molecules
shows a direct relationship with the serotoninergic phenotype. A way to explore their
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role would be to create in vitro assays in which slices containing normal thalamus
and cortex would be cultured in presence of diffusible molecules and the clustering
of granular neurons and the segregation of thalamic axons would be assessed.
II Chapter IV
To understand how monoamines could act on the developing brain, it is
crucial to have a clear picture of the location of molecules that could participate in
the regulation of monoamines levels such as the 5-HT transporter, the vesicular
monoamine transporter types I and II, and monoamine oxidases types A and B.
Recently, the developmental studies of the monoamine transporters have been
completed, suggesting an unexpected role of monoamine during development
(Hansson et al., 1997; Lebrand et ah, 1998). Since I have started my "scientific
career" by studying some of the phenotypes caused by altered MAOA activity (Cases
et ah, 1996; Vitalis et ah, 1998), I have decided to provide deeper insights into the
developmental course of the monoamine oxidases in the murine central (Chapter IV)
and peripheral nervous system (Chapter IV and data not reported).
In Chapter IV, I have combined in situ hybridization, histochemistry and
immunocytochemistry to locate precisely MAOA and MAOB in the developing
nervous system. Several important points emerged from this study which have been
extensively discussed in Chapter IV. Briefly, I showed that MAOA mRNA
expression was tightly linked to the catecholaminergic (transient or permanent) and
serotoninergic phenotypes. This showed that the regulation of embryonic serotonin
levels is, at least in part, performed by the embryo itself soon after the genesis of its
own serotoninergic neurons. Interestingly, whereas MAOA expression decreased
dramatically in serotoninergic neurons during early postnatal development, MAOB
expression increased strongly during the same period and reached its maximum
expression by P21. This differential pattern of expression ofMAOA and MAOB in
serotoninergic neurons could explain the normalisation of 5-HT levels in MAOA
knockout mice. I also showed that MAOB mRNA expression was located in most
forebrain cholinergic neurons and all non-neuronal cells, such as the ventricular
ependymal cells or astrocytes. In addition, I found two novel localizations ofMAOB:
i) in the olfactory placode and olfactory epithelium where MAOB is expressed from
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E10, and ii) in astrocytes at the spinal and cranial nerve interface between the CNS
and PNS.
To my point of view, one of the most interesting perspective of research
would be to elucidate the role ofMAOB activity in these two novel locations that I
have described. For instance, it would be exciting to find out whether MAOB activity
is playing a physiological role during the period of crossing and arborization of the
nerves in the CNS and whether a re-expression of MAOB could help the re-growth
of peripheral nerves after lesions into the CNS. The other interesting perspective
would be to investigate the physiological role of MAOB activity in the olfactory
epithelium using MAOB knockout mice.
Ill Chapter V and Chapter VI
The studies reported in Chapters V and VI aimed initially to give deeper
insights into the development of dopaminergic populations notably those
progressively lost in Parkinson's disease (i.e.: the substantia nigra). This would have
both satisfied my scientific curiosity and interest and provided, I hoped, the seeds for
future therapeutic researches. More precisely, I wanted to elucidate what were the
"factors" necessary for a normal proliferation, specification and migration of
dopaminergic neurons of the substantia nigra.
Pax6 was previously suggested to be a strong candidate in regulating the
proliferation of isthmic progenitors (the isthmus is the proliferative region where
dopaminergic neurons of the substantia nigra and ventral tegmental area originate)
and the maintenance of dopaminergic neurons where its expression was protracted
(Stoykova and Grass, 1995). I was therefore strongly attracted to study the location
of Pax6 in dopaminergic neurons and the phenotype displayed by mice lacking Pax6.
This study is described in Chapter V and leads me to conclusions and hypothesis that
I started to explore and are reported in Chapter VI.
Briefly, in Chapter V, I showed that Pax6 is expressed in discrete
catecholaminergic neuronal populations of the developing ventral thalamus,
hypothalamus and telencephalon and that in mice lacking Pax6, these
catecholaminergic populations develop abnormally: those in the telencephalon are
reduced in cell number or absent whereas those in the ventral thalamus and
hypothalamus are greatly displaced and densely packed. My study suggested that
Pax6 may be involved directly or indirectly in regulating adhesive properties, cell
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Figure VII-2 A schematic drawing of the migratory process of mesencephalic
dopaminergic (DA) neurons in mice. DA neurons are generated at the
ventricular surface of the ventral mesencephalon. The neurons migrate in two
phases: first they migrate toward the ventromedial part of the mesencephalon
along tenascin (TN)-immunoreactive processes of the neuroepithelial cells
(Kawano et al., 1995); second they migrate laterally in the basal part of the
mesencephalon along LI-positive tangentially arranged nerve fibers. The
migratory DA neurons are immunoreactive for 6B4 proteoglycan, which bind LI
(From Ohyama et al., 1998).
migration but not cell proliferation of discrete catecholaminergic populations
expressing Pax6. In addition, I found that catecholaminergic neurons of the
substantia nigra (SN) and the ventral tegmental area (VTA) do not express Pax6
protein. Nevertheless, mice lacking Pax6 display an altered pathfmding of SN-VTA
projections: instead of following the route of the medial forebrain bundle ventrally,
most of the SN-VTA projections are deflected dorso-rostrally at the pretectal-dorsal
thalamic transition zone and in the dorsal thalamic alar plate. Moreover, some
catecholaminergic neurons are displaced dorsally to an ectopic location at the
pretectal-dorsal thalamic transition zone. Interestingly, from the pretectal-dorsal
thalamic to the dorsal thalamic-ventral thalamic transition zones, mice lacking Pax6
display a ventral to dorsal expansion of the chemorepellant/chemoattractive
molecule, Netrin-1.
This study opened new perspectives regarding the development of SN-VTA
dopaminergic neurons and I was interested to test whether Netrin-1 was playing a
role in guiding the pathway and the migration of catecholaminergic populations. I
have therefore started to analyse the phenotype displayed by Netrin-1 and DCC
knockout mice and established an in vitro essay to directly test whether Netrin-1
gradients could guide/attract SN-VTA projections or SN-VTA migrating neurons.
Preliminary results presented in Chapter VI showed that VTA but not SN projections
display an increase growth toward Netrin-1 secreting cells. In addition, the analysis
of Netrin-1 knockout mice show that dopaminergic neurons, most likely
corresponding to A9-A11 groups are ectopically located in the mutant brain
suggesting a direct or indirect role for Netrin-1 in the migration and/or survival of
these dopaminergic populations. Preliminary analysis of DCC knockout mice
suggests that DCC may play a role in early apoptosis of dopaminergic neurons.
Additional experiments would be required to fully analyse the phenotype
displayed by Netrin-1 and DCC knockout mice and to explore more widely, in vitro,
the role of Netrin-1 on dopaminergic neurons. It would be important to precisely
determine the emergence of the phenotypes displayed by both Netrin-1 and DCC
mutants. This would allow to relate the alterations to the different phases of
development that SN-VTA dopaminergic neurons undergo: genesis (E10-E15),
migration (radial: E10-E14, tangential: from El4) and cell death (believed to start in
neonates; Jackson-Lewis et al., 2000). The analysis of the repartition of BrdU
labelled progenitors may also help to give a clear picture of the mutants phenotype. It
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would also be necessary to repeat in vitro experiments with younger tissues to test
whether newly postmitotic dopaminergic neurons migrate toward Netrin-1 secreting
cells. Finally, it is likely that DCC participates in the regulation of apoptosis in
dopaminergic neurons of the SN-VTA complex. The generation of mice over-
expressing DCC in SN-VTA neurons or alternately the use of in vitro assays in
which SN-VTA explant would be transfected with DCC under the control of a
specific promoter (using the gene-gun technique) may answer this important
question.
During my PhD, I was surprised by the lack of data available on migration
and cell death of dopaminergic neurons. So far, only descriptive and coincidental
evidences are available to support the molecular basis of the migratory behavior of
dopaminergic neurons of the SN-VTA complex (Fig. VII-2). Recent and preliminary
analysis of LI knockout mice which display ectopic dopaminergic neurons appear to
confirm these observations (Demyanenko et al., 2000). Interestingly, Pax6 mutant
mice display abnormal organisation of LI-positive fibers associated with an
abnormal topographical organization of DA neurons and one of my hypothesis was
that dopaminergic neurons had abnormally migrated along abnormally guided Ll-
fibers. These two independent observations seems to reinforce the idea that LI is
playing a direct role in the tangential migration of SN-VTA dopaminergic neurons.
However, only a small proportion of the dopaminergic population seems to be
affected by LI alterations suggesting that other molecules are likely to be involved in
tangential migration of DA neurons. Regarding cell death of dopaminergic neurons
of the SN-VTA complex, few and controversial data are available but recent findings
support the idea that SN-VTA neurons are subject to a regressive event that begins
before birth (Jackson-Lewis et ah, 2000). The regulation of the number of SN
dopaminergic neurons seems therefore to be influence by several events: i) one
which takes place during late embryonic development and which is not described, ii)
one which takes place between P7 and P21 and which tend to match the number of
dopaminergic neurons and target cells and iii) a later one which may be involved in
Parkinson's disease. Indeed, it has been proposed that in Parkinson's disease
neuronal cell death may result from the inappropriate re-activation of the
developmental cell death process (Burke and Kholodilov, 1998).
General Point
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Science offers an incredible number of fields in which one can dig and find
one's own satisfaction in discovering new elements that could help to cure disease or
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ABSTRACT
Genetic inactivation ofmonoamine oxidaseA (MAOA) in C3H/HeJmice causes a complete
absence of barrels in the somatosensory cortex, and similar alterations are caused by
pharmacological inhibition of MAOA in wild type mice. To determine when and how MAOA
inhibition affects the development of the barrel field, the MAOA inhibitor clorgyline was
administered to mice of the outbred strain OF1 for various time periods between embryonic
day 15 (E15) and postnatal day 7 (P7), and the barrel fields were analyzed with cytochrome
oxidase and Nissl stains in P10 and adult mice. High-pressure liquid chromatography
measures of brain serotonin (5-HT) showed three- to eightfold increases during the periods of
clorgyline administration. Perinatal mortality was increased and weight gain was slowed
between P3 and P6. Clorgyline treatments from E15 to P7 or from P0 to P7 disrupted the
formation of barrels in the anterior snout representation and in parts of the posteromedial
barrel subfield (PMBSF). Treatments from P0 to P4 caused similar although less severe barrel
field alterations. Clorgyline treatments only during embryonic life or starting on P4 caused no
detectable abnormalities. In cases with barrel field alterations, a rostral-to-caudal gradient of
changes was noted: Rostral barrels of the PMBSF were most frequently fused and displayed
an increased size tangentially.
Thus, MAOA inhibition resulting in increased brain levels of 5-HT affects barrel
development during the entire first postnatal week, with a sensitive period between P0 and
P4. The rostral-to-caudal gradient of changes in the barrel field parallels known developmen¬
tal gradients in the sensory periphery and in the maturation thalamocortical afferents. The
observed barrel fusions could correspond to a default in the initial segregation of thalamic
fibers or to a continued, exuberant growth of these fibers that overrides the tangential domain
that is normally devoted to individual whiskers. J. Comp. Neurol. 393:169-184, 1998.
© 1998 Wiley-Liss, Inc.
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t A number of mechanisms underlying the formation and
plasticity of cortical sensory maps have been uncovered by
studying the barrel field in the rodent somatosensory
cortex. The appeal of this system for developmental analy¬
ses lies in the fact that its precise topographical organiza¬
tion can be visualized readily: The peripheral tactile
receptors associated with the whiskers are isomorphically
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Fig. 1. Chart showing the different schedules of clorgyline treatment used in the present study are in¬
dicated with bars along a time scale that marks the days ofpre- and postnatal development. E, embryonic
day; P, postnatal day.
TABLE 1. Clorgyline- and Saline-Treated Pups and Dams Used in the Different Experiments in This Report1
Dose Interval between Period of the Dams P0 pups Animals
Treatments (mg/kg) injections (hours) treatment (n) (n) analyzed (n) Ages
Experiment 1: Optimization of clorgyline dosage
Saline E15-P7 4 51 10 P8, P10, P15
Clorgyline 5 24 E15-P7 3 37 14 P8, P15
Clorgyline 30 24 E15-P7 2 24 7 P8, P15
Clorgyline 5 8 E15-P7 2 16 5 P8, P15
Clorgyline 10 8 E15-P7 7 60 9 P8, P10
Experiment 2: Varying the period of clorgyline
administration2
Clorgyline 10 8 P0-P7 6 50 17 P8, P10, adults
Clorgyline 10 8 P0-P4 3 16 9 P10
Clorgyline 10 8 E15-P0 3 15 11 P10
Clorgyline 10 8 P4-P7 2 24 5 P10
1Animals that were used for immunocytochemistry and biochemical analyses are not counted in this Table.
2For all of these periods, saline-treated controls (n = 6) were analyzed in parallel with the clorgyline-treated mice. P, postnatal day; E, embryonic day.
represented as discrete elements, called barrelettes in the
sensory relays of the brainstem, barreloids in the thalamic
relay, and barrels in the primary somatosensory cortex
(SI). In SI, barrels form clear units in layer IV, consisting
of a ring of granular cells that surrounds a cell-sparse
hollow containing the clustered terminal arbors of tha¬
lamic neurons (Woolsey and Van der Loos, 1970; Jensen
and Killackey, 1987a). The crucial role of the sensory
periphery in the formation of barrels was demonstrated
early on. Lesioning a row of whiskers early in postnatal
development causes defective formation of barrels in the
corresponding cortical representation (Van der Loos and
Woolsey, 1973; Woolsey and Wann, 1976; Belford and
Killackey, 1980; Jeanmonod et al., 1981). Conversely, the
presence of additional whiskers on the snout induces
additional barrels to form in the cortex (Welker and Van
der Loos, 1986). However, the nature of the signal con¬
veyed by the periphery is still unclear, because blockade of
neural activity with tetrodotoxin or bupivacaine does not
alter barrel formation (Chiaia et al., 1992, 1994; Hender¬
son et al., 1992). Nevertheless, normal glutamatergic
neurotransmission appears to be necessary for the refine¬
ment of topographic order in the thalamocortical projec¬
tion, because whisker-related patterns fail to develop in
the brainstem, thalamus, and cortex of mice genetically
deficient for the key subunit of the N-methyl-D-aspartate
(NMDA) receptors (Li et al., 1994; Iwasato et al., 1996) and
because pharmacological blockade of NMDA receptors in
normal SI disrupts the topographic refinement of the
thalamocortical projection and the functional columnar
organization ofbarrels (Fox et al., 1996).
Recently, defective formation of barrels has been shown
to occur, despite the presence of normal peripheral recep¬
tors, in two other strains ofmice. One strain is character¬
ized by a spontaneous mutation, named "barrelless," lo¬
cated on the proximal segment of chromosome 11 (Welker
et al., 1996). The other strain has a serendipitous knockout
for the gene encoding monoamine oxidase A (MAOA)
located on the X chromosome (Cases et al., 1995). In these
two strains ofmice, the tangential clustering ofthalamocor¬
tical afferents is lacking, and granular neurons in layer IV
do not form the characteristic rings. An excess of brain
serotonin (5-HT) amounts during early postnatal develop¬
ment appears to be responsible for the abnormalities in the
MAOA knockout mice, because lowering 5-HT amounts in
the brain ofdeveloping pups allows normal barrels to form
in SI (Cases et al., 1996). Excess of 5-HT could alter two
components of the normal developmental processes that
underlie cortical barrel formation: The ingrowth of thala¬
mocortical fibers and the differentiation ofcortical neurons




































Fig. 2. General developmental effects of clorgyline administration.
A: Weight increase in gram units (g) during pregnancy in dams
injected with saline (solid circles; n = 5) and 10 mg/kg/8 hours
clorgyline (open circles; n = 7). Mean ± S.E.M. B: Litter size at birth in
mice treated with saline (n = 7), 5 mg/kg/24 hours clorgyline (n = 3), or
10 mg/kg/8 hours clorgyline (n = 7) from E15 to P0. Mean ± S.E.M.
C: Survival of pups receiving injections of saline (solid circles) or 10
Age (days)
mg/kg/8 hours clorgyline from E15 to P7 (squares) or from P0 to P7
(open circles). D: Weight increase in grams of 10 mg/kg/8 hours
clorgyline-treated pups from six litters (open circles) vs. saline-treated
pups from five litters (solid circles). Injections were administered
during the P0—P7 period. Mean ± S.E.M. Significant differences
between groups (P < 0.05; Student's t-test) are indicated with an
asterisk in B and D.
in layer IV. In mice, thalamocortical fibers reach the
cortical anlage as early as embryonic day 15 (E15), invade
the deep cortical layers in late embryonic life (Catalano et
al., 1996), reaching the nascent layer IV in the lower
cortical plate by P2. Barrel-like periodicities of the thala¬
mocortical afferents become detectable on P3 (Senft and
Woolsey, 1991a,b; Agmon et al., 1993) and are soon accom¬
panied by changes in the distribution of the layer IV
neurons: In Nissl-stained tangential sections, barrels first
appear by P3.5 as oval-shaped patches of decreased pack¬
ing density of perikarya. Clear, ring-like arrangements of
granular neurons are observed by P5 (Rice and Van der
Loos, 1977).
Although the exact targets of 5-HT in this intricate
developmental process remain to be determined, there are
strong arguments for a direct effect of 5-HT on the
thalamocortical neurons originating from the ventrobasal
(VB) thalamic nuclei. Serotonin receptors of the 5-HT1B
subtype are located transiently on VB terminals in the
somatosensory cortex (Bennett-Clarke et al., 1993) and
presynaptically inhibit the excitatory thalamocortical
transmission, at least in vitro in brain slices (Rhoades et
al., 1994). Furthermore, developing VB neurons tran¬
siently express the genes encoding the serotonin trans¬
porter (SERT) and the vesicular monoamine transporter
(VMAT2). 5-HT, as a result, is taken up and stored in
thalamocortical axons innervating SI (Lebrand et al.,
1996), giving the picture of a dense 5-HT+ innervation of
the barrel field during the first postnatal week (Fujimiya
et al., 1986; D'Amato et al., 1987; Rhoades et al., 1990;
Blue et al., 1991; Lebrand et al., 1996).
In the present study, we sought to obtain more precise
information on the sensitive period during which in¬
creased levels of brain 5-HT affect barrel development. In
our previous work, which focused on the absence of barrels
in MAOA knockouts, we showed that, in wild-type C3H/
HeJmice, transient pharmacological inactivation ofMAOA
with clorgyline from P0 to P6 caused important and
permanent barrel field abnormalities (Cases et al., 1996).
The purpose of the present report, which was performed on
172 T. VITALIS ET AL.










































Fig. 3. A: Whole brain amounts of serotonin (5-HT; shaded bars)
and 5-hydroxyindoleacetic acid (5-HIAA; hatched bars) in P3 pups
after a single 10 mg/kg clorgyline injection. Pups were killed 3.5, 8.0,
or 24.0 hours later (n = 5 for each point). Saline-treated controls were
killed at the beginning (t = 0; n = 3) and at the end (t = +24 hours;
n = 3) of the experiment. No difference was observed between these
two control groups, which are pooled in the first histogram. Values are
expressed in picograms per milligram ofwet brain and represent the
mean ± S.E.M. Asterisk indicates that the results are statistically
significant CP < 0.005; Student's t-test). B,C: 5-HT (B) and 5-HIAA (C)
amounts in whole brains ofmice receiving repeated injections of saline
(solid bars) or 10 mg/kg/8 hours clorgyline (shaded bars) following the
E15-P7 schedule. Measures were performed at E19 (n = 12), P0
(n = 4), and P7 (n = 7). In A and B, all values of the clorgyline-treated
group were statistically different from controls (P < 0.005; Student's
t-test).
another strain of mice, the outbred OF1 strain, was to
compare the extent of changes following a variety of
clorgyline dosages and schedules in prenatal and early
postnatal life and to provide a more detailed analysis of the
pattern of barrel field abnormalities. We also analyzed the
general physiological effects of the pharmacological treat¬
ments to determine whether any observed alterations of
the barrel field could be related to the effects of MAOA
inhibition on overall growth and development of the mice.
MATERIALS AND METHODS
Animals
Experiments were carried out on mice of the outbred
strain OF1 (Iffa Credo, Orleans, France). All animal
procedures were conducted in strict compliance with ap¬
proved institutional protocols and in accordance with the
provisions for animal care and use described in the Scien¬
tific Procedures on Living Animals Act of 1986. The day of
birth was counted as postnatal day 0 (P0).
Pharmacological treatments
Clorgyline (5, 10, or 30 mg/kg; M-3778; Sigma-Aldrich,
Strasbourg, France) or physiological saline was adminis¬
tered intraperitoneally to pregnant dams and subcutane-
ously to mouse pups by using a 30-gauge needle. Injections
were given either daily or every 8 hours over the following
developmental periods: E15-P0, E15-P7, P0-P4, P4-P7,
and P0-P7 (Fig. 1). The first injection at P0 was made 4-8
hours after delivery. Each day, surviving pups were num¬
bered and weighed. The total numbers of OF1 mice that
were treated with the different dosages and schedules are
indicated in Table 1.
Biochemical analysis
Embryos (E19) and P7 pups treated for various times
with clorgyline (10 mg/kg/8 hours) or saline were decapi¬
tated after cold anesthesia 3 hours after the dams or the
pups received their last injection. P0 pups born from
treated mothers were killed in the same way, but, in this
case, the delay with the last clorgyline injection to the
mother was uncertain (between 3 and 10 hours). In
addition, P3 pups were killed 3.5, 8, and 24 hours after a
single clorgyline injection (10 mg/kg). The brains were
rapidly frozen in liquid nitrogen and kept at -80°C. After
homogenization of the whole brains, 5-HT, 5-hydroxyindole-
acetic acid (5-HIAA), and tryptophan (Trp) amounts were
measured with high-pressure liquid chromatography
(HPLC) and fluorometric detection (Kema et al., 1993).
Histology
For Nissl and cytochrome oxidase (CO) stains, most
animals were killed at P8 or P10 (Table 1). Some treated
mice were killed as adults (at 2 months). Mice were deeply
anesthetized with ether at P8 and P10 and with chloral
hydrate (0.5 g/kg) as adults and were perfused transcardi-
ally with 4% paraformaldehyde in 0.1 M phosphate buffer,
pH 7.4. After perfusion, brains were removed from the
skull and weighed. One hemisphere was separated from
the rest of the brain by a section through the internal
capsule and was flattened between two glass slides sepa¬
rated by spacers. The rest of the brain was kept as one
block. Blocks were postfixed overnight in the same buff¬
ered paraformaldehyde and were cryoprotected in 30%
sucrose phosphate buffer. Serial, 40-pm-thick, frozen sec¬
tions were obtained in the coronal or tangential planes.
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Fig. 4. Serotonin (5-HT) immunostaining in tangential sections of
the flattened cortex at P7. A: In a saline-treated pup, moderate 5-HT
immunostaining delineates the primary somatosensory cortex (SI)
with a barrel pattern visible in the posteromedial barrel subfield
(PMBSF) and the anterior snout (AS); the auditory cortex is also
visible. B: In a P0-P7 clorgyline-treated pup, 5-HT immunostaining is
more intense, obliterating the normal pattern of some barrels in SI.
An artifactual crack on this section is indicated with an asterisk. Scale
bar = 330 pm.
Alternate series of sections were used for CO, as described
by Wong-Riley and Welt (1980), and for Nissl (0.025%
thionine in acetate buffer, pH 5.5). 5-HT immunocytochem-
istry (rat monoclonal antibody from Harlan-Sera Labora¬
tory, Loughborough, England; clone YC5/45, 1/50; Consola-
zione et al., 1981) was performed on frozen sections from
animals killed at P0 and P7, as described previously by
Lebrand et al. (1996).
Histological analysis
Barrels were examined in Nissl- or CO-stained coronal
sections, and the entire barrel field was reconstructed from
serial CO-stained tangential sections. The outlines of all
CO-dense clusters (barrels, abnormally shaped barrels, all
fused barrels) were drawn by using a camera lucida, and
the drawings from consecutive sections were aligned by
using blood vessels. Reconstructions from four to six
animals were made for each administration schedule at 10
mg/kg/8 hours clorgyline.
From the reconstructions made with the 6.3X objective,
we determined the total number of CO-dense clusters
(barrels, abnormally shaped barrels, and fused barrels) in
the posteromedial barrel subfield (PMBSF). To evaluate
the topographical distribution of changes, the number of
normal barrels were counted 1) along the five longitudinal
rows (A—E) of the PMBSF and 2) along the eight transver¬
sal arcs (1—8) of the PMBSF (for nomenclature, see Rice
and Van der Loos, 1977). The most caudal barrels (a, p, y,
and 8), which straddle barrel rows, were not counted in
this scheme.
The surface area covered by the PMBSF and the ante¬
rior snout (AS) was outlined on reconstructions made with
the 2.5X objective and was measured by using a morpho¬
metry software (Image Tool; The University of Texas
Health Science Center, San Antonio, TX). The surface area
of individual barrels was measured from reconstructions
made with the 10 X objective. Only unfused barrels in
B1-B4, C1-C5, and D1-D5 in P0-P4 saline- or clorgyline-
treated mice could be evaluated.
The thickness of cortical layers II-IV and layers II-VI
were measured in Nissl-stained coronal sections by using
an eyepiece graticule (10X objective). The thickness of
layer IV was measured in CO-stained coronal sections
(16x objective). Measurements were taken along a line
perpendicular to the pial surface at two different levels:
one in the PMBSF (level —1 posterior and —3.1 lateral to
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CLORGYLINE P0-P4
Fig. 5. Representative reconstructions of SI were made from a
complete series of cytochrome oxidase (CO)-stained tangential sec¬
tions of flattened cortex. A: In a saline-treated pup, the different
regions of the somatosensory representation are indicated: The large
mystachial vibrissae (PMBSF), the anterior snout (AS), the lower lip
(LL), and the forepaw (FP). These regions are separated by large
septa. Each division is subdivided into barrels and stripes. B: Embry¬
onic clorgyline injections (E15—PO) have no effects. C,D: Severe
CLORGYLINE P4-P7
alterations are seen in protracted postnatal clorgyline treatments. A
complete barrel fusion is seen in the AS, and partial row fusions (open
arrow) or arc-fusions (solid arrow) are visible in the PMBSF. E: Early
postnatal clorgyline administration (P0-P4) causes barrel disorganiza¬
tion and fusions in the LL, in the AS, and, to a lesser extent, in the
PMBSF. F: P4-P7 clorgyline injections have no visible effects on
formation of barrels in the different subfields.
PMBSF
E
SALINE P0-P7 CLORGYLINE El 5-PO
CLORGYLINE P0-P7 CLORGYLINE El 5-P7
Bregma) and the other in the AS (level +0.7 anterior and
— 3 lateral to Bregma).
RESULTS
Optimization of clorgyline dosage regime
We determined the minimal dose and frequency of
administration of clorgyline capable of producing major
alterations in the formation of the barrel field. After each
of the various protocols listed in Table 1 (experiment 1),
the barrel field was examined with Nissl and CO stains at
P8. We started with a 5 mg/kg daily injection of clorgyline,
a dose that is known to acutely inhibit MAOA activity by
nearly 100% in adult rats and that does not produce
obvious behavioral alterations (Green and Youdim, 1975;
Sleight et al., 1988). After daily administrations from E15
to P7, a few abnormally shaped barrels were observed in
CO-stained coronal sections (4 of 14 pups). Increasing the
daily dose to 30 mg/kg did not produce more substantial
modifications of the barrel field. Taking into account the
treated pups, barrels appear larger than in controls on CO stains (C)
and are less clearly defined cytoarchitecturally on Nissl stains (D).
E,F: In P0-P7 clorgyline-treated pups, increased CO activity (E) and
granular neurons (F) form a continuous band in layer IV. Scale bar =
320 pm.
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Fig. 6. Gradual alterations of the cortical barrels according to the
period and the duration of the clorgyline treatment. A,B: Normal
barrels are visible as blobs of increased cytochrome oxidase (CO)
activity (A) or as clustered granular cells in layer IV (B) surrounding a
cell-sparse hollow with Nissl staining. C,D: In P0-P4 clorgyline-
higher rate of MAOA synthesis in pups (Nelson et al.,
1979; Samsa et al., 1979), we then increased the frequency
of clorgyline administration. Treating animals from E15 to
P7 with 5 mg/kg/8 hours of clorgyline produced alterations
in rostral barrels but had little effect on the PMBSF. The
10 mg/kg/8 hours regime led to constant and severe
abnormalities throughout the barrel field. Therefore, the
following report will deal mainly with the latter dosage
regime.
General developmental and behavioral
effects of clorgyline administration
In mothers treated from E15 to P0 (5 mg/kg/24 hours or
10 mg/kg/8 hours), we observed no effects of the clorgyline










Fig. 7. Typical examples of barrel field alterations caused by
monoamine oxidase A (MAOA) inhibition viewed on cytochrome
oxidase (CO)-stained tangential sections. A: Reconstruction of SI in a
saline-treated mouse killed at P10 showing the different trigeminal
subfields, posteromedial barrel subfield (PMBSF), anterior snout (AS),
and lower lip (LL) as well as the hind paw (HP) and forepaw (FP)
representations. The five rows in the PMBSF are indicated with
letters from A to E, and the first five barrel arcs are indicated with
numbers. B: An E15—P7 clorgyline-treated mouse killed at P10: Note
the lack ofbarrels or cytochrome oxidase (CO+) clusters inAS, LL, and
FP. In the PMBSF, the most rostral barrels are lacking, with arc-like
fusions of barrels along arc 5 (D5 and E5). C: A similar pattern of
barrel field alterations is visible in a P0-P7 clorgyline-treated mouse
killed at P8. Arc-like fusions ofbarrels along arc 4 (C4, D4, and E4) and
arc 5 (D5 and E5) are indicated by solid arrows. A row-like fusion is
also visible along row A (open arrow). D: High magnification of C,
showing the fusion along row A delineated by arrows. Scale bars =
320 pm.
treatment on the duration ofpregnancy, or weight increase
during pregnancy (Fig. 2A). However, the size of the
litters, which was evaluated 4-8 hours after delivery, was
reduced by 30% (Fig. 2B), reflecting an increased perinatal
mortality. Mortality of clorgyline-treated pups was consid¬
erably increased during the subsequent 4 days ofpostnatal
life (Fig. 2C), with survival rates at P7 of 30% and 36% in
the E15-P7 and P0-P7 administration schedules, respec¬
tively. Surviving clorgyline-treated pups at P3-P6 dis¬
played a slight, temporary retardation of their growth
curve relative to controls, but their growth returned to
normal at P7 (Fig. 2D). Clorgyline-treated pups displayed
some of the behavioral abnormalities described in the
MAOA knockout pups (Cases et al., 1995), such as agita¬
tion, trembling, hunched posture, increased righting time
(15-20 seconds instead of 1 second in controls), and
abnormal rooting reflex. However, these behavioral alter¬
ations were less intense and were no longer observable 24
hours after the last injection.
Clorgyline-treated dams, contrary to saline-treated dams,
showed almost constantly increased locomotor activity and
excitability, even after the end of the treatment, which
were probably due to the long-lasting effects of clorgyline
in adults (Maitre et al., 1976). This could explain in part
the high mortality rate of the pups observed in the E15-P7
group. Nursing and nurturing defects have also been noted
previously when rat pups were treated with inhibitors of
monoamine oxidases (Whitaker-Azmitia et ah, 1994).
Biochemical abnormalities
To evaluate the duration of MAOA inhibition provoked
by the administration of clorgyline, we measured the
amounts of 5-HT and its metabolite, 5-HIAA, 3.5, 8, and 24
hours after a single subcutaneous injection at P3 (10
mg/kg; Fig. 3A). Judging by the reduction in the amounts
of 5-HIAA, MAOA inhibition was maximal 3.5 hours after
the injection (55% reduction from controls), and a partial
recovery was observed by 8 hours (20-25% reduction from
controls). 5-HT amounts were increased threefold by 3.5
and 8 hours after the injection.
Repeated injections of clorgyline (10 mg/kg/8 hours) over
the P0-P7 period led to a more complete inhibition of
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Fig. 8. Normal patterning in the lower stations of the somatosen¬
sory pathway in P10 pups. Different relays of the somatosensory
pathway are shown with CO activity (A-D) and Nissl (E,F). Bar-
relettes have similar staining and distribution patterns in the trigemi¬
nal nucleus principalis of controls (A) and P0-P7 clorgyline-treated
pups (B). Barreloids have similar staining and distribution in the
ventrobasal thalamic nucleus of controls (C,E) and P0-P7 clorgyline-
treated pups (D,F). Scale bar = 320 pm.
MAOA. There was a larger increase in 5-HT (eightfold;
Fig. 3B), a larger decrease in 5-HIAA (80% reduction; Fig.
3C), and a 6% increase in Trp levels (not shown). Pharma¬
cological inhibition with clorgyline was also effective in
embryos. In E19 embryos taken from treated pregnant
dams or in P0 pups born from treated mothers, the
amounts of brain 5-HT were fourfold higher than in
controls, whereas 5-HIAA was reduced by 70%, or 50% of
the controls (Fig. 3C).
5-HT immunostaining
5-HT immunostaining at P7 was increased in the brain¬
stem, diencephalon, and cerebral cortex of P0-P7 clorgy¬
line-treated pups. This increase was also visible in P0 pups
born to clorgyline-treated mothers. In tangential sections
of the cerebral cortex of P7 clorgyline-treated pups, 5-HT
immunolabeling was markedly increased in SI as well
as in the primary auditory and primary visual cortices. In
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Fig. 9. Permanent alterations of layer IV in a 2-month-old mouse
treated with 10 mg/kg/8 hours clorgyline from P0 to P7: Granular
neurons observed with Nissl staining (the asterisk indicates a dis¬
placed fragment of the choroid plexus; A) and cytochrome oxidase (CO)
activity (B) form a continuous band in layer IV instead of clustered
granular cells (Fig. 7A) or blobs of increased CO activity (Fig. 7B).
Scale bar = 640 pm.
SI, the frontiers between cortical barrels were blurred
(Fig. 4B).
Effects on the barrel field
The patterning of the barrels was affected diversely by
the different schedules of clorgyline administration. In
animals that received clorgyline treatments only during
the embryonic period E15-P0, cortical barrels had a
normal appearance on CO- and Nissl-stained coronal
sections. On reconstructions from CO-stained tangential
sections, the organization of SI was similar to that of
controls (Fig. 5A,B). Barrels and other characteristic CO-
dense elements were distinguished in the four main do¬
mains of SI: The PMBSF, the AS, the lower lip (LL), and
the forepaw (FP). They normally have different aspects
and sizes in these different parts: They are largest and
quadrangular in the PMBSF, smaller and roughly circular
in the caudal part ofthe AS, have a stripe-like organization
in the rostral part of the AS, and are the least sharply
defined in LL and FP, where ovoid blobs are visible.
Severe alterations of the barrel field were observed in all
pups that received clorgyline from E15 to P7 and from P0
to P7. On CO-stained coronal sections, barrels were distin-
B1 B2 B3 B4 C1 C2 C3 C4 C5 D1 D2 D3 D4 D5
Barrels
Fig. 10. A: Area of the posteromedial barrel subfield (PMBSF) plus
theAS measured on cytochrome oxidase (CO) stains from pups treated
with saline (n = 4) or 10 mg/kg/8 hours clorgyline during different
periods: E15-P0 (n = 6), P0-P4 (n = 6), P4-P7 (n = 5), P0-P7 (n = 6),
and E15-P7 (n = 4). Asterisks indicates that the results are statisti¬
cally significant (*P < 0.025, **P < 0.005; Student's t-test).
B: Histograms representing the area of individual CO-stained barrels
after saline (n = 4) and P0-P4 clorgyline treatment (n = 6). Asterisk
indicates that the results are statistically significant (*P < 0.05;
Student's t-test) between saline- and clorgyline-treated pups.
guished only in a few cases: Large patches with blurred
outlines were observed in the most caudal part of the
PMBSF (Fig. 6E). Tangential reconstructions of SI were
made in 12 cases. In the AS, barrels or stripes were
completely absent in 11 cases and, in one case, showed a
few disorganized clusters. In the LL, CO* clusters or blobs
were completely lacking in eight cases (Fig. 5C,D). In the
PMBSF, some barrels were visible in all of the cases, but
there were fusions of barrels within a given row, mainly in
rowA, or along the barrel arcs, mainly between the rostral
barrels of rows C, D, and E (Fig. 7). Nissl-stained coronal
sections did not show the characteristic clusters in layer IV
of SI (Fig. 6B); instead, granular neurons formed a uni¬
form band with a moderate packing density (Fig. 6F).
These cortical alterations were not accompanied by any
obvious abnormalities in the barrelette or barreloid pat¬
terns of the lower sensory stations (Fig. 8). Furthermore,
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TABLE 2. Number ofCytochrome Oxydase-Positive Clusters (Normal barrels, abnormal shaped barrels, or fused barrels) and Clearly Defined Barrels
That Can Be Identified in the Posteromedial Barrel Subfield ofP10 Pups Treated With Saline or Clorgyline (10 mg/kg/8 hours) During Different Periods1
Saline Clorgyline
P0-P7 (n = 5) E15-P0 (n = 6) E15-P7 (n = 4) P0-P7 (n = 5) P0-P4 (n = 6) P4-P7 (n = 4)
CO clusters in the PMBSF 30* 29.5 ± 0.7* 17 ± 1.3** 19.4 ± 1.5** 23.8 ± 2.3*** 29.7 ± 0.6*
Clearly defined barrels in the PMBSF 30* 29.5 ± 0.7* 12.3 ± 1.8** 14 ± 0.4** 19 ± 1.8*** 29.7 ± 0.6*
1Counts were obtained from flattened reconstructions. Mean ± S.E.M. CO, cytochrome oxydase; PMBSF, posteromedial barrel subfield.
^Statistical difference between the different clorgyline schedules and the P0-P7-treated group (P < 0.05; Student's t-test).
**Statistical difference relative to the control group (P < 0.05; Student's t-test).
TABLE 3. Topographical Distribution ofBarrel Alterations1
Saline Clorgyline
P0-P7 E15-P0 E15-P7 P0-P7 P0-P4 P4-P7
(n = 5) (n = 6) (n = 4) (n = 5) (n = 6) (n = 4)
Rows
A 5 5 1 ± 0.7** 1.6 ± 0.9** 3 ± 1.3* 4.7 ± 0.5
B 4 4 4 4 4 4
C 6 6 2** 3.2 ± 0.6** 4.2 ± 0.6* 6
D 7 7.5 i+ o 2.7 ± 0.9** 2.2 ± 0.3** 3.3 ± 1** 7
E 8 8 3 ± 0.7** 2.8 ± 0.6** 4.3 ± 0.7** 8
Arcs
1 5 5 4.3 ± 0.9 4.4 ± 0.5 4.5 ± 0.6 5
2 5 5 4 4.4 ± 0.5 4 ± 0.7 5
3 5 5 2.3 ± 0.4** 2.8 ± 0.6** 4 ± 0.3* 5
4 5 5 1.7 ± 0.9** 2 ± 0.4** 4.3 ± 0.7 5
5 4 4 0 2 ± 0.4** 1.3 ± 1.0** 3.7 ± 0.4
6 3 2.7 ± 0.4 0 0.2 ± 0.3** 0.5 ± 0.5** 3
7 2 2 0 0 0.5 ± 0.7* 2
8 1 1 0 0 0.2 ± 0.3* 1
1Number of clearly defined barrels along rows and arcs of the PMBSF as identified on
complete primary somatosensory cortex reconstructions. Analysis was done in P10 pups
treated with saline or clorgyline (10 mg/kg/8 hours). Values represent the mean ±
S.E.M. ofn cases.
*Statistical difference relative to the saline group (P < 0.05; Student's t-test).
**Statistical difference relative to the saline group (P < 0.01; Student's t-test).
TABLE 4. Cortical Thickness in P10 Pups Treated With Saline or








Saline (n = 3) P0-P7 467 ± 20 1,195 ± 34
Clorgyline (n = 6) E15-P0 413 ± 32 1,023 ± 22
Clorgyline (n = 6) P0-P4 410 ± 39 1,088 ± 90
Clorgyline (n = 6) P0-P7 462 ± 24 1,169 ± 64
Measures were obtained from Nissl-stained coronal sections at the level -1 mm
posterior, -3.1 mm lateral to Bregma. Mean ± S.E.M.
cortical changes were permanent, because no barrels were
distinguished on CO- and Nissl-stained coronal sections
from four adult mice that had been treated with 10
mg/kg/8 hours of clorgyline from P0 to P7 (Fig. 9A,B).
Less severe alterations of the barrel field were visible in
P0-P4 clorgyline-treated pups. In coronal sections, clus¬
tered, CO-stained blobs were observed in the caudal
PMBSF (Fig. 6C) and also occasionally in coronal sections,
through the anterior part of the barrel field. These CO
clusters had irregular shapes and blurred contours. Tan¬
gential reconstructions ofSI were made in six cases. In the
AS, barrels were completely lacking in only one case: The
other five cases displayed barrel-like, CO+ clusters, albeit
with a disorganized appearance compared with controls
(Fig. 5E). In the LL, segregation into blobs was absent in
four cases. In the PMBSF, barrels were always distinguish¬
able, but with some barrel fusions similar to those de¬
scribed previously along arcs or rows (Figs. 5E, 7). Nissl-
stained coronal sections through SI revealed a disorganized
distribution of granular cells in layer IV with periodic
differences in cellular density (Fig. 6D), suggesting that
some architectonic differentiation had occurred.
In P4—P7 treated pups, barrels appeared to be normal on
coronal sections, and, in all of the five reconstructed cases,
all PMBSF barrels could be identified, and barrels were
found in the AS (Fig. 5E). In the case illustrated, the
patterning of the AS differed slightly from controls, but
this is difficult to interpret, because there are some
variations in the patterning of this subfield in normal
animals.
To provide a quantitative comparison of the effect of
these different treatments, we counted the total number of
CO+ clusters as well as the number of clearly formed
barrels in the PMBSF (see Materials and Methods). These
counts confirmed that clorgyline had more potent effects
when it was administered during the E15-P7 and P0-P7
periods rather than only during the P0-P4 period, whereas
a prenatal treatment did not significantly augment the
deleterious developmental effect of clorgyline (Table 2).
Furthermore, counts of the number of the normally formed
barrels along the rows and arcs confirmed the impression
of a topographical distribution of the barrel alterations:
The reduction in the number of barrels was most severe in
row A. Row B, which is formed of four caudal barrels
appeared to be relatively spared. Normal barrels were also
less frequent within rostral barrel arcs, comprising arcs
3-8 in the E15-P7 and P0-P7 clorgyline-treated pups and
arcs 5-8 in the P0—P4 clorgyline-treated pups (Table 3).
Barrel straddlers (a, |3, y, and 5), which were not included
in the counts, appeared to be fused in about half of the
clorgyline-treated cases (E15-P7, P0-P7, and P0-P4).
Morphometry
Brain weights were similar in P0-P7 clorgyline-treated
mice (308 ± 30 mg) and P10 control mice (310 ± 7 mg). On
Nissl-stained coronal sections, neither the thickness of
cortical layers II-VI nor the thickness of the layers (II—IV)
were significantly changed by any of the treatments
(Table 4). By contrast, the thickness of layer IV, measured
as the reactive CO-dense zone, was reduced by 10-20%
(Table 5).
The surface area comprising the PMBSF and the AS in
the tangential sections showed a significant (10-20%)
increase in the P0-P7 and E15-P7 clorgyline-treated pups
but appeared unchanged with the E15-P0, P0-P4, and
P4—P7 treatments (Fig. 10A). Measurements of the indi¬
vidual barrel areas were taken in the P0-P4 clorgyline-
treated pups, considering only the unfused barrels that
could be identified in rows B, C, and D. Significant
increases in size were noted for barrels C3—C5 and D3-D5,
whereas changes were nonsignificant for the more caudal
barrels CI, C2, Dl, and D2 and for barrels B1-B4 (Fig.
10B). Measurements of individual barrel areas in the
P4-P7 treated mice showed no significant difference from
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TABLE 5. Thickness ofCortical Layer IV in P10 Pups TreatedWith Saline





Thickness of layer IV
(pm) at level to Bregma
-1,-3.1mm +0.7,-3 mm
Saline (n = 2) P0-P7 203 ± 17 201 ± 2
Clorgyline (n = 6) E15-P0 189 ± 20 207 ± 12
Clorgyline (n = 6) P0-P4 169 ± 16 209 ± 14
Clorgyline (n = 6) P0-P7 168 ± 8 177 ± 7
Measures were obtained from CO-stained coronal sections at two different stereotaxic
levels: -1 mm posterior and -3.1 mm lateral, and +0.7 mm anterior and -3 mm
lateral, to Bregma. Mean ± S.E.M.
controls. Such measures were not feasible in the other
treated groups because of the frequency of fused barrels.
DISCUSSION
The present study shows that pharmacological inhibi¬
tion of MAOA activity during development irreversibly
alters the formation ofbarrels in the mouse somatosensory
cortex. The degree of cortical abnormality is strongly
related to the time period during which MAOA activity is
inhibited, with a critical period during the first 5 days of
postnatal life but with more pronounced effects when
MAOA inhibition is maintained throughout the first post¬
natal week.
Pharmacological blockade ofMAOA activity:
Evaluation of the present model and
comparison with MAOA knockout mice
MAOs are key enzymes in the degradation pathway of
monoamines. Two MAOs exist in the brain, MAOA and
MAOB (for review, see Weyler et ah, 1990). Although they
are closely related in their gene structure (Shih, 1991),
MAOA and MAOB differ in several characteristics: MAOA
is abundant in noradrenergic neurons (Luque et al., 1995;
Jahng et al., 1997), has a preferential affinity for 5-HT, and
is selectively inhibited by clorgyline, whereas MAOB is
abundant in serotoninergic neurons and glial cells, has a
lower affinity for 5-HT, and is selectively inhibited by
deprenyl. Compounds that inhibit MAOs exhibit antide¬
pressant activity (for review, see Tipton, 1989). In rodents,
developmental studies have shown that MAO activity in
the brain appears early in ontogeny, by E15 (Bourgoin et
al., 1977), with MAOA activity initially predominating
over MAOB (Mantle et al., 1976). By P15, MAOA is
maximal, whereas MAOB activity reaches 50% of adult
values (Jourdikian et al., 1975).
In a transgenic mouse line characterized by the deletion
of exons 2 and 3 of the gene encoding MAOA and resulting
in the absence ofmeasurable MAOA activity, we observed
a peculiar developmental abnormality in SI, where layer
IV cortical neurons and afferent thalamic fibers failed to
organize in barrels (Cases et al., 1995, 1996). Similar,
although less extensive, alterations were produced when
the corresponding wild type mice (inbred strain C3H/HeJ)
were treated with the MAOA inhibitor clorgyline (Cases et
al., 1996). To generalize these findings, an important first
step was to show that similar effects could be obtained in
othermouse strains. In the present study, abnormalities in
barrel formation were observed after MAOA inhibition in
the OF1 mouse strain. We found that these alterations
were similar to those observed in the C3H/HeJ mice.
However, in parallel, unpublished studies, we observed
variations of the effects of MAOA inhibition among differ¬
entmouse strains. In F1 hybrids between the C57BL/6 and
C3H/HeJ strains, clorgyline treatments from P0 to P7
induced only minor changes in the AS field, whereas
treatment from P0 to P4 produced no visible cortical
alterations (T. Vitalis and O. Cases, unpublished observa¬
tions). Correspondingly, MAOA knockouts with a C57BL/6
genetic background, which were obtained by repeated back
crossing, have some ill-defined barrels in the caudal PMBSF
(I. Seif and P. Gaspar, unpublished observations). This
suggests that, according to the mouse strain used, factors
that modulate the levels or effects of 5-HT are differently
regulated. Indeed, amounts of MAOs (Voitenko, 1992),
tryptophan hydroxylase (Knapp et al., 1981; Daszuta et
al., 1984; Kulikov et al., 1995), 5-HT receptors, and 5-HT
transporter as well as the number of serotonergic raphe
neurons (Daszuta and Portalier, 1985) appear to differ
among inbred mouse strains.
The milder severity of alterations in elorgyline-treated
mice compared with MAOA knockouts with identical ge¬
netic backgrounds could be due to incomplete inhibition of
MAOA. Incomplete inhibition ofMAOA might be particu¬
larly critical during specific periods, such as the perinatal
period. Clorgyline is an irreversible inhibitor of MAOA,
and the duration of its effects is linked to its elimination
and the rate of synthesis of MAOA, with a replacement
rate in MAO activity varying from 24 hours in rat or mouse
pups (Nelson et al., 1979; Samsa et al., 1979) to 10-12 days
in adult rats (Maitre et al., 1976). Present observations
indicate that a partial recovery ofMAOA activity occurs as
soon as 8 hours after a single clorgyline administration at
P3. Thus, although chronic administration of clorgyline
every 8 hours resulted in near-complete inhibition of
MAOA at P7, as reflected by the increased levels of brain
5-HT that mirrored the levels observed in the MAOA
knockouts, there could be fluctuations in these levels. For
instance, at P0, brain levels of 5-HT increased fourfold in
pharmacologically treated vs. ninefold in MAOA knock¬
outs, probably reflecting the difficulty of drug administra¬
tions during the perinatal period. A continuous mode of
administration of clorgyline, such as that afforded by
minipumps, would be needed to evaluate the importance of
these fluctuations. A critical threshold ofbrain 5-HTmight
exist above which cortical abnormalities occur. Below such
a level, compensatory mechanisms might be active: For
instance, other neurotransmitters could antagonize the
effects of 5-HT, or changes in number or affinity of 5-HT
receptors and monoaminergic transporters could dampen
the effects of 5-HT increase. Such compensations would
become ineffective when the brain is overwhelmed with
large amounts of 5-HT.
The present protocol is potentially flexible and could be
applied to other useful experimental species, such as rats
or felines, to determine whether similar effects of MAOA
inhibition on the formation of cortical maps can be ob¬
served. The variability of effects observed between differ¬
ent mouse strains, however, is an indication that interspe¬
cies differences are to be expected.
Period sensitive to MAOA inhibition:
Relationship to stages in barrel field
development
The present pharmacological study, together with our
previous observations in the MAOA knockout mice, allows
us to narrow down the sensitive period during which
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MAOA inhibition can alter the development of barrels. In
the rodent trigeminal system, the formation of the cortical
map and its differentiation into barrels results from a
precisely timed sequence ofevents, which can be separated
into three main epochs. The first period corresponds to the
formation of a topographic map of the VB in the cortex.
During fiber outgrowth, VB axons maintain a strictly
ordered topography (Molnar and Blakemore, 1995; Cata-
lano et al., 1996) that is in register with the peripheral
topography initiated in the trigeminal nerve and is trans¬
mitted to the trigeminal nerve nuclei and to the VB
(Erzurumlu and Killackey, 1983). None of these processes
that occur during embryonic life are affected by MAOA
inhibition. Indeed, clorgyline treatments during embryonic
life caused no visible effects and did not increase signifi¬
cantly the postnatal effects of MAOA inhibition (E15-P7
compared with P0-P7 clorgyline treatments). Accordingly,
in MAOA knockouts, inhibition of 5-HT synthesis during
postnatal life (P0-P6) suffices to reverse the barrel field
abnormalities (Cases et al., 1996). Furthermore, the topo¬
graphic organization of the thalamocortical projection,
revealed with anterograde tracers in adult MAOA knock¬
outs, appeared to be normal (Cases et al., 1996).
The second major step is the formation of periphery-
related clusters in SI. This process seems to be dictated by
a tendency of thalamic terminal axons carrying informa¬
tion from a functional group of peripheral receptors (large
vibrissa, sinus hair, or digits) to cluster together, first in
layer VI, then in layer IV, where they induce the character¬
istic cellular, ring-like cytoarchitectonic differentiation
(Rice and Van der Loos, 1977; Senft and Woolsey, 1991a,b;
Agmon et al., 1993). These processes, which occur essen¬
tially during the first 4-5 days of postnatal life, appear to
be most affected by the clorgyline treatments. Indeed,
clorgyline treatments during the first 5 days of life sufficed
to cause alterations in the barrel field, whereas clorgyline
treatments after P4 caused no visible changes of the
barrels. This time limit coincides with that disclosed for
the effects of lesions of peripheral receptors (Woolsey and
Wann, 1976; Belford and Killackey, 1980; Jeanmonod et
al., 1981), indicating that the cytoarchitectonic differentia¬
tion of granular neurons in layer IV is an irreversible
process once it has been initiated. The exact step that is
disrupted by excess 5-HT during this 4-day period remains
to be determined.
The third and last phase of barrel development extends
probably until P21 and is characterized by the functional
maturation of the barrels coinciding with an extensive
collateral arborization ofthe thalamic axonal arbors within
the confines of a given barrel (Agmon et al., 1993). A
corresponding maturation of the cortical targets occurs
with extensive dendritic remodeling: Formation of den¬
dritic spines and synapses (White et al., 1997). The general
result of these cellular events is growth in the size of
individual barrels and in the total area of SI (Rice and Van
der Loos, 1977; Riddle et al., 1992). We could not detect a
clear effect of clorgyline treatments between P4 and P7.
However, the histological methods used in the present
study do not allow us to monitor more subtle developmen¬
tal events that could be affected by the excess of brain
5-HT, such as the fine topographic arrangement ofthalamo¬
cortical afferents. For instance, early sensory deprivation
or application of an NMDA-receptor antagonist to the
cortex caused no cytoarchitectonic changes of the barrel
field, although electrophysiological studies demonstrated
the presence of topographically inappropriate thalamic
projections (Fox, 1992; Fox et al., 1996).
An observation for which we do not yet have a clear
interpretation is that barrel field changes were more
important when MAOA inhibition was maintained until
the end of the first postnatal week rather than just during
the first 5 postnatal days. This difference could be inter¬
preted as resulting from a delay in the cellular processes of
barrel formation, which could still be reinitiated when
MAOA inhibition ceases at P4 but not when it ceases at P7.
However, in other experimental situations in which a
delay in barrel formation was observed, such as that
caused by 5-HT neurotoxins (Blue et al., 1991; Osterheld-
Haas et al., 1994; Osterheld-Haas and Hornung, 1996) or
protein malnutrition (Vongdokmai, 1980), a normal barrel
field eventually formed, whereas the patterning of the
barrel field remained abnormal after P0-P4 clorgyline
treatments. The synergism ofP4-P7 clorgyline treatments
with the P0-P4 treatments could indicate that there are
some later effects of 5-HT on barrel development but that
these become apparent only when they are primed by an
early effect during the initial stages ofbarrel development.
Gradients of changes in the barrel field
Barrel alterations in the representation of the whisker
pad were not distributed uniformly: Effects were more
marked in the rostral fields, where the small vibrissae are
represented, than in the posterior field, where the large
caudal vibrissae are represented. Indeed, barrel fusions
were more frequent in the AS representation and in the
rostral part of the PMBSF, where significant enlargements
of "intact" individual barrels were also seen. Exceptions to
this general trend were the largest and caudalmost barrels
(a, (3, y, and 8), which were frequently fused.
Several hypotheses can be proposed to explain this
phenomenon. The sequence of development of the face
vibrissae proceeds from ocular to nasal, and this temporal
sequence is replicated at least at the level of the trigeminal
nerve and the brainstem (Erzurumlu and Killackey, 1983).
A caudal-to-rostral sequence of emergence of periphery-
related patterns has also been described in the somatosen¬
sory cortex. This can be seen in the acetylcholinesterase
preparations of Schlaggar and O'Leary (1994), in which
barrel-like patterning is visible in the PMBSF before it
emerges in the AS. By using 5-HT immunostaining, which
also reveals the thalamocortical afferents, Rhoades et al.
(1990) described a clear caudal-to-rostral sequence of fiber
clustering in SI. Later in development, boundary patterns
of cortical glia (McCandlish et al., 1989) and markers of
synaptogenesis (Stettler et al., 1996) were described as
following a similar gradient of maturation. In this view,
excess 5-HT would have more pronounced effects on the
rostral, relatively immature thalamic fibers compared
with the more mature caudal fibers, and the fact that we
were not able to disrupt the caudalmost barrels, even
when administering clorgyline before birth, could be due to
insufficient MAOA inhibition during late embryonic and
early postnatal life.
These gradients should also be considered in the context
of a difference in the geometry and function of the periph¬
eral receptors that are mapped in the caudal vs. the rostral
parts of SI: The large vibrissae mapped in the PMBSF are
more widely separate on the snout than the anterior sinus




Fig. 11. Schematic representation of the barrel field (posterome¬
dial barrel subfield [PMBSF] and anterior snout [AS]) pattern after
MAOA inhibition compared with reported changes after infraorbital
expected to be functionally autonomous and to have asyn¬
chronous activity. This would provide a larger drive for
segregation of afferents than in the case of the small AS
vibrissae. If excess 5-HT antagonizes this process, then
one could have more visible effects in the AS than in the
PMBSF. This hypothesis derives from the general hypoth¬
esis that activity-dependent mechanisms are regulating
the segregation of sensory afferents, following the prin¬
ciple that "cells that fire together wire together" (for
review, see Shatz, 1990).
Effects ofMAOA inhibition
It is important to consider whether the effects of clorgy-
line on barrel field development are due to a general effect
on growth, because clorgyline administration caused a
deficit in weight gain between P3 and P6. This is an
unlikely explanation, however, because protein malnutri¬
tion in mice causes only a 2-day delay in the development
of the barrels (Vongdokmai, 1980), and not a persistent
absence of barrels as observed in this study. Despite our
ignorance about the precise mechanism of 5-HT action in
the developing somatosensory thalamocortical system, the
developmental pattern of expression of 5-HT receptors in
this system should be a good indication of the potential
cellular targets of 5-HT.
In the cortex, pyramidal cells in layers II—III express
functional 5-HT2 receptors during development, and their
activation reduces gap-junction coupling (Rorig and Sutor,
1996). Scattered cortical neurons have been shown to
express the 5-HT3 receptor gene (Tecott et al. 1995).
However, it has not yet been determined whether layer IV
neurons or glia express any 5-HT receptors during the
critical period of barrel development.
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Clorgyline
Early pattern (P0)
nerve transection (Killackey et al., 1994) and with described patterns
of thalamocortical afferents in P0 rat pups (redrawn from Schlaggar
and O'Leary, 1994).
On the other hand, developing VB thalamic fibers ex¬
press both SERT (Lebrand et al., 1996) and the 5-HTiB
receptor subtype between E15 and P10 (Bennett-Clarke et
al., 1993; Lebrand et al., unpublished observations). SERT
causes 5-HT to accumulate in large excess in VB neurons
when MAOA is inhibited (Cases et al., unpublished obser¬
vations) and, thereby, could cause an abnormal develop¬
ment. Indeed, an abnormal tangential distribution of
thalamocortical fibers in the clorgyline-treated mice was
presently visualized with 5-HT immunocytochemistry. Ex¬
cessive stimulation of the presynaptic 5-HT1B receptor
subtype might cause a complete inhibition of the excita¬
tory neurotransmission in the thalamocortical circuit,
interrupting any activity-dependent mechanism that could
be responsible for the segregation of the thalamocortical
axons. Alternatively, activation of the 5-HTiB receptor
subtype or internalization of 5-HT might also have a
direct, trophic action on axonal growth that would mask
the underlying segregation processes.
Indirect clues about the mechanisms underlying the
effects of 5-HT may be drawn by comparing the effects of
MAOA inhibition with those of different types of lesions.
The fact that 5-HT has no instructive effects per se on
barrel formation is demonstrated by the early lesions of
the 5-HT system that cause no disruption in the general
patterning of the barrel field (Blue et al., 1991; Bennett-
Clarke et al., 1994; Osterheld-Haas et al., 1994). On the
other hand, those studies suggest that 5-HT may have a
trophic effect on thalamocortical and barrel development.
In neonatal rat pups, 5,7-dihydroxytryptamine (5,7-DHT)
or fenfluramine administration caused a decrease in the
tangential area covered by individual barrels in the PMBSF
(Bennett-Clarke et al., 1994, 1995), and a delay in the
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laminar differentiation of layer IV was noted in 5,7-DHT-
treated mice (Osterheld-Haas and Hornung, 1996). How¬
ever, these findings are hampered by the possibility that
5,7-DHT could have a direct toxic effect on the developing
thalamic neurons, because it may be taken up in these
neurons by SERT.
5-HT could be acting as a modulator of peripheral
influences derived from the periphery. Lesions of the
infraorbital nerve (ION), the trigeminal branch that sup¬
plies the whisker pad, produced effects similar to that of
MAOA inhibition, in that there was a loss of the character¬
istic thalamocortical clustering and a lack of cytoarchitec-
tonic differentiation in layer IV. However, the pattern of
PMBSF alterations resulting from such lesions differed:
The deprived territory appeared atrophic and disorga¬
nized, with a main outline of the five barrel rows (Jensen
and Killackey, 1987b; Killackey et al., 1994; Fig. 11). By
contrast, clorgyline treatment during the sensitive period
resulted in barrel fusions both within and across rows,
with a general trend for hypertrophy, because there was an
increase in the size of the trigeminal representation or of
individual barrels. Furthermore, MAOA inhibition caused
no visible alterations in the trigeminal nerve nucleus and
VB, contrary to the effects of lesions (Durham andWoolsey,
1984; Killackey et al., 1994). These different patterns of
alterations could indicate that peripheral lesions interrupt
a trophic influence that originates from the peripheral
receptors, whereas excess 5-HT does not. Anterograde
transport of neurotrophic molecules from the periphery
has been demonstrated recently in the chick developing
visual system (Von Bartheld et al., 1996) and could well
exist in the rodent somatosensory system, as suggested by
recent observations (Chiaia et al., 1996; Wilkinson et al.,
1997). In this respect, the effects of 5-HT may be viewed as
being limited to the distalmost component of this ascend¬
ing sensory pathway, which is the synaptic interaction of
ingrowing terminals with their maturing cortical targets.
Direct evidence derived from electrophysiological studies,
pharmacology, single axonal reconstructions, and electron
microscopy will be necessary to comprehend precisely
what these effects are.
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Plasma Membrane Transporters of Serotonin, Dopamine, and
Norepinephrine Mediate Serotonin Accumulation in Atypical
Locations in the Developing Brain of Monoamine
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Genetic loss or pharmacological inhibition of monoamine oxi¬
dase A (MAOA) in mice leads to a large increase in whole-brain
levels of serotonin (5-HT). Excess 5-HT in mouse neonates
prevents the normal barrel-like clustering of thalamic axons in
the somatosensory cortex. Projection fields of other neuron
populations may develop abnormally. In the present study, we
have analyzed the localization of 5-HT immunolabeling in the
developing brain of MAOA knock-out mice. We show numerous
atypical locations of 5-HT during embryonic and postnatal
development. Catecholaminergic cells of the substantia nigra,
ventral tegmental area, hypothalamus, and locus ceruleus dis¬
play transient 5-HT immunoreactivity. Pharmacological treat¬
ments inhibiting specific monoamine plasma membrane trans¬
porters and genetic crosses with mice lacking the dopamine
plasma membrane transporter show that the accumulation of
5-HT in these catecholaminergic cells is attributable to 5-HT
uptake via the dopamine or the norepinephrine plasma mem¬
brane transporter. In the telencephalon, transient 5-HT immu¬
nolabeling is observed in neurons in the CA1 and CA3 fields of
the hippocampus, the central amygdala, the indusium griseum,
Serotonin (5-HT) has been shown to modulate brain develop¬
mental events such as neural crest migration (Moiseiwitsch and
Lauder, 1995), cortical neuronal differentiation (Ladvas et al.,
1997), and the refinement of thalamocortical connections (Gu and
Singer, 1995; Cases et al., 1996). We recently demonstrated that
■ mice that cannot normally degrade 5-HT because of a genetic
lack of monoamine oxidase A (MAOA) have greatly enhanced
levels of 5-HT in the brain during early postnatal life (Cases et al.,
1995) and display an abnormal development of the primary so¬
matosensory cortex in which the barrel-like clustering of neurons
. and thalamic axons fails to occur (Cases et al., 1996). This can be
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and the deep layers of the anterior cingulate and retrosplenial
cortices. In the diencephalon, primary sensory nuclei, as well as
the mediodorsal, centrolateral, oval paracentral, submedial,
posterior, and lateral posterior thalamic nuclei, are transiently
5-HT immunolabeled. The cortical projections of these thalamic
nuclei are also labeled. In the brainstem, neurons in the lateral
superior olivary nucleus and the anteroventral cochlear nucleus
are transiently 5-HT immunolabeled. None of these structures
appear to express the monoamine biosynthetic enzyme
L-aromatic amino acid decarboxylase. The administration of
monoamine plasma membrane transporter inhibitors indicates
that the 5-HT immunolabeling in these structures is attributable
to an uptake of 5-HT by the 5-HT plasma membrane trans¬
porter. This points to neuron populations that form highly pre¬
cise projection maps that could be affected by 5-HT during
specific developmental stages.
Key words: monoamine oxidase; serotonin; serotonin trans¬
porter; dopamine transporter; norepinephrine transporter; brain
development
prevented by reducing 5-HT levels in MAOA knock-outs during
an early postnatal developmental period (Cases et al., 1996).
Similarly, an abnormal development of the barrel field can be
reproduced in wild-type mice by inhibiting MAOA pharmaco¬
logically during the same critical period (Cases et al., 1996;
Vitalis et al., 1998). Interestingly, during this same critical
period, somatosensory thalamic neurons that instruct the for¬
mation of the cortical barrels transiently express serotonergic
markers such as the 5-HT1B receptor (Bennett-Clarke et al.,
1993), the 5-HT plasma membrane transporter SERT, and the
vesicular monoamine transporter VMAT2 (Lebrand et al.,
1996). The presence of these transporters allows an active
internalization of 5-HT from the extracellular space into pre¬
synaptic terminals and its storage in vesicles (Lebrand et al.,
1996). Thus, although somatosensory thalamic neurons do not
produce 5-HT, they appear to transiently contain the amine.
This phenomenon is amplified when the degradation of 5-HT
is prevented by MAOA inhibitors (D'Amato et al., 1987;
Lebrand et al., 1996; Vitalis et al., 1998) and is best observed
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in MAOA knock-outs. Indeed, this phenomenon was first
strongly suggested by observations in MAOA knock-outs that
showed unambiguously the transient presence of 5-HT in tha¬
lamic neurons (Lebrand et al., 1996).
As first reported here in detail, MAOA knock-outs have been
a most powerful tool to identify neuronal populations in which
5-HT is internalized during development. We have determined
whether each suspected case of 5-HT internalization is attribut¬
able to an heterologous expression of SERT or to a cross-binding
to other monoamine plasma membrane transporters. Our previ¬
ous immunocytochemical localization of 5-HT in MAOA knock¬
outs (Cases et al., 1995) in 8-d-old pups had suggested the
possibility of an internalization by the catecholaminergic trans¬
porters, because 5-HT was observed in the brainstem cat¬
echolaminergic neurons (Cases et al., 1995). Monoaminergic
plasma membrane transporters specific for 5-HT, dopamine, or
norepinephrine belong to the family of Na+/Cl~-dependent
transporters and display a significant degree of amino acid iden¬
tity (Amara and Kuhar, 1993; Giros and Caron, 1993; Nelson and
Lill, 1994), but no clear evidence of significant cross-reactivity of
catecholaminergic transporters with 5-HT in vivo has ever been
reported.
We report here transient and abnormal 5-HT immunolabeling
in a number of neuronal structures in the cerebral cortex, the
hippocampal formation, the amygdala, the thalamus, the hypo¬
thalamus, and the brainstem. In most of the nonaminergic struc¬
tures, specific inhibitors of SERT abolished the 5-HT immuno¬
labeling. Indeed, these locations coincide with the transient
expression pattern of SERT (Hansson et al., 1998; Lebrand et al.,
1998). Interestingly, 5-HT immunolabeling of each of these struc¬
tures has a developmental timing, suggesting that they may be
sensitive to the effects of 5-HT during these specific periods.
Furthermore, we analyzed in greater detail the abnormal local¬
ization of 5-HT in catecholaminergic structures. Using pharma¬
cological experiments and genetic crosses with mice lacking the
dopamine plasma membrane transporter (Giros et al., 1996), we
determined that 5-HT uptake in catecholaminergic neurons can
be entirely accounted for by the dopamine plasma membrane
transporter (DAT) or the norepinephrine plasma membrane
transporter (NET).
MATERIALS AND METHODS
Animals. MAOA knock-outs and their C3H/He controls were as de¬
scribed in Cases et al. (1995). MAOA-DAT double knock-outs and their
diverse controls were obtained in the F2 progeny from crosses between
the MAOA knock-outs and DAT knock-outs (Giros et al., 1996) having
a mixed genetic background (129/Sv, C57BL/6, and DBA/2). MAOA
knock-outs were analyzed at embryonic day 12 (E12), E15, E16, E17,
E18, EI9 (the day of the vaginal plug was counted as El), postnatal day
0 (PO), P4, P7, P10, P15, P21, P28, P60, and 2-6 months (the day of birth
was counted as PO). MAOA-DAT double knock-outs were analyzed at
E16, E19, PO, P4, and P7. All mice lacking DAT were given hydrated
food pellets on the cage floor, and it was not necessary to transfer
offspring to foster mothers. Animal procedures were conducted in strict
compliance with approved institutional protocols and in accordance with
the provisions for animal care and use described in the Scientific Proce¬
dures on Living Animals ACT 1986.
hnmunocytochemistry. 5-HT immunocytochemistry was performed us¬
ing a rat anti-5-HT monoclonal antibody (1:50; Harlan, Sussex, UK). The
specificity of this antibody has been demonstrated previously (Consola-
zione et al., 1981; Lebrand et al., 1996). Rabbit polyclonal antibodies
were used for detection of tyrosine hydroxylase (TH) (1:5000; gift from
A. Vigny) and l-aromatic amino acid decarboxylase (AADC) (1:1000;
Protos Biotech) (Joh and Ross, 1983).
Embryonic and postnatal mice were transcardially perfused with sa¬
line, followed by 4% paraformaldehyde in 0.1 m phosphate buffer, pH 7.2.
Whole embryos or brains were post-fixed 1-5 d in the same fixative and
cryoprotected in 30% sucrose in 0.1 m phosphate buffer. Serial coronal
sections (40 /am) were cut on a freezing microtome and immediately
processed for 5-HT, TH, or AADC immunocytochemistry as described
previously (Cases et al., 1996). In brief, sections were washed in 0.1 m
phosphate buffer and incubated 1 hr in PBS+ (0.1 m PBS with 0.2%
gelatin and 0.25% Triton X-100). Sections were incubated with the
primary antibodies for 24 hr at 4°C. Then, sections were washed in PBS+
and incubated with secondary antibodies (biotinylated goat anti-rat for
5-HT immunocytochemistry or biotinylated swine anti-rabbit for AADC
immunocytochemistry) (1:200; Dako, High Wycombe, UK) for 2 hr at
room temperature. Sections were washed in PBS+ and incubated with a
streptavidin-biotin-peroxidase complex (1:200; Amersham, Arlington
Heights, IL) for 2 hr at room temperature. Sections were then reacted
with a solution containing 0.02% diaminobenzidine, 0.6% nickel ammo¬
nium sulfate (Carlo Erba), and 0.003% H202 in 0.05 m Tris buffer, pH
7.6. Sections were mounted on 3-aminopropyltriethoxysilane-coated
slides, dehydrated, and coverslipped in DePeX.
Some coronal sections were counterstained with a solution containing
1% methyl green in 70% ethanol.
Double 5-HT and TH immunofluorescence. Frozen cryostat sections (20
p.m) were incubated in the 5-HT antiserum (clone YC5/45) (1:1000 of a
5x concentrated batch) mixed with the TH antiserum (1:5000) overnight
at room temperature. After rinsing in PBS + , sections were incubated
with rhodamine-conjugated anti-rat (1:100; Amersham) and fluorescein-
conjugated anti-rabbit (1:70; Silenus, Hawthorne, Australia) for 2 hr at
room temperature. Sections were rinsed in PBS for 30 min and mounted
with glycerol-PBS (3:1).
In situ hybridization. To prepare the SERT cRNA probes, a cDNA
fragment corresponding to nucleotides 1510-2009 of the transcript
(Blakely et al., 1991) was amplified by PCR and subcloned into pBlue-
script SKII (Stratagene, La Jolla, CA). The plasmid was linearized with
BamHX (Boehringer Mannheim, Indianapolis, IN) for antisense RNA
synthesis by T7 polymerase (Pharmacia, Piscataway, NJ) and with LcoRI
(Boehringer Mannheim) for sense RNA synthesis by T3 polymerase
(Boehringer Mannheim).
The in vitro transcription was performed using a kit from Promega
(Madison, WI), and probes were labeled with 3SS-UTP (>1000 Ci/mmol;
Amersham) as described by Fontaine and Changeux (1989). In situ
hybridization for cRNA probes was performed using fresh frozen brain
sections (15 /xm thick). Tissue sections were post-fixed for 15 min in 4%
paraformaldehyde, washed in PBS, acetylated, washed in PBS, dehy¬
drated, and air-dried. Sections were covered with hybridization buffer
containing 5 X 104 cpm//xl 35S-SERT (12.5 /xl/section) and then incu¬
bated overnight in a humid chamber at 48°C. Washes were then per¬
formed as described previously (Fontaine and Changeux, 1989). Auto-
radiograms were obtained by apposing the sections to /3-max hyperfilms
(Amersham) for 4 d. For histological analyses, the slides were dipped in
photographic emulsion (NTB2; Eastman Kodak, Rochester, NY) and
exposed for —10 d. After development of the emulsion, the sections were
counterstained with cresyl violet.
Pharmacological treatments. Drugs and vehicle (0.9% saline) were
administered subcutaneously in P6-P7 pups. Four main administration
protocols were used: (1) two injections at a 14 hr interval; (2) three
injections at 4 hr intervals; (3) three injections at 10 hr intervals; and (4)
seven injections at 4 hr intervals. All animals were killed 4-6 hr after the
last injection. The drugs used were fluoxetine (10 or 30 mg/kg; Eli Lilly),
paroxetine (50 mg/kg; Beecham), GBR12783 (10 or 30 mg/kg; gift of Dr.
J. Constentin, Unite de Neuropsychopharmacology, Saint Etienne de
Rouvray, France), nisoxetine (10 or 30 mg/kg; Research Biochemicals,
Natick, MA), or NO-711 (50 mg/kg; Research Biochemicals). Fluoxetine
was also administered intraperitoneally to pregnant dams (30 mg/kg)
during the E18-E19 developmental period. Embryos were removed by
cesarean section and perfused 4 hr after the last injection.
RESULTS
Unusual localization of 5-HT-containing neurons in
MAOA knock-outs
The immunocytochemical localization of 5-HT was performed in
parallel in MAOA-deficient and normal mice during embryonic
and postnatal development. In the following, we will focus our
description on the localization of 5-HT-labeled structures in
MAOA knock-outs that was not observed in normal mice. The
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Table 1. Locations of nonraphe 5-HT-positive neurons in the brain of MAOA knock-outs
E15 E18 P0 P7 P10 P15 P21 Adult
n = 4 n = 5 n = 6 n = 6 n = 2 n = 1 n — 3 n = 2
Telencephalon
Cingulate cortex (Cgl + Cg2) - + + +2 + + 2 + + 2 + +2 - - -
Retrosplenial cortex - + + +2 +2 - - - - -
Indusium griseum - + + +3 + 2 - - - - -
Hippocampus (CA1 + CA3) - + + +3 + 2 - - - - -
Amygdala + + 1 + + + 1 + + + 1 - - - - -
Diencephalon
Hypothalamic nuclei
Periventricular preoptic + + 2 + +2 - - - - - -
Suprachiasmatic preoptic ++2 ++3 - - - - - -
Suprachiasmatic - - - + 1 + +2 ++2 +2 -
Paraventricular ++3 - - - - - - -
Arcuate + +2 ++2 - + + 1 + + 1 + + 1 - -
Thalamic nuclei
Mediodorsal - +2 +2 + + +3 + +3 - - -
Centrolateral - - ++2 + + + 2 + +2 - - -
Oval paracentral - - +3 + + +3 + +3 - - -
Submedial - + +3 + +3 ++3 +3 - - -
Ventroposteromediai (VPM) - + ++3 -t- + +3 + + +3 + +3 - - -
Ventroposterolateral (VPL) + + 2 + ++3 + + + 3 + + +3 4-4-3 +2 - -
VPM, parvicellular +2 + +3 + + +3 + +3 - - - -
VPL, parvicellular +2 + + 3 + + +3 + +3 - - - -
Posterior - - +2 + +2 +2 - - -
Lateral posterior - - - + ++2 + +2 - - -
Dorsal lateral geniculate + +3 + + +3 + + +3 + + +3 + +3 +3 - -
Medial geniculate ventral - -1—I—E 3 -T + +3 + + + 3 + +3 - - -
Medial geniculate medial - - + + 2 + -t-+3 + +3 - - -
Medial geniculate dorsal - - + + 2 + ++3 + +3 - - -
Brainstem
Substantia nigra (A9) + +3 + -t-+3 + + +3 + + +3 + + +3 + +3 ++3 -
Ventral tegmental area (A10) + +3 + + + 3 + + +3 + + + 3 + + +3 +3 + 3 -
Retrorubral field (A8) + +3 + + +3 + + +3 + + + 3 + + +3 +3 +3 -
Lateral superior olivary n. - + 2 + +3 + +3 - - - -
Anteroventral cochlear n. - + +2 - - - - - -
Subcoeruleus (A5) + +3 + +3 + + +3 + + +3 + +3 + +3 - -
Locus coeruleus (A6/7) + + +3 + + +3 H—h + 3 4-4- +3 + ++3 + + +3 4-4-3 —
Staining intensity of neurons at prenatal and postnatal ages according to locations in the brain.
Cell staining: - none; + light staining; + + moderate staining; + + + heavy staining.
Cell number: 1, few scattered cells; 2, moderate number of cells (10 to 50%); 3, majority of cells.
general distribution of these labeled structures is given in Tables
1 and 2. The nomenclature is taken from Schambra et al. (1992)
and Paxinos et al. (1991) for embryonic stages and from Franklin
and Paxinos (1994) for postnatal stages. For the normal distribu¬
tion of 5-HT, see the descriptions of Steinbusch (1981) for adult
rats and Lidov and Molliver (1982a,b) and Wallace and Lauder
(1983) for developing rats and mice. Throughout the developing
brain of MAOA knock-outs, the innervation originating in the
raphe displayed a much increased 5-HT immunoreactivity, sug¬
gesting that extracellular levels of 5-HT could also be higher than
in normal mice.
5-HT in catecholaminergic cell groups
As early as E12 or E15 and at least until P15 or P21, neuronal cell
bodies in the substantia nigra (SN) (cell group A9), the ventral
tegmental area (VTA) (A10), the retrorubral field (A8), the locus
ceruleus (LC) (A6-A7), and the locus subceruleus (A5) displayed
5-HT immunolabeling in MAOA knock-outs (Table 1). In LC,
cells were already intensely labeled at E12. Dendritic trees were not
apparent in these neuronal populations. Double immunolabeling
with antibodies to the catecholamine synthesizing enzyme TH
showed that these 5-HT-containing neurons were catecholaminer¬
gic. The varicose 5-HT-positive terminal network contained no TH
immunolabeling (Fig. 1). Double immunolabeling also showed that
most of the TH-positive neurons contained detectable levels of
5-HT in MAOA knock-out embryos and pups, indicating that this
immunolabeling was not limited to specific subpopulations of the
A5-A10 catecholamine cell groups. It persisted until P28 in the
dopaminergic A8-A10 cell groups, whereas it disappeared be¬
tween P21 and P28 in the noradrenergic A5-A7 cell groups.
In contrast, rostral catecholaminergic cell groups were not 5-HT
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Table 2. Locations of nonaminergic 5-HT-positive fibers in the brain of MAOA knock-outs
E15 E18 PO P7 P10 Pl5
n = 4 n = 5 n = 6 n = 6 n — 2 n = 1
Orbital cortex a a - + + + + +
Gustatory cortex a a + Hb + + + + + +
Visceral cortex a a + Hb + + + + + +
Somatosensory cortex a a + Hb + + + + + +
Auditory cortex a a + Hb + + + + + +
Visual cortex a a + Hb + + + + + +
Thalamocortical tract + + + + + + Hb + + + + + +
Fimbria/Fornix + + + + + - -
Ventral hippocampal commissure + + + + + - -
Ventral fornix + + + + - -
Optic chiasm and tract + + + + + + + Hb + + + +
Superior colliculus - + + + Hb + + + + + + +
Inferior colliculus - - + + + -
Trigeminal tract + + + + - - -
Staining intensity of fibers at prenatal and postnatal ages according to locations in the brain.
Fiber staining: - none; + light staining; ++ moderate staining; + H- + heavy staining.
" Before birth, thalamocortical axons are still confined to the subplate.
Figure 1. Catecholaminergic neurons
accumulate 5-HT in P7 MAOA knock¬
outs. Coronal section through the SN-
VTA complex (A, C) and the LC (B, D)
were double immunostained with anti¬
bodies to 5-HT (A, B) and TH (C, D). As
indicated by the arrowheads, almost all
TH-positive neurons contain 5-HT im-
munolabeling. The varicose 5-HT-
positive terminal network contains no
TH immunolabeling (arrow). Scale bar
(in D): A, C, 140 jurn; B. D, 50 jlcm.
immunolabeled or lightly 5-HT immunolabeled. No 5-HT-
containing neurons were observed in the olfactory bulb, whereas
hypothalamic catecholaminergic cells showed moderate 5-HT im-
munolabcling during shorter developmental times than in the brain¬
stem. Thus, 5-HT-containing neurons were observed in the periven¬
tricular preoptic (PVPO) and suprachiasmatic preoptic (SPO)
nuclei, the paraventricular nucleus (PAVH), and the arcuate nucleus
(Arc) primarily during late embryonic life with a transient upsurge
for a few neurons in the Arc between P7 and P15 (Table 1).
5-HT in classically nonmonoaminergic cell groups
Telencephalon
In normal embryos and pups, we did not observe 5-HT-
immunolabeled cell bodies in the telencephalon (Fig. 2A,C). In
contrast, MAOA knock-out embryos and pups displayed 5-HT-
containing neurons in cortical, hippocampal, or amygdaloid areas.
By E18, 5-HT-containing neurons were observed in the ante¬
rior cingulate cortex (ACG) in both its supra and pregenual parts
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Figure 2. Atypical locations of 5-HT accu¬
mulation in the telencephalon of E18
MAOA knock-outs. Coronal brain sections
are shown for controls (A, C) and MAOA
knock-outs (B, D-G).A, In controls, 5-HT-
immunostained fibers are primarily ob¬
served in the medial forebrain bundle
(MFB). B, In MAOA knock-outs, 5-HT im-
munostaining of the MFB is increased, and
a dense 5-HT immunolabcling is visible in
the nucleus reticularis (RT), the thalamo¬
cortical fibers in the internal capsule (/C),
the hippocampus (HI), and the amygdala
(AMG). A higher magnification of the me¬
dial cortical area is shown in C and D at a
more rostral level through the corpus callo-
sum (CC), anterior cingulate cortex (ACG),
and indusium griseum (IG). C, In controls,
5-HT immunoreactivity is only observed in
terminal fibers or fiber tracts in the septum
and ACG; the 5-HT-positive fibers in ACG
form a bilaminar pattern in layer 1 and in
the deep cortical layers. D, In MAOA
knock-outs, 5-HT-positive fibers are more
intensely stained, and additional labeling is
visible in the fornix (FX) and in neuronal
cell bodies in ACG and IG. E, A closer view
of the 5-1 IT-immunolabeled cell bodies in
the hippocampus reveals that these neurons
have the morphological aspect of the prin¬
cipal pyramidal cells. Arrow indicates a neu¬
ron with a clear labeling of the dendritic
tree. F, A closer view of the 5-HT immuno-
labeled neurons in the central nucleus of the
amygdala. Arrows indicate neurons having a
typical ovoid shape. G, Higher magnifica¬
tion of the 5-HT-positive thalamocortical
fibers as they reach the cortical primordium.
A dense network of fibers (fiber tracts and
varicose fibers) is observed in the subplate
(SP), with some fibers (open arrows) starting
to penetrate in the cortical plate (CP). In
contrast, a few long varicose fibers (arrow),
probably representing afferents from the ra¬
phe. run in the intermediate zone (IZ).
Only varicose fibers in SP and IZ were
5-HT immunoreactive in control mice, and
this staining was much less intense than in
MAOA knock-outs. VZ, Ventricular zone.
Scale bar (in G): A, B, 625 /xm; C, D, 150
/am; E, 27 /xm; F, 40 /xm; G, 33 pm.
F
(Fig. 2B,D) and in the granular (RSG) and agranular (RSA)
retrosplenial cortex (Table 1). Their labeling generally appeared
to be of medium intensity and was visible during late embryonic
life until birth in RSG and RSA and until P10 in ACG (Fig. 3A).
These 5-HT-containing neurons were located in the deep cortical
layers (V-VI) and had the morphological appearance of pyrami¬
dal neurons (Fig. 3C). In normal mice, the corresponding cortical
areas only displayed a dense network of thick serotonergic axons
arranged in a bilaminar array (Fig. 2A,C).
By El 7, 5-HT-containing neurons were observed in the hip-
pocampal primordium. Their number sharply decreased by PO
(Table 1). As identified by the light 5-HT immunolabeling of their
main dendrites, these neurons were pyramidal neurons in the
indusium griseum (Fig. 2D) and in the CA1 and CA3 hippocam-
pal fields (Fig. 2B,E). The efferent projections of these neurons
most likely correspond to 5-HT-immunolabeled bundles observed
in the fimbria, the ventral hippocampal commissure (containing
the crossed projections from CA3 neurons), and the dorsal fornix
from E18 to PO (Fig. 2D). The subiculum, the other major output
region of the hippocampal formation, did not show 5-HT-
containing neurons. However, axons projecting through the ven¬
tral fornix known to contain subicular efferents appeared lightly
5-HT positive between E15 and El9. Correspondingly, pyramidal
neurons in the dorsal subiculum, a projection area for the CA1
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Figure 3. Atypical locations of 5-HT ac¬
cumulation in the forebrain of P7
MAOA knock-outs. A, The coronal sec¬
tion through the frontal cortex shown in
the inset indicates the position of unusual
5-HT immunolabeling in the orbital cor¬
tex (ORB) ventrally (curved arrow) and
in the medial prefrontal and pregenual
anterior cingulate cortex (ACG) medi¬
ally; the primary somatosensory cortex
(SI) was shown previously to be 5-HT-
labeled in normal pups. B, At higher
magnification, 5-HT immunolabeling in
the orbital cortex is seen to be localized
in a plexus of fine fibers in layer III. C,
Higher magnification shows the presence
of 5-HT-containing neurons in ACG. Ar¬
row points to a neuron with a typical
pyramidal shape. D, Coronal section
through the thalamus showing strong
5-HT-immunolabeling in different tha¬
lamic nuclei. MDc, Central part of the
mediodorsal nucleus; SUB, submedial
nucleus; OPC, oval paracentral nucleus;
VPM, ventropostcromedial nucleus. E,
Higher magnification shows the presence
of 5-HT-immunolabeled cell bodies in
MDc and OPC. F, Higher magnification
shows the presence of 5-HT-immuno-
labeled cell bodies in SUB. Scale bar (in
E): inset, 820 /am; A, B, D, 150 /am; C, 19
/am; E, F, 24 /am.
pyramidal neurons, showed transient expression of SERT mRNA
(Lebrand et al., 1998).
Finally, 5-HT-containing neurons were observed at the periph¬
ery of the central nucleus of the developing amygdala between
E15 and PO (Table 1). These neurons had a piriform shape with
generally two to three primary dendrites and displayed medium
to intense 5-HT immunolabeling (Fig. 2F).
Diencephalon
5-HT-containing cell bodies were found in primary sensory tha¬
lamic nuclei of the diencephalon of normal mice essentially be¬
tween P4 and P7. In MAOA knock-outs, 5-HT immunolabeling
was also seen in embryos and pups in other thalamic nuclei and in
the suprachiasmatic nucleus.
Thalamus. We have shown previously that in normal pups,
neurons in the somatosensory ventroposterolateral (VPL) and
ventroposteromedial (VPM) nuclei, the visual dorsal lateral
geniculate nucleus (DLG), and the auditory ventral medial genic¬
ulate nucleus (MGV) are transiently 5-HT immunoreactive (Lcb-
rand et al., 1996). The 5-HT immunolabeling of these thalamic
neurons was considerably increased in MAOA knock-outs of
corresponding ages. While in normal mice the 5-HT immunola¬
beling is concentrated in the axonal compartment with only a
faint diffuse labeling of the cell bodies, MAOA knock-outs dis¬
played a clear and intense immunostaining of both individual cell
bodies and axons running in the internal capsule or projecting to
the reticular thalamic nucleus. Furthermore, the 5-HT immuno¬
labeling was visible over a larger developmental period than in
controls. In normal pups, 5-HT immunolabeling was noted at P4
and P7 in cell bodies and at PO. P7, and P10 in thalamocortical
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fibers. In MAOA knock-outs, it was noted already at the earliest
embryonic age examined (E15) in VPL and DLG and persisted
until P15 (Table 1).
MAOA knock-outs displayed neuronal labeling in additional
nuclei (Table 1). The visceral parvicellular part of VPL and the
gustatory parvicellular part of the VPM displayed very strong
5-HT immunolabeling. Less intensely labeled neurons were ob¬
served in the central part of the mediodorsal nucleus (MDc) (Fig.
3D,E), the nociceptive submedial nucleus (SUB) (Fig. 3D,F), the
oval paracentral nucleus (Fig. 3D,E), the rostral part of the
posterior nucleus, the centrolateral nucleus (small patches of
cells), the rostrolateral part of the lateral posterior nucleus, and
the dorsal and medial parts of the medial geniculate nucleus
(Table 1).
Sensory thalamocortical axons arising from the dorsal thalamus
displayed intense 5-HT immunolabeling in MAOA knock-outs as
early as E15 (at PO in normal mice) (Table 2). By E18, the 5-HT
immunolabeled thalamocortical axons reach the subplate through
the internal capsule forming a dense plexus in the subplate (Fig.
2B,G, see also 5C). Later in development, a dense plexus was
visible in the layers IV and VI of the primary somatosensory,
auditory, visual, gustatory, and visceral cortices (Table 2). A
plexus of moderate density was visible in the secondary somato¬
sensory, auditory, and visual cortices between P4 and P10. Pro¬
jections from the MDc and SUB were labeled in layer II—III of the
lateral and ventral orbital cortex (Fig. 3B; Table 2) between P4
and P10, whereas a 5-HT-positive plexus was not observed in this
part of the cortex in normal mice.
Hypothalamus. 5-HT-containing neurons were observed in the
ventral and medial zones of the suprachiasmatic nucleus (SCN)
during a protracted period of postnatal life (Table 1), whereas
only a dense serotonergic innervation was present in normal mice
(van den Pol and Tsujimoto, 1985; van den Pol, 1986). A positive
correlation was found between the amount of label in individual
cell bodies and the number or size of the 5-HT varicosities in
close contact with the soma.
Brainstem
In MAOA knock-outs, 5-HT-containing neurons were observed
in two auditory relays, the anteroventral cochlear nucleus and the
lateral superior olivary nucleus (LSO) (Fig. 4A, Table 1). The
major auditory center, the inferior colliculus (IC), did not contain
5-HT-positive cell bodies. In LSO, the 5-HT-positive cell bodies
were in the lateral and central parts of the nucleus, as determined
by counterstaining with methyl green, and immunostaining in¬
creased from central to lateral along the tonotopic axis. During
the same period, 5-HT-positive bundles of fibers entering the IC
and a dense 5-HT-positive plexus in the central nucleus of the IC
were also observed (Fig. 4B,D, Table 2). The distribution resem¬
bled that of LSO efferent fibers.
In the somatosensory pathway, 5-HT immunolabeling was not
observed in neurons of the principal nucleus of the trigeminal,
although primary sensory fibers entering this nucleus were tran¬
siently 5-HT immunolabeled (our unpublished observations) (Ta¬
ble 2). Retinal afferents were transiently 5-HT immunolabeled
(Figs. 4B, 5C; Table 2) (Upton et al., 1997; our unpublished
observations). Other projections from peripheral neurons were
5-HT immunoreactive and will be described in separate reports
(our unpublished observations).
AADC in 5-HT-containing neurons
The presence of 5-HT in atypical locations in developing mice
could reflect a local synthesis of 5-HT. We determined whether
the biosynthetic enzyme AADC is present at these sites at E18,
PO, P7, P10, and P21 in MAOA knock-outs and normal controls.
At all ages, the AADC immunolabeling was normally localized in
the serotonergic, noradrenergic, and dopaminergic cell bodies
and fibers, as well as in the 14 "D" groups of AADC-expressing
cells (for review, see Jaeger et al., 1984). No AADC-containing
neurons were observed in the cortex, amygdala, hippocampal
formation, and thalamus (Fig. 5A,B,D). 5-HT-containing neurons
in LSO and the anteroventral cochlear nucleus also lacked
AADC.
Pharmacological treatments with inhibitors
of transporters
To determine whether the 5-HT immunolabeling is caused by an
uptake of 5-HT, MAOA knock-outs were injected with inhibitors
of the monoaminergic transporters. Repeated administration of
fluoxetine, a selective inhibitor of 5-HT uptake, to pregnant
MAOA knock-out dams (30 mg/kg, seven injections at 4 hr
intervals) completely eliminated 5-HT-immunolabeling in the
nonaminergic 5-HT-containing neurons of the cortex, hippocam¬
pus, thalamus, and LSO of E19 embryos without affecting 5-HT
immunolabeling in the catecholaminergic cell groups (data not
shown). Similarly, in P7 MAOA knock-outs, repeated adminis¬
tration (three injections at 10 hr intervals) of the SERT inhibitors
fluoxetine (30 mg/kg) or paroxetine (50 mg/kg) abolished 5-HT
immunolabeling in all the thalamic nuclei and in the correspond¬
ing cortical projection areas (Fig. 6C), although a very faint
labeling was still observed in the thalamocortical fibers in the
internal capsule and in a few cell bodies. In contrast, fluoxetine or
paroxetine treatments increased 5-HT immunolabeling in all the
catecholaminergic cell groups (even after a single injection 6 hr
before perfusion) (Fig. 6A,B). It was particularly apparent for
Arc neurons (Fig. 1A) and for SN neurons and SN axonal termi¬
nals. Indeed, a fine 5-HT immunolabeled network was readily
visible in the striatum after such treatments. Nisoxetine (10 or 30
mg/kg, two injections), a selective inhibitor of norepinephrine
uptake, eliminated 5-HT immunolabeling in noradrenergic neu¬
rons (Fig. 6D) without affecting 5-HT immunolabeling in SN
(Fig. 6E) and thalamic nuclei (Fig. 6F). GBR12783 (10 or 30
mg/kg, two injections), a selective inhibitor of dopamine uptake,
abolished 5-HT immunolabeling in dopaminergic neurons (Fig.
6H) without affecting 5-HT immunolabeling in LC (Fig. 6G) or
thalamic nuclei (Fig. 67). Curiously, neither blocking 5-HT up¬
take with fluoxetine nor blocking catecholamine uptake with
GBR12783 or nisoxetine could diminish the number of 5-HT-
containing neurons in SCN. On the contrary, fluoxetine or par¬
oxetine treatments enhanced neuronal staining in SCN (Fig. IB).
Treatment with NO-711 (50 mg/kg, three injections), a specific
inhibitor of GAT-1, a neuronal GABA transporter that shares
structural similarities with monoaminergic transporters, did not
diminish the number of 5-HT-containing neurons in SCN.
MAOA-DAT double knock-out mice
We generated double knock-outs by crossing MAOA knock-outs
and DAT knock-out mice (Giros et al., 1996). In contrast to
MAOA knock-outs, MAOA-DAT double knock-out mice
showed a total lack of 5-HT immunolabeling in the dopaminergic
neurons of the SN-VTN complex (Fig. 8), PAVH, and Arc
between E16 and P7, whereas 5-HT immunolabeling was main-
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Figure 4. 5-HT uptake in neurons of the LSO. Coronal sections through the brainstem of P7 MAOA knock-outs (A, B, D) and control (C).A, 5-HT
immunoreactivity is normally localized in 5-HT-producing neurons of the dorsal raphe (DR), median raphe (MnR), and raphe magnus (RMg) and is
abnormally localized in auditory neurons of LSO. B, 5-HT immunolabeling is found in the projection area of LSO neurons in the central nucleus of the
inferior colliculus (CeIC). See higher magnification in D. 5-HT immunolabeling is also visible in the stratum zonale and stratum griseum of the superior
colliculus (SC) and is primarily contained in retinal afferents (A. L. Upton, N. Salichon, I. Seif, and P. Gaspar, personal communication). C, In situ
hybridization with a radiolabeled SERT riboprobe shows the presence of SERT RNA in LSO neurons and in the raphe nuclei. D, At higher
magnification, 5-HT immunolabeling in CeIC is not seen in cell bodies but in auditory afferents, presumably from LSO, as suggested by the trajectory
of corresponding fiber bundles in adjacent sections. Scale bar (in D): A-C, 200 pm; D, 80 /cm.
tained in LC (Fig. 8), MGV (Fig. 8), and the other thalamic
nuclei, and SCN (data not shown) 5-HT immunolabeling was also
maintained in PVSO, SPO, and SCN (data not shown).
Using MAOA-DAT double knock-out pups, we determined
whether the previously reported behavioral abnormalities of
MAOA single knock-out pups, such as tremor, myoclonus, agita¬
tion, frantic running, biting, and abnormal postures (Cases et al.,
1995), could be related to the presence of 5-HT in dopamine
neurons. MAOA-DAT double knock-out pups, but not DAT
single knock-out pups, displayed the same behavioral abnormal¬
ities as MAOA single knock-out pups. Conversely, MAOA-DAT
double knock-outs, but not MAOA single knock-outs, showed the
same lethality as DAT single knock-outs at weaning age, which
was prevented in both cases by supplementing the diet with
hydrated food.
SERT RNA in nonmonoaminergic
5-HT-containing neurons
In a companion study using in situ hybridization and immunocy-
tochemistry (Lebrand et al., 1998), we have analyzed the spatio-
temporal expression patterns of SERT, DAT, and NET in devel¬
oping normal mice, focusing on the forebrain and
catecholaminergic groups. These normal patterns proved to be in
good agreement with our spatiotemporal and pharmacological
analyses of 5-HT accumulation in MAOA knock-outs. All of the
nonmonoaminergic 5-HT-containing neurons observed in the
forebrain of MAOA knock-outs appeared to transiently express
SERT RNA in normal mice, except the amygdala and SCN
neurons, in which no RNA expression of SERT, DAT, or NET
could be found. Similarly, normal brainstem and midbrain cat¬
echolaminergic neurons did not show SERT RNA expression,
whereas they expressed DAT or NET RNA abundantly. Here, we
show additionally that SERT RNA is expressed in neurons of the
LSO in normal mice (Fig. 4C).
DISCUSSION
In this report, we describe that in the developing CNS of MAOA
knock-outs, 5-HT immunoreactivity is abnormally and transiently
localized in catecholaminergic and nonmonoaminergic neurons.
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Figure 5. Immunocytochemical local¬
ization of AADC in E18 MAOA
knock-outs. A, B, As viewed on coronal
brain sections from rostral (A) to cau¬
dal (B), AADC immunoreactivity is lo¬
calized in terminal fibers in the stria¬
tum, cortex, and hippocampus and in
fiber tracts in the MFB or stria termi-
nalis. AADC immunostaining of
perikarya appears to be limited to cat-
echolaminergic and D-group (Jaeger et
al., 1984) neurons in the hypothalamus
(Hyp). C, D, Coronal sections at com¬
parable levels of the diencephalon are
shown with 5-HT (C) and AADC im¬
munostaining (D); both antisera label
fibers in the MFB. On the other hand,
the dense 5-HT immunolabeling of the
ventroposterior complex (VP), dorsal
lateral geniculate nucleus (DLG),
thalamocortical fibers (Ta), and optic
tract (Op) has no visible counterpart
with AADC immunostaining. Scale bar
(in D): A-D, 625 /am.
This is attributable to the lack of the normal degradation pathway
of 5-HT and to the existence of functional transport of 5-HT,
either by SERT, which is transiently expressed in nonmonoam-
inergic neurons, or by DAT and NET in catecholaminergic neu¬
rons. These abnormal accumulations of 5-HT during develop¬
ment could underlie some of the developmental and behavioral
abnormalities that are observed in MAOA knock-outs (Cases et
al., 1995).
Mechanisms of 5-HT accumulation in
MAOA knock-outs
Early descriptions of rodent serotonergic systems in adult (Stein-
busch, 1981) or during development (Lidov and Molliver,
1982a,b; Wallace and Lauder, 1983) have localized 5-HT exclu¬
sively in the neurons of the raphe complex (B1-B9) and in their
widespread axonal arbors throughout the brain and spinal cord.
However, recent studies during early postnatal development have
questioned this view by showing that the transient dense 5-HT
innervation of the primary somatosensory, visual, and auditory
cortices (Fujimiya et al., 1986; D'Amato et al., 1987; Rhoades et
al., 1990) is related to a 5-HT uptake in the corresponding
thalamocortical neurons (Lebrand et al., 1996). This 5-HT uptake
in developing thalamic neurons is attributable to the transient
expression of SERT. More recent studies with in situ hybridiza¬
tion (Hansson et al., 1998; Lebrand et al., 1998) or autoradio¬
graphic binding (Bruning et al., 1997) have shown extensive sites
of SERT expression during CNS development, both in the dien¬
cephalon and the telencephalon, and there appears to be an
excellent correlation between the spatiotemporal pattern of
SERT expression and 5-HT accumulation patterns that are de¬
tected in MAOA knock-outs in the cortex, hippocampus, and
thalamus. The demonstration that 5-HT is only taken up but is
not synthesized locally in these neurons is established by the lack
of AADC, the last biosynthetic enzyme in the 5-HT biosynthesis
pathway, in the developing cortical, hippocampal, or thalamic
neurons. Furthermore, the 5-HT labeling of these structures was
abolished by selective inhibitors of 5-HT uptake such as fluox¬
etine or paroxetine. It is noteworthy that these uptake inhibitors
had to be administered repeatedly and at least during 24 hr to
abolish the immunolabeling of the large thalamocortical fibers at
P7, suggesting that 5-HT can be extremely resilient in neurons
that lack MAOA. This resilience may be partly linked to a storage
of 5-HT into vesicles via the vesicular monoamine transporter
VMAT2, because VMAT2 RNA expression is observed in tha¬
lamic sensory neurons (Lebrand et al., 1996). If 5-HT was indeed
stored into synaptic vesicles in these neurons, it could be released
in an activity-dependent manner in normal mice. In MAOA
knock-outs, such a release could be blocked by excess extracellu¬
lar 5-HT acting on the inhibitory 5-HT,B receptors that are
present on thalamocortical fibers (Rhoades et al., 1994); this
would counterbalance the lack of 5-HT replenishment during
fluoxetine treatments. In comparison with MAOA knock-outs,
normal mice displayed a much more limited 5-HT immunolabel¬
ing; 5-HT was not detected in any of the neurons that transiently
express SERT during embryonic life, and during postnatal life,
5-HT was only sometimes visible in primary sensory thalamic cell
bodies but was never observed in the other dorsal thalamic
neurons, cortex, or hippocampus. These observations suggest that
in normal conditions 5-HT is rapidly degraded in these neurons
or is present in a labile compartment with a rapid turnover (e.g.,
immediate release and degradation in the extracellular space).
Besides the 5-HT accumulation in the neurons that transiently
express SERT, MAOA knock-outs accumulated 5-HT in the
major catecholaminergic cell groups of the brainstem and hypo¬
thalamus. This accumulation is mediated by DAT in the A8-A10
dopaminergic complex and in the hypothalamic PAVH and Arc,
as demonstrated after pharmacological treatments and our obser¬
vations in double knock-out mice that lack both DAT and
MAOA. In the noradrenergic cell groups, 5-HT is taken up
through NET, as indicated by our pharmacological blocking ex¬
periments. Previous pharmacological studies in vitro have shown








Figure 6. Changes of 5-HT immunoreac-
tivity in P7 MAOA knock-outs after admin¬
istration of selective inhibitors of monoam-
inergic transporters. Comparable coronal
brain sections are shown in the metenceph-
alon (A, D, G), mesencephalon (B, E, H),
and diencephalon (C, F, /), after repeated
administration of fluoxetine (A-C), nisox¬
etine (D-F), or GBR12783 (G-/) at P6 and
P7. Control brain sections obtained from un¬
treated MAOA knock-outs are not shown.
5-HT immunolabeling of the raphe nuclei is
not visibly affected by any pharmacological
treatment, although the staining of the fine
varicose afferents from the raphe is reduced
by the fluoxetine treatment. A-C, Fluox¬
etine, a selective inhibitor of SERT, causes
the disappearance of 5-HT immunolabeling
in the SC (6) and thalamus at the level of
DLGn and V P (C) but increases staining of
dopaminergic neurons in the SN and VTA
(B), with no visible change in the LC (A).
D-F, Nisoxetine, a selective inhibitor of
NET, greatly reduces 5-HT immunolabeling
in the LC (D) but does not cause changes of
staining in the SN, VTA, SC (E), or thala¬
mus (F). G-l, GBR12783, a selective inhib¬
itor of DAT, abolishes 5-HT immunolabel¬
ing in the SN and VTA (H) but not in the
LC (G), SC (//), or thalamus (/). Scale bar
(in /): A-I, 625 gm.
that in transfected cell lines expressing DAT or NET, 5-HT
cannot competitively inhibit catecholamine uptake (Giros et al.,
1991; Pacholczyk et al., 1991). However, the kinetics of 5-HT
transport in such cell lines have not been investigated, and the
possibility should be considered that in native monoaminergic
neurons, transporters have higher affinities for 5-HT than in in
vitro expression systems.
Shaskan and Snyder (1970) showed that brain slices of stri¬
atum and hypothalamus displayed both high- and low-affinity
uptake sites for 5-HT and suggested that the low-affinity up¬
take reflected an uptake in catecholaminergic terminals. Sim¬
ilar observations were made in autoradiographic studies after
uptake of tritiated monoamines in brain slices (Berger and
Glowinski, 1978; Doucet et al., 1988). In vivo, 5-HT accumu¬
lation was noted in dopaminergic neurons of the SN (Steinbush
et al., 1982), hypothalamus (Lichtensteiger et al., 1967; Chan-
Palay, 1977; Beaudet and Descarries, 1979), and pituitary
intermediate lobe (Vanhatalo and Soinila, 1994) after supple¬
menting animals with exogenous 5-HT or the 5-HT precursor
L-tryptophan and blocking 5-HT degradation with inhibitors of
monoamine oxidases. Arai et al. (1995) showed that when adult
rats are injected with the 5-HT precursor 5-hydroxytryptophan
(5-HTP), 5-HT accumulates in SN neurons, whether MAO
inhibitors are added or not. They concluded that 5-HT was
synthesized by the SN neurons (although it was not investi¬
gated whether DAT plays a role in this 5-HTP effect) and that
the amine was not rapidly degraded in these neurons. The
latter observation suggests that in MAOA knock-outs, in¬
creased extracellular levels of 5-HT surrounding SN neurons
could be more critical than the lack of 5-HT degradation by
MAOA in these neurons. In any case, in MAOA knock-outs,
the intensity of 5-HT immunolabeling in individual SN neu¬
rons appeared to correlate with the abundance of 5-HT termi¬
nal innervation in close association with the cell body. It is not
known whether within these structures rich in extracellular
5-HT the density of DAT sites on the surface of the dopami¬
nergic cell body is high enough to cause an efficient uptake of
5-HT. Quite the opposite, it has been reported that DAT is
primarily localized to dendritic and axonal plasma membranes
(Ciliax et al., 1995; Nirenberg et al., 1997), although this was
studied in adult rats, and it is known that DAT expression
varies with age (Coulter et al., 1996).
5-HT immunolabeling in catecholaminergic neurons was ob¬
served as early as E12 in MAOA embryos. This suggests efficient
release of 5-HT from raphe fibers at El2, as well as efficient DAT
and NET uptake at this age. In postnatal MAOA knock-outs, the














Figure 7. Increase in the number of 5-HT-containing neurons in the
hypothalamus of P7 MAOA knock-outs after fluoxetine treatments. Con¬
trol brain sections obtained from untreated MAOA knock-outs are not
shown. A, The number of 5-HT-containing neurons is increased in the
Arc. Arrow indicates a dorsal periventricular neuron. B, The number of
5-HT-containing neurons is increased in the SCN. 3V, Third ventricle.
Scale bar (in B): A, 24 p,m; B, 90 /urn.
5-HT-immunolabeling of catecholaminergic neurons was noted
only during the first 3 weeks of postnatal life when brain 5-HT
levels are highest (Cases et al., 1995). Thereafter, 5-HT imrnu-
nolabeling diminished and eventually disappeared in cat¬
echolaminergic neurons, in relationship with the relative normal¬
ization of 5-HT levels because of the compensatory activity of the
monoamine oxidase B (MAOB), possibly in association with
intervening glial processes. When MAOB activity was pharma¬
cologically inhibited in 5-month-old MAOA knock-outs, the
5-HT immunolabeling of catecholaminergic neurons reappeared
(our unpublished observations).
One developmental localization of 5-HT in MAOA knock-outs
that could not be clarified by the present pharmacological block¬
ing experiments is the localization of 5-HT in neurons of the
ventral and medial zones of the SCN. No SERT, DAT, or NET
expression has been detected in these neurons (Lebrand et ah,
1998). However, a very low expression of SERT might be suffi¬
cient, because 5-HT-labeled neurons in SCN benefit from an
abundant 5-HT innervation originating in the raphe, and our
pharmacological treatments cannot achieve total inhibition of
SERT. Alternatively, 5-HT could be taken up by another trans¬
porter, such as a putative melatonin transporter (Helton et al.,
1993; Liu et al., 1997).
Functional consequences of 5-HT accumulation in
MAOA knock-outs
The functional consequences of 5-HT accumulation in the cat¬
echolaminergic neurons of MAOA knock-outs could not be pre¬
dicted. Comparison of MAOA-DAT double knock-outs and
MAOA single knock-outs failed to reveal developmental or be¬
havioral consequences of 5-HT accumulation in dopaminergic
neurons. MAOA-DAT double knock-outs lacked cortical barrels
(our unpublished observations). Similarly, MAOA-DAT double
knock-out pups displayed the flagrant behavioral abnormalities of
MAOA knock-out pups (Cases et al., 1995), such as trembling. In
fact, 5-HT accumulation in catecholaminergic neurons could be
less detrimental to catecholaminergic function than the presence
of excess extracellular 5-HT.
A particularly important feature of the spatiotcmporal pattern
of nonmonoaminergic 5-HT-containing neurons in MAOA
knock-outs is the preferential localization of 5-HT uptake to
glutamatergic neurons that form precise projection maps, which
may be regarded as an indirect indication that extracellular 5-HT
levels modulate the formation of these maps. We have described
previously that somatosensory thalamocortical fibers, which accu¬
mulate large amounts of 5-HT in MAOA knock-out pups, de¬
velop abnormally, because they do not form proper axonal
branches and barrel clusters in layer IV of the somatosensory
cortex (Cases et al., 1996). Remarkably, as shown in the present
report, thalamocortical fibers take up 5-HT from their initial
outgrowth in MAOA knock-out embryos. This suggests that in
normal mice, 5-HT has an effect on these fibers before they reach
their specific cortical targets. However, in MAOA knock-outs,
excess 5-HT does not seem to disrupt the major embryonic
guidance mechanisms of the somatosensory thalamic fibers, be¬
cause a normal barrel pattern can be obtained by decreasing 5-HT
levels postnatally.
As in the case of the somatosensory cortex, postnatal alter¬
ations could be expected to occur in the primary visual, auditory,
gustatory, and visceral thalamocortical projections that also dis¬
play intense 5-HT accumulation during a critical period of their
development. The presence of 5-HT immunoreactivity in neu¬
rons of the SUB, which relays thermoceptive and nociceptive
information (Yoshida et al., 1991, 1992; Roberts and Dong, 1994),
and in neurons of the central part of the MDc, which receives
inputs from olfactory-related structures (Price and Slotnick, 1983;
Groenewegen et al., 1990), also suggests that these thalamic
neurons have a critical period during which the spatial tuning of
their projections to the orbital cortex is sensitive to 5-HT.
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Figure 8. Lack of 5-HT accumulation in
dopaminergic cell bodies of P7 MAOA-
DAT double knock-outs. Comparable
coronal brain sections are shown in the
metencephalon (A, C,E) and the pons (B,
D, F) of mice knock-outs for MAOA (A,
B), DAT (C, D), or both MAOA and
DAT (£, F). A, B, In the MAOA single
knock-out, 5-HT-containing neurons are
observed in the MGV, SN, VTA, and LC.
C, D, In contrast, in the DAT single
knock-out, no 5-HT-containing neurons
are observed in the MGV, SN. VTA, and
LC. E, F, In the MAOA-DAT double
knock-out, 5-HT-containing neurons are
still observed in the MGV and LC but are
no longer observed in the SN and VTA.
Scale bar: A-F, 265 p.m.
Changes in the orbital cortex would be interesting to investigate
in adult MAOA knock-outs, which display altered sexual, aggres¬
sive, and nociceptive behaviors (Cases et al., 1995; Kim et al.,
1997). The orbital cortex is implicated in complex olfactory be¬
haviors, such as olfactory-guided male sexual behavior (Eichen-
baum et al., 1980; Sapolsky and Eichenbaum, 1980; Slotnick and
Kaneko, 1981) and intermale aggression (De Bruin et al., 1983;
De Bruin, 1990; Kolb and Gibb, 1990). In addition to causing
developmental defects possibly leading to behavioral alterations
in adult MAOA knock-outs, the considerable levels of 5-HT in
the brain ofMAOA knock-outs during the first 2 postnatal weeks
have been shown to acutely cause much exaggerated behavioral
responses. For example, P12 pups display defensive biting and
prolonged responses to tail pinches. These behaviors may involve
the orbital cortex and the SUB.
Abnormal segregation of neuronal projections in MAOA
knock-outs is not confined to cortical fields and has been ob¬
served in the lower brain. In a preliminary report, we indicated
that the segregation of contralateral and ipsilateral retinal pro¬
jections is abnormal in the dorsal lateral geniculate thalamus of
MAOA knock-outs (Upton et al., 1997; A. L. Upton, N. Salichon,
I. Seif, and P. Gaspar, personal communication). This suggests
that the projections from the LSO, which is involved in binaural
hearing, could also be altered (Shneiderman and Henkel, 1987;
Rietzel and Friauf, 1998). LSO neurons receive glutamatergic
excitatory and glycinergic inhibitory neurons originating from the
ipsilateral and contralateral ear, respectively, along an exquisitely
organized tonotopic gradient (Caird and Klinke, 1983). During
perinatal development, there is a shift in the effects of glycinergic
inputs received by LSO neurons that have depolarizing effects
before P8 and hyperpolarizing effects thereafter (Kandler and
Friauf, 1995). LSO projects to the central nucleus of the inferior
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colliculus. Most of the ipsilateral projection is glycinergic and
most of the contralateral projection is glutamatergic, although
this remains controversial (Glendenning et al., 1992; Moore et al.,
1995; Saint Marie, 1996), and there appears to be little overlap of
the ipsilateral and contralateral terminals (Shneiderman and
Henkel, 1987). In MAOA knock-outs, 5-HT-positive neuronal
cell bodies were observed in the lateral and central LSO (a region
that responds to lower sound frequencies). Immunocytochemical
and tracing experiments are needed to establish the nature of
these 5-HT-containing neurons (glycinergic or glutamatergic) and
the degree of patterning of their projections.
In the anterior cingulate cortex, a part of the brain involved in
attention, 5-HT immunolabeling was located in pyramidal-like
neurons of the deep layers of the cortical plate. The topography
and morphology of these 5-HT-accumulating neurons resemble
that of the pioneering callosal neurons that have been described
in the rat cingulate cortex (Koester and O'Leary, 1994). In
rabbits, prenatal exposure to cocaine, a general inhibitor of
monoamine uptake systems, alters the bundling of apical den¬
drites of anterior cingulate pyramidal cells (Levitt et al., 1997),
and in male rats, prenatal exposure reduces the midsagittal area
of the corpus callosum (Ojima et al., 1996). It could be speculated
that 5-HT has an effect on the differentiation and growth of these
cortical neurons and that cocaine acts in part by elevating extra¬
cellular levels of 5-HT.
In conclusion, our study points to particular neurons that could
develop abnormal projections in children exposed to drugs en¬
hancing brain levels of 5-HT or in individuals having a genetic
deficiency in MAOA (Brunner et al., 1993; Lenders et al., 1998)
or SERT. This study also emphasizes how mice that have been
genetically modified, here with a null mutation of the MAOA
gene, could be a most valuable model to exacerbate and visualize
unexpected mechanisms.
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Defects of Tyrosine Hydroxylase-lmmunoreactive Neurons in the
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In the CNS, the lack of the transcription factor Pax6 has been
associated with early defects in cell proliferation, cell specifica¬
tion, and axonal pathfinding of discrete neuronal populations. In
this study, we show that Pax6 is expressed in discrete cat-
echolaminergic neuronal populations of the developing ventral
thalamus, hypothalamus, and telencephalon. In mice lacking
Pax6, these catecholaminergic populations develop abnormally:
those in the telencephalon are reduced in cell number or absent,
whereas those in the ventral thalamus and hypothalamus are
greatly displaced and densely packed. Catecholaminergic neu¬
rons of the substantia nigra (SN) and the ventral tegmental area
(VTA) do not express Pax6 protein. Nevertheless, mice lacking
Pax6 display an altered pathfinding of SN-VTA projections: in¬
stead of following the route of the medial forebrain bundle ven-
Recently, a neuromeric model for catecholaminergic (CA) neuro¬
nal development has been proposed in several species, including
lizard (Medina et al., 1994), chick (Puelles and Medina, 1994), and
human (Puelles and Verney, 1998). In this model, it is proposed
that permanent or transient CA (dopaminergic and noradrenergic)
neurons are generated in or near the region that they occupy in the
adult, rather than being generated at a few localized sources and
distributed through migration (Olson and Seiger, 1972). Despite
the apparent anatomical diversity of noradrenergic (NA) and do¬
paminergic (DA) neurons, it appears that their early specification
relies on a small number of molecules. For instance, essential
transcription factors such as Mashl, Phox2a, and Phox2b have been
implicated in controlling the specification of all noradrenergic
neurons (Pattyn et al., 1997; Hirsh et al., 1998). It appears that the
two secreted molecules sonic hedgehog (SHH) and fibroblast
growth factor 8 are critical for the specification of DA neurons, and
the stereotypic location of most DA neurons along the anteropos¬
terior and dorsoventral axes is defined by the integration of these
two signals (Ye et al., 1998).
Gene expression studies have shown that the transcription factor
Pax6 is transiently expressed in areas containing discrete CA neu¬
rons in the mesencephalon, the ventral thalamus, the hypothalamus
(Stoykova and Gruss, 1994), and the olfactory bulb (Dellovade et
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trally, most of the SN-VTA projections are deflected dorsoros-
trally at the pretectal-dorsal thalamic transition zone and in the
dorsal thalamic alar plate. Moreover, some catecholaminergic
neurons are displaced dorsally to an ectopic location at the
pretectal-dorsal thalamic transition zone. Interestingly, from the
pretectal-dorsal thalamic to the dorsal thalamic-ventral thalamic
transition zones, mice lacking Pax6 display an ectopic ventral to
dorsal expansion of the chemorepellant/chemoattractive mole¬
cule, Netrin-1. This may be responsible for both the altered
pathway of catecholaminergic fibers and the ectopic location of
catecholaminergic neurons in this region.
Key words: catecholaminergic neuron; Pax6; netrin; prolifera¬
tion; adhesion; axonal pathfinding
al., 1998). Pax6 is a member of a highly conserved gene class and
encodes a transcription factor containing a paired domain and a
homeodomain (Callaerts et al., 1997). The spatiotemporal expres¬
sion of Pax6, from E8.5 to adulthood, suggested that Pax6 plays key
roles in CNS development (Walther and Gruss, 1991). Indeed,
mice lacking Pax6 display early defects in axonal pathfinding (Ma-
stick et al., 1997), in the specification of several prosomeric transi¬
tion zones (Stoykova et al., 1996; Grindley et al., 1997), in cell
proliferation (Warren and Price, 1997), in the specification of
motor (Ericson et al., 1997) cell subtypes, and in cell migration
(Caric et al., 1997; Brunjes et al., 1998; Engelkamp et al., 1999).
In the present study, we first defined the localization of the Pax6
protein in CA [tyrosine hydroxylase-immunoreactive (TH-IR)]
populations during development. We then investigated the role of
Pax6 in these populations by looking at their development in mice
lacking Pax6. We found that developing TH-IR neurons of the
ventral thalamus [zona incerta (Zi)], hypothalamus (paraventricu¬
lar nucleus), olfactory bulb, and basal telencephalon (anterior
olfactory nucleus, piriform cortex, anterior amygdala, and olfactory
tubercle) display high levels of Pax6 protein during a critical period
of their development. Despite severe positional alterations, dien¬
cephalic and hypothalamic TH-IR neurons were identified in mice
lacking Pax6, showing that Pax6 is not necessary for their specifi¬
cation. In contrast, TH-IR neurons were greatly reduced in number
in the basal telencephalon and the remaining olfactory bulb. In
addition, we found that ectopic TH-IR neurons were distributed
ventrodorsally along the pretectal-dorsal thalamic transition zone
and that TH-IR fibers were misguided in this zone and in the
dorsal thalamic alar plate. Interestingly, this region displayed an
increased and ectopic expression of the SHH-induced chemorepel¬
lant/chemoattractive molecule, Netrin-1 (Leonardo et al., 1997;
Lauderdale et al., 1998), which might contribute to its having
altered cues for cell migration and axonal navigation.
MATERIALS AND METHODS
Animals. The original small-eye (Pax6sey) mutation arose spontaneously in
a stock called "CSR" and was subsequently outcrossed. The genetic back¬
ground of the small-eye strain used in this study was derived from the
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outbred Swiss background. The mating of Pax6sey/+ (small-eye heterozy-
gotes) was confirmed by the presence of a vaginal plug the following
morning. This was designated embryonic day 0.5 (E0.5). Experiments were
performed on E11.5, E12.5, E13.5, E14.5, E16.5, E17.5, and E18.5 em¬
bryos. Embryos were dissected from deeply anesthetized mothers into cold
PBS on ice and examined under a dissecting microscope. Homozygous
Pax6sey/Pax6sey embryos were easily distinguished by their absence of eyes
and characteristic craniofacial phenotype of foreshortened upper jaw.
From E12.5, heterozygotes (Pax6sey/+) were distinguished by the charac¬
teristic appearance of their iris lacking its inferior margin (Kaufman et al.,
1995). In each experiment, wild-type and Pax6sey/Pax6sey embryos were
obtained from the same litter. Some additional experiments were also
performed on embryos and postnatal and adult mice of the Swiss genetic
background. Animal procedures were conducted in strict compliance with
approved institutional protocols and in accordance with the provisions for
animal care and use described in the Scientific Procedures on Living Ani¬
mals ACT 1986. In all the experiments, adult mice were anesthetized with
0.3 ml 25% urethane injected intraperitoneally.
Immunocytochemistry. El 1.5, E12.5, and E13.5 embryos were fixed by
immersion in 4% paraformaldehyde in 0.1 m phosphate buffer (PB), pH
7.6. Embryos from E14.5 to E19.5 and postnatal mice were perfused
transcardially with saline followed by 4% paraformaldehyde in PB. Whole
embryos or brains were post-fixed for 2-5 d in the same fixative and
cryoprotected in 30% sucrose in PB. Serial coronal or sagittal sections
(40 |U.m) were cut on a freezing microtome and immediately processed for
immunocytochemistry. In brief, sections were incubated with the primary
antibodies diluted in PBS+ (0.1 m PBS with 0.2% gelatin and 0.25% Triton
X-100) overnight at 4°C. Rabbit polyclonal anti-TH antibodies (1:8000,
kind gift of A. Vigny, or 1:800, Protos Biotech), rabbit polyclonal anti-
calretinin antibody (1:10,000: Swant), rabbit polyclonal anti-calbindin an¬
tibody (1:20,000; Swant), rat monoclonal anti-Ll antibody (1:50, Roche
Diagnostics), and rat monoclonal anti-NCAM antibody (1:50; Roche Di¬
agnostics) were used. Biotinylated goat anti-rabbit and biotinylated goat
anti-rat (1:200, Dako, Glostrup, Denmark) were used as secondary anti¬
bodies and revealed with a streptavidin-biotin-peroxidase complex (1:200,
Amersham, Buckinghamshire, UK). Sections were then reacted with a
solution containing 0.02% diaminobenzidine, 0.6% nickel ammonium sul¬
fate, and 0.003% H202 in 0.05 m Tris buffer, pH 7.6 (DAB-Ni). From these
sections, the total number of TH-IR neurons in A14 paraventricular
hypothalamic nucleus (PAVH) and the diameters of randomly selected
TH-IR neurons (n = 20) were measured in A14PAVH from E17.5 wild-
type (n = 4) and Pax6seyPax6sey (n = 4) embryos.
Double Pax6 and TH immunocytochemistry. Whole embryos (El 1.5,
E12.5, E14.5, E16.5, E17.5, and E18.5) and dissected postnatal (P0, P2, P4,
and P9) and adult brains (5 and 16 weeks old) were immediately frozen in
isopentane (—40°C) and stored at —80°C until sectioning. Coronal and
sagittal sections (10-14 gm) were cut on a cryostat and processed the same
day. Sections were dried at room temperature, fixed for 10 min in metha-
nol/acetone (1:1; -20°C), dried for 15 min at room temperature, hydrated
for 5 min in PBS, and blocked for 15 min in a solution containing 2%
bovine serum albumin, 2% sheep serum, 7% glycerol, and 0.2% Tween 20
(BS). Sections were then incubated overnight at room temperature with
three different antibodies: a rabbit polyclonal anti-TH antibody (1:5000,
kind gift of A. Vigny) and two mouse monoclonal anti-PAX6 antibodies
[AD1.5.6 and AD2.35; 1:50 in embryos and 1:30 in adults (Engelkamp et
al., 1999)] diluted in BS. Sections were washed in PBS 0.2% Tween 20
(PBST) and incubated for 1 hr with secondary antibodies [TRITC anti-
mouse antibody, 1:200 (Vector Laboratories, Burlingame, CA), and FITC
anti-rabbit antibody, 1:200 (Sigma. St. Louis, MO)], diluted in PB. Sections
were washed in PBST and analyzed with a Leica (Nussloch, Germany)
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We used the same neuromeric criteria as those applied to describe the early neuromeric TH-IR neurons in human embryos (Puelles and Verney, 1998). According to the models
described in Lumsden (1990), Krumlauf (1994), Rubenstein et al. (1994), Puelles (1995), and Guthrie (1996) (see also Material and Methods, Nomenclature), the different
neuromeres are individualized by longitudinal and transverse black bars, and the different histogenetic fields are labeled in black capitals. The optic recess is marked with a black
circle. In this scheme, the different TH-IR groups are mapped. Groups displaying a transient tyrosine hydroxylase immunoreactivity are labeled with a superscript "t". Each
subgroup was labeled according to its location; for instance, the isthmic component of A10 is labeled AlOi where "i" stands for the isthmus, except for the transient TH-IR groups
located in the piriform cortex (pir), the anterior amygdala (AA), and the olfactory tubercle (OT), which appear in the intermediate telencephalic territory (ITA), the region
from which they are supposed to be derived (Fernandez et al., 1998). TH-IR groups displaying Pax6 immunoreactivity appear in boxed black italics. A1-A17, Catecholaminergic
groups; AB, anterobasal nuclei; ACB, nucleus accumbens; ACX, archicortex; AEP, entopeduncular area; AH, anterior hypothalamus; AP, alar plate; BP, basal plate; BST, bed
nucleus of stria terminalis; C1-C3, putative adrenergic groups; CB, cerebellar primordium; CGEL, caudal ganglionic eminence, lateral part; CGEM, caudal ganglionic eminence,
medial part; DMH, dorsal medial hypothalamic nucleus; DT, dorsal thalamus; ET, epithalamus; FP, floor plate; HCC, hypothalamic cell cord; IC, inferior colliculus; Is, isthmus;
LGE, lateral ganglionic eminence; LL, lateral lemniscus; MA, mammillary region; mes, mesencephalon; MGE, medial ganglionic eminence; OB, olfactory bulb; pl-p6,
prosomeres; PC, posterior commissure; PAVH, paraventricular hypothalamic nucleus; PEP, posterior entopeduncular area; PF, prechordal floor plate; POA, anterior preoptic
area; POP, posterior preoptic area; PP, prechordal plate; PTECT, pretectum; rl-r8, rhombomeres; RCH, retrochiasmatic nucleus; RP, roof plate; SCH, suprachiasmatic nucleus;
SPV, supraoptic/paraventricular region; EMT, thalamic eminence; TECT, midbrain tectum; TU, tuberal hypothalamic region; VT, ventral thalamus.
confocal microscope. In addition, alternate sections immunostained with
anti-TH antibody or anti-PAX6 antibody or Nissl-stained were analyzed in
parallel.
Morphometric analysis. Free-floating sections (45 gm) were processed
for TH immunocytochemistry as described above, except that immunola-
beling was revealed using an FITC anti-rabbit antibody (1:200, Dako).
Propidium iodide, a nuclear dye (1/10,000, Molecular Probes, Eugene,
OR), was added during the last 10 min of incubation with the secondary
antibody. Our analysis was performed on sections obtained from four
wild-type and four Pax6sey/Pax6scy embryos. In each case, seven sections
from wild-type embryos and five sections from Pax6soy/Pax6sey embryos
taken through the Zi and the dorsomedial hypothalamic nucleus (DMH)
were selected. By confocal microscopy (Leica), each section was resec-
tioned into serial 7-/xm-thick sections. To estimate the volume of A13 and
A14DMH in wild-type and Pax6sey/Pax6soy embryos, the surface area of
these nuclei in each section was measured using Leica TCNS software. For
each brain, volumes were obtained by multiplying each area by the thick¬
ness of tissue between sections and summing the values. To estimate cell
densities in A13 and A14DM H, the same sections were analyzed. In the
areas defined by TH immunoreactivity, all propidium-labeled nuclei and
all cells with a visible TH immunostaining were counted, and the averages
of total cell density and of TH-IR neuronal density (per millimeter cubed)
were calculated for each nucleus. From these sections, the diameters of
randomly selected TH-IR neurons (n = 30) were measured in A13 and
A14DMH in wild-type and Pax6sey/Pax6sey embryos using the same
software.
Proliferation of tyrosine hydroxylase neurons. Pregnant mice were injected
with a single dose of bromodeoxyuridine (BrdU; 25 mg/kg in sterile saline,
i.p.) on E9.75, E10.5, E11.5, and E12.5 and were killed when embryos
reached E17.5. Embryos were perfused transcardially with saline followed
by 4% paraformaldehyde in PB, and brains were dissected, post-fixed
overnight in the same fixative, and cryoprotected in 10% sucrose in PB.
Brains were embedded in a solution containing 7% gelatin and 10%
sucrose and frozen in isopentane. Alternate coronal sections (20 pm) were
cut on a cryostat and processed for sequential immunolabeling. Half of the
alternate sections were reacted for both TH and BrdU. Sections were first
processed for TH immunocytochemistry as described above except that
only DAB was used (0.03% DAB, 0.01% hydrogen peroxide in 0.1 m PBS).
Then, sections were washed in TBS (0.09% NaCl, 50 mM Tris, pH 7.6),
incubated for 8 min in 1 m HC1 at 60°C, washed for 4 min with tap water,
rinsed in TBS, incubated for 10 min in 20% rabbit serum in TBS, and
finally incubated overnight with a solution containing mouse anti-BrdU
(1:200, Becton-Dickinson) in 20% rabbit serum-TBS. Sections were
washed in TBS, incubated for 2 hr with a biotinylated rabbit anti-mouse
(1:200, Dako) in 20% rabbit serum-TBS, washed in TBS, incubated with
a streptavidin-biotin-peroxidase complex (1:200, Amersham) for 2 hr at
room temperature, and revealed with the DAB-Ni protocol (see above).
The other half was Nissl-stained. To estimate the number of BrdU-labeled








































Figure 2. Pax6 protein expression in discrete developing TH-IR groups. Sections through the A8-A10 complex (A-C), the diencephalon and the
hypothalamus (D-F), and the telencephalon (G-K) were double-immunostained with antibodies to TH (green; cytoplasmic staining) and Pax6 (red;
nuclear staining).A-C, Absence of Pax6 and TH colocalization in the SN-VTA (A9-A10) complex and the retrorubral field (A8). A, The sagittal section
shows a lack of Pax6 immunoreactivity in the developing SN-VTA of E12.5 embryo. Note the strong Pax6 immunolabeling of the deep mesencephalic
nucleus (DPMe). B, The coronal section shows Pax6 immunoreactive cells (short arrows) in close proximity with TH-IR neurons of the dorsal part of the
SN in E16.5 embryo. C, The coronal section shows Pax6 immunoreactive cells in the retrorubral field close to A8 neurons. D, The coronal section shows
the colocalization of TH and Pax6 in A13 neurons of the zona incerta in the ventral thalamus. E, Higher magnification of the box shown in D showing
individual double-immunolabeled cells (white arrows). Note the presence of TH-IR neurons (A13d) that do not express Pax6 (white arrow). F, The coronal
section shows the lack of Pax6 immunoreactivity in A14DMH neurons of the hypothalamus. G, Coronal section showing Pax6-immunoreactive cells in
the basal telencephalon. Pax6-immunoreactive cells are located in the anterior amygdala (large arrowhead) and the region of the piriform cortex (small
arrowhead). Note Pax6 immunoreactive cells also in the cerebral cortex, hypothalamus, and ventral thalamus. H, Higher (Figure legend continues)
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cells, a minimum of six sections taken through Zi and DMH were selected.
On each section, A13 and A14DMH were identified, and the number of
TH-IR neurons heavily labeled (defined as having >50% of the nucleus
immunolabeled) for BrdU was estimated using 40x and 100X objectives.
Only heavily labeled cells were counted because they would have been
generated at the time of BrdU administration, whereas many lightly
labeled cells would have been the products of further progenitor cell
divisions (Gillies and Price, 1993). For each age of BrdU injection, wild-
type (n = 4) and Pax6sey/Pax6sey (n = 4) embryos were obtained from at
least two independent litters. In addition, the total number of TH-IR
neurons in A13 and A14DMH was estimated from these sections in
wild-type (n = 6) and Pax6sey/Pax6sey (n = 6) embryos.
Nissl staining and counterstaining. Complete series of parasagittal and
coronal paraffin sections (10 p,m) obtained from E11.5, E12.5, E14.5,
E16.5, and E18.5 wild-type and Pax6sey/Pax6sey embryos were Nissl-
stained in a solution containing 0.05% thionin in acetic acid, pH 5.5.
In situ hybridization. E11.5, E12.5, E13.5, E14.5, E16.5, and E19.5 wild-
type and Pax6sey/Pax6sey embryos were dissected in PBS, fixed, and
cryoprotected overnight in 4% paraformaldehyde-30% sucrose. Sections
(80-100 jum thick) were obtained on a freezing microtome, washed in PBS
0.1% Tween 20 (PTW), dehydrated for 20 min in methanol, and rehy-
drated in PTW before hybridization. Hybridization was performed as
described in Henrique et al. (1995). Briefly, sections were treated with
proteinase K (10 mg/ml) for 10 min, rinsed in PTW, fixed for 20 min in 4%
paraformaldehyde-0.2% glutaraldehyde, rinsed in PTW, rinsed in the hy¬
bridization medium (50% formamide, 1.3X SSC, 50 mM EDTA, 0.2% Tween
20, 10% 3-[(3-cholamidopropyl)dimethylammonio]-l-propanesulfonic acid,
100 mg/ml heparin) at room temperature until the sections settled, and
rinsed in the hybridization medium (HM) at 65°C before hybridization.
Sections were then hybridized overnight at 65°C with digoxigenin-labeled
(Roche Diagnostics) riboprobes for Netrin-1 (kind gift of M. Tessier-
Lavigne; EcoRI, T3: antisense; SacI, T7: sense) or Pax6 (kind gift of
S. Saule; Pstl, T3: antisense; Hin&lW, T7: sense). The following day,
sections were rinsed in HM (2 x 30 min, 65°C), washed in a 1:1 mixture of
HM and MABT (100 mM maleic acid, 150 mM NaCl, pH 7.5, 0.1% Tween
20) for 10 min at 65°C and 15 min at room temperature, incubated for 1 hr
in MABT with 2% blocking reagent (Roche Diagnostics), and incubated
for 4 hr in MABT with 2% blocking reagent and 20% heat-treated sheep
serum (MABT+), and finally incubated overnight with anti-digoxigenin
antibody conjugated with alkaline phosphatase (1:2000, Roche Diagnos¬
tics) in MABT+. Sections were washed in MABT for 4 hr and in a mixture
of 100 mM NaCl, 100 mM Tris-HCl, pH 9.5, 50 mM MgCl2, and 0.1%
Tween 20 for 20 min before the enzymatic color detection with the nitro
blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate substrate (Roche
Diagnostics).
Nomenclature. On the basis of gene expression domains and anatomical
features (constrictions in the neural wall and regions of low cell density),
the brain has been subdivided into neuromeres. The rhombomeric and
mesencephalic organizations have been described by Lumsden (1990),
Krumlauf (1994), and Guthrie (1996), and the prosomeric organization has
been described in Rubenstein et al. (1994) and Puelles (1995). Eight
consecutive rhombomeres (rl-r8), the isthmus (Is), and the mesencepha¬
lon (mes) are identified in the rhombencephalon and midbrain. Note that
rhombomere 1 and isthmus are represented as a single entity (rl-Is) in this
scheme. According to the prosomeric model, the forebrain is subdivided
into six transverse domains called prosomeres (pl-p6). The diencephalon
develops in prosomeres 1-3 (pi—p3), and the secondary prosencephalon
(hypothalamus, preoptic areas, and its hyper-alar extension, the telenceph¬
alon) develops in p4-p6. In addition, these transverse domains are subdi¬
vided dorsoventrally into roof plate, alar plate, basal plate, and floor plate
or prechordal plate (from p4) (Shimamura at al., 1995). Telencephalic
organization refers also to the work of Fernandez et al. (1998). Our
anatomical description refers to the atlas of the developing rat brain
(Paxinos, 1991), the atlas of the mouse brain (Franklin and Paxinos, 1995),
and the chemoarchitectonic atlas of the developing mouse brain (Jacobo-
witz and Abbott, 1998). To describe the permanent TH-IR cell groups
(A1-A17), we have mainly used the nomenclature of Hokfelt et al. (1984)
and Jacobowitz and Abbott (1998). The description of the distribution of
TH-IR neurons in the hypothalamus and preoptic regions also refers to the
work of Ruggiero et al. (1984) and Foster (1994). A14 complex was
subdivided into subgroups relative to their main anatomical locations. In
addition, some transient TH-IR neuronal populations have already been
described in the developing CNS (Jaeger and Joh, 1983; Verney et al.,
1988; Nagatsu et al., 1990).
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RESULTS
Neuromeric location of TH-immunoreactive groups in
E14.5 wild-type embryos
So far, no description of the neuromeric location of permanent and
transient TH-IR groups is available in developing mice despite the
increasing references to the neuromeric organization of the brain
(Bulfone et al., 1993; Rubenstein et al., 1994; Puelles, 1995; Shi¬
mamura et al., 1995, 1997). In this study we first provide a com¬
prehensive neuromeric location of the different TH-IR groups in
E14.5 wild-type mice. At this age, most of the permanent TH-IR
groups (A1-A17) (Hokfelt et al., 1984) occupy their definitive
position, some transient TH-IR groups are detected, and the neu¬
romeric limits are still visible. The topological landmarks necessary
for the description of the neuromeric organization were obtained
by studying alternate sections stained for Nissl (Fig. 1A) or for
several differentiation markers, principally, the two calcium-
binding proteins calbindin (Fig. 1B) and calretinin (Fig. 1C), which
display complementary immunoreactive patterns [Jacobowitz and
Abbott (1998) and Fig. 1]. The neuromeric location of the main
discrete TH-IR groups is shown in Figure 1D-F and detailed in
Table 1. The description of TH-IR groups that did or did not
display Pax6 immunoreactivity in wild-type mice is presented
within this framework (see below and Table 1).
Colocalization of Pax6 and TH immunoreactivities
TH-immunoreactive neurons displaying Pax6 immunoreactivity
(Table 1)
Pax6 immunoreactivity was detected in three dopaminergic groups
of the forebrain. In the alar plate of the ventral thalamus, a
subpopulation (~40%) of TH-IR neurons of the zona incerta
(A13) displayed a strong and transient Pax6 immunoreactivity
from E12.5 to P9 (Fig. 2D,E). This subpopulation corresponds to
the body of A13. In the hypothalamus, TH-IR neurons of the
magnocellular part of the hypothalamic paraventricular nucleus
displayed transient Pax6 immunoreactivity from E14.5 to P2
(A14PAVH in Table 1; data not shown). TH-IR neurons of the
supraoptic nucleus (A15v) display also a transient Pax6 immuno¬
reactivity from P0 to P9 (Table 1; data not shown). In the telen¬
cephalon, transient TH-IR neurons located in the anterior olfac¬
tory nucleus (A16AON) displayed Pax6 immunoreactivity from
E14.5 to E18.5 (Table 1; data not shown). Transient TH-IR neu¬
rons of the piriform cortex, the olfactory tubercle, and the anterior
amygdala display Pax6 immunoreactivity from E14.5 to E18.5 (Fig.
2 G-7). In the olfactory bulb (A160B), TH-IR external tufted cells
displayed Pax6 immunoreactivity from E14.5 and TH-IR periglo-
merular interneurons from E18.5 (Fig. 2J,K, Table 1).
TH-immunoreactive neurons not displaying Pax6
immunoreactivity (Table 1)
Noradrenergic (A1-A7) and adrenergic (C1-C3) neurons of the
brainstem never displayed Pax6 immunoreactivity (Table 1). Do¬
paminergic neurons of the ventral tegmental area (AlOi, AlOm,
AlOpl, A10p2, and A10p3) in the floor plate, of the substantia
nigra (A9m, A9pl, and A9p2), and of the retrorubral field (A8) in
the basal plate, and ofAll complex (Allm, Allpl, Allp2) in the
alar plate did not display Pax6 immunoreactivity throughout de¬
velopment (Fig. 2A-C). In the hypothalamus, the TH-IR groups
listed below did not display Pax6 immunolabeling at any stage of
development: the lateral hypothalamic nucleus (A141), the medial
preoptic area (POA and A14d), the arcuate nucleus (A12). In the
telencephalon, TH-IR neurons of the bed nucleus of the stria
terminalis (A15d) did not display Pax6 immunoreactivity. Al-
magnification of G showing individual double-labeled neurons at the level of the anterior amygdala. /, Higher magnification of G showing individual
double-labeled neurons at the level of the piriform cortex (arrows). J. K. Coronal sections of the olfactory bulb. J. TH-IR external tufted cells display a
strong Pax6 immunostaining in E15.5 embryo (small arrow). K, Both TH-IR periglomerular neurons and TH-IR external tufted cells in A16 display Pax6
immunoreactivity at P0. Scale bar: A, G, 6 mm; B, C, 4 mm; D, F, J, 1 mm; E, 0.25 mm; H, 0.12 mm; /, 0.5 mm; K, 5 mm.
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Figure 3. Determination of the presump¬
tive ncuromeric organization of TH-IR
groups in E14.5 Pax6sey/Pax6sey embryos.
Nissl-staining (A) and immunolabeling
for calbindin (B) or cairetinin (C) have
provided prosomeric landmarks used for
the determination of the segmental orga¬
nization of TH-IR groups (D). A, The
sagittal section shows constrictions in the
neural wall and regions of low cell densi¬
ties associated with neuromeric bound¬
aries. From caudal to rostral, arrowheads
point to the isthmic constriction and the
presumptive, pl-p2, p2-p3, and p3-p4
boundaries. Thin arrows point to the pre¬
sumptive p2-p3 and p3-p4 boundaries.
Arrows point to the presumptive pl-p2,
p2-p3, p3-p4, and p4-p5 boundaries. The
dotted line represents the angle used for
coronal sectioning. B, The sagittal section
immunoreacted for calbindin shows a nor¬
mal medial longitudinal fasciculus (mlf),
retrochiasmatic (RCH) and anterobasal
(AB) areas, and septum (SE). The white
star indicates the lack of clustering of the
presumptive dorsal thalamus and the lack
of thalamocortical axons. C, Sagittal sec¬
tion immunoreacted for cairetinin shows
normal immunoreactivity in the thalamic
eminence (EMT), the stria medullaris
(im), and the subthalamic nucleus (Sut) in
p4. D, The sagittal section immunoreacted
for TH shows numerous groups and com¬
plexes: All, A9-A10, and in anterobasal
and preoptic (POA) areas. The limit be¬
tween mes and pi is not indicated be¬
cause this neuromeric limit is altered in
the mutant (Mastick et al., 1997). Scale
bar: A-D, 4 mm.
though no colocalization of TH and Pax6 was observed in TH-IR
neurons of the dorsal medial hypothalamic nucleus (Fig. 2F,
A14DMH), Pax6 was expressed in the neuroepithelium of
A14DMH during its period of genesis (from E9.75 to E12.5; see
below).
An overview of defects in Pax6sey/Pax6sey embryos
From E10.5 to EI4.5, Pax6sey/Pax6sey embryos displayed a delay in
their growth. A marked difference in their crown-rump length was
observed at El 1.5 (wild type: 4.8 ± 0.3 mm, n = 15; Pax6sey/
Pax6sey: 3.8 ± 0.33 mm, n = 15). By E14.5, wild-type and Pax6sey/
Pax6sey embryos displayed no significant difference in their crown-
rump iength (wild type: 11.7 ± 0.07 mm, n = 30; Pax6sey/Pax6sey:
11.1 ± 0.1 mm, n = 30). By E17.5, brain weights were similar in
wild-type and Pax6sey/Pax6sey embryos (wild type: 0.76 ± 0.07 gm,
n = 30; Pax6sey/Pax6sey: 0.74 ± 0.06 gm, n = 25). Some brain
regions in Pax6sey/Pax6sey embryos have been shown to display
higher than normal cell densities (Schmahl et al., 1993; Caric et al.,
1997), and there may be hypertrophy of brain regions in response
to an increased SHH expression. This may compensate for the
reduction of some structures such as the olfactory bulbs and, for
example, the decrease of the cortical thickness.
TH-IR groups that did or did not display Pax6 immunoreactivity
were described in Pax6sey/Pax6sey embryos within the same frame¬
work used above (see Fig. 3 for a general overview at E14.5). We
observed several alterations in both Pax6-expressing TH-IR pop¬
ulations and TH-IR neurons that did not express Pax6, such as SN
and VTA neurons. Noradrenergic (A1-A7) and adrenergic (Cl-
C3) neurons and mesencephalic dopaminergic neurons of A8,
which did not express Pax6 (Table 1), displayed no delay and
appeared normally organized in Pax6sey/Pax6sey embryos. The
following description will focus on TH-IR groups displaying
alterations.
Defects in Pax6-immunoreactive components of the
incerto-hypothalamic axis
The incerto-hypothalamic axis (Bjorklund et al., 1975) includes
TH-IR neurons of A11-A14. In this structure in normal animals,
TH-IR neurons appear fused together along an axis extending
from the mesencephalon to the anterior hypothalamus. In this
structure, TH-IR neurons are arranged either in discrete nuclei
(A12, A13, A14PAVH, and A14DMH) or in a periventricular
position (All, A14Periv). A13 and A14PAVH express Pax6 tran¬
siently during development, whereas All, A12, A14DMH,
A14Periv, and A141 do not express Pax6.
Cell generation
In Ell.5 wild-type embryos, it was possible to identify scattered
TH-IR neurons in the ventral thalamus at the level of the primor-
dium of A13 and a few medium-sized TH-IR neurons of the A14
complex in p4 and p5. These cells were more numerous by E12.5
(Fig. 4,4). In Pax6sey/Pax6sey embryos, the A13 and A14 primordia
appeared with a 2 d delay (Fig. 4A,B), and when they first ap¬
peared, they contained fewer TH-IR neurons than in wild-type
embryos (50% reduction estimated). This delay did not persist. By
E17.5, the total numbers of TH-IR profile counts in mutants and
wild types were similar in A13 (n = 600 ± 65, from six wild types;
n = 524 ± 60, from six mutants; values are means ± SEM), in
A14DMH (n = 510 ± 40, from six wild types; n = 486 ± 60, from
six mutants), and in A14PAVH (n = 40 ± 4, from four wild types;
n = 38 ± 3, from four mutants). Because the mean diameters of
TH-IR neuronal cell bodies were similar in wild-type (A13, n = 10
pm ± 0.7; A14DMH, n= 11 jam ± 0.7; A14PAVH, n = 12 jum ±
0.9; values are means ± SEM from 30 TH-IR neurons from four
wild types) and Pax6sey/Pax6sey embryos (A13, n = 11 /xm ± 0.6;
A14DMH, n = 10.5 /am ± 1.0; A14PAVH, n = 11.5 /am ± 0.4,
values are means ± SEM from 30 TH-IR neurons from four
mutants), this indicates that there is no difference in TH-IR cell
number in these structures.
Although Pax6 is expressed in differentiated TH-IR neurons of
A13 and A14PAVH but not A14DMH, Pax6 is expressed during
the time of genesis of all of these TH-IR populations. We have
investigated a possible delay in cell generation of the cells destined
for these groups in Pax6sey/Pax6sey embryos. Cell proliferation was
studied by analyzing BrdU incorporation into S-phase cells and
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Figure 4. Delay in the appearance of a TH phenotype in A13 and A14DMH is not caused by a cell proliferation defect. A, B, Sagittal sections of
E12.5 wild-type (A) and Pax6sey/Pax6sey (B) embryos immunolabeled for TH. A, Arrow points to the A13 and A14 primordia. B, The black asterisk
indicates the presumptive location of the A13 and A14 primordia in the mutant; note the lack of TH-IR neurons in these regions. C-F, Double
immunolabeling for TH and BrdU of E17.5 wild-type (C, D) and Pax6sey/Pax6sey embryos (E, F) at the level of A13. BrdU was injected on E10.5.
D, F, Arrows point to TH-BrdU double-labeled neurons. G, H, Histograms showing similar mean percentages (±SEM) of TH-IR neurons darkly
labeled for BrdU in A13 (G) and A14DMH (H) in wild-type (white bars) and Pax6sey/Pax6sey (black bars) E17.5 embryos after injections of BrdU
on E9.75-E12.5. Scale bar: A, B, 2 mm; C, E, 0.5 mm; D, F, 0.1 mm.
visualizing them at E17.5 using anti-BrdU and anti-TH antibodies
(Fig. 4C-F). To identify the embryonic stages at which the neurons
of these nuclei are generated, a single injection was applied at four
different developmental stages; E9.75, E10.5, El 1.5, and E12.5. The
number of BrdU-TH-positive cells and TH-positive cells was de¬
termined on coronal sections at E17.5. The labeling index was
calculated as the percentage of the total number of TH-positive
cells that were BrdU-TH-positive. In wild-type embryos, A13 and
A14DMH are generated from E9.75 to E11.5 with a peak at E10.5
(Fig. 4G,H, white bars). In Pax6sey/Pax6sey embryos, the labeling
index after each injection was unchanged and no delay was ob¬
served (Fig. 4G,H, black bars), suggesting that cell generation is
unaffected in A13 and A14DMH.
Positional alterations
In wild-type embryos, A13, A14DMH, and A14PAVH were pop¬
ulated by large TH-IR neurons and appeared fused with each other
from E14.5 (Figs. IF, 5A,C). In Pax6sey/Pax6sey embryos, A13,
A14DMH, and A14PAVH appeared greatly disjoined and abnor¬
mally shaped (Fig. 5E-G). In wild-type embryos, three distinct A13
subgroups were observed from E16.5 (Hokfelt et al., 1984): a dorsal
group (A13d), a lateral group (Fig. 5B, A13L), and a medial group
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Figure 5. Alterations of the incerto-hypothalamic axis in
E18.5 Pax6sey/Pax6sey embryos. Coronal sections are shown
for wild-type (A-D) and Pax6sey/Pax6sey (E~H) embryos
and are organized from caudal (top) to rostral (bottom).
A-C, The components of the interlo-hypothalamic axis,
A13, A14PAVH, and A14DMH appear fused together in
wild-type embryos. The medial forebrain bundle is also
indicated inA-D and F-H (large unlabeled arrows).A,Arrow
indicates TH-IR neurons of the A14DMH complex.
B, TH-IR neurons of A13 are divided into three distinct
groups: a dorsal group (A13d), a lateral group (A13L), and
a medial group A13 (A13). C, Arrow indicates TH-IR neu¬
rons of the paraventricular hypothalamic nucleus
(A14PAVH). D, Rostral section at the level of the anterior
commissure showing TH-IR neurons located in the medial
preoptic nucleus (MnPo), the striato-hypothalamic nucleus
(StHy), and the anterobasal region (AB). E-G, In Pax6sey/
Pax6sey embryos, the components of the incerto-
hypothalamic axis are completely disjoined and display
abnormally high packing of the neurons. E, Arrows indicate
A13 and A14DMH. Open arrows indicate abnormally lo¬
cated TH-IR fibers originating from the SN-VTA. F. Ar¬
rows indicate A13 and A14DMH. Projections from
A14DMH to the area of the arcuate nucleus-median emi¬
nence are abnormally highly fasciculated. G, H, Arrows
indicate the location of A14PAVH, StHy, the anterior me¬
dial preoptic nucleus (AMPo), MnPo, and AB. Scale bar:
A-H, 2 mm.













(A13) (Fig. 5B). In Pax6sey/Pax6sey embryos, only two subgroups
were identified in A13; they were displaced laterally from the third
ventricle and appeared as a ventral round-shaped group (Fig.
5E,F) and as a dorsal group (Fig. 5F). The presumptive
A14PAVH was observed more rostrally, as a small nucleus densely
packed with few TH-IR neurons (Fig. 5G). The presumptive
A14DMH group was laterally displaced and organized as an ovoid-
shaped nucleus (Fig. 5E,F).
Cellular segregation
In wild-type embryos, the structures of the incerto-hypothalamic
axis, Zi, DMH, and PAVH are each composed of several neuronal
groups with different phenotypes, such as TH, neurotensin, or
vasopressin neurons. In these structures, TH-IR neurons are mixed
with other cell types that do not express TH (Fig. 6A). In Pax6sey/
Pax6sey embryos, TH-IR neurons constituting A13, A14DMH, and
A14PAVH appeared more highly clustered (Fig. 6B). As described
above, the total number of TH-IR neurons in A13, A14DMH, and
A14PAVH are the same in the wild-type and Pax6sey/Pax6sey
embryos (Fig. 6C-F); however, the volume occupied by A13 and
A14DMH was smaller in Pax6sey/Pax6sey embryos (Fig. 6C). In¬
terestingly, although the mean cellular density was similar between
wild-type and Pax6sey/Pax6sey embryos (Fig. 6D), the cellular
density of TH-IR neurons in these structures was higher in Pax6sey/
Pax6sey embryos (Fig. 6F), indicating a higher segregation of
TH-IR neurons in these structures as estimated by the increased
percentage of TH-IR neurons within them (Fig. 6E). TH-IR neu¬
rons were more clustered or less mixed with cell types that did not
express TH. This suggests altered adhesive properties of cells
composing the Zi and DMH in Pax6sey/Pax6sey embryos.
Defects of TH-immunoreactive neurons in the
telencephalon of Pax6sey/Pax6sey embryos
In wild-type embryos, from E14.5, TH-IR neurons were observed
at the level of the bed nucleus (Fig. 7A, A15d) and the anterior
olfactory nucleus (A16AON) (Nagatsu et al., 1990) (Fig. 8C). In
Pax6sey/Pax6sey embryos, A15d was greatly reduced in cell number
(Fig. 7C), whereas A16AON was absent by E14.5 (Fig. 8G). In
wild-type embryos, TH-IR neurons were also observed in the
olfactory bulb as soon as E16.5 (Fig. 8D). Based on their age, large
soma size, and the location in the developing glomerular layer,
these neurons probably correspond to external tufted cells. By
E18.5, a large number of TH-IR neurons were observed in the
glomerular layer of the olfactory bulb, corresponding to both
external tufted cells and the earliest population of periglomerular
interneurons. In Pax6sey/Pax6sey embryos, from E16.5, only a few
lightly labeled TH-IR neurons were observed at the level of the
residual olfactory bulb (Fig. 8G). Evidence for the development of
a residual olfactory structure is provided by calretinin and calbi-









































neurons were scattered but differentiated: they were large with
angular shapes and short processes probably corresponding to the
external tufted cells (Fig. 8H). The reduction in the mutant of
TH-IR neurons in A15d (Fig. 7C) and A16 (data not shown)
persisted in older Pax6sey/Pax6sey embryos. No small TH-IR neu¬
rons corresponding to the periglomerular interneurons were ob¬
served in older Pax6sey/Pax6sey embryos.
In wild-type embryos, from E16.5, TH-IR neurons were ob¬
served at the level of the strio-hypothalamic nuclei (Fig. 5D). In
Pax6sey/Pax6sey embryos, despite the lack of the anterior commis¬
sure, TH-IR neurons were observed at the presumptive level of the
strio-hypothalamic nucleus (Fig. 5H).
Figure 6. Increased cellular segregation of
TH-IR neurons in A13 and A14DMH of
mice lacking Pax6. TH was revealed with
fluorescein-coupled antibodies (green in A
and B), and nuclei were revealed on the same
sections with propidium iodide (red in A and
B). Pictures show the addition of two confocal
images acquired simultaneously with a two-
channel excitation beam. A, In A13 in the
wild-type embryo, TH-IR neurons were mixed
with non-TH-IR neurons. B, In Pax6sey/
Pax6sey embryos, TH-IR neurons of A13 ap¬
peared more densely clustered and more
segregated from the non-TH-IR neurons.
C, Histogram shows the estimated volume oc¬
cupied by TH-IR neurons in AI4DMH and
A13 in wild-type (white bars) and Pax6sey/
Pax6sey (black bars) embryos. D, Histogram
shows that the mean cell density of propidium-
positive nuclei in A14DMH and A13 was sim¬
ilar in wild-type (white bars) and Pax6sey/
Pax6sey (black bars) embryos. E, Histogram
shows a significant increase of the percentage
of TH-IR neurons compared with the total
number of propidium-positive nuclei in
A14DMH and A13 of Pax6sey/Pax6sey em¬
bryos. F, Histogram shows a significant in¬
crease in the density of TH-IR neurons in
A14DMH and A13 in Pax6sey/Pax6scy em¬
bryos. C-F, Significant differences with Stu¬
dent's t test between groups are indicated: *p
< 0.05; **p < 0.01. Scale bar: A, B, 0.75 mm.
In addition, transient TH-IR neurons were observed in the
piriform cortex (Fig. 1A,B, near A15v) from E14.5 to E18.5 and in
the anterior amygdala (data not shown) and olfactory tubercle
(data not shown) from E16.5 to E18.5 in wild-type embryos. In
Pax6sey/Pax6sey embryos, TH-IR neurons were rare, round, and
pale (« = 15 ± 4, values are mean ± SEM from four mutants; n =
90 ± 10, values are mean ± SEM from four wild types) at the
presumptive level of the anterior amygdala. By E18.5, TH-IR
neurons were not detected, and no pyknotic profiles were observed
in this region. This suggests that these neurons were generated and
had progressively lost their ability to maintain TH expression.
TH-IR neurons were never observed in the presumptive olfactory




Figure 7. Defects of the telencephalic TH-IR neurons in Pax6sey/Pax6sey embryos. Coronal sections through the basal telencephalon and hypothalamus
of E14.5 (A, C) and E18.5 (B, D) wild-type (A, B) and Pax6sey/Pax6sey (C, D) embryos. A, The section shows both the transient TH-IR neurons of the
piriform cortex (pir) and the permanent TH-IR groups ofA15v and A15d in continuation with A14d. Note the location of the medial forebrain bundle
(mfb). B, High magnification of the pir-A15v area. C, The section shows a reduced A15d still in continuation with A14d. The black star indicates the lack
of pir-A15v at the presumptive level of the rhinal fissure. D, The lack of pir-A15v persists in older age embryos (black star). The large asterisk indicates
the abnormal swirl of TH-IR fibers at the medial forebrain bundle (mfb). Scale bar: A-E, 2 mm.
tubercle, the piriform cortex (Fig. 1C,D), and the neighboring
hypothalamic A15v (Fig. 7C) and at any age studied in Pax6sey/
Pax6sey embryos.
Defects in TH-immunoreactive groups not
expressing Pax6
Defects in the SN-VTA (A9-A10) andAll complex
In wild-type embryos, from El 1.5 to E13.5, TH-IR neurons of the
primordium of the ventral tegmental area (AlOi, AlOm, AlOpl,
Ai0p2, and A10p3) and of the substantia nigra (A9m, A9pl, and
A9p2) migrate radially from their proliferative zones to more
superficial positions (Kawano et al., 1995). These cells are shown in
Figure 9A. In Pax6sey/Pax6scy embryos, by Ell.5, TH-IR neurons
of A9m and A9pl and of AlOm and AlOpl were normally radially
organized, suggesting that they were normally migrating to their
ventral positions (data not shown). At this age, TH-IR neurons of
A10p2 and A10p3, in the p2-p3 floor plate of the mutants, were less
numerous than in wild type (75% reduction estimated), probably
because of a delayed TH expression. By E12.5, although sagittal
mediolateral sections of wild-type embryos showed that the oldest
TH-IR neurons of A9pl and A9p2 were oriented caudorostrally in
pi and p2, in Pax6sey/Pax6sey embryos, very few radially oriented
TH-IR neurons were observed on medial-most sections in mes, pi,
p2, and p3. Strikingly, in mediolateral and lateral sections, TH-IR
neurons of A9 were abnormally positioned along the presumptive
pl-p2 transition zone (Fig. 9, compare E with A).
In wild-type embryos, the number of radially oriented TH-IR
neurons detected in the vicinity of the ventricular surface gradually
decreased by E13.5. By E14.5, most A9 and A10 neurons had
reached their final locations in more superficial positions of the
ventral floor plate and basal plate, respectively, and were oriented
parallel to the ventral pial surface. From E16.5, TH-IR neurons of
the A9 complex displayed their characteristic "inverted fountain"
pattern (Hanaway et al., 1971; Kawano et al., 1995). This arrange¬
ment was even more striking in embryos of older stages (Fig. 9B).
Strikingly, in Pax6sey/Pax6sey embryos, from E16.5, defects in the
topography of A9 neurons were accentuated at the pl-p2 border,
and in p2, A9 did not show its characteristic inverted fountain
organization (Fig. 9, compare F and B). On sagittal sections,
TH-IR neurons accumulated abnormally at the pl-p2 border in
Pax6sey/Pax6sey embryos (Fig. 9, compare C with G and D with H).
Taken together, these results suggest defects in the migration of
TH-IR A9 and A10 neurons in the mutant.
TH-IR fiber pathway alterations in Pax6sey/Pax6sey embryos
In wild-type embryos, by E11.5, nigrostriatal and mesocortical
fibers originating from A9 and A10 followed the pathway of the
medial forebrain bundle (mfb) in mes, pi, p2, p3, and p4 basal
plate. By E14.5, nigrostriatal fibers terminated in the lateral portion
of the caudate-putamen (Fig. 1CL4), whereas mesocortical fibers
continued rostrally to reach the prefrontal cortex and the striatum
by E15.5. In addition, a few TH-IR fibers originating from A10
were observed running along the fasciculus retroflexus toward the
epithalamus (Skagerberg et al., 1984). By E18.5, the caudate-
putamen and the globus pallidus were homogeneously labeled, and
a denser band of terminals was visible under the external capsule
(Fig. \{)K). Mesocortical fibers emerged from mfb and entered the
olfactory tubercle or ramified into the ventral lateral part of the
nucleus accumbens (Fig. 10K). The remaining mesocortical TH-IR
fibers turned dorsally to enter the medial, prefrontal, and anterior
cingulate cortices (Verney et al., 1982; Voorn et al., 1988; present
study).
In Pax6sey/Pax6sey embryos, by Ell.5, most TH-IR fibers did not
follow the pathway of mfb. Fibers were misguided along the pre¬
sumptive pl-p2 transition zone where they followed a straight
ventrodorsal course (Fig. 10B,C). A few fibers originating from the
more rostral and ventromedial neurons of the A9-A10 complex
followed the pathway of the presumptive mfb (Fig. 10D), although
they only reached p4 by E12.5. By E14.5, misguided TH-IR fibers
looped in the roof of p2, plunged mediolaterally after the presump-
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General fiber pathway alterations in
Pax6sey/Pax6sey embryos
Using the neuronal cell adhesion molecules NCAM and LI as
general markers of most axonal pathways, we analyzed whether
alterations of TH-IR axons in the presumptive diencephalon were
a selective defect of catecholaminergic fibers or a general defect of
all ascending and descending fibers.
NCAM (from E11.5 to E13.5) and LI (from E14.5) immunore-
activities revealed most of the fiber pathways traveling in the
diencephalon. In wild-type embryos, the posterior, pretectal, and
tectal commissures, the fasciculus retroflexus, and the stria med-
ullaris were labeled with NCAM (Fig. 115) or LI (Fig. 115). In
addition, the zona limitans intrathalamica (Zli) at the p2-p3
boundary displayed NCAM immunoreactivity from El 1.5 to E13.5
(Fig. 116).
In Pax6sey/Pax6seyembryos, fibers traveling medially followed a
normal trajectory in the basal plate of the rhombencephalon, mes,
pi, p2, and p3, whereas fibers located laterally in basal plate and
alar plate were misguided at the presumptive pl-p2 transition zone
and in p2 alar plate (Fig. 11 D,F). In p2, most of the LI immuno-
reactive fibers were highly fasciculated into several straight and
parallel bundles (Fig. 116). In the roof of p2, most fibers looped
and descended at the presumptive p2-p3 limit.
Altered expression of the
chemorepellent/chemoattractive molecule Netrin-1 in
Pax6sey/Pax6sey embryos
In Pax6sey/Pax6sey embryos, from El 1.5, the developmental ex¬
pression of Netrin-1 was roughly normal in the rhombencephalic
and mesencephalic floor plate, along the floor of the fourth ventri¬
cle and along the wall of the lateral ventricle (Fig. 12). From E13.5,
Netrin-1 was normally expressed in the striatum and from E14.5 in
the vicinity of the SN-VTA complex (Livesey and Hunt, 1997)
(Fig. 12A,C). However, an abnormally high and expanded expres¬
sion of Netrin-1 was observed from the presumptive pl-p2 transi¬
tion zone to the p2-p3 transition zone. Instead of being expressed
in the ventral part of the diencephalic basal plate and in the Zli
(Fig. 12C), Netrin-1 expression was expanded in all of the basal
plate and the most ventral part of the presumptive alar plate (Fig.
126). This altered Netrin-1 expression persisted and was corre¬
lated with increased and expanded expression of SHH reported
previously (Grindley et al., 1997) (data not shown). The compari¬
son of the pattern of Netrin-1 expression with TH-IR immunore¬
activity (compare Figs. 126 and 105,6) showed that TH-IR fibers
and neurons seemed orientated abnormally toward the increased
and ectopic Netrin-1 expression located at the pretectal-dorsal
thalamic transition zone.
DISCUSSION
Our results in normal mice are in good agreement with previous
comparative analyses on catecholaminergic systems in sauropsides
(Medina et al., 1994) and humans (Puelles and Verney, 1998). The
main TH-IR neurons clearly arise independently along the whole
brain axis. Table 1 shows the resulting topological map of these
groups. This mosaic pattern strongly suggests that this phenotype
is generated by the combinatorial effects of regionally expressed
transcription factors, such as Pax6, and diffusable morphogens such
as SHH or FGF8. Differences between groups of TH-IR neurons
may be caused by differences in the factors they express and the
signals they receive.
It has been suggested that Pax6 could be a good candidate for
controlling the proliferation, specification, or maintenance of dis¬
crete CA populations (Stoykova and Gruss, 1994; Dellovade et al.,
1998). Our study indicates that discrete CA populations in the
diencephalon, the hypothalamus, and the basal telencephalon ex¬
press Pax6, either permanently or transiently. By analyzing mice
lacking Pax6, we show that Pax6 is not necessary for the specifica¬
tion and time of generation of diencephalic and hypothalamic DA
neurons but is needed for the normal packing and segregation of
these cells. The lack of Pax6 leads also to a virtual absence of
Figure 8. Delay and diminution in the number of A16 neurons in the
anterior olfactory nucleus and the residual olfactory structure of Pax6sey/
Pax6scy embryos. Sagittal (A-C) and coronal (6-6) sections are shown for
El4.5 (A-C, E-G) and E16.5 (6, H) wild-type (A-D) and Pax6sey/Pax6suy
(E-H) embryos. Alternate sections are immunostained for calbindin (A, E),
calretinin (5, F), or TH (C, F).A, Calbindin immunoreactivity labels short
axon cells of the olfactory bulb. B, Calretinin immunoreactivity labels
mitral and tufted cells of the olfactory bulb. C, Arrows indicate neurons of
A16 in the anterior olfactory bulb in A16AON. 6, Section showing TH-IR
external tufted cells in the olfactory bulb of E16.5 wild-type embryo.
E, Calbindin immunoreactivity strongly labels cells that may correspond to
short axon cells. F, Calretinin immunoreactivity strongly labels cells that
may correspond to the mitral and tufted cells of the remaining olfactory
bulb. G, TH-IR neurons are absent in the remaining olfactory structure of
E14.5 Pax6sey/Pax6s,:y embryo. E-G, Arrow points to the residual olfactory
structure. H, High magnification shows scattered TH-IR neurons with short
processes (arrows) in the residual olfactory bulb of E16.5 Pax6sey/Pax6sey
embryo. Scale bar: A-C, E-G, 2 mm; 6, H, 1 mm.
tive p2-p3 border, and turned rostroventrally in p3 basal plate to
reach and follow the pathway of the presumptive mfb in p4 and p5
(Fig. 105-7). In addition, few TH-IR fibers looped rostrally in
presumptive p2 alar plate (Fig. 105, G). In their ascending and
descending courses, TH-IR fibers appeared abnormally highly fas¬
ciculated (Fig. 106). At the presumptive level of the internal
capsule and the optic tract, TH-IR fibers swirled just before they
entered the caudate putamen (Fig. 76). From El8.5, at least some
TH-IR fibers reached the same rostral levels as observed in wild-
type embryos, although the number of terminals was greatly re¬
duced, particularly in the olfactory tubercle (Fig. 105).
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Figure 9. Developmental defects of the SN-VTA complex
in Pax6sey/Pax6scy embryos. A, Sagittal section showing the
developing SN-VTA complex of E12.5 wild-type embryo.
Arrowheads indicate the radially oriented TH-IR neurons
from mes to p3. Note that TH-IR neurons of A10 in p3
(A10p3) display a less intense immunoreactivity. B, Coro¬
nal section of E18.5 wild-type embryo showing the charac¬
teristic topographical inverted fountain-like organization of
the SN-VTA complex. C, D. Medial (C) and lateral (D)
sagittal sections of E18.5 wild-type embryo showing the
organization of the SN-VTA complex. E, Sagittal section of
the developing SN-VTA complex in E12.5 Pax6sey/Pax6sey
embryo showing the abnormal topographical organization
of TH-IR neurons in pi and p2 (small arrowheads). Small
arrows point to A10p3; large arrowheads point to radially
migrating TH-IR neurons. F, The coronal section shows the
abnormal topographical organization of the SN-VTA com¬
plex in an E18.5 Pax6sey/Pax6sey embryo. B. F. Curved
arrows emphasize the topographical organization of dopa¬
minergic neurons of the SN and the main direction of their
neuropils. G. H, Medial (G) and lateral (H) sagittal sec¬
tions of E18.5 Pax6soy/Pax6sey embryo. The arrows point to
TH-IR neurons abnormally located along the pl-p2 border
and in p2. C, D, The black star indicates the lack of TH-IR
neurons in wild-type embryo at the corresponding location
where ectopic TH-IR neurons arc seen in the mutant. Scale
bar: A, E, 2 mm; B, F, 1 mm; C, D, G, H, 0.5 mm.
TH-IR neurons in the basal telencephalon. We also describe non-
cell autonomous defects among DA neurons of the SN-VTA
complex: some are abnormally located, and the medial forebrain
bundle, the major ascending pathway of DA neurons, is misrouted.
Dopaminergic populations expressing Pax6
Diencephalic and hypothalamic TH-IR neurons: cell
adhesion defect
The neuroepithelium of prosomeres 3, 4, and 5 expresses Pax6
during the time of genesis of diencephalic and hypothalamic
TH-IR neurons. Our study indicates that differentiated TH-IR
neurons of A13 and A14PAVH continue to express Pax6 until the
first postnatal days, whereas A14DMH does not. In mice lacking
Pax6, these populations differentiate but display a 1-2 d delay in
their appearance. Because previous studies have shown abnormally
low proliferative rates in the entire diencephalic alar plate of mice
lacking Pax6 (Warren and Price, 1997), we looked for a delay in the
genesis of these TH-IR groups. Our results clearly indicate no
significant delay in genesis in A13 and A14DMH and no reduction
in cell number of TH-IR neurons in A13, A14PAVH, and
A14DMH.
In mice lacking Pax6, A13, A14PAVH, and A14DMH. TH-IR
neurons display an increase in cell density, suggesting altered
adhesive properties. Previous studies have suggested that Pax6
regulates the expression of adhesion molecules (Stoykova et al.,
1997; Meech et al., 1999). In mice lacking Pax6, there is a loss of
R-cadherin expression in areas in which this gene is normally
coexpressed with Pax6. Moreover, it has been shown that the
segregation normally observed in aggregates of cortical and striatal
cells in an in vitro assay is lost in mice lacking Pax6 (Stoykova et al.,
1997). This could be explained by a model in which loss of Pax6
disrupts the adhesive mechanisms involving R-cadherin, thereby
increasing cell mixing and leading to some of the morphological
disruptions observed. Interestingly, TH-IR neurons in A13,
A14PAVH, and A14DMH do not display a particular scattering or
increased cell mixing, as might be expected, but paradoxically they
are more densely packed in roundish cell clusters. We suggest that
the selective loss of some adhesion molecules (such as R-cadherins)
may alter the balance between heterophilic and homophilic inter¬
actions in such a way that some cells may have reduced ability to
adhere to other types of cells and may have a tendency to adhere
more strongly to cells of their own type.
Telencephalic populations: cell migration/maintenance defect
In the olfactory bulb, Pax6 is expressed from E15.5 in TH-IR
external tufted cells and from E18.5 in TH-IR periglomerular
interneurons. In mice, external tufted cells are born between E13
and E18 (Hinds, 1968a,b) and proliferate in the ventricular zone of
the olfactory bulb. In mice lacking Pax6, we observe rare TH-IR
neurons in the region of the olfactory structure, and their onset of
TH expression and morphology correspond to those expected for
external tufted cells. This suggests that Pax6 is important for the
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Figure 10. Alterations of TH-IR fibers pathway in Pax6sey/Pax6sey embryos. Sagittal (A-J) and coronal (K, L) sections arc shown for wild-type (A, K)
and Pax6scy/Pax6soy (B-J, L) embryos. Embryos were sectioned at E11.5 (B-D), E14.5 (A, E-J), and E18.5 (K. L). Large arrows indicate the direction of
the fibers. A, Large arrow indicates the direction of the medial forebrain bundle (mfb), the major fiber pathway originating from TH-IR neurons of the
SN-VTA complex. B, The sagittal section shows early alterations of TH-IR fiber pathway. C, D, Small arrowheads point to growth cones. C, Higher
magnification of area outlined in B, showing that most of the TH-IR fibers are abnormally deflected dorsally after the presumptive pretectal-dorsal
thalamic boundary. D, Higher magnification of area outlined in B shows that some TII-IR fibers are not deflected dorsally. E, A lateral section shows a
high number of fibers from the SN-VTA complex misguided in the diencephalic alar plate (arrow). F, A mediolateral section of Pax6sey/Pax6sey embryos
indicating neurons of the SN and their projections. Arrow indicates some TH-IR neurons of the SN that are not misguided. G, A medial section shows
TH-IR fibers looping in the roof of the diencephalon (arrow). H, I, J, Higher magnifications of E, G, andF, respectively. H, Reconstruction of TH-IR fiber
pathway. K. The coronal section shows the main projecting areas of TH-IR fibers, the striatum (ST), the nucleus accumbens (ACB), and the olfactory
tubercle (OT). L, TH-IR fibers terminated normally in the striatum and the nucleus accumbens of Pax6sey/Pax6seyembryo. The black star indicates a lack
of terminals in the olfactory tubercle. Scale bar: A, E-G, K, J, 4 mm; B, 2 mm; C, H-J, 1 mm; D, 0.5 mm.
specification of external tufted cells in the olfactory bulb. Prolifer¬
ation defects may account for the low number of external tufted
cells. Alternatively, because mice lacking Pax6 fail to develop a
nasal olfactory epithelium, this dramatic reduction could be attrib¬
utable to the lack of induction by primary olfactory afferents
(McLean and Shipley, 1988; Baker and Farbman, 1993; Cigola et
al., 1998).
In contrast to external tufted cells, periglomerular cells are born
from E18 and arise along the anterior subventricular zone (Hinds,
1968a,b; Betarbet et al., 1996). In mice lacking Pax6, no TH-IR
periglomerular interneurons are observed in late embryos or neo¬
natal pups. Interestingly, Pax6sey/+ heterozygote mice display a
dramatic and specific decrease of TH-IR periglomerular interneu¬
rons, whereas external tufted cells are preserved. This reduction
has been correlated to a progressive diminution in primary affer¬
ents (Dellovade et al., 1998).
Pax6 is strongly and transiently expressed in all TH-IR neurons
of the piriform cortex, olfactory tubercle, and anterior amygdala.
Recently, it has been suggested that cells populating these struc¬
tures may be derived in part from a transient structure, the inter¬
mediate telencephalic territory (ITA), located at the transition
zone between the neocortex and the lateral ganglionic eminence.
Pax6 is expressed (from E12.5 to El4.5) in both proliferating cells
and cells located near or in migrating neurons of the lateral cortical
migratory stream derived from ITA (our unpublished results).
When cells reach their targets, most of them express Pax6 during
the formation of the different structures of the basal telencephalon.
In mice lacking Pax6, ITA is dramatically altered: radial glial
fascicles do not form at the cortical-ganglionic eminence transition
zone and the expression of R-cadherin and the extracellular matrix
molecule tenascin-C is lost (Stoykova et al., 1997). Interestingly,
cellular migration in the lateral cortical migratory stream occurs in
Pax6sey/Pax6sey embryos, although cells fail to stop in their final
locations in the basal telencephalon and continue to migrate to the
pial surface of the brain (Brunjes et al., 1998). We observe that the
transient TH-IR neurons of the piriform cortex, the anterior amyg¬
dala, and the olfactory tubercle are decreased in number and fail to
maintain TH expression in Pax6sey/Pax6sey embryos. We suggest
that the absence of TH immunoreactivity in these cells may be
because of the failure of TH induction or maintenance of TH
expression in these migrating neurons that do not recognize a "stop
signal " in the basal telencephalon.
Defects in catecholaminergic populations not
expressing Pax6
Although TH-IR neurons of the SN-VTA complex never display
Pax6 immunoreactivity, we show in mice lacking Pax6 an abnormal
location of TH-IR neurons and an altered pathway of cat¬
echolaminergic fibers along the pretectal-dorsal thalamic transi¬
tion zone and in the alar plate of the dorsal thalamus. The abnor¬
mal location of TH-IR neurons might be caused by either an
ectopic genesis induced by altered expression of morphogenetic
molecules or an altered migratory behavior induced by changes in
the navigational environment.
Ectopic genesis of TH-IR neurons
Pax6sey/Pax6sey mice display an early abnormal ventral to dorsal
expansion of the signaling secreted morphogen SHH and the
SHH-induced gene, the winged helix transcription factor hepato-
cyte nuclear factor 3/3 (HNF-3j3) at the level of the pretectal-
dorsal thalamic transition zone and in the alar plate of the dorsal
thalamus (Grindley et al., 1997) (our unpublished observation).
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Figure 11. Alterations of specific fiber pathways
in Pax6sey/Pax6seyembryos. Sagittal sections are
shown for E12.5 wild-type (A, B) and Pax6sey/
Pax6scy (C, D) embryos. Nissl-stained sections
(A, C) are shown in parallel with sections immu-
noreacted for NCAM (B, D). A, C, The sagittal
section shows constrictions and regions of low
cell densities associated with prosomeric bound¬
aries. A, C, Arrows indicate, from caudal to ros¬
tral, the mes-pl boundary and the pl-p2 bound¬
ary. B, NCAM immunoreactivity reveals
ascending and descending fibers of the posterior
commissure (pc), the fasciculus retroflexus (ft),
the stria medullaris (sm), and thalamic axons. A
cellular labeling also reveals the zona limitans
intrathalamica (zli). D, A remaining pc is distin¬
guishable in pi but most of the fiber tracts are
misguided in the diencephalon (white arrow¬
head). E, F, Sagittal sections immunoreacted for
LI are shown for E18.5 (E), wild-type, and (F)
Pax6sey/Pax6sey embryos. E, The sagittal section
shows the posterior commissure (pc) in the cau¬
dal part of the pretectum and the fasciculus ret¬
roflexus (fr) at the pretectal-dorsal thalamic
transition zone. F, The sagittal section shows
aberrant fiber pathways in the pretectal and dor¬
sal thalamic alar plate (between the arrows).
Note that fibers traveling in the lower part of the
basal plate and in the floor plate maintain a nor¬
mal trajectory. Scale bar: A-D, 4 mm; E, F, 8 mm.
There is evidence that HNF-3/3, SHH, and FGF8 create induction
sites for TF1-IR neurons along the dorsoventral axis (Sasaki and
Hogan, 1994; Hynes et al., 1995; Wang et al., 1995; Ye et al., 1998).
It is possible that the early ectopic SHH and HNF-3/3 expression
domains in Pax6sey/Pax6sey mice induce ectopic catecholaminergic
neurons.
Changes in navigational environment
Clearly a complex set of attractive and repulsive guidance mole¬
cules is provided in the environment. Ectopic expression of SHH
or FGF8 could induce an ectopic expression of guidance cues,
leading to the misrouting of growth cones or defects in cellular
+/+ C -/-
Y IFigure 12. Alteration of Netrin-1 expression
in the diencephalon of Pax6sey/Pax6sey em¬
bryos. Coronal (A, C) and sagittal (B, D)
sections of E14.5 (B, D) and E16.5 (^4, C) \/T A \/TA
wild-type (A, B) and Pax6sey/Pax6scy (C, D) V I A—p. V I A
embryos. A, In the mesencephalon, Netrin-1
is expressed at the level of the SN-VTA „ .. \ „
complex. B, The sagittal section shows rs \ P I • I ) mp„ „ t
Netrin-1 expression in the floor of the fourth \ fflCS \ InCS-pi
ventricle and in the basal plate ofpl,p2, and j-.P \ V \
p3. Note also a weak expression along the F \ \ \
zona limitans intrathalamica (Zli). C, The . \ -—^ \
coronal section shows a normal Netrin-1 zn x • ' mm \
expression at the level of the SN-VTA ^5
complex. D, In the diencephalon, Netrin-1 - WJiMI
expression is increased and expanded dor-
sally. Arrows indicate the dorsal expansion p3
in the ventral and dorsal thalamic alar i
plates, mes, Mesencephalon. Scale bar: A, ** P3
C, 4 mm; B, D, 2 mm.
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migration. For instance, it has been shown recently that ectopic
expression of Hedgehog molecules induces ectopic Netrin-1 ex¬
pression in the CNS of zebrafish embryos (Lauderdale et al., 1998).
In mice lacking Pax6, the early ventral to dorsal expansion of SHH
(Grindley et al., 1997) coincides with the ventral to dorsal expan¬
sion of Netrin-1. Netrin-1 is a laminin-related secreted protein with
critical roles in axon guidance (Leonardo et al., 1997) and cell
migration (Przyborski et al., 1998; Bloch-Gallego et al., 1999) that
induces either attractive or repulsive responses, depending on the
netrin receptor expressed. Normally, TH-IR neurons of the SN-
VTA complex migrate in two phases: first, radially along tenascin-
bearing glial processes, and second, tangentially, giving the SN its
characteristic inverted fountain shape (Hanaway et al., 1971;
Kawano et al., 1995). In Pax6sey/Pax6sey embryos, the radial mi¬
gration of SN-VTA neurons occurs normally (our unpublished
results). Later, the rostral pretectal SN-VTA neurons are disori¬
entated at the pretectal-dorsal thalamic transition zone near the
expansion of Netrin-1 expression, and ectopic TH-IR neurons in
the dorsal thalamus are disorientated and appear to be migrating
away from the expanded Netrin-1 expression.
Nearly all SN-VTA projections are also misrouted at the pre-
tectal-dorsal thalamic transition zone. Instead of following the
medial forebrain bundle ventrally, SN-VTA projections are de¬
flected rostrodorsally away from the expanded Netrin-1 expression.
Taken together, we speculate that Netrin-1 has a chemorepellant
activity on both the tangential migration and the pathfinding of
SN-VTA neurons.
In conclusion, our study indicates that Pax6 is directly or indi¬
rectly involved in the adhesion and migration of discrete cat¬
echolaminergic populations and the maintenance of their pheno-
type. Second, Pax6 has a primordial role in determining the correct
navigational environment for early diencephalic axonal pathfinding.
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